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ABSTRACT 
The first half of the present dissertation describes the mechanistic investigation of the 
palladium-catalyzed cross-coupling reaction of alkenyl- and arylsilanolates. The combination of 
reaction kinetics (both stoichiometric and catalytic), solution and solid state characterization of 
arylpalladium(II) organosilanolate complexes, and computational analysis, enabled the 
formulation of a detailed mechanistic picture for the cross-coupling of these classes of 
nucleophiles. The intermediacy of covalent adducts containing Si-O-Pd linkages in the cross-
coupling reactions of organosilanolates has been unambiguously established. From such 
intermediates, two mechanistically distinct transmetalation pathways have been demonstrated: 
(1) transmetalation via a neutral 8-Si-4 intermediate (thermal transmetalation); (2) 
transmetalation via an anionic 10-Si-5 intermediate (activated transmetalation). In general, 
potassium salts of alkenylsilanolates react via neutral intermediates (8-Si-4), whereas the 
enhanced nucleophilicity of cesium alkenylsilanolates allows for the reaction to access the       
10-Si-5 intermediate and proceed via the anionically-activated pathway. However, if the direct 
transmetalation is slower, as in the case of arylsilanolates (which require interruption of 
aromaticity), then anionic activation via the 10-Si-5 intermediate is predominant, regardless of 
the cation employed. These conclusions mandate a revision of the paradigm that organosilicon 
compounds must be anionically activated to engage in transmetalation processes (Hiyama-
Hatanaka paradigm). Through the agency of the critical Si-O-Pd linkage, direct transmetalation 
of silicon to palladium can be achieved under mild conditions without anionic activation. The 
thorough mechanistic understanding of the transmetalation step for organosilanolates was 
leveraged in the study of the cross-coupling of γ-disubstituted allenylsilanolates. For the cross-
coupling reaction of this class of nucleophiles, it was concluded that the transmetalation pathway 
(activated vs. thermal) dictates which isomer is accessed (α vs. γ). 
The second half of this dissertation details the efforts made toward the application of the 
Water-Gas Shift Reaction (WGSR) in the catalysis of fundamental C-C bond forming reactions. 
To this end, three strategies were envisioned and investigated. In a first approach, the CO/H2O 
couple was exploited as the terminal reducing agent for a metal catalyst that is directly involved 
in the formation of a new C-C bond. This strategy was studied in the context of carbonyl addition 
and reductive homocoupling reactions. The multiple conditions that must be strictly met for this 
approach to be successful (ranging from electrochemical requirements to properly balanced bond 
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enthalpies of the complexes along the catalytic pathway) made the development of new, WGSR-
based catalytic methods quite challenging. In a second approach, the CO/H2O couple provides 
reducing equivalents for an organocatalyst that is implicated in the C-C bond formation. This 
second strategy poses fewer challenges because it consists of two independent catalytic 
processes: a metal-catalyzed one for the WGSR, and an organo-catalyzed one for the formation 
of the C-C bond. This strategy was used in the development of a catalytic, Wittig-type 
olefination reaction. It was demonstrated that the use of tributylstibine enabled catalytic turnover 
under WGSR conditions. A third, simpler approach to engage the WGSR in C-C bond formation 
relies on the well-established capacity of CO/H2O to act as a H2 surrogate. In this approach, an 
independent C-C bond forming event leads to a functional group that can be reduced 
(hydrogenated) by CO/H2O. The metal catalyst for the WGSR is not involved in the formation of 
the C-C bond, but only in the generation of a metal-hydride species that will hydrogenate the 
substrate. The outcome is an overall reductive, tandem transformation that combines two steps in 
one, therefore enhancing step- and redox economy. This strategy has been successfully 
illustrated in the tandem Knoevenagel condensation/reduction reaction, in which an alkene 
formed by Knoevenagel condensation is readily reduced under WGSR conditions. The 
compatibility with several classes of electrophiles and nucleophiles under mild conditions has 
been demonstrated, resulting in a method that is comparable and, for certain aspects, even 
superior to established alkylation or reductive alkylation protocols. 
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Chapter 1:  
Mechanistic investigation of the palladium-catalyzed cross-coupling 
reaction of alkenyl- and arylsilanolates
*
 
 
1.1. INTRODUCTION 
Transition-metal catalyzed cross-coupling reactions have revolutionized organic synthesis 
and have emerged as one of the most powerful and general methods for the formation of carbon-
carbon and carbon-heteroatom bonds.
1
 The new opportunities offered by cross-coupling 
reactions to form bonds within highly functionalized and sensitive substrates constituted a 
substantial breakthrough in the total synthesis of natural products, as well as in medicinal and 
process chemistry.
2
 The extraordinary impact of cross-coupling on organic synthesis has also 
been highlighted by the award of the 2010 Nobel Prize in Chemistry to Heck, Negishi and 
Suzuki.
3
 Although palladium-catalyzed cross-coupling reactions of organoboron, -zinc and -tin 
reagents remain the most popular methods, organosilane-based cross-coupling has recently 
received significant consideration. Within this context, our group has demonstrated that 
organosilanols and silanolates are effective nucleophiles in palladium-catalyzed cross-coupling 
reactions, as well as a valuable, mild and versatile alternative to conventional organoboron, -zinc 
and -tin reagents.
4
   
A generally accepted catalytic cycle unifies all of the various Pd-catalyzed organometal 
cross-coupling reactions (Scheme 1.1). The cycle involves: (1) oxidative addition of Pd(0) into 
the carbon-heteroatom bond of the halide (or pseudohalide) ii; (2) transmetalation with an 
organometallic reagent iv to provide a Pd(II) intermediate vi bearing two organic moieties (either 
through coordination to palladium or direct attack of the nucleophile on the metal center); and 
(3) reductive elimination, resulting in the formation of the new C-C bond in vii and regeneration 
                                                          
*
  The contents of Chapter 1 were partially reproduced (adapted) from (a) Tymonko, S. A.; Smith, R. C.; Ambrosi, 
A.; Denmark, S. E. J. Am. Chem. Soc. 2015, 137, 6192-6199; (b) Tymonko, S. A.; Smith, R. C.; Ambrosi, A.; 
Ober, M. H.; Wang, H.; Denmark, S. E. J. Am. Chem. Soc. 2015, 137, 6200-6218. This is an unofficial 
adaptation of an article that appeared in an ACS publication. ACS has not endorsed the content of this 
adaptation or the context of its use. 
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of the Pd(0) catalyst i. Despite being a Pd(0)/Pd(II) catalytic cycle, many of the precatalysts used 
in cross-coupling reactions are Pd(II) precursors which must be reduced to enter the catalytic 
cycle. 
 
Scheme 1.1. Consensus catalytic cycle for Pd-catalyzed cross-coupling reactions.  
Extensive mechanistic studies have played a significant role in formulating the current 
understanding of the mechanistic detail for cross-coupling reactions. For two of the elementary 
steps, oxidative addition and reductive elimination, investigations involving kinetic, 
spectroscopic, crystallographic and computational analysis have revealed a clear, consistent 
picture of the structure of the intermediates and the structural attributes of substrate and reagents 
that influence the rate of these steps.
5
 
Whereas the oxidative addition and reductive elimination steps unify all cross-coupling 
reactions, the transmetalation step is dependent upon the organometal employed and thus 
differentiates the various cross-coupling processes. With the exception of the Suzuki and Stille 
couplings, fewer decisive mechanistic studies are extant for this critical step in the catalytic 
cycle.
5,6
 The scarcity of mechanistic details for the transmetalation step is due to its location in 
the middle of the catalytic cycle, which makes it difficult to study in isolation, and the fact that 
pre-transmetalation intermediates are highly reactive. 
The understanding of the transmetalation step for the cross-coupling of organosilanes has 
historically been guided by the dogma that an anionically-activated, hypercoordinate silicon 
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species such as viii (Scheme 1.2a) is needed for transmetalation (Hiyama-Hatanaka paradigm).
7
 
However, as part of our ongoing preparative and mechanistic studies on the cross-coupling of 
silanolate salts xi (Scheme 1.2b), our group obtained compelling kinetic evidence for the 
intermediacy of a neutral, pre-transmetalation intermediate xii (8-Si-4).
8,9
 Transmetalation from 
intermediate xii (thermal transmetalation) was extremely rapid and did not require additional 
activation via a 10-Si-5, pentacoordinate siliconate species such as xiii (activated 
transmetalation). 
 
Scheme 1.2. Modes of transmetalation in the cross-coupling of organosilanes.  
Thus, the reigning Hiyama-Hatanaka paradigm that mandated anionic activation for 
transmetalation was challenged. This critical conclusion, based solely on kinetic analysis, 
demanded additional validation, ideally through isolation of the putative pre-transmetalation 
intermediates xii, followed by a full structural and kinetic characterization. In addition, a 
thorough understanding of the controlling elements that influence the rate and pathway of 
transmetalation (thermal vs. activated) was needed. 
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1.2. BACKGROUND 
1.2.1. Transmetalation from organotin reagents 
The mechanism of the transmetalation step in the Stille coupling has been studied in great 
detail. Multiple mechanistic proposals have been formulated, although no consensus on a 
specific mechanism has been reached. The lack of consensus arises because each variable in the 
reaction (electrophile, nucleophile, ligands, solvent, additives) is capable of producing dramatic 
changes in the process.
10
 
The main mechanistic proposals for the Stille coupling are the associative (or cyclic) 
mechanism, and the dissociative (or open) mechanism (Scheme 1.3). The associative mechanism 
proceeds through a cyclic organopalladium intermediate xiv. Transmetalation leads to the cis 
diorganopalladium complex xv. Alternatively, transmetalation from Sn to Pd may be preceded 
by ligand dissociation. In this proposal, coordinatively unsaturated Pd complex xvi reacts 
directly with the stannane in a SE2 reaction to provide xv. 
 
Scheme 1.3. Mechanistic proposals for the transmetalation of organotin reagents.  
The implication of the associative mechanism is supported by kinetic analysis,
11
 and by the 
observation of retention of configuration of chiral stannanes subjected to the cross-coupling 
reaction.
12
 On the other hand, the dissociative mechanism is thought to be operative with 
organotriflates, which can form cationic palladium intermediates after oxidative addition.
13
 
Experimental evidence that supports the dissociative mechanism includes measurement of half-
order kinetics with pre-formed, dimeric oxidative addition complexes,
14
 and inversion of 
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configuration with certain chiral stannanes.
15
 Computational analysis has clarified that both 
mechanisms are energetically accessible. The associative mechanism proceeds via a lower 
energy pathway when organohalides are used. On the contrary, the dissociative mechanism is 
preferred with triflates and polar solvents.
16
 
1.2.2. Transmetalation from organoboron reagents 
The mechanism of the transmetalation step in the Suzuki-Miyaura coupling has been the 
subject of debate for decades.
17
 Two limiting mechanisms have been considered, which differ for 
the role of the hydroxide ion but eventually converge to a common intermediate (Scheme 1.4). In 
pathway A, the base binds to the boronic acid to form a boronate xviii. Combination of xviii with 
ix generates an intermediate xix containing a Pd-O-B linkage. Transmetalation occurs from xix 
by extrusion of boric acid. In the alternative pathway B, the role of the base is to displace the 
halide on the Pd center. The combination of palladium hydroxide complex xx with a neutral 
boronic acid xvii yields the same intermediate xix. 
 
Scheme 1.4. Mechanistic proposals for the transmetalation of organoboron reagents.  
Evidence exists in support of both mechanistic proposals. Pathway A is supported by the fact 
that pre-formed boronates undergo smooth cross-coupling with aryl halides.
18
 In addition, 
computational studies predicted a faster turnover for pathway A, due to the difficulty in 
accessing Pd-hydroxide complex xx.
19
 However, kinetic analysis demonstrated that pathway B is 
favored by several orders of magnitude under catalytic conditions.
20
 The coexistence of both 
pathways was proposed for cyclic alkyl boranes, depending on their Lewis acidity.
21
 The key 
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pre-transmetalation intermediate xix, which has remained elusive for years, has been recently 
detected and characterized in our group, thus providing independent validation for both 
pathways.
22
 
1.2.3. Transmetalation from organosilicon reagents 
1.2.3.1. Fluoride activation 
The capacity of organosilicon reagents to engage in cross-coupling reactions was first 
demonstrated by Kumada et al. in 1982.
23
 In this seminal report, pentafluorosilicates were 
combined with organic halides to access cross-coupled products in moderate yield (Scheme 
1.5a). The harsh conditions and the necessity for a hexacoordinate silicate are indicative of the 
reduced capability of organosilanes to transfer an organic group compared to other organometals. 
This has been attributed to the lower polarization of the C‒Si bonds, which require activation as 
penta- or hexacoordinate species (siliconates) in order to effectively transfer an organic group.
7
 
 
A major advance was achieved in 1988 by Hiyama and Hatanaka, who demonstrated that 
trimethylsilanes undergo cross-coupling by activation through an external fluoride source 
(Scheme 1.5b).
24
 The requisite pentacoordinate siliconate 1.1 is obtained by the facile 
coordination of fluoride to silicon. As a result of this activation, the C‒Si bonds are polarized and 
the transfer of an organic group is thus facilitated.  
 
Scheme 1.5. Fluoride activation. 
The implication of species such as 1.1 has been proposed but never corroborated by direct 
evidence.
7,25
 On the contrary, recent computational
26
 and kinetic
27
 studies have suggested that 
discrete, hypercoordinate fluorosilicates are not involved in the transmetalation event. Rather, the 
accelerating effect of fluoride may be the result of the formation of an organopalladium(II) 
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fluoride complex xxi, which reacts with the silane in a turnover-limiting transmetalation 
(Scheme 1.16). 
 
Scheme 1.6. Alternative proposal for fluoride activation. 
Previous investigations in these laboratories have identified the detailed mechanism by which 
alkenylsilanols undergo fluoride-promoted cross-coupling reactions (Scheme 1.7).
28
 A 
bimolecular transmetalation of a fluoride-activated disiloxane 1.2 with an arylpalladium(II) 
halide has been identified by both kinetic and spectroscopic methods. The transmetalation step is 
turnover-limiting given the second order dependence on silanol, first order dependence on 
arylpalladium halide and the inability to saturate the silane cross-coupling partner as the 
activated disiloxane. 
 
Scheme 1.7. Fluoride activation in the cross-coupling of alkenylsilanols. 
1.2.3.2. Brønsted base activation 
The breakthrough in the development of silicon-based cross-coupling is represented by the 
discovery that organosilanols can serve as competent nucleophiles without the need for fluoride 
activation.
4
 Due to their Brønsted acidity, organosilanols are capable of cross-coupling in the 
presence of Brønsted base promoters, which generate the corresponding silanolate salts either in 
situ (Scheme 1.8a),
29
 or by independent preparation (Scheme 1.8b).
30
 
 
Scheme 1.8. Brønsted base activation. 
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Early hypotheses on the mechanism of the cross-coupling of alkenylsilanols under activation 
by Brønsted bases proposed that a silanolate xi serves a similar role as fluoride by anionically 
activating silicon towards transmetalation (xiii, Scheme 1.2). However, the hypothesis of a 
direct, thermal transmetalation from xii could not be discounted. To distinguish between these 
two possibilities, kinetic analysis was performed on the cross-coupling of potassium alkenyl 
silanolate K
+
(1.3)
−
 with 2-iodothiophene, with catalytic and stoichiometric amounts of palladium 
(Scheme 1.9).
8a
  
 
Scheme 1.9. Initial kinetic studies for the cross coupling of alkenylsilanolates. 
Under catalytic conditions, the reaction exhibited first-order behavior in K
+
(1.3)
− 
at low 
concentrations (K
+
(1.3)
−
/Pd < 20:1), indicating a turnover-limiting formation of 1.4 or 1.5, or a 
turnover-limiting transmetalation from 1.4 or 1.5. At higher concentrations of K
+
(1.3)
−
 
(K
+
(1.3)
−
/Pd > 20:1), a zeroth-order dependence on K
+
(1.3)
− 
was observed, consistent with a 
turnover-limiting transmetalation from 1.4 or 1.5 (with saturated pre-equilibrium). The analysis 
with a stoichiometric amount of Pd revealed a first-order behavior in K
+
(1.3)
−
. This result rules 
out the intermediacy of 1.5, because a second-order dependence would have been otherwise 
observed. Therefore, compelling evidence for a direct, thermal transmetalation from a putative 8-
Si-4 intermediate 1.4 was obtained. 
1.2.3.2.1. Synthesis and reactivity of palladium(II) silanolate complexes
31
 
The kinetic studies on the cross-coupling of K
+
(1.3)
− 
suggested but did not unambiguously 
prove the existence of an intermediate 1.4, featuring a silicon-oxygen-palladium linkage. 
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Therefore, the existence and kinetic competence of intermediates such as 1.4 had to be 
demonstrated through their direct synthesis. 
The use of strongly coordinating monodentate and bidentate phosphine ligands allowed for 
the synthesis, isolation and characterization of a number of alkenyl- (1.6, 1.7) and arylpalladium 
silanolate complexes (1.8-1.13, Figure 1.1). Structural determination by X-ray crystallography 
clearly established the presence of the critical Si-O-Pd linkage. 
 
Figure 1.1. Pre-formed organopalladium(II) silanolate complexes. 
Heating the alkenylsilanolate Pd complex 1.6 at T > 100 °C led to the formation of the 
expected cross-coupling product 1.14 in nearly quantitative yield (Scheme 1.10). The addition of 
a catalytic amount of copper thiophene-2-carboxylate (CuTC) to the reaction mixture allowed for 
the crossc-oupling reaction to proceed at room temperature, even in the case of 1.7. Presumably, 
addition of CuTC aids in the decomplexation of the phosphine ligand from 1.6 and 1.7, thus 
10 
 
facilitating the transmetalation step.
32,33
 
 
Scheme 1.10. Thermal reaction of alkenylsilanolate complexes. 
In a similar fashion, heating arylsilanolate Pd complexes 1.8-1.12 triggered the formation of 
the cross-coupling product 1.15 (Table 1.1). The measured rates of product formation were 
strongly dependent on the phosphine used, reflecting the ease of ligand dissociation from 
palladium. Again, the addition of CuTC caused a significant rate acceleration, except for dppbz 
complex 1.12, which remained unreactive. 
Table 1.1. Thermal reaction of arylsilanolate complexes. 
 
Complex 
Rate  
(10
-2
 mM/s) 
Rate with CuTC  
(10
-2
 mM/s) 
Increase 
1.11 1.77 4.76 2.7 
1.8 0.671 0.815 1.2 
1.9 0.139 1.84 13.3 
1.10 0.0941 9.21 97.9 
1.12 0 0 -- 
 
The T-shaped, tricoordinate Pd complex 1.13 generated the expected cross-coupling product 
1.16 at a much lower temperature (50 °C) compared to complexes 1.8-1.12 (Scheme 1.11). In 
this case, the availability of an open coordination site on palladium greatly facilitated the 
reaction and removed the need for ligand dissociation. Indeed, the rate did not vary when excess 
t-Bu3P was added to the reaction mixture (see Section 1.4.2.2). 
11 
 
 
Scheme 1.11. Thermal reaction of tricoordinate arylsilanolate complex 1.13. 
The formation of cross-coupling products 1.14-1.16 upon heating palladium(II) silanolate 
complexes 1.6-1.13 clearly demonstrated the ability of silanolate complexes to undergo 
transmetalation without the need for external activation. Thus, the existence of the unactivated, 
thermal transmetalation pathway through an 8-Si-4 complex xii could be unambiguously 
confirmed. However, these results were obtained from pre-formed Pd-silanolate complexes 
featuring a 1:1 silanolate to Pd ratio. These conditions are not representative of the catalytic 
cross-coupling reactions, which employ a large excess of silanolate relative to palladium. 
Although the thermal transmetalation pathway was shown to be viable, its operation in the 
catalytic reaction could not be assessed from these data alone. 
1.2.3.2.2. Kinetic analysis of the catalytic cross-coupling reactions
31
 
Kinetic studies of catalytic cross-coupling reactions were undertaken to gain insights into the 
preferred mode of transmetalation under catalytic conditions. Initially, ligandless conditions 
were used in the determination of the rate equations. Previous studies had established that the use 
of allylpalladium chloride dimer (APC) affords ligandless palladium(0) because the reduction is 
effected by silanolate displacement of the allyl ligand to produce an allyl silyl ether and 
potassium chloride.
34
 Moreover, it was discovered that phosphine oxides serve very effectively 
as weakly coordinating, stabilizing ligands for the palladium nanoparticles formed and increase 
the turnover number by preventing precipitation of palladium black.
35
  
The partial order in each component in the reaction of potassium (E)-2-
styryldimethylsilanolate (K
+
(1.17)
–
) with 2-iodotoluene (1.18) catalyzed by APC in the presence 
of  dppp(O)2 was determined individually at 40 ˚C in benzotrifluoride (Eq. 1.1).  
    (1.1) 
The kinetic data established the overall rate equation as: 
 rate = kobs[K
+
(1.17)
–
]
0
[1.18]
0
[dppp(O)2]
0
  with kobs = k[Pd]  (1.2) 
12 
 
This rate equation matches that of the alkenylsilanolates reported previously,
8a
 in which 
turnover-limiting, direct transmetalation from a neutral palladium(II) silanolate intermediate (xii 
to x) takes place without anionic activation via xiii (Scheme 1.2). However, this rate equation is 
also consistent with an activated mechanism where xii is completely saturated as xiii. Indeed, 
turnover-limiting, activated transmetalation from xiii will also result in a zeroth-order 
dependence on K
+
(1.17)
–
.
36
 The kinetic analysis of the catalytic reaction with K
+
(1.17)
–
 alone 
cannot unambiguously distinguish between the two possible mechanisms. 
Similarly, the initial rate kinetic analysis of the coupling of cesium 4-
methoxyphenyldimethylsilanolate (Cs
+
(1.19)
–
) with 2-bromotoluene (1.20) using APC and 
dppp(O)2 was carried out (Eq. 1.3), establishing the overall rate equation as shown in Eq. 1.4. 
  (1.3) 
 rate = kobs[Cs
+
(1.19)
–
]
0
[1.20]
0
[dppp(O)2]
0 
with kobs = k[Pd] (1.4) 
Kinetic investigation of the cross-coupling reaction between K
+
(1.19)
–
 and 1-bromo-4-
fluorobenzene (1.21), catalyzed by (t-Bu3P)2Pd (1.22). provided rate equation (1.6), which again 
displayed zeroth-order behavior in silanolate. 
  (1.5) 
 rate = kobs[K
+
(1.19)
–
]
0
[1.21]
0 
with kobs = k[1.22] (1.6) 
As in the case of alkenylsilanolates, rate equations (1.4)  and (1.6) are consistent with either 
turnover-limiting, direct transmetalation from an arylpalladium(II) arylsilanolate intermediate 
(xii to x, Scheme 1.2) or turnover-limiting, activated transmetalation from the saturated complex 
(xiii to x). Thus, the identification of the transmetalation regime under catalytic conditions was 
precluded. 
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1.3. RESEARCH OBJECTIVES 
The ability to independently prepare competent intermediates along the catalytic cycle for the 
cross-coupling reaction of organosilanolates created a unique opportunity to systematically study 
the features of the transmetalation step in detail. The thermal reactivity of complexes 1.6-1.13 
provided compelling evidence for the existence of an unactivated transmetalation pathway, thus 
refuting the Hiyama-Hatanaka paradigm. However, the identification of the predominant 
transmetalation mode under catalytic conditions (where the silanolate/palladium ratio is high) 
was precluded by the ambiguity of the kinetic data. 
The following studies were designed to provide a clear mechanistic picture for the cross-
coupling of organosilanolates under catalytic conditions. A refined mechanistic understanding 
could be obtained from the combination of data from several experiments: 
1. Kinetic analysis of the cross-coupling reaction, both under catalytic conditions and with pre-
formed reactive intermediates; 
2. Comparison of kinetic data from different classes of organosilanolates (alkenyl and aryl), and 
different metal counterions (potassium and cesium); 
3. Validation of the results by means of computational analysis. 
1.4. RESULTS 
1.4.1. Alkenylsilanolates 
The kinetic study of the catalytic cross-coupling reaction of styrylsilanolate K
+
(1.17)
–
 with 
1.18 (Eq. 1.1) resulted in zeroth-order dependence in K
+
(1.17)
–
 (Eq. 1.2). These data did not 
allow for discerning between thermal or activated transmetalation regimes. 
Support for the assertion that K
+
(1.17)
–
 was reacting via a direct, thermal transmetalation of 
an 8-Si-4 species was obtained from the kinetic analysis of the reaction of the cesium salt (Table 
1.2 and Figure 1.2). Reaction of Cs
+
(1.17)
–
 with 1.18 (with APC and dppp(O)2 in 
benzotrifluoride at 40 ˚C) changed the rate equation such that a fractional order in Cs+8– was 
observed (Eq. 1.7), as determined by a log(rate)/log[Cs
+
(1.17)
–
] plot (Figure 1.3).  
 rate = kobs[Cs
+
(1.17)
–
]
0.55
[1.18]
0
[dppp(O)2]
0
  with kobs = k[Pd]  (1.7) 
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Table 1.2. Kinetic studies using Cs
+
(1.17)
–
.
 
 
Entry 
Cs
+
(1.17)
–
 
(mM) 
1.18 
(mM) 
dppp(O)2 
(mM) 
Pd 
(mM) 
Rate
 a
 
(10
-2
 mM/s) 
1
 
60 80 3.6 3.6 4.28 
2
 
80 80 3.6 3.6 5.23 
3
 
120 80 3.6 3.6 6.37 
4 160 80 3.6 3.6 7.96 
5
 
240 80 3.6 3.6 9.05 
6
 
320 80 3.6
 
3.6 11.1 
7
 
400 80 3.6 3.6 11.2 
a. Average of triplicate runs. 
 
Figure 1.2. Summary of kinetic regimes for the transmetalation in the presence of Cs
+
(1.17)
–
. 
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Figure 1.3. Kinetic order determination for Cs
+
(1.17)
–
. 
Apparently, the more nucleophilic Cs
+
(1.17)
–
 is not operating the same kinetic regime as 
K
+
(1.17)
–
 and may open an activated pathway for transmetalation. The partial order indicates 
that two separate mechanistic pathways are operative involving equilibration of the intermediates 
xxii and xxiii (Figure 1.2). Moreover, as the loading of Cs
+
(1.17)
–
 increased, the rate leveled to a 
zeroth-order behavior for this component (Table 1.2, entries 6 and 7). This is consistent with a 
regime of complete saturation of xxii as xxiii, such that only an activated transmetalation 
pathway is operative. 
1.4.2. Arylsilanolates 
The rate law established in Eq. 1.4 was not sufficient to distinguish between thermal and 
activated transmetalation regimes for the cross-coupling of Cs
+
(1.19)
–
 under catalytic conditions. 
Attempts to differentiate these possibilities by studying the cross-coupling reaction rates of 
stoichiometric amounts of 1.20 and APC with varying amounts of Cs
+
(1.19)
–
 were thwarted by 
the requirement of a full equivalent of Cs
+
(1.19)
–
 to reduce APC to catalytically active Pd(0). 
Additional attempts using Pd(0) precatalysts led to slow oxidative addition and irreproducible 
kinetics. 
Despite the accumulation of compelling evidence that isolated arylpalladium(II) 
arylsilanolate complexes 1.8-1.13 can undergo transmetalation without anionic activation, an 
irrefutable demonstration that a pathway involving an 8-Si-4 species is operative under catalytic 
conditions was still elusive. Fortunately, a solution to this problem presented itself in the 
development of a preparatively useful cross-coupling of arylsilanolates with aryl halides using 
y = 0.55x - 2.34
R² = 0.99
-2.00
-1.50
-1.00
-0.50
0.00
1.00 1.50 2.00 2.50 3.00
log(rate)
log[Cs+(1.17)-]
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bis(tri-tert-butyl)phosphine palladium(0) (Eq. 1.5)
37
 and in the ability to synthesize and isolate 
the corresponding pre-transmetalation intermediate 1.13.
38
 
1.4.2.1. In situ formation of the pre-transmetalation complex 1.13 
The synthesis of the transmetalation precursor began with the preparation of the oxidative 
addition complex 1.23.
39
 The oxidative addition of aryl halides employing t-Bu3P has been 
studied extensively by Hartwig and co-workers.
40
 Three-coordinate arylpalladium(II) bromide 
1.23 can be prepared by treating (t-Bu3P)2Pd (1.22) with an excess of 1.21 at elevated 
temperatures in the presence of t-Bu3P•HBr, which has been demonstrated to catalyze the 
oxidative addition starting from 1.21.
40a
 Thus, combining 1.21 with 1.22 in 2-butanone at 70 °C 
in the presence of 3 mol % of t-Bu3P•HBr resulted in the formation of 1.23 in 82% yield 
(Scheme 1.12).  
 
Scheme 1.12. Synthesis of 1.23 and bromide displacement by silanolate salts. 
Previous studies had demonstrated that the displacement of bromide in 1.23 by arylsilanolate 
salts is fast and irreversible.
31b,38
 Accordingly, combining either K
+
(1.19)
– 
or Cs
+
(1.19)
–
 with 
1.23 in toluene at room temperature resulted in the quantitative formation of 1.13, as determined 
by the appearance of the diagnostic 
31
P and 
19
F NMR resonances (65.4 ppm and -119.8 ppm). 
The ability to synthesize and identify complex 1.13 finally enabled the establishment of the 
kinetic regime operative under catalytic conditions. 
1.4.2.2. Transmetalation of 1.13 in the presence of potassium silanolate K
+
(1.19)
–
  
With the desired arylpalladium(II) arylsilanolate complex 1.13 in hand, a systematic study of 
the transmetalation process was initiated. Treatment of 1.23 with one equivalent of K
+
(1.19)
–
 in 
toluene at room temperature generated complex 1.13 in situ. The transmetalation and subsequent 
reductive elimination to the biaryl product 1.16 did not initiate until the reaction mixture was 
heated to 50 °C. The formation of 1.16 was monitored by 
19
F NMR spectroscopy furnishing a 
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rate of 2.45·10
-3
 mM/sec (Table 1.3, entry 1).
41,42
 The stoichiometric transmetalation was also 
performed in the presence of t-Bu3P to establish if a partial order in ligand could be detected. 
Heating a solution of complex 1.13 in the presence of 2.0 and 5.0 equivalents of t-Bu3P led to a 
clean reaction with rate constants of 2.66·10
-3
 mM/s and 2.42·10
-3
 mM/s, respectively (entries 2 
and 3). Thus, the similar rates of thermal reaction at varying concentrations of free phosphine 
clearly indicate a 0
th
 order concentration dependence for the ligand. These data suggest that, 
unlike complexes 1.8-1.12, phosphine dissociation is not required for transmetalation, and that 
the arene simply transfers to the open coordination site on palladium directly. 
Table 1.3. Thermal transmetalation of 1.13.
 
 
Entry 
t-Bu3P 
(equiv) 
Rate
 a
 
(10
-3
 mM/s) 
1
 
0 2.45 
2
 
2 2.66 
3
 
5 2.42 
a. Average of triplicate runs. 
Since the rate of the purely thermal conversion of 1.13 to 1.16 was established above (Table 
1.3, entry 1), any increase in the rate with superstoichiometric amounts of K
+
(1.19)
–
 would 
reveal the operation of the activated pathway. Moreover, if the rate increased continuously, then 
a pre-equilibrium activation step would be established and if the rate leveled off, then a turnover-
limiting, activated transmetalation would be established due to saturation. Thus, the same 
experiment described in Table 1.3, entry 1 was repeated with substoichiometric amounts of 
K
+
(1.19)
–
 (relative to 1.23), as well as superstoichiometric amounts (Table 1.4).  
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Table 1.4. Determination of kinetic regimes for transmetalation of 1.13 in the presence of K
+
(1.19)
–
. 
 
Entry 
K
+
(1.19)
–   
(equiv) 
rate
a
   
(mM/s) 
1 0.5 7.72 · 10
-4
 
2 0.6 9.17 · 10
-4
 
3 0.75 1.48 · 10
-3
 
4 1.0 2.45 · 10
-3
 
5 1.5 1.72 · 10
-2
 
6 2.0 2.00 · 10
-2
 
7 3.0 2.56 · 10
-2
 
8 5.0 2.91 · 10
-2
 
9 7.5 3.02 · 10
-2
 
a. Average of triplicate runs. 
As the amount of K
+
(1.19)
–
 was increased from 0.5 to 1 equivalents, the rate of formation of 
1.16 increased, reflecting a higher concentration of 1.13 in solution (entries 1-3). Increasing the 
amount of K
+
(1.19)
–
 between 1.5 and 5 equivalents caused a dramatic increase in the rate of the 
reaction (entries 5-8): 2.00·10
-2
 mM/sec and 2.91·10
-2
 mM/sec when 2.0 and 5.0 equiv of 
K
+
(1.19)
–
, respectively, were used, corresponding to an 8-fold and a 12-fold increase compared 
to the rate measured with 1.0 equivalent (entry 4). Further increasing the amount of K
+
(1.19)
–
 
beyond 5.0 equiv did not change the rate of the reaction (entry 9). 
Overall, these data suggest the existence of three different kinetic regimes (Figure 1.4). With 
one equivalent of K
+
(1.19)
–
 and below, the rate is determined by an unactivated, thermal 
transmetalation process via the 8-Si-4 intermediate 1.13. Between 1.0 and 5.0 equivalents of 
K
+
(1.19)
–
, the sudden increase in rate suggests an activated pathway via the 10-Si-5 complex 
K
+
(1.24)
–
, where the excess silanolate engages in a pre-saturation equilibrium with 1.13. Beyond 
5 equivalents, the mechanism still follows an activated pathway, but with complete saturation of 
1.13 as K
+
(1.24)
–
, such that no further increase in rate is observed. Because the catalytic reaction 
is necessarily performed with a large excess of silanolate with respect to palladium, it follows 
that the catalytic reaction must fall into this activated, saturated regime. 
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Figure 1.4. Summary of kinetic regimes for the transmetalation of 1.13 in the presence of K
+
(1.19)
–
. 
1.4.2.3. Transmetalation of 1.13 in the presence of cesium silanolate Cs
+
(1.19)
–
  
Additional evidence for an activated transmetalation process was obtained by employing the 
more nucleophilic cesium silanolate Cs
+
(1.19)
–
. Importantly, the rate measured with one 
equivalent of Cs
+
(1.19)
–
 was similar to that previously determined for K
+
(1.19)
–
 (Table 1.5, 
entry 1). However, when 1.23 was treated with more than one equivalent of Cs
+
(1.19)
–
 at 50 °C, 
the formation of 1.16 was so fast that the rate could not be measured. The reaction was instead 
performed at 25 °C. The reaction rates measured with increasing amounts of Cs
+
(1.19)
– 
are 
summarized in Table 1.5 and Figure 1.5. As was already observed with K
+
(1.19)
–
, different 
kinetic regimes could be identified. Superstoichiometric amounts of Cs
+
(1.19)
–
 ranging from 1.5 
and 5.0 equivalents (entries 2-5) induced a much faster reaction than with 1.0 equiv. For 
instance, the rate measured at 25 °C with 2 and 5 equivalents of Cs
+
(1.19)
–
 were 1.01·10
-2
 
mM/sec and 1.98·10
-2
 mM/sec, respectively, with a 3.3-fold and a 6.5-fold increase compared to 
the rate measured with 1.0 equivalent at 50 °C. This regime corresponds to an activated pathway 
via the 10-Si-5 intermediate Cs
+
(1.24)
–
 engaging in a pre-saturation equilibrium. At loadings of 
Cs
+
(1.19)
–
 greater than 5.0 equivalents (entry 6), a saturation regime was reached and the rate 
remained constant. Although a direct comparison of the rates obtained for K
+
(1.19)
–
 at 50 °C and 
Cs
+
(1.19)
–
 at 25 °C would be meaningless, it is clear that the increased nucleophilicity of 
Activated 
transmetalation
Activated 
transmetalation
(saturated)
Thermal
transmetalation
0
0.03
0.06
0 1 2 3 4 5 6 7 8
rate              
(mM/s)
K+(1.19)‒
(equiv)
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Cs
+
(1.19)
–
 facilitates the formation of the 10-Si-5 intermediate and thus provides further 
evidence for an activated pathway. 
Table 1.5. Determination of kinetic regimes for transmetalation of 1.13 in the presence of Cs
+
(1.19)
–
. 
 
Entry 
Cs
+
(1.19)
–
  
(equiv) 
Rate
a
   
(mM/s) 
1
b
 1 3.06 · 10
-3
 
2 1.5 6.46 · 10
-3
 
3 2 1.01 · 10
-2
 
4 3 1.45 · 10
-2
 
5 5 1.98 · 10
-2
 
6 7.5 1.99 · 10
-2
 
a. Average of triplicate runs;  
b. Measured at 50 °C. 
 
Figure 1.5. Summary of kinetic regimes for the transmetalation of 1.13 in the presence of Cs
+
(1.19)
–
. 
1.4.2.4. Comparison of saturation points 
It was initially hypothesized that the increased Lewis basicity of Cs
+
(1.19)
–
 would increase 
the equilibrium concentration of the 10-Si-5 intermediate Cs
+
(1.24)
–
 and thus account for an 
Activated 
transmetalation
Activated 
transmetalation
(saturated)at 50 C
0
0.025
0.05
0 1 2 3 4 5 6 7 8
rate              
(mM/s)
Cs+(1.19)‒
(equiv)
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increased rate of transmetalation compared to K
+
(1.19)
–
. However, this hypothesis was not 
supported by the experimental data. If the Lewis basicity was a major factor, then saturation 
would take place at a lower silanolate loading when Cs
+
(1.19)
–
 is used. Moreover, once 
saturation is reached, the rate of the reaction should be the same, regardless of which counterion 
is involved, as the reaction would proceed through the same, fully saturated intermediate 
M
+
(1.24)
–
. However, the experimental reaction rates show that saturation is reached roughly at 
the same silanolate loading (5.0 equiv) for both K
+
 And Cs
+
. In addition, when the reaction was 
run with 7.5 equivalents of K
+
(1.19)
–
 at 25 °C, a rate of 2.71·10
-3
 mM/sec was measured, 7 times 
slower than with Cs
+
(1.19)
–
 under the same conditions (1.99·10
-2
 mM/sec). These observations 
rule out a substantial contribution of the Lewis basicity of the silanolate in determining the 
reaction rate. In other words, the position of the equilibrium between 1.13 and M
+
(1.24)
–
 relies 
on the intrinsic anionic character of M
+
(1.19)
–
, and is not dependent (or only moderately 
dependent) upon which cation is used. It seems, rather, that different cations affect the rate of the 
reaction as a consequence of their association in the anionic intermediate M
+
(1.24)
–
. Under this 
hypothesis, the reactive silanolate complex M
+
(1.24)
–
 would carry more negative charge when 
paired with the larger, less coordinating cesium cation, which would promote a faster 
transmetalation than when paired with the more strongly coordinating potassium cation.
43
  
1.5. DISCUSSION 
1.5.1. Alkenylsilanolates 
The rate equation found from kinetic experiments involving K
+
(1.17)
–
 and 1.18 employing 
APC and dppp(O)2 at 40 ˚C in trifluorotoluene (Eq. 1.2) was identical to that for the cross-
coupling of 1-heptenyl(dimethyl)silanolate, for which no rate effect is observed with increasing 
the concentration of silanolate.
8a
 On the other hand, the use of Cs
+
(1.17)
–
 (with 1.18) led to a 
fractional dependence (0.55) on the concentration of the silanolate (Eq. 1.7). Clearly, these two 
salts are operating for the most part in different kinetic regimes. 
The various steps of the catalytic cycle predict different concentration dependence on each 
component. The experimentally established rate laws can eliminate a number of possibilities for 
the turnover limiting steps (Scheme 1.13 and Table 1.6). Starting from the palladium(II) 
precatalyst [allylPdCl]2, reduction to the active Pd(0) catalyst involves the participation of the 
silanolate.
34
 Oxidative addition to Pd(0) occurs with the aryl halide producing a palladium(II) 
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halide intermediate xxiv (1
st
 order in [1.18], step A). Displacement of the palladium iodide 
proceeds by a nucleophilic attack by an equivalent of M
+
(1.17)
–
 and predicts a first-order 
dependence on M
+
(1.17)
–
 (step B). Next, if the transmetalation is proceeding via a direct, 
unactivated process, then a 0
th
 order behavior for M
+
(1.17)
–
 should arise (step C). Alternatively, 
either a 0
th
 or 1
st
 order behavior could result from an activated transmetalation step (step E). 
Finally, if reductive elimination from xxv is turnover limiting (step F), then 0
th
 order in both 
components, M
+
(1.17)
–
 and 1.18, will be observed.  
 
Scheme 1.13. Proposed cross-coupling pathways for alkenylsilanolates. 
Table 1.6. Expected kinetic consequences. 
Turnover-
limiting step 
Order for 
M
+
(1.17)
–
 
Order for  
1.18 
A 0
th
 1
st
 
B 1st 0
th
 
C 0
th
 0
th
 
D 1
st
 0
th
 
E 0
th
 or 1
st
 0
th
 
F 0
th
 0
th
 
 
Zeroth-order dependence on M
+
(1.17)
–
 and 1.18 is consistent with either step C, E, or F 
being turnover-limiting. However, step F has already been eliminated.
36
 The most reasonable 
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explanation is that the styrylsilanolate cross-coupling involves turnover-limiting transmetalation 
that proceeds via either neutral 8-Si-4 (xxii) or 10-Si-5 (xxiii) intermediates depending upon the 
nucleophilicity of the silanolate. Previous studies on alkenylsilanolate cross-coupling using 
Pd(dba)2 demonstrated 0
th
 order dependence for the silanolate once saturation of the intermediate 
1.4 is achieved (Scheme 1.9).
8a
 Thus, intermediate xxii undergoes turnover-limiting 
transmetalation without activation in the presence of the potassium salt K
+
(1.17)
–
, due to 
saturation of xxii and negligible equilibrium concentration of xxiii. However, the increased 
nucleophilicity of the cesium silanolate Cs
+
(1.17)
–
 opened the possibility for the activated 
transmetalation pathway via xxiii not seen previously. This intermediate reaches saturation at ca. 
90 equivalents of Cs
+
(1.17)
–
 per Pd. At the saturation limit, the rate of cross-coupling represents 
the intrinsic rate of activated transmetalation via xxiii. Before saturation is reached, the fractional 
order in Cs
+
(1.17)
–
 most likely represents simultaneous operation of both pathways (Figure 1.2). 
Thus, the kinetic analysis of the reaction involving the cesium salt enabled the identification 
of the preferred mode of transmetalation of alkenylsilanolates under catalytic conditions. For the 
less nucleophilic potassium salts, the equilibrium concentration of the activated species xxiii is 
low and transmetalation occurs thermally. For the more nucleophilic cesium salts, activated 
transmetalation via xxiii dominates, and reaches saturation when a 90-fold excess of silanolate 
with respect to Pd is used. 
1.5.2. Arylsilanolates 
The analysis for the cross-coupling catalyzed by (t-Bu3P)2Pd is identical to that presented in 
Scheme 1.13 and Table 1.6, however with different intermediates (Scheme 1.14). The 
experimentally determined rate equation for the cross coupling of K
+
(1.19)
–
 has no order 
dependence for either aryl bromide or silanolate (Eq. 1.6). This rate equation matches that of the 
alkenylsilanolates and either a turnover-limiting transmetalation from an arylpalladium(II) 
intermediate is taking place, or rate-limiting reductive elimination from the diarylpalladium 
species xxvi.
44
 Turnover-limiting reductive elimination has already been discounted.
36
 However, 
this rate equation cannot differentiate between direct transmetalation via 1.13 or activated 
transmetalation via M
+
(1.24)
–
 as the ratio of silanolate/Pd is high. 
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Scheme 1.14. Proposed cross-coupling pathways for arylsilanolates. 
1.5.2.1. Isolation of the transmetalation step 
The independent isolation and X-ray crystallographic analysis of the palladium complex 1.13 
has unambiguously established the generation of the Pd-O-Si bond prior to transmetalation. The 
transmetalation event most likely occurs directly from complex 1.13 and not a ligand-free 
species, as no dependence on the concentration of free phosphine was determined. Moreover, the 
independence of the reaction rates for 1.13 on the source of the silanolate (K
+
 or Cs
+
) further 
supports the conclusion that the transmetalation is a purely thermal process.  
Thus, the three-coordinate arylpalladium(II) arylsilanolate 1.13 is sufficiently poised to allow 
the arene to transfer onto palladium without any ligand dissociation.
45
 The X-ray crystal structure 
of 1.13 provides some insight into the transmetalation process as the nucleophilic arene is 
proximal to the empty coordination site of the palladium center. Therefore, the arene likely 
coordinates to palladium and subsequently suffers transfer with formation of a polysiloxane 
subunit (Scheme 1.15). This formulation can be viewed as an electrophilic aromatic substitution 
at the ipso carbon bearing silicon with the Pd(II) electrophile. Support for this depiction comes 
from the Hammett study of the electronic demands of the aryl residues in which increased 
transmetalation rates correlate with the lesser electron density at palladium and greater electron 
density at silicon.
46
 Alternatively, this process can be viewed as a -aryl elimination. 
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Scheme 1.15. Transmetalation via SEAr mechanism. 
The ability to isolate complex 1.13 enabled the unambiguous establishment of an activated 
transmetalation pathway via a 10-Si-5 intermediate M
+
(1.24)
–
 (Scheme 1.14). The kinetic data in 
Figure 1.4 clearly show a significant increase in the rate of the cross-coupling with 1.23 as the 
amount of K
+
(1.19)
–
 increased. This rate acceleration is consistent with an increasing 
concentration of a more reactive 10-Si-5 species K
+
(1.24)
–
 formed in rapid pre-equilibrium. At 
5.0 equivalents of K
+
(1.19)
–
, the rate leveled off signaling that the concentration of K
+
(1.24)
–
 
had reached a maximum and thus the turnover-limiting step had reached saturation. Thus, a 
bimolecular transmetalation step can be ruled out. The second molecule of arylsilanolate is 
proposed to activate the silicon atom of the palladium complex generating a hypervalent 
siliconate M
+
(1.24)
–
. This pathway is similar to the Hiyama-Hatanaka proposal for fluoride-
activated transmetalation of organosilicon reagents.
7
 Presumably, the activated silicon atom 
redistributes the electron-density onto its peripheral ligands, creating a greater partial negative 
charge on the ipso carbon of the arene. The more nucleophilic organic moiety then transfers via a 
lower energy pathway. Accordingly, given that the catalytic, aryl-aryl cross-coupling reactions 
employ a 60-fold excess of silanolate compared to the intermediate arylpalladium halide,
37
 it is 
safe to conclude that these reactions (unlike the alkenylsilanolate cross-couplings) proceed via 
the activated, 10-Si-5 pathway. 
Further evidence for the activated transmetalation pathway was established by employing the 
cesium arylsilanolate salt Cs
+
(1.19)
–
. This salt reacted so rapidly under activation (i.e. greater 
than 1.0 equivalent of Cs
+
(1.19)
–
 per substrate 1.23) that the kinetic studies had to be run at room 
temperature, compared to 50 °C for K
+
(1.19)
–
. The greater rate of cross-coupling of the cesium 
silanolate clearly implicates a kinetically significant role for the silanolate anion in the 
transmetalation step. The initial hypothesis was that the increased rate arose from a greater 
equilibrium concentration of the reactive complex Cs
+
(1.24)
–
 as a consequence of the greater 
nucleophilicity of the cesium vs. the potassium silanolate. Curiously, however, the saturation 
26 
 
points for the two are nearly identical.
47,48
 Thus, if the two silanolate salts reach pre-equilibrium 
saturation at the same stoichiometry, the difference in cross-coupling rates must be the intrinsic 
reactivity of the two hypercoordinate complexes K
+
 and Cs
+
(1.24)
–
! Given the fact that these 
species are most likely not solvent separated ion pairs in toluene, the difference may arise from 
the greater negative charge localized on the 10-Si-5 species associated with the less coordinating 
cesium ion, compared to the potassium ion.
43
  
1.5.2.2. Computational analysis of the transmetalation step
49
 
Although further details of the transmetalation event were not available experimentally, it 
was possible to glean important insights into this step through computational analysis of the 
transition states for transmetalation in both the thermal (8-Si-4) and anionically activated (10-Si-
5) processes. The availability of the X-ray crystal structure coordinates for 1.13 greatly 
facilitated the computational study and placed the calculated structures on firm experimental 
grounds.   
All crystallographically defined T-shaped arylpalladium phosphine complexes, including 
1.13, take up the same configuration in which the aryl group is located opposite the empty 
coordination site. This arrangement has been rationalized on the basis of the greater trans 
influence of the aryl group compared to the phosphorus or the oxygen or halogen ligand.
50
 
However, for completeness, both isomers of the ground state complexes and all of the 
intermediates and transition states for both neutral and activated pathways were calculated. The 
isomer found crystallographically is referred to throughout as “iso1” shown in black and the 
other isomer, in which the phosphine ligand is located opposite the empty coordination site is 
referred to as “iso2” shown in red. Also, all of the structures for neutral (8-Si-4) pathway are 
labeled “N” and those for the anionic (10-Si-5) pathway are labeled “A”.  
1.5.2.2.1. Thermal (8-Si-4) transmetalation process  
The energy surface identified for the neutral pathway is summarized in Figure 1.6. The first 
notable observation is that the ground state structures for the two isomers are nearly identical 
(after correction for solvation). However at transition state and for all intermediates thereafter, 
the structures in the iso2 family are all of significantly lower energy than those in the iso1 family 
derived from the crystallographically identified complex. The difference at the transition states is 
a remarkable 14.1 kcal/mol.  
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Figure 1.6. Energy profile for the transmetalation of 1.13 via the neutral (8-Si-4) pathway. Energies are 
in kcal/mol, energies given in parentheses have been computed using the CPCM solvent model (UFF 
radii, toluene). 
Simple inspection of the transition state and product structures reveals that exchange of the 4-
fluorophenyl and (t-Bu)3P groups leads to dramatic distortion of the structures resulting from 
steric repulsion between the extremely bulky phosphine and the neighboring aryl groups attached 
to palladium (Figure 1.7). This steric repulsion constitutes a barrier to the migration of the 4-
methoxyphenyl group to the empty coordination site in N-TS-iso1.  Contrariwise, migration of 
the 4-methoxyphenyl group to the empty coordination site in N-TS-iso2 relieves steric repulsion 
and advances the intermediates toward the reductive elimination step.  
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Figure 1.7. Transition state and complexed product structures for transmetalation of 1.13 via the neutral 
(8-Si-4) pathway.  
The immediate products from transmetalation of 1.13 are diorganopalladium complexes that 
remain coordinated to the silicon-containing byproduct (N-CProd). To enable reductive 
elimination, presumably, the silicon moiety must dissociate to form a tricoordinate or free 
diarylpalladium complex (N-FProd). This step has been extremely problematic to address 
computationally (and conceptually) because the silicon unit is an extremely high-energy 
dimethylsilanone (Me2Si=O).
51
 Thus, calculation of the dissociation event (and subsequent 
reductive elimination) leads to a prohibitively endergonic process (45.8 and 25.9 kcal/mol for N-
FProd-iso1 and N-FProd-iso2, resp.). Since it has been unambiguously established that the 
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neutral process occurs in the absence of any nucleophilic scavengers, it must be assumed that 
some kind of bimolecular oligomerization takes place to remove the silanone as a polysiloxane 
byproduct. Thus, to calculate the energy of the pre-reductive elimination intermediates (N-
FProd) the energy of the silanone trimer, hexamethylcyclotrisiloxane (D3) was calculated and 
1/3 of that energy was added to the palladium complex to arrive at much more realistic energies 
(Figure 1.6).  
1.5.2.2.2. Anionic (10-Si-5) transmetalation process  
The energy surface identified for the anionic pathway is summarized in Figure 1.8. The 
starting points are the same neutral ground state structures which must first form the activated 
10-Si-5 species (A-Inter-iso1 and A-Inter-iso2) by association with a molecule of (1.19)
−
. The 
calculations located the anionic intermediates as stationary points albeit structurally and 
energetically quite similar to the transition states for their formation (A-TS1-iso1 and A-TS1-iso2, 
resp). As was seen for the neutral pathway, the iso2 family of structures is uniformly more stable 
than the iso1 family though by a significantly lesser extent until the products are reached.  
The structural details of the intermediates and transmetalation transition states warrant 
comment. Both intermediates exist as trigonal bipyramidal siliconate species in which both 
oxygen substituents occupy the apical positions as expected (Figure 1.9). The steric inhibition 
toward transmetalation in the iso1 family is easily seen by comparison of the Pd–C distances in 
the intermediates, 3.425 Å for A-Inter-iso1 vs. 2.352 Å for A-Inter-iso2 and transition states 
2.414 Å for A-TS2-iso1 vs. 2.269 Å for A-TS2-iso2. Moreover, the respective transition states 
manifest different geometries about the silicon atom which result in very different Si–C bond 
distance (2.395 Å for A-TS2-iso2 vs. 2.127 Å for A-TS2-iso2). One possible interpretation is that 
the silicon atom in A-TS2-iso1 places a methyl group in an apical position to enhance the 
localization of negative charge on the migrating aryl group, thereby assisting in overcoming the 
sterically disfavored activation barrier. As was seen in the neutral pathway, the activated reaction 
profile results in the formation of a diarylpalladium product complexed to a silicon-containing 
byproduct (A-CProd). However, in this case the dissociation of the disiloxane anion is not 
terribly unfavorable because all of the silicon atoms are tetracoordinate and can easily 
accommodate the negative charge.  
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Figure 1.8. Energy profile for the transmetalation of (1.24)
–
 via the anionic (10-Si-5) pathway. Energies 
are in kcal/mol, energies given in parentheses have been computed using the CPCM solvent model (UFF 
radii, toluene). 
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Figure 1.9. Intermediates and transition state structures for transmetalation of (1.24)
–
 via the anionic 
(10-Si-5) pathway. 
1.5.2.2.3. Comparison of activation energies  
Comparison of the activation free energies for the neutral (N-TS-iso2) and anionic (A-TS2-
iso2) pathways estimates that the barrier for the anionic pathway is 1.8 kcal/mol lower. Although 
it is difficult to compare the rates of first (neutral) and second (anionic) order reactions, the 
kinetic data from Tables 1.4 and 1.5 allow a qualitative comparison of the fundamental rates. 
Experimentally, both pathways were evaluated at 50 °C (for K
+
(1.19)
–
) and 25 °C (for 
Cs
+
(1.19)
–
) and the comparisons are compiled in Table 1.7. The rate measured with one 
equivalent of M
+
(1.19)
–
 (relative to 1.23) corresponds to the rate of purely thermal 
transmetalation, whereas the rate measured with 7.5 equivalents of M
+
(1.19)
–
 is the rate of 
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activated transmetalation. For K
+
(1.19)
–
, the activation barrier for the anionic pathway is 1.61 
kcal/mol lower than the thermal pathway, whereas for Cs
+
(1.19)
–
 the difference is 2.59 kcal/mol. 
These values are within satisfyingly qualitative agreement with the calculated difference.  
Table 1.7. Comparison of rates for thermal and anionic cross-coupling. 
 
 
Entry 
M
+
(1.19)
–
  
(equiv) 
[M
+
(1.19)
–
] 
(mM) 
Temp.  
(°C) 
Rate 
(10
-2 
mM/s) 
G‡ 
(kcal/mol) 
1 K
+
5
–
 (1.0) 25.0 50 0.254 
–1.61 
2 K
+
5
–
 (7.5) 187.5 50 3.05 
3 Cs
+
5
–
 (1.0) 25.0 25 0.0251 
–2.59 
4 Cs
+
5
–
 (7.5) 187.5 25 1.99 
 
The ability to computationally describe the energy profiles for the transmetalation of 
intermediates 1.13 and (1.24)
–
 provides compelling support for the experimentally documented 
observation of two, simultaneously operating pathways for the cross-coupling of 
organosilanolate salts. A critical discovery from these calculations was that the 
crystallographically defined intermediate is not as kinetically competent as an isoenergetic 
isomer which allows for a much more facile transfer of the migrating aryl group to the empty 
coordination site of the T-shaped complex. 
1.6. CONCLUSION 
The mechanistic formulation for the cross-coupling of alkenyl- and arylsilanolates with aryl 
halides is now substantially understood. The isolation and characterization of arylpalladium(II) 
silanolate complexes allowed for the unambiguous demonstration of the neutral (8-Si-4) 
mechanistic pathway for transmetalation from silicon to palladium. In addition, detailed kinetic 
studies confirmed the existence of the activated (10-Si-5) pathway under catalytic conditions.  
In general, potassium salts of alkenylsilanolates react via neutral intermediates (8-Si-4), 
whereas the enhanced nucleophilicity of cesium alkenylsilanolates allows for the reaction to 
access the 10-Si-5 intermediate and proceed via the anionically activated pathway. However, if 
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the direct transmetalation is slower, as in the case of arylsilanolates (which require interruption 
of aromaticity), then anionic activation via the 10-Si-5 intermediate is predominant, regardless of 
the cation employed.  
Computational analysis provided support for the operation of the two modes of 
transmetalation, as well as theoretical evidence for the problematic siloxane byproduct extrusion 
step. Transition states for the transmetalation of neutral and anionic intermediates have been 
located and the anionic pathway is favored by 1.8 kcal/mol. 
These conclusions mandate a revision of the paradigm that organosilicon compounds must be 
anionically activated to engage in transmetalation processes (Hiyama-Hatanaka paradigm). 
Through the agency of the critical Si-O-Pd linkage, direct transmetalation of silicon to palladium 
can be achieved under mild conditions without anionic activation. 
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Chapter 2:  
The palladium-catalyzed cross-coupling reaction of allenylsilanolates 
 
2.1. INTRODUCTION
*
 
The impact of transition metal catalyzed cross-coupling reactions cannot be overestimated. 
This Nobel Prize winning chemistry has transformed the practice of synthetic organic chemistry 
in academic and industrial laboratories alike.
1,2
 The ability to construct single bonds between sp
3
, 
sp
2
 and sp hybridized carbon atoms in myriad chemical environments has enabled the 
straightforward, strategic disconnection of target molecules into pairwise combinations of donors 
and acceptors. The recent development of high performance ligands has enabled the use of more 
and more acceptors such as chlorides, tosylates, phosphates and carboxylates.  
However, on the donor side, the boronic acid derivatives have monopolized the attention of 
practitioners, particularly in the pharmaceutical sector.
3
 This preference has stimulated the 
commercial production of hundreds of boronic acid derivatives, which then leads to the self-
fulfilling consequence of using only these reagents and disregarding the advantages and in some 
cases superiority of other donors, including tin and silicon. What makes boronic acid derivatives 
so appealing is their versatility, stability and perceived low toxicity, all desirable features that 
justify their use as coupling partners in large scale processes. However, a 2011 toxicological 
report unveiled the mutagenic properties of several boronic acids and esters.
4
 These results are 
further strengthened by a recent study that discloses the mutagenicity associated with a large 
number of boronic acids, esters, MIDA boronates, potassium trifluoroborates, as well as their 
precursors bis(pinacolato)diboron and bis-boronic acid.
5
 The newly-assessed genotoxicity of 
boron compounds naturally poses some serious limitations to their applications in medicinal and 
process chemistry, both in terms of worker exposure hazards and more stringent standards of 
purity to avoid the persistence of genotoxic impurities.  
                                                          
*
  The contents of Section 2.1 were partially reproduced (adapted) with permission from Denmark, S. E.; 
Ambrosi, A. Org. Process Res. Dev. 2015, 19, 982-994. Copyright 2015 American Chemical Society. 
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Beginning in 2000, the rapid development of organosilicon cross-coupling in our group has 
led to the discovery that organosilanols are competent nucleophiles in cross-coupling reactions 
under Bronsted base activation.
 6
 The activation step can take place either in situ (by the addition 
of a base to the reaction mixture),
7
  or by preforming a silanolate salt stoichiometrically with a 
strong base.
8
 The latter approach offers some practical advantages and minimizes the occurrence 
of side-reactions, such as protodesilylation and disiloxane formation. 
The advantages of organosilanols as coupling partners are manifold in comparison to other 
silanes or organometals. In particular: (1) silanols are stable, non-hydrolytically labile, amenable 
to purification and compatible with many functional groups; (2) many well-established protocols 
are available to install silanol functionalities; (3) due to their low molecular weight, silanols 
enhance atom economy; (4) silanols are non-toxic
9
 and the cross-coupling reactions produce 
innocuous polysiloxane byproducts,
 
which are easily removed by chromatography or distillation; 
(5) the fluoride-free conditions make the process compatible with substrates bearing other 
silicon-based functional groups (such as silyl-ether protecting groups); (6) the conjugate bases of 
organosilanols are stable, often free-flowing powders that are “self-activating” cross-coupling 
partners, i.e., they require no additional activators. 
Research efforts in our group have helped establish the cross-coupling of organosilanols and 
-silanolates as a reliable and versatile synthetic method. The scope for the cross-coupling 
reaction encompasses a wide range of substrates. Thus, aryl, heteroaryl, alkenyl, alkynyl, and 
allyl silanols/silanolates can be successfully coupled with several classes of aryl and alkenyl 
halides (Scheme 2.1).
6,10
  
 
Scheme 2.1. Organosilanolate cross-coupling reaction. 
The cross-coupling of allylsilanolates is an interesting case because of the site-selectivity 
issue that arises.
11
 Allylsilanolates have the potential to react either at the α- or γ-position, with a 
marked selectivity for the γ-substituted product when bulky trialkyl phosphines are used as the 
ligands (Scheme 2.2a).
12
 Mechanistic studies with enantiomerically-enriched and geometrically-
defined allylsilanolate 2.1 clarified that the transmetalation step takes place as a stereospecific 
syn SE2' process, via a chair-like transition state.
13
 In the preferred transition structure i, the      
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Si-O-Pd linkage controls the delivery of the palladium electrophile to the -terminus of the 
allylic silane (Scheme 2.2b). 
 
Scheme 2.2. Cross-coupling of allylsilanolates.  
Due to the fact that γ-substituted allylsilanolates generate a stereogenic center upon cross-
coupling, an additional challenge addressed by our group was the catalytic, enantioselective 
cross-coupling employing a chiral ligand.
14
 Unfortunately, despite extensive ligand screening, 
the reaction was always found to proceed with low enantioselectivity (er = 75:25 or lower). 
Similar to allylic nucleophiles, allenylsilanolates (and allenylmetal species in general) also 
display site-selectivity duality upon cross-coupling. Indeed, an allenylmetal iii can react at the α-
terminus, generating an allene iv, or at the γ-terminus, generating an alkyne v (Scheme 2.3). 
Despite the potentials for harnessing such dual behavior in synthetic methods, the cross-coupling 
of allenyl nucleophiles is an underdeveloped transformation. Only one report details the use of 
an allenylboron reagent in the framework of the preeminent Suzuki-Miyaura reaction.
15
 
However, only unsubstituted allenyl-9-BBN is used in this study (see section 2.2.1). 
 
Scheme 2.3. Cross-coupling of allenylmetal reagents.  
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To the best of our knowledge, the cross-coupling of allenylsilanolates and other 
allenylsilanes is unknown. Yet, the development of reaction conditions for the cross-coupling of 
this class of nucleophiles is a stimulating challenge, because of the intriguing stereochemical 
consequences that arise. The γ-selective cross-coupling of a γ-disubstituted allenylsilanolate vi 
will result in a product vii that necessarily contains a quaternary stereocenter, if R  R1 (Scheme 
2.4). In contrast to γ-substituted allylsilanolates, where the configuration of the newly formed 
stereocenter has to be controlled by a chiral catalyst, allenylsilanolates such as vi bear the 
advantage of being chiral reagents (again, if R  R1). Therefore, an enantioenriched 
allenylsilanolate vi may in principle afford an enantioenriched cross-coupling product vii 
through an enantiospecific axial-to-central chirality transfer. This assertion is supported by the 
fact that chiral, non-racemic allenylsilanes are known to participate in SE' reactions without loss 
of stereospecificity.
16  
 
Scheme 2.4. γ-selective cross-coupling of γ-disubstituted allenylsilanolates. 
Our efforts toward the development of the γ-selective cross-coupling of allenylsilanolates, 
with the ultimate goal of accessing quaternary stereocenters in a stereocontrolled fashion, are 
described herein. 
2.2. BACKGROUND 
2.2.1.  Cross-coupling of allenylmetal reagents 
The cross-coupling of allenes, either in the form of allenyl halides or allenylmetals, is an 
underdeveloped transformation.
17
 Only scattered reports have appeared in the literature that 
document the palladium-catalyzed cross-coupling of allenylmetal reagents. Examples are known 
using allenyllithium,
18
 -copper,
19
 -magnesium,
19
 -zinc,
19,20
 -tin,
21,22
 and boron
15
 reagents. 
Selected examples are shown in Scheme 2.5. 
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Scheme 2.5. Examples of cross-coupling of allenylmetal reagents. 
In all of the cases shown in Scheme 2.5, only the allenic α-product is observed. Exclusive α-
selectivity is also reported when allenylpalladium(II) complex 2.2 is treated with PhZnCl, 
generating the allenic product 2.3 in quantitative yield (Scheme 2.6).
23
 
 
Scheme 2.6. Cross-coupling from a pre-formed allenylpalladium(II) complex. 
The possibility of accessing the γ-coupling product was anticipated by the isolation of η3-
propargylpalladium(II) complex 2.5 by Kurosawa and co-workers (Scheme 2.7), which was 
obtained by combining the propargylic chloride 2.4 with Pd2(dba)3CHCl3 and PPh3, followed by 
C6F5Li.
24
 When 2.5 is heated, only the propargylic γ-product 2.6 is obtained. However, a related 
experiment, involving transmetalation from organotin reagents, gives either α- or γ-coupling 
products from a common η3-propargylpalladium intermediate. Reaction with PhC≡CSnBu3 
affords the α-product 2.7, whereas PhSnBu3 affords the γ-product 2.8.
25
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Scheme 2.7. Cross-coupling via a η3-propargylpalladium(II) intermediate. 
Additional reports by Ma et al. illustrate the impact of reagent control in determining the site-
selectivity for the cross-coupling of propargylic nucleophiles (Scheme 2.8). For instance, the 
organozinc reagent derived from propargylic deprotonation of alkyne 2.9 and transmetalation to 
Zn undergoes cross-coupling with γ-selectivity (2.10), whereas the more hindered organozinc 
originating from 2.11 cross-couples with α-selectivity (2.12).26 The site-selectivity could also be 
tuned by altering the reaction conditions. The organozinc reagent accessed by deprotonation of 
2.9 and transmetalation to Zn affords either the α-product 2.13 or the γ-product 2.14 depending 
on the conditions (base, temperature) employed for the deprotonation/transmetalation steps.
27
 
 
Scheme 2.8. Site-selectivity in the cross-coupling of propargylic nucleophiles. 
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More recently, a report by Williams et al. shows that a 6:4 mixture of stannanes 2.15 and 
2.16, when subjected to cross-coupling conditions, affords exclusively the α-isomer 2.17 
(Scheme 2.9).
28
 This outcome indicates that a common intermediate is accessed from both 
allenyl and propargyl stannanes 2.15 and 2.16. 
 
Scheme 2.9. Cross-coupling of allenyl and propargyl stannanes. 
In a unified picture, the above examples suggest the mechanistic scenario depicted in Scheme 
2.10. The organometallic partner can be in the form of either allenylmetal viii or propargylmetal 
ix. Organometals viii and ix may be stable species, or undergo equilibration, depending on the 
propensity of the metal to engage in 1,3-metallotropic shift.
16
 From viii and ix, transmetalation to 
palladium furnishes η1-complexes x and xi, either through a SE or SE' process. Species x and xi 
do interconvert through the η3-complex xii, which could be either a stable, isolable intermediate 
or a transient species, depending upon the nature of the ligand L.
25,16
 Reductive elimination from 
x or xi, or directly from xii, furnishes the α- or γ-coupling products. Therefore, there are three 
stages along the reaction pathway where the α- vs. γ-selectivity may be determined: (1) the 
interconversion of organometals viii and ix (if viable); (2) the transmetalation event (SE or SE'); 
or (3) the interconversion of organopalladium intermediates x and xi.  
Note that the same set of intermediates x and xi can be accessed either by transmetalation 
from viii and ix, or by oxidative addition of Pd(0) into allenyl (xiii) or propargylic (xiv) halides. 
In the latter case, the site-selectivity must be determined by the interconversion of the resulting 
organopalladium complexes x and xii. 
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Scheme 2.10. Mechanism for the cross-coupling of allenyl- and propargylmetal reagents. 
The preference for the α- or γ-isomer is difficult to rationalize and seems to be influenced by 
a multitude of factors (nature of the substrates, organometallic donor involved, reaction 
conditions, ligands, etc.), which in turn determine the relative rate constants of the steps of the 
catalytic cycle. Unfortunately, no extensive studies have been carried out in an attempt to 
rationalize the preference for either isomer. Steric arguments (repulsion between the geminal 
substituents on a sp
2
 carbon) have been advanced to explain the preferential formation of γ-
isomers; electronic factors (more facile reductive elimination to an sp
2
 carbon than an sp
3
 
carbon) have been invoked to rationalize the preference for α-isomers.25 
A limited number of γ-disubstituted allenylmetal reagents have been employed in cross-
coupling reactions. γ-Disubstituted allenylzinc20 and -tin29 reagents have been shown to undergo 
cross-coupling at the α-position exclusively. Again, the steric hindrance at the γ-terminus might 
disfavor an SE' transmetalation event (viii to xi), and/or disfavor reductive elimination to the γ-
product from xii. 
The overarching goal of the present research project consists in the achievement of the γ-
selective coupling of γ-disubstituted allenylsilanolates. For the cross-coupling of this class of 
nucleophiles, transmetalation is expected to occur by means of formation of an intermediate xv 
containing a Si-O-Pd linkage (Scheme 2.11).
30
 In analogy with allylsilanolates,
13
 two 
transmetalation pathways can be envisioned (SE or SE') leading to an equilibrating mixture of xvi 
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and xvii, respectively. The agency of the critical Si-O-Pd linkage might overcome the intrinsic 
steric barrier to the SE' process, as intermediate xv is set for an intramolecular SE' transmetalation 
via a favorable 6-member arrangement in the transition state. The relative rates of equilibration 
of xvi and xvii versus reductive elimination will then dictate the final isomeric composition of 
the cross-coupling products. 
 
Scheme 2.11. Role of the Si-O-Pd linkage in the cross-coupling of allenylsilanolates. 
2.2.2.  Enantioselective synthesis of quaternary stereocenters 
The endless interest of organic chemists in asymmetric synthesis is justified by the fact that 
the majority of drugs and agrochemicals are chiral. Indeed, Food and Drug Administration 
(FDA) recommends that chiral drugs be developed as single enantiomers, rather than racemates, 
for the judicious assessment of absorption, distribution, metabolism, and excretion (ADME) 
profiles, efficacy, and toxicity.
31
 The importance of isomerism in drugs is emphasized by the 
notorious case of thalidomide, whose (R) enantiomer displayed devastating teratogenic 
properties when the drug was marketed as a racemate.
32
  
It is estimated that, among the drugs currently on the market, nearly 300 contain a quaternary 
stereocenter.
33
 Hence, it is not surprising that the creation of quaternary stereogenic centers is a 
field of extensive investigation and an ongoing challenge in organic synthesis.
34
 From a synthetic 
standpoint, the difficulties associated with the asymmetric construction of quaternary carbon 
atoms arise mainly from the steric repulsion between the substituents. At present, only a limited 
number of catalytic, asymmetric transformations have been shown to be successful in 
constructing quaternary stereocenters with good stereocontrol. These include Diels-Alder 
reactions, cyclopropanations, alkylation of enolates, aldol and Michael additions, allylation of 
aldehydes, allylic substitutions, and Heck reactions. Many of these methods, however, are not 
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generalized and their application in the context of a total synthesis is all but straightforward. The 
lack of generalized, robust procedures is also witnessed by the fact that, among the drugs on the 
market containing quaternary stereocenters, no instances are found where the stereocenter is 
forged via asymmetric synthesis!
35
 These drugs are either: (1) naturally occurring compounds 
extracted from natural sources, or (2) more complex structures assembled from a natural 
precursor containing the quaternary stereocenter (usually a steroid or opioid), or (3) obtained 
from a racemate via resolution (Figure 2.1). 
 
Figure 2.1. Methods of preparation of selected marketed drugs containing quaternary stereocenters. 
From the perspective of the pharmaceutical or agrochemical industry, such options may be 
undesirable; extraction from natural sources may be laborious, the natural supply of biologically 
active compounds is often low, and resolution processes are wasteful. These difficulties often 
lead to the abandonment of promising drug candidates, owing to the high costs of production. 
Conversely, catalytic, asymmetric methods are more sustainable and may help reduce the costs. 
The majority of the existing methods for the synthesis of quaternary stereocenters focus on 
targeting cyclic structures. Acyclic structures are more challenging, due to the increased degrees 
of freedom in open chains. Nevertheless, several approaches have been illustrated in past years.
36
 
Successful strategies include allylation of aldehydes,
37
 allylic substitution,
38
 alkylation of 
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enolates,
39
 aldol,
40
 Mannich,
41
 Michael,
42
 conjugate addition,
43
 lithiation-borylation and 
enantiospecific cross-coupling,
44
 and ring-opening of alkylidenecyclopropanes (Scheme 2.12).
45
  
 
 
Scheme 2.12. Methods for the synthesis of quaternary stereocenters in acyclic systems. 
The selection of methods shown in Scheme 2.12 is illustrative of the state of the art in the 
construction of quaternary stereocenters in acyclic systems. However, these methods require 
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certain functional groups in the starting material, and are limited to very specific substitution 
patterns in the final product, thus precluding the possibility of generalization of the method. 
The development of the enantiospecific, γ-selective cross-coupling of allenylsilanolates 
(Scheme 2.4)  could potentially offer a generalized, widely-applicable solution to the problem of 
forging acyclic quaternary stereocenters. The strength of this transformation is evident from 
different standpoints: (1) silanolate cross-coupling reactions are attractive strategies, whose 
multiple benefits have been discussed above; (2) the stereocontrol is imparted by the inherent 
chirality of the substrate, therefore an added chiral reagent or catalyst is not needed; (3) several, 
well-established methods exist for the enantioselective synthesis of allenes;
46
 (4) the resulting 
cross-coupling product, an alkyne, is a versatile intermediate that could be used in a plethora of 
subsequent transformations,
47
 including Sonogashira coupling, [3+2] cycloaddition, alkyne 
metathesis, hydrogenation, conversion to a methyl ketone.  
On the other hand, the proposed method remains challenging because controlling the site-
selectivity in the cross-coupling of allenylmetal species is inherently difficult (section 2.2.1). 
Moreover, the substituent delivered to the quaternary center via cross-coupling has to be 
compatible with cross-coupling conditions. For palladium-catalyzed, silanolate-based cross-
coupling reactions, compatibility has been demonstrated only for aryl and alkenyl halides (or 
pseudo-halides), which cannot undergo β-hydride elimination. 
The synthesis of enantiomerically-enriched, alkynyl-substituted quaternary centers has 
already been documented by Caporusso and co-workers (Scheme 2.13).
48
 In this approach, 2.19 
is accessed from an enantioenriched bromoallene 2.18 through a copper-mediated SN2' 
displacement reaction. Although the reaction was shown to proceed enantiospecifically via an 
anti-mechanism, a major drawback is that the starting bromoallene 2.18 could not be synthesized 
in highly enantioenriched form. 
 
Scheme 2.13. Synthesis of quaternary stereocenters via Cu-mediated SN2' displacement. 
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2.3. RESEARCH OBJECTIVES 
The work discussed in this chapter addresses the major objective of developing the 
enantiospecific, γ-selective cross-coupling of γ-disubstituted allenylsilanolates to construct 
quaternary stereocenters (Scheme 2.4). With this goal in mind, the specific aims of this project 
are: 
1. Devise a convenient method for the synthesis of γ-disubstituted allenylsilanols/silanolates; 
ideally, the synthetic route should be short, flexible, and amenable to the preparation of 
allenylsilanols as single enantiomers; 
2. Optimize the γ-selective cross-coupling of allenylsilanolates through extensive screening of 
ligands, palladium sources and reaction conditions, relying on the thorough mechanistic 
understanding of the transmetalation step for this class of nucleophiles;
30
 
3. Demonstrate the stereospecificity of the cross-coupling reaction with enantiomerically-
enriched allenylsilanolates. 
2.4. RESULTS 
2.4.1.  Synthesis of allenylsilanolates 
A variety of procedures have been reported for the preparation of allenylsilanes. The most 
common and synthetically useful ones involve: (1) the silylation of an allenyllithium 
intermediate; or (2) the SN2' displacement of a propargylic electrophile, usually with an 
organocopper reagent.
46
 Allenylsilanol 2.20 was chosen as a model substrate to explore the 
synthesis of allenylsilanols and to carry out preliminary cross-coupling experiments. The 
disconnections shown in Scheme 2.14 to target compound 2.20 encompass the main strategies 
employed for the synthesis of allenylsilanes. 
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Scheme 2.14. Major disconnections for the synthesis of 2.20. 
Disconnection a provides a silyl-substituted propargylic derivative, which would furnish the 
desired allenylsilane upon reaction with a reducing agent in a SN2' reaction. Disconnection b1 
involves a similar approach, whereby the silyl group is introduced via a Cu-mediated SN2' 
displacement using a silyl-cuprate reagent. Conceptually different, disconnection b2 reverses the 
roles of the reagents and provides the product by silylation of an allenyllithium. Finally, 
disconnection c consists of another Cu-mediated SN2' displacement on a propargylic substrate, 
with the silyl group now located α to the leaving group.  
The critical aspect in each of these pathways is how to access the target allenylsilanol 2.20 in 
an enantioenriched form. Considering that the stereospecificity of SN2' displacements on 
propargylic electrophiles is well assessed,
46
 routes a, b1 and c will deliver an enantiomerically-
enriched allenylsilanol if the precursor propargylic intermediate is enantiomerically enriched. On 
the contrary, route b2 is not suitable for a stereoselective synthesis, as allenyllithium reagents are 
not configurationally stable species.
49
 
2.4.1.1.  Reduction of a propargylic alcohol 
The investigations of the synthesis of 2.20 began with disconnection a. The synthetic plan is 
outlined in Scheme 2.15. Starting with alkynylsilane xviii, an enantioselective alkynylation of 
acetophenone is employed to access the tertiary, propargylic alcohol xix. SN2' reduction to allene 
xx and removal of the protecting group furnish the desired allenylsilanol 2.20. 
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Scheme 2.15. Forward synthesis following disconnection a. 
Isopropoxy-substituted silyl acetylene 2.22 was identified as a suitable precursor, as the i-
PrO group is easily converted into a silanol under mildly acidic conditions (Scheme 2.16).
50
 To 
prepare 2.22, dichlorodimethylsilane was subjected to a nucleophilic substitution with i-PrOH, 
and the resulting silyl chloride 2.21 was treated with ethynylmagnesium bromide.  
 
Scheme 2.16. Preparation of 2.22. 
Unfortunately, the subsequent asymmetric alkynylation was not as straightforward as 
anticipated. Although a number of procedures for the asymmetric alkynylation of ketones have 
been reported, the substrate scope is limited.
51
 Following Wang’s (Scheme 2.17a)52 and Cozzi’s 
(b and c)
53,54
 protocols, the alkynylation of acetophenone with alkyne 2.22 was attempted, but no 
product 2.23 was observed and 2.22 underwent unproductive consumption instead. Since the 
third set of reaction conditions is compatible with trimethylsilyl acetylene (Scheme 2.17d), the 
unsuccessful alkynylation with 2.22 was attributed to the labile nature of the i-PrO group. 
52 
 
 
Scheme 2.17. Attempts toward asymmetric alkynylation using 2.22. 
Therefore, a more robust protecting group was needed, and the trimethoxyphenyl group 
(TMOP)
55
 was identified for this purpose. TMOP-protected silyl acetylene 2.24 was synthesized 
from 1,3,5-trimethoxybenzene and employed in an asymmetric alkynylation reaction under a 
slightly modified protocol, but no product 2.25 was observed (Scheme 2.18).  
Scheme 2.18. Introduction of TMOP protecting group. 
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Reasoning that 2.25 does not necessarily have to be constructed via an asymmetric 
alkynylation, but could also be accessed by the asymmetric addition of dimethyl- or diphenylzinc 
to an alkynyl ketone, it was deemed wise to proceed with the preparation of 2.25 in racemic form 
for the time being, at least until the feasibility of the subsequent steps in the synthesis had been 
evaluated. Consequently, racemic 2.25 was synthesized by the addition of 2.24 to acetophenone 
following Imamoto’s protocol involving the use cerium(III) chloride (Scheme 2.19).56 Simple 
deprotonation of 2.24 with n-BuLi, t-BuLi or LDA gave <50% yields, probably due to the 
occurrence of enolization reactions. Among the limited number of protocols available to reduce a 
propargylic alcohol to an allene, the procedure reported by Ready et al. seemed the most 
attractive, as the Schwartz reagent (Cp2ZrHCl) cleanly reduces propargylic alcohols via a cis-
hydrozirconation/syn-elimination mechanism.
57
 Although 2.25 was successfully converted to the 
allene 2.26 on a small scale (0.4 mmol), the reaction was somewhat capricious on a larger scale 
(> 1 mmol). Attempts at scaling up the reaction were always accompanied by a considerable 
amount of inseparable side products. Nevertheless, the removal of the TMOP group was 
accomplished successfully by treating 2.26 with one equivalent of HCl in Et2O. The target 
silanol 2.20 was subsequently subjected to a number of different deprotonation conditions. 
Unfortunately, complex reaction mixtures were obtained and none of the conditions delivered the 
expected metal silanolate salts M
+
(2.20)
−
. 
 
Scheme 2.19. Racemic synthesis of silanol 2.20. 
In an effort to increase the stability of the silanol and prevent the occurrence of side reactions 
upon deprotonation, the diethyl-substituted silanol 2.27 became the new synthetic target (Scheme 
2.20). Similar to the route discussed in Schemes 2.18 and 2.19, TMOP-protected silyl acetylene 
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2.28 was added to acetophenone. However, the addition product 2.29 was unstable and 
spontaneously decomposed to alkynylsilanol 2.30, a result that was attributed to the increased 
steric repulsion between the ethyl substituents on silicon and the methoxy groups on the TMOP 
ring.  
 
Scheme 2.20. Change to diethylsilanol. 
Consequently, the less sterically encumbered 3,5-dimethoxyphenyl  group (3,5-DMOP) was 
employed (Scheme 2.21). The synthesis of 2.33 from alkyne 2.31 (via the alcohol 2.32) 
proceeded smoothly, but 2.33 could not be hydrolyzed to 2.27, even under forcing acidic 
conditions. Hydration of the allene and protodesilylation were observed instead. 
 
Scheme 2.21. Introduction of 3,5-DMOP protecting group. 
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Finally, the synthetic route was repeated using 2,4-dimethoxybenzene (DMOP) as the 
protecting group, starting from 2.34 (Scheme 2.22). Although the deprotection of 2.36 was 
successful on the basis of an NMR experiment, the reduction of propargylic alcohol 2.35 to 
allene 2.36 gave complex reaction mixtures upon scale-up, hampering the possibility of 
synthesizing 2.27 in useful amounts for the subsequent steps. 
 
Scheme 2.22. Introduction of DMOP protecting group. 
2.4.1.2.  Silylation of an allenyllithium reagent 
Following disconnection b2 (Scheme 2.14), the target silanol 2.27 could be obtained by 
trapping an allenyllithium intermediate 2.37 (accessed by Li-I exchange or deprotonation) with a 
silyl chloride (Scheme 2.23). Although this approach is not suitable for an enantioselective 
synthesis, it may offer a convenient access to racemic 2.27. 
 
Scheme 2.23. Forward synthesis following disconnection b2. 
The exploration of this route began with the known allenyl iodide 2.38,
58
 which, upon 
lithium-iodine exchange, trapping with Et2SiCl2 and hydrolysis, afforded silanol 2.39 (Scheme 
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2.24). 2.39 was then subjected to a number of deprotonation conditions and was cleanly 
converted to the corresponding lithium or sodium silanolate salts (as judged by 
1
H NMR). 
 
Scheme 2.24. Synthesis and deprotonation of silanol 2.39. 
Encouraged by these results, the same strategy was next employed for the intended substrate 
2.27. Due to the lack of a reliable procedure to synthesize an allenyl iodide bearing an aromatic 
substituent at the 3-position, the required allenyllithium was accessed by direct deprotonation of 
the terminal allene 2.41, easily made via Skattebøl rearrangement of gem-dibromocyclopropane 
2.40 (Scheme 2.25).
59
 However, lithiation and silylation of 2.41 resulted in a reaction mixture 
containing only trace amounts of the desired silanol 2.27, with the major components being the 
disubstitition product 2.42 and unreacted starting material 2.41. Addition of TMEDA did not 
bring about any improvement. 
 
Scheme 2.25. Synthesis of silanol 2.27 via Skattebøl rearrangement. 
2.4.1.3.  SN2' displacement on a propargylic mesylate 
The remaining disconnections b1 and c (Scheme 2.14) entail an SN2' reaction of an 
organocopper reagent on a propargylic alcohol derivative (mesylate or acetate). Disconnection 
b1 requires a silyl cuprate reagent (PGMe2Si)2CuLi. Although (PhMe2Si)2CuLi is a well-known 
and effective reagent for the stereospecific synthesis of allyl- and allenylsilanes,
60
 the preparation 
of related reagents is often challenging or unsuccessful, depending on the nature of the 
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substituents.
61
 Therefore, the synthesis of 2.27 via route b1 was not attempted. On the other 
hand, disconnection c offers a relatively easy synthetic approach, which is summarized in 
Scheme 2.26. Silylation of 2-butyn-1-ol and reverse Brook rearrangement furnishes the 
secondary alcohol xxi in racemic form. Oxidation and subsequent stereoselective reduction of 
the silyl ketone affords the same alcohol in an enantioenriched form. Mesylation, Cu-mediated 
SN2' displacement and deprotection complete the sequence. For a racemic preparation of 2.27, 
racemic alcohol xxi can be directly converted into xxii. 
 
Scheme 2.26. Forward synthesis following disconnection c. 
The required DMOP-protected silyl chloride 2.43 was prepared from 1-bromo-2,4-
dimethoxybenzene and used in a reverse Brook rearrangement with 2-butyn-1-ol (Scheme 
2.27).
62
 Despite optimization, the yield of this step was always modest (50-72%) and the product 
2.45 was accompanied by a certain amount of inseparable silanol 2.46. A control experiment 
demonstrated that 2.46 does not originate from simple hydrolysis of the starting material 2.43. 
Indeed, when the intermediate silyl ether 2.44 was isolated and re-subjected to the reaction 
conditions, the product 2.45 was still contaminated with 2.46. Fortunately, the presence of 2.46 
did not affect the subsequent steps; a mixture of 2.45 and 2.46, treated with MsCl and then with 
PhMgBr/CuBr·2PBu3, provided allene 2.36 in good yield via mesylate 2.47. Similar to 2.26 
(Scheme 2.19), the deprotection of 2.36 was carried out with one equivalent of HCl in Et2O. 
Whereas no reaction occurred in THF, dichloromethane afforded the desired allenylsilanol 2.27. 
Unfortunately, extensive decomposition was observed in the deprotonation of 2.27 to silanolate 
salts M
+
(2.27)
−
. 
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Scheme 2.27. Synthesis of silanol 2.27. 
Since the dialkyl-substituted silanolate M
+
(2.39)
−
 had been generated successfully and did 
not undergo decomposition (Scheme 2.24), the instability of M
+
(2.27)
−
 was attributed to the 
presence of the phenyl group as a substituent on the allene. Consequently, the 3-benzyl-3-
methyl-substituted allenylsilanol 2.48 became the new target (Scheme 2.28). The required 
structural variation was introduced in the SN2' displacement step, where PhMgBr was replaced 
with BnMgCl. The removal of DMOP from 2.49 proceeded smoothly and the silanol 2.48 could 
be deprotonated with NaH, KH or t-BuLi to generate silanolates M
+
(2.48)
−
. Li-, Na- and K-
silanolates (2.48)
−
 were used as stock solutions (titrated by GC) in the optimization of cross-
coupling conditions (section 2.4.2).  
The optimization of cross-coupling conditions also required the preparation of diisopropyl 
silanol 2.50. The synthetic route was identical to that employed for 2.48 (Scheme 2.29). Thus, 
after the preparation of silyl chloride 2.51, reverse Brook rearrangement afforded the secondary 
alcohol 2.52 along with inseparable silanol 2.53. The yield and the 2.52:2.53 ratio were much 
worse than previously reported in the synthesis of 2.45 (Scheme 2.27). Mesylation and SN2' 
displacement provided 2.55; deprotection of 2.55 under slightly harsher acidic conditions 
afforded the desired silanol 2.50, which could be deprotonated with NaH or KH to generate Na- 
and K-silanolates (2.50)
−
. 
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Scheme 2.28. Synthesis and deprotonation of diethyl silanol 2.48. 
 
Scheme 2.29. Synthesis and deprotonation of diisopropyl silanol 2.50. 
2.4.2.  Optimization of cross-coupling conditions 
The optimization of the γ-selective cross-coupling of allenylsilanolates was undertaken 
through extensive screening of ligands, Pd sources and reaction conditions (Scheme 2.30). The 
reactions were run on a 0.05 mmol scale of aryl halide (bromide or iodide) and monitored by GC 
60 
 
analysis. The amounts of residual silanol 2.48 or 2.50, aryl halide, α-product, γ-product, and 
protodesilylated allene 2.56 in the reaction mixtures were determined by integration of GC peaks 
relative to an internal standard (biphenyl). 
 
Scheme 2.30. General cross-coupling reaction. 
2.4.2.1.  Initial conditions 
In a first set of reactions, sodium silanolate Na
+
(2.48)
−
 was treated under the conditions that 
were found to be optimal to maximize the γ-selectivity in the cross-coupling of allylsilanolates.12  
Specifically, Pd(dba)2 (dba = dibenzylideneacetone) and the trialkylphosphonium salts 2.57, 2.58 
and 2.59 were used in combination with bromoanisole 2.60 (Table 2.1). Although the reactions 
with allylsilanolates were run at 70 C, the initial screenings involving Na+(2.48)− were run at 
room temperature. This choice was motivated by the fact that 2.48 is more structurally similar to 
an alkenylsilanolate than an allylsilanolate, and alkenylsilanolates readily undergo cross-
coupling at room temperature.
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 No products 2.61 or 2.62 were detected under these conditions. 
Table 2.1. Use of trialkylphosphonium salts with sodium silanolate Na
+
(2.48)
−
. 
 
Entry Ligand 
α (2.61)  
(%) 
γ (2.62)  
(%) 
2.48  
(%) 
2.60  
(%) 
2.56  
(%) 
α:γ 
ratio 
1 
 
- - 38 72 9 - 
2 
 
- - 41 79 10 - 
3 
 
- - 0 98 4 - 
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Due to the steric encumbrance around the silicon atom in diethyl silanolate Na
+
(2.48)
−
, it was 
envisaged that the displacement of the halide from palladium to form the Si-O-Pd linkage might 
be the turnover-limiting step. Consequently, the rate of the reaction might be increased by the 
use of a more nucleophilic potassium silanolate in combination with an aryl iodide. K
+
(2.48)
−
 
and iodoanisole 2.63 were reacted under the same conditions, but no product was observed, and 
K-73 underwent unproductive consumption (Table 2.2). 
Table 2.2. Use of trialkylphosphonium salts with potassium silanolate K
+
(2.48)
−
. 
 
Entry Ligand 
α (2.61)  
(%) 
γ (2.62)  
(%) 
2.48  
(%) 
2.63  
(%) 
2.56  
(%) 
α:γ 
ratio 
1 2.57 - - - 88 35 - 
2 2.58 - - - 93 33 - 
3 2.59 - - - 95 29 - 
 
Since the reaction conditions reported in Tables 2.1 and 2.2 were optimized for γ-
monosubstituted allylsilanolates, these might not be directly applicable to the more rigid and 
sterically hindered substrate (2.48)
−
. Interestingly, the -acidic ligand 4,4'-CF3-dba (2.64) and 
Pd(dba)2 had been found to be the optimal combination for the γ-selective cross-coupling of γ-
disubstituted allylsilanolates.
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 When such reaction conditions were tested with Na
+
(2.48)
−
, no 
product was detected using the electron-deficient 4-bromobenzotrifluoride 2.65 (Table 2.3, entry 
1). However, when 4-iodobenzotrifluoride 2.66 was used, a 31% conversion to the α-product 
2.67 was observed (entry 2). 2.67 was isolated from the reaction mixture in 30% yield and its 
identity assessed by 
1
H NMR and MS. 
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Table 2.3. Use of dba-type ligand 2.64. 
 
Entry Halide 
α (2.67)  
(%) 
γ (2.68)  
(%) 
2.48  
(%) 
halide 
(%) 
2.56  
(%) 
α:γ 
ratio 
1 2.65 (Br) - - 71 85 7 - 
2 2.66 (I) 31
a
 - 27 23 3 - 
a. Isolated in 30% yield. 
2.4.2.2.  Survey of ligands 
This encouraging result prompted a screening of ligands with different electronic and steric 
properties, in order to increase the conversion to the products and drive the selectivity towards 
the desired γ-product 2.68. Thus, Na+(2.48)− and 2.66 were combined in the presence of Pd(dba)2 
and a ligand in toluene at 40 C, hoping that an increase in temperature would be beneficial for 
the conversion (Table 2.4). In the absence of an added ligand, 2.67 was obtained in 20% 
conversion (entry 1). The -acidic ligand 2.64 gave a slightly higher conversion than previously 
noted at room temperature (entry 2). The more -acidic ligand 3,3',5,5'-CF3-dba (2.69) provided 
a lower conversion (entry 3). The use of norbornadiene resulted in a 30% conversion to 2.67 and 
traces of 2.68 (entry 4). Electron-rich aromatic phosphines did not have any beneficial impact; 
triphenylphosphine and tri(4-methoxyphenyl)phosphine were unreactive (entries 5 and 6), 
whereas tri(2-furyl)phosphine provided 2.67 in 14% conversion, along with traces of 2.68 (entry 
7). On the contrary, the electron-deficient tri(pentafluorophenyl)phosphine appeared to be more 
reactive, giving 40% of 2.67 and 3% of 2.68 (entry 8). The bulky, electron-rich aliphatic 
phosphonium salts 2.57 and 2.58 did not outperform any of the previous ligands in terms of 
conversion, but, significantly, 2.57 afforded a relatively higher α:γ ratio (82:18) (entries 9 and 
10). With 2.59, the reaction did not proceed (entry 11). The Buchwald-type phosphines SPhos 
and RuPhos provided 2.67 in low conversion (entries 12 and 13), and caused significant 
protodesilylation. Interestingly, Ph3As appeared to be the best ligand, as it afforded a mixture of 
α- and γ-products in a 81:19 ratio and overall 42% conversion (entry 14). Despite the small scale 
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of the reaction, 2.68 could be isolated from the reaction mixture and identified by 
1
H NMR and 
MS. Finally, Ph3Sb resulted only in traces of 2.67 (entry 15) and precipitation of Pd black. 
Table 2.4. Survey of ligands. 
 
Entry Ligand Time 
α (2.67)  
(%) 
γ (2.68)  
(%) 
2.48  
(%) 
2.66 
(%) 
2.56  
(%) 
α:γ 
ratio 
1 - 18 h 20 - 37 65 4 100:0 
2 2.64 18 h 35 - 17 36 7 100:0 
3 
 
18 h 22 - 29 54 7 100:0 
4 norbornadiene 18 h  30 1 20 42 6 98:2 
5 Ph3P 3 h - - 87 92 10 - 
6 (4-MeO-C6H4)3P 3 h - - 94 92 9 - 
7 (2-furyl)3P 18 h 14 1 28 49 8 93:7 
8 (C6F5)3P 
1 h 
3 h 
18 h 
28 
34 
40 
- 
- 
3 
54 
33 
10 
60 
49 
22 
4 
4 
4 
100:0 
100:0 
94:6 
9 2.57 
1 h 
3 h 
18 h 
2 
7 
10 
- 
1 
2 
75 
29 
3 
82 
34 
14 
10 
12 
36 
100:0 
90:10 
82:18 
10 2.58 
1 h 
3 h 
18 h 
10 
25 
36 
- 
1 
2 
78 
56 
20 
65 
24 
- 
11 
7 
23 
100:0 
95:5 
94:6 
11 2.59 3 h - - 85 95 12 - 
12 
 
18 h 13 - 17 59 28 100:0 
13 
 
18 h 7 - 37 79 22 100:0 
14 Ph3As 
1 h 
3 h 
18 h 
32 
34 
34 
0 
2 
8
a
 
49 
40 
17 
61 
51 
34 
6 
4 
6 
100:0 
93:7 
81:19 
15 Ph3Sb 18 h 2 - 80 97 7 100:0 
a. Isolated in 6% yield. The reaction was subsequently repeated on a 1.0 mmol scale; 2.67 (40%) and 2.68 
(13%) were isolated and unambiguously characterized by  
1
H NMR, 
13
C NMR, MS, and IR spectroscopy. 
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From these results, the following observations were made: (1) the α-product is preferred, 
regardless of the electronic and steric properties of the ligand; (2) in all cases, the reaction is 
sluggish and stalls before complete conversion of the starting materials; (3) when the γ-product is 
detected, the α:γ ratio decreases over the time, with the α-product being formed exclusively at 
the early stages of the reaction (entries 8-10, and 14). 
2.4.2.3.  Survey of palladium sources 
Having identified Ph3As as a promising ligand, the effects of different Pd(0) and Pd(II) 
sources were evaluated next (Table 2.5).  
Table 2.5. Survey of Pd sources with triphenylarsine. 
 
Entry Pd source Time 
α (2.67)  
(%) 
γ (2.68)  
(%) 
2.48  
(%) 
2.66 
(%) 
2.56  
(%) 
α:γ 
ratio 
1 Pd2(dba)3 
1 h 
18 h 
36 
37 
- 
5 
46 
20 
54 
37 
3 
5 
100:0 
88:12 
2 Pd(4,4’-CF3-dba)2 
1 h 
18 h 
33 
34 
- 
4 
55 
27 
61 
45 
2 
4 
100:0 
89:11 
3 APC 
1 h 
18 h 
22 
25 
0 
5 
25 
4 
46 
- 
- 
- 
100:0 
82:18 
4 PdCl2(PhCN)2 
1 h 
18 h 
15 
25 
- 
5 
63 
18 
77 
48 
4 
4 
100:0 
82:18 
5 PdCl2(CH3CN)2 
1 h 
18 h  
12 
14 
1 
10 
55 
12 
78 
49 
5 
6 
93:7 
58:42 
6 Pd(acac)2 
1 h 
18 h 
15 
15 
- 
9 
57 
14 
77 
51 
4 
6 
100:0 
62:38 
7 PdBr2 
1 h 
18 h 
12 
12 
1 
7 
28 
7 
73 
34 
2 
2 
96:4 
62:38 
8 Pd(OAc)2 
1 h 
18 h 
10 
10 
2 
10 
50 
14 
82 
61 
6 
9 
83:17 
49:51 
9 Pd(OCOCF3)2 
1 h 
18 h 
8 
10 
1 
11 
55 
10 
85 
53 
3 
6 
90:10 
47:53 
 
Palladium(0)-olefin complexes Pd2(dba)3 and Pd(4,4'-CF3-dba)2 maintained the levels of 
conversion observed for Pd(dba)2, but with a worse α:γ ratio (entries 1 and 2). Among the Pd(II) 
sources that were investigated, allylpalladium chloride dimer (APC) caused a rapid consumption 
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of the starting materials, with only a modest 29% overall conversion to the products in a 82:18 
α:γ ratio (entry 3). Similar conversion and α:γ ratio were observed with PdCl2(PhCN)2, although 
without rapid decomposition of the starting materials (entry 4). PdCl2(CH3CN)2 and Pd(acac)2 
provided a lower α:γ ratio (nearly 6:4) in 25% conversion (entries 5 and 6). Similar to APC, 
PdBr2 caused extensive decomposition of the starting materials (entry 7). Finally, the best results 
in terms of γ selectivity were obtained with Pd(OAc)2 and Pd(OCOCF3)2, which afforded a 
nearly 1:1 mixture of products, albeit in low conversion (20%, entries 8 and 9). 
A survey of other ligands in combination with Pd(OCOCF3)2 did not lead to any 
improvement (results not shown). Therefore, on the basis of the results reported in Tables 2.4 
and 2.5, Ph3As and Pd(OCOCF3)2 were identified as the best combination. Although still 
unsatisfactory, a 1:1 α:γ ratio was considered a reasonable starting point to carry out further 
optimization.  
As already observed while carrying out the ligand survey, none of the reaction conditions 
afforded synthetically useful yields of the product. Furthermore, the screening of Pd sources 
revealed an even more dramatic change in α:γ ratio over the course of the reaction. For instance, 
in Table 2.5, entry 6, the formation of the α-product ceased after one hour, and only the γ-
product was generated (at a lower rate) afterwards. 
2.4.2.4.  Effect of additives 
The fact that the α:γ ratio is not constant over the course of the reaction suggests a change in 
mechanism as the reaction progresses. Typically, this behavior originates from the accumulation 
of a byproduct, which provides an alternative mechanistic pathway. In the cross-coupling 
reaction under investigation, polysiloxanes and sodium iodide are obtained in stoichiometric 
amount from Na
+
(2.48)
−
 and 2.66, whereas triphenylarsine oxide is generated 
substoichiometrically from the reduction of Pd(II) to Pd(0). In addition, the α-product 2.67 is 
accumulating in the reaction vessel. To assess the potential impact of these species on the γ-
selectivity, a series of cross-coupling experiments were carried out by adding either NaI, 
Ph3As=O, or 2.67 to the reaction mixture (Table 2.6). None of these experiments resulted in an 
improvement of the γ-selectivity. Sodium iodide maintained conversion and α:γ ratio essentially 
unchanged relative to the experiment without additive (entry 1). Triphenylarsine oxide added 
either in a 1:1 or 1:2 ratio relative to Ph3As, improved the conversion but worsened the 
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selectivity (entries 2 and 3). The same scenario was observed for the addition of 2.67; the 
conversion increased to 50%, but the α:γ ratio changed from 1:1 to 9:1 (entry 4). 
Table 2.6. Effect of additives. 
 
Entry Conditions Time 
α (2.67)  
(%) 
γ (2.68)  
(%) 
2.48  
(%) 
2.66 
(%) 
2.56  
(%) 
α:γ 
ratio 
1 
Pd(dba)2 (5 mol%) 
Ph3As (10 mol%) 
NaI (0.5 equiv) 
1 h 
18 h 
31 
34 
- 
5 
51 
24 
62 
44 
3 
5 
100:0 
87:13 
2 
Pd(OCOCF3)2 (5 mol%) 
Ph3As (5 mol%) 
Ph3As=O (5 mol%) 
1 h 
18 h 
37 
44 
2 
8 
33 
7 
53 
17 
4 
14 
96:4 
84:16 
3 
Pd(OCOCF3)2 (5 mol%) 
Ph3As (10 mol%) 
Ph3As=O (5 mol%) 
1 h 
18 h 
29 
38 
1 
7 
44 
10 
62 
33 
4 
15 
97:3 
84:16 
4 
Pd(OCOCF3)2 (5 mol%) 
2.67 (10 mol%) 
1 h 
18 h 
16
a
 
47
a
 
- 
6 
82 
9 
80 
- 
1 
17 
100:0 
88:12 
a. These values were corrected to account for the added 2.67. 
The observation that the change in selectivity over the course of the reaction is not dependent 
upon  the accumulation of a byproduct led to formulation of a different mechanistic hypothesis. 
We envisioned that an activated transmetalation pathway would account for the formation of the 
α-isomer, whereas a thermal transmetalation mechanism would lead to the γ-isomer. In order to 
test such hypothesis, several other experimental variables were examined: concentration, cation, 
solvent, and alkyl substituents on silicon. A more thorough discussion of the connection between 
these parameters and the transmetalation pathway is provided in section 2.5.2.  
2.4.2.5.  Effect of the concentration 
Because the α-product is formed almost exclusively at the early stages of the reaction, when 
Na
+
(2.48)
−
 is still abundant, an increased amount of Na
+
(2.48)
−
 should lead to a higher α-
selectivity. This hypothesis was confirmed by the experiment shown in Table 2.7. The use of 3.9 
equivalents of Na
+
(2.48)
−
 resulted in a 91:9 α:γ ratio, with 74% overall conversion (compared to 
22%, 47:53, Table 2.5, entry 9). 
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Table 2.7. Effect of increased concentration. 
 
Time 
α (2.67)  
(%) 
γ (2.68)  
(%) 
2.48  
(%) 
2.66 
(%) 
2.56  
(%) 
α:γ 
ratio 
1 h 
18 h 
48 
67 
1 
7 
68 
27 
40 
- 
4 
10 
98:2 
91:9 
 
2.4.2.6.  Effect of the cation 
The nature of the cation M
+
 determines the nucleophilicity of M
+
(2.48)
−
, which in turn 
affects the likelihood of an activated transmetalation.
30
 Thus, Li
+
(2.48)
−
 is expected to be less 
nucleophilic than Na
+
(2.48)
−
, whereas K
+
(2.48)
−
 and Cs
+
(2.48)
−
 should be more nucleophilic, as 
the tightness of the ion pair decreases with the increasing ionic radius.
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 The cross-coupling 
experiments carried out by varying the cation are summarized in Table 2.8.  
Table 2.8. Effect of the cation. 
 
Entry Conditions Time 
α (2.67)  
(%) 
γ (2.68)  
(%) 
2.48  
(%) 
2.66 
(%) 
2.56  
(%) 
α:γ 
ratio 
1 
Li
+
(2.48)
−
 
40 C 
18 h 1 4 69 92 1 10:90 
2 
Li
+
(2.48)
− 
60 C 
1 h 
18 h 
- 
1 
5 
13 
76 
8 
88 
77 
- 
- 
0:100 
8:92 
3 
K
+
(2.48)
− 
40 C 
1 h 
18 h 
35 
45 
- 
1 
47 
18 
67 
53 
9 
34 
100:0 
98:2 
4 
K
+
(2.48)
− 
80 C 
1 h 
18 h 
57 
82 
1 
7 
22 
2 
42 
- 
12 
20 
98:2 
93:7 
5 
2.48, Cs2CO3 (1.3 equiv) 
80 C 
18 h 29 7 17 - - 81:19 
 
The lithium silanolate Li
+
(2.48)
−
 afforded the γ-product 2.68 with high selectivity. However, 
the reaction was very slow even when the temperature was raised to 60 C (entries 1 and 2). This 
68 
 
is not surprising, as the reduced nucleophilicity of Li
+
(2.48)
−
 also impacts the rate of formation 
of the Si-O-Pd linkage. Conversely, K
+
(2.48)
−
 provided high selectivity for the α-product and 
high conversion (89%, 93:7 α:γ ratio at 80 C, entry 4), in agreement with K+(2.48)− being more 
nucleophilic than Na
+
(2.48)
−
 (compare Table 2.8, entry 3 with Table 2.5, entry 9). However, 
reactions with K
+
(2.48)
−
 were accompanied by a significant amount of protodesilylated allene 
2.56. Finally, Cs
+
(2.48)
−
 was not pre-formed, but generated in situ by adding Cs2CO3 to the 
reaction mixture containing the silanol 2.48. The outcome was a 36% conversion to a 81:19 
mixture favoring the α-product (entry 5). This approach is not directly comparable to the 
previous cases, because, due to the insolubility of Cs2CO3, the actual concentration of Cs
+
(2.48)
−
 
in the reaction mixture is low. 
2.4.2.7.  Effect of the solvent 
Coordinating solvents may increase the nucleophilicity of the silanolate by solvating the 
cation.
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 Indeed, when the cross-coupling reactions of Li
+
(2.48)
−
 were carried out in ethereal 
solvents [THF, 1,4-dioxane, DME, cyclopentyl methyl ether (CPME)] a worse selectivity profile 
was encountered, with α:γ ratios ranging from 6:4 to 4:6 (Table 2.9). 
Table 2.9. Effect of the solvent. 
 
Entry Solvent 
α (2.67)  
(%) 
γ (2.68)  
(%) 
2.48  
(%) 
2.66 
(%) 
2.56  
(%) 
α:γ 
ratio 
1 THF 5 4 48 73 6 64:36 
2 1,4-dioxane 1 1 67 90 - 51:49 
3 DME 3 4 52 77 10 41:59 
4 CPME 1 2 72 88 - 38:62 
 
2.4.2.8.  Effect of the alkyl substituents on silicon 
The possibility of achieving transmetalation through an activated pathway is also dependent 
upon the steric bulk around the Si atom, as a more sterically encumbered environment disfavors 
the formation of a pentacoordinate (10-Si-5) intermediate. To establish the influence of increased 
steric bulk around silicon on the reactivity and selectivity, the diisopropyl sodium and potassium 
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silanolates (2.50)
−
 and the silanol 2.50 (with Cs2CO3) were subjected to cross-coupling 
conditions with the usual combination of reagents (Table 2.10). As the reaction of Na
+
(2.50)
−
 did 
not proceed at 40 C (entry 1), the temperature was raised to 80 C for the subsequent 
experiments. At that temperature, Na
+
(2.50)
−
 afforded 7% of a 8:92 mixture favoring the γ-
product (entry 2). The more reactive K
+
(2.50)
−
 gave higher conversion (39%), but with poorer 
selectivity (41:59) and extensive protodesilylation (entry 3). Finally, the cesium silanolate 
generated in situ from 2.50 afforded 23% of the γ-isomer, in 11:89 α:γ ratio (entry 4). Combining 
2.50 and Cs2CO3 in refluxing toluene or in ethereal solvents (CPME, 1,4-dioxane) only worsened 
the conversion and the selectivity. As anticipated, the diisopropyl substrate 2.50 caused an 
overall improvement of the γ-selectivity, however at the expense of the reactivity. 
Table 2.10. Effect of the alkyl substituents on silicon. 
 
Entry Conditions Time 
α (2.67)  
(%) 
γ (2.68)  
(%) 
2.50  
(%) 
2.66 
(%) 
2.56  
(%) 
α:γ 
ratio 
1 
Na
+
(2.50)
−
 
40 C 
18 h - - 52 85 - - 
2 
Na
+
(2.50)
−
 
80 C 
1 h 
18 h 
2 
1 
1 
6 
74 
14 
76 
11 
1 
1 
77:23 
8:92 
3 
K
+
(2.50)
−
 
80 C 
1 h 
18 h 
13 
16 
1 
23 
61 
11 
85 
43 
14 
28 
94:6 
41:59 
4 
2.50, Cs2CO3 (1.3 equiv) 
80 C 
1 h 
18 h 
1 
3 
1 
23 
84 
9 
76 
- 
- 
1 
54:46 
11:89 
 
2.5. DISCUSSION 
2.5.1.  Synthesis of allenylsilanolates 
The synthesis of allenylsilanolates turned out to be more challenging than anticipated. 
Among the possible synthetic routes (Scheme 2.14), only disconnection c offered a viable 
approach. The synthetic pathway that was developed (Schemes 2.27 and 2.28) meets the 
requirements of being short (four steps from 2-butyn-1-ol, 59% overall yield) and flexible, as one 
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of the γ-substituents is introduced by an SN2' reaction and can easily be varied from a common 
intermediate 2.47.  
2.5.1.1. Potential enantioselective variants 
The synthetic route is also suitable for an enantioselective variant (Scheme 2.31). Indeed, the 
oxidation of a similar secondary alcohol (2.70) to an acyl silane and its subsequent 
stereoselective reduction (with Ipc2BCl) have been documented.
67
 Since the oxidation/reduction 
process adds two extra steps to the synthesis, a more efficient and elegant solution is represented 
by an asymmetric, reverse-Brook rearrangement. Although asymmetric, reverse [1,2]-Brook 
rearrangements are unprecedented, an enantioselective, reverse [1,4]-Brook rearrangement has 
been demonstrated in the cyclocarbolithiation of 2.71 in the presence of (‒)-sparteine.68 
 
Scheme 2.31. Proposed enantioselective variants and literature precedents. 
2.5.1.2. Reverse Brook rearrangement 
The reverse Brook rearrangement was the most problematic step in the preparation of 
allenylsilanols 2.48 and 2.50 (Schemes 2.27 and 2.29). The products 2.45 and 2.52 were obtained 
in variable yield (25-72%) and were always accompanied by the concomitant formation of 
silanols 2.46 and 2.53 (which did not originate from simple hydrolysis of silyl chlorides 2.43 and 
2.51). Notably, increasing the steric bulk on silicon also increased the amount of silanol 2.53 
formed. Although it is not clear how 2.46 and 2.53 are formed, the low yields observed in the 
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rearrangement could be attributed to two factors: (1) equilibration of 2.44 and 2.45 under the 
reaction conditions; or (2) competitive deprotonation at C(3) of the DMOP ring, yielding 
(unproductively) a chelation-stabilized organolithium. The former hypothesis seems less likely, 
because the use of a stoichiometric amount of a strong lithium base is known to greatly favor O-
to-C migration of silyl groups.
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2.5.1.3. Silanol masking groups 
Significant efforts were also dedicated to the development of a practical protecting group 
strategy amenable to revealing the silanol moiety at the end of the synthetic sequence. Among 
the silanol surrogates, the most atom-economical solution is represented by a hydrosilane, which 
can be converted into a silanol by mild oxidation.
70
 However, attempts to carry out the reverse 
Brook rearrangement with Et2SiHCl or i-Pr2SiHCl failed.  
The ability to cleave an aromatic group from silicon under acidic conditions has been known 
since 1949,
71
 and a number of acid-labile protecting groups for silicon have been reported 
(Figure 2.2a).
55,72,73
 The TMOP group appeared an attractive choice; despite the poor atom-
economy, it is easy to install and its cleavage requires mildly acidic conditions, thus limiting 
unwanted side reactions such as hydration of the allene, protodesilylation, and formation of 
disiloxane. However, the TMOP group proved incompatible with a double ethyl substitution on 
silicon (2.29), probably due to the increased steric repulsion between the ethyl substituents and 
the ortho-methoxy groups, compared to the dimethyl silane 2.25. The less sterically demanding 
3,5-DMOP did not cleave even under forcing acidic conditions (Scheme 2.21); hydration of the 
allene and protodesilylation were observed. The stability of 3,5-DMOP towards acidic cleavage 
is surprising, considering that a 3-methoxyphenyl group and a 4-methoxyphenyl group were 
cleaved at comparable rates from silicon.
74
 A good compromise between electronic and steric 
effects was offered by the DMOP group (Figure 2.2b). Although no cleavage was observed with 
the conditions used for removing the more electron-rich TMOP group, replacing THF with the 
less solvating dichloromethane allowed for a rapid deprotection of 2.36 and 2.49 (the 
diisopropyl-substituted silane 2.55 required two equivalents of HCl at room temperature for 
complete cleavage). In addition to emphasize the importance of substituent effects in the 
cleavage of aromatic groups from silicon, these results demonstrate the utility of the DMOP 
group as a silanol surrogate in sterically encumbered silanes. 
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Figure 2.2. Silanol masking groups and conditions for their cleavage. 
2.5.1.4. Deprotonation of allenylsilanols 
The deprotonation of γ-dialkyl silanols 2.39, 2.48 and 2.50 proceeded cleanly with a variety 
of lithium, sodium and potassium bases. However, the presence of an aromatic substituent at the 
γ-position was not tolerated. When the γ-phenyl-substituted allenylsilanols 2.20 and 2.27 were 
treated with strong bases, complex reaction mixtures were observed, consisting mainly of 
polymerization byproducts and protodesilylated allene. It seems that the presence of a phenyl 
group at the γ-position facilitates the cleavage of the C-Si bond by delocalizing the charge of the 
resulting allenyl anion. On the contrary, protodesilylation is not as favorable in the case of γ-
dialkyl-substituted silanols, which can be deprotonated cleanly. 
2.5.2.  Cross-coupling of allenylsilanolates 
2.5.2.1. Explanation of the observed α/γ-selectivity 
The experimental results accumulated by surveying reaction conditions showed that γ-
disubstituted allenylsilanolates react preferentially at the α-position to generate an allenic 
product. This tendency was difficult to overcome. Despite extensive investigation, the γ-product 
was obtained in a 89:11 ratio and 23% conversion, at best. 
According to the general mechanistic picture presented in Scheme 2.10, the α:γ ratio may be 
determined at three stages: (1) interconversion of allenyl- and propargylsilanes; (2) SE versus SE' 
transmetalation; (3) interconversion of allenyl- and propargylpalladium intermediates. The 
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equilibration of the silanolate M
+
(2.48)
−
 with its propargylic isomer can be ruled out, as 
allenylsilanes (with the exception of trichlorosilanes)
75
 do not undergo 1,3-shift.
16
  
An initial hypothesis that can be formulated to justify the preference for the α-isomer 2.67 
requires that the interconversion of the allenylpalladium xxiii and propargylpalladium xxiv 
intermediates be the selectivity-determining step (Scheme 2.32). Under this circumstance, the 
presence of two substituents at the γ-terminus would decrease the rate of reductive elimination 
from xxiv, and facilitate reductive elimination from xxiii. Moreover, it is known that reductive 
elimination to an sp
2
 carbon is more facile than to an sp
3
 carbon.
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Scheme 2.32. Isomerization of organopalladium(II) intermediates xxiii and xxiv. 
However, a more careful examination of the experimental data, and particularly of the fact 
that the α:γ ratio decreases over the course of the reaction, made us consider the alternative 
explanation that the transmetalation pathway (activated vs. thermal) dictates which mechanism is 
operative (SE vs. SE') and, therefore, which isomer is accessed (Scheme 2.33). Following 
oxidative addition and formation of the Si-O-Pd linkage in xxv by iodide displacement, a thermal 
transmetalation event via an SE' mechanism converts xxv into propargylpalladium(II) complex 
xxiv. The Si-O-Pd linkage is crucial in enabling this process, as intermediate xxv is set for an 
intramolecular SE' transmetalation via a favorable 6-member transition state. Reductive 
elimination from xxiv generates the γ-product 2.68. If another molecule of silanolate coordinates 
to the silicon center in xxv, then activated transmetalation will take place from the hypervalent 
siliconate xxvi. A transmetalation event, proceeding exclusively via an SE mechanism, will form 
allenylpalladium(II) intermediate xxiii. Reductive elimination from xxiii will then lead to the α-
product 2.67. This mechanistic hypothesis does not exclude the possibility of equilibration of 
xxiii and xxiv. However, in the presence of a weakly coordinating ligand (such as 
triphenylarsine), reductive elimination is expected to be faster than the isomerization between the 
short-lived intermediates xxiii and xxiv, such that the transmetalation step is selectivity-
determining.  
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Scheme 2.33. Proposed catalytic cycle featuring a selectivity-determining transmetalation step. 
2.5.2.2. Mechanistic implications 
If the proposed mechanism is operative, then several experimental parameters can be varied 
to favor one transmetalation pathway over the other: 
1. Concentration of the silanolate. A higher concentration of M+(2.48)− favors the formation of 
the pentacoordinate intermediate xxvi and therefore increases the preference for activated 
transmetalation; 
2. Nature of the cation M+. Larger, less coordinating cations (K+, Cs+) are expected to produce 
more nucleophilic silanolates, which therefore tend to form the activated complex xxvi more 
easily. On the contrary, a lithium cation is tightly coordinated to the oxygen of the silanolate, 
making it less nucleophilic and capable of forming xxvi. Thermal transmetalation from xxv is 
expected to occur preferentially in this case; 
3. Nature of the R substituents on silicon. Increasing the steric bulk around silicon will decrease 
the likelihood of forming the already sterically congested complex xxvi. Larger R groups on 
silicon should therefore result in a preference for thermal transmetalation; 
4. Solvent. Coordinating solvents that are capable of loosening the silanolate-metal ion pair will 
increase the nucleophilicity of the silanolate and facilitate the activated transmetalation; 
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5. Presence of additives. As for the solvent, additives capable of binding the cation (amines, 
crown ethers) will increase the nucleophilicity of the silanolate. 
The experimental results fully support the proposed mechanistic hypothesis, as varying some 
of the above parameters always had the expected outcome on the α:γ ratio. First of all, the effect 
of the concentration of the silanolate is immediately apparent from the decreasing preference 
toward α-selectivity over the course of the cross-coupling reaction. At the early stages of the 
reaction, the silanolate is more concentrated and activated transmetalation is therefore preferred. 
As the reaction proceeds, the concentration of the silanolate decreases (by productive or 
unproductive consumption), and the thermal transmetalation becomes competitive. In addition, 
the experiment shown in Table 2.7 unambiguously proves that a higher concentration of 
silanolate favors the formation of the α-product.  
Varying the cation and the R substituents on silicon also resulted in a trend of γ-selectivity 
increasing in the order K
+
 < Na
+
 < Li
+
 and Et < i-Pr (Tables 2.8 and 2.10). As expected, 
however, the reactivity trends were reversed; the less nucleophilic lithium silanola te Li
+
(2.48)
−
 
and the more hindered diisopropyl silanolates M
+
(2.50)
−
 were less reactive.
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The observation of γ-selectivity with the cesium silanolates requires additional explanation. 
Since the cesium silanolates Cs
+
(2.48)
−
 and Cs
+
(2.50)
−
 were not pre-formed stoichiometrically, 
but generated in situ by adding Cs2CO3 to the reaction mixture containing the silanols 2.48 or 
2.50, it is expected that the actual concentration of Cs
+
(2.48)
−
 or Cs
+
(2.50)
−
 be very low. As a 
consequence, the selectivity is determined by the subtle balance between the nucleophilicity and 
the actual concentration of the silanolate. For Cs
+
(2.48)
−
, the selectivity was intermediate 
between that of Na
+
(2.48)
−
 and K
+
(2.48)
−
 (Table 2.8). With Cs
+
(2.50)
−
, the bulkiness of the i-Pr 
groups greatly decreased the nucleophilicity of the silanolate, and the selectivity became 
comparable to that of Na
+
(2.50)
−
 (Table 2.10).  
Lastly, replacing toluene with Lewis-basic solvents (THF, DME, 1,4-dioxane, CPME) 
resulted in the expected lowering of the γ-selectivity (Table 2.9). 
The other parameters that were examined over the course of the optimization are not directly 
related to the interpretation of the α:γ selectivity. The fact that no reaction was observed with an 
aryl bromide (Table 2.3) suggests that the displacement step might be turnover-limiting. No 
specific trend was observed with respect to the ligand (Table 2.4) or the palladium source (Table 
2.5). -Acidic ligands (dba, 4,4'-CF3-dba, 3,3',5,5'-CF3-dba) and norbornadiene, which are very 
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active ligands in the γ-selective coupling of allylsilanolates,11 provided relatively high 
conversion, but exclusive α-selectivity. Among the phosphines, only the electron-deficient 
tri(pentafluorophenyl)phosphine and the bulky, electron-rich 2.58 resulted in comparable 
conversion, but again with α-selectivity. Electron-rich aromatic phosphines and other bulky 
aliphatic phosphines (including Buchwald-type ligands) afforded little to no product. The best 
compromise between reactivity and selectivity was provided by the weakly coordinating 
triphenylarsine, already known to have a beneficial effect on the rate of Stille reactions.
78
 With 
Ph3As, an 8:2 α:γ ratio was obtained using Pd(dba)2, and a nearly 1:1 α:γ ratio using Pd(II) 
sources (Pd(OAc)2 and Pd(OCOCF3)2). The heavier analog Ph3Sb, although known to weakly 
coordinate to metal centers,
79
 caused the precipitation of Pd(0). 
2.6. CONCLUSION 
The optimization of the γ-selective cross-coupling of γ-disubstituted allenylsilanolates turned 
out to be a challenging endeavor. Despite extensive surveying of reaction conditions, the γ-
product was obtained in 89:11 ratio and 23% conversion at best. On the other hand, the 
preference of γ-disubstituted allenylsilanolates to undergo cross-coupling at the α-terminus 
allowed for the quick identification of conditions for the α-selective coupling. The α-product was 
obtained in 93:7 ratio and 82% conversion. 
Through the screening of reaction conditions, a large amount of information was 
accumulated that helped gain insight into the mechanism of this transformation. The mechanistic 
hypothesis emerging from the experimental data was crucial in determining which factors should 
be adjusted to attain improved γ-selectivity. However, the reaction parameters that led to higher 
γ-selectivity also caused diminished reactivity. Thus, even though the trends were successfully 
reversed in favor of the γ-isomer, the yields were always below the level required for synthetic 
utility. 
Of the proposed research goals, the primary objective of developing optimal conditions for 
the γ-selective cross-coupling of allenylsilanolates was, unfortunately, not achieved.  The major 
accomplishments in this research project can be summarized as follows: 
1. Development of a convenient and flexible synthesis of allenylsilanols, which could 
potentially be enantioselective; 
2. Introduction of a new protecting group for sterically encumbered silanes; 
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3. Identification of optimal conditions for the α-selective cross-coupling of allenylsilanolates. 
The latter topic is open to further investigation, particularly with regards to substrate 
generality and stereospecificity of the transformation with enantiomerically-enriched silanolates. 
The successful development of the enantiospecific α-selective cross-coupling of 
allenylsilanolates may constitute a valuable alternative to copper-mediated SN2' reactions for the 
synthesis of allenes, especially with highly-functionalized and sensitive substrates. 
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Chapter 3:  
Applications of the Water-Gas Shift Reaction in organic synthesis: 
approaches toward the catalysis of fundamental C-C bond forming 
reactions 
 
3.1. INTRODUCTION
*
 
The Water-Gas Shift Reaction (WGSR) is a transformation of long-standing industrial 
relevance that converts a mixture of carbon monoxide and water into hydrogen and carbon 
dioxide (Eq. 3.1).
1
 
  (3.1) 
Many industrial manufacturing processes rely on synthesis gas (CO + H2) as the raw 
material.
2
 This mixture can be obtained either by coal gasification or, more commonly, from 
steam reforming of natural gas. Depending upon the method of production, synthesis gas will 
constitute different ratios of CO and H2. The WGSR is employed to adjust this ratio to the 
optimal value, or to remove CO altogether by converting it to CO2. Thus, the WGSR finds 
application in the Haber-Bosch process for ammonia synthesis,
3
 in which high purity H2 is 
obtained from synthesis gas by removal of CO (which would poison the Fe-based ammonia 
synthesis catalyst). Also, it is used to tune the H2/CO ratio in the production of methanol
4
 and in 
the Fischer-Tropsch process for the synthesis of hydrocarbons.
5
 
The WGSR is not limited to industrial applications, but has also been used sporadically in 
organic synthesis as a method to carry out reductive processes. In these instances, H2 is not a 
direct product of the reaction, but rather, the reductive potential of the WGSR is channeled 
toward the reduction of organic substrates, or exploited to insure turnover of catalytic cycles. The 
hydroformylation reaction is an excellent example to illustrate this concept. In its original 
                                                          
*
  The contents of Sections 3.1 and 3.2 were partially reproduced (adapted) with permission from Angew. Chem. 
Int. Ed. 2016, DOI: 10.1002/anie.201601803. Copyright 2016 Wiley-VCH Verlag GmbH & Co. KGaA, 
Weinheim. 
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incarnation, the hydroformylation reaction converts terminal alkenes into homologous aldehydes 
utilizing a mixture of CO and H2 over a Co or Rh catalyst (Eq. 3.2).
6
  
   (3.2) 
In 1953, Reppe and Vetter introduced a modified protocol that used H2O in lieu of H2, and 
Fe(CO)5 as the catalyst in basic media (Eq. 3.3).
7
 Under these conditions, the WGSR generates 
intermediate metal-hydride complexes that account for the overall reductive process. Formally, 
this can be seen as formation of H2 in situ. 
  (3.3) 
In addition to hydroformylation, the operation of the WGSR has also been documented in 
several other reductive processes, including nitro reduction, reductive amination, hydrogenation 
of carbonyls and alkenes.
8
 
3.1.1. Serendipitous discovery in our laboratories 
Our group became interested in the WGSR in 2008, after the serendipitous discovery that the 
WGSR was operative in a transformation being studied in our laboratories.
9
 At that time, the 
goal was to develop an allylation reaction of aldehydes that was catalytic in metal (i.e. without 
stoichiometric amounts of metal reducing agents). Two decades earlier, Watanabe and coworkers 
had reported the formation of homoallylic alcohols from allyl acetate and aldehydes under 
ruthenium catalysis using triethylamine as the stoichiometric reducing agent (Scheme 3.1a).
10
 
The reaction required harsh conditions and high pressures of CO to stabilize the low-valent 
ruthenium carbonyl catalyst, but nevertheless suited our requirement of being catalytic in metal. 
In an attempt to identify a more practical protocol, reaction conditions were surveyed in our 
laboratories using a six-well autoclave. To our surprise, it was found that the reaction proceeded 
much faster after the autoclave had been cooled and opened in air for sampling and monitoring, a 
fact that was attributed to the presence of oxygen or water. Control experiments showed indeed 
that addition of water significantly accelerated the reaction and allowed for milder conditions to 
be employed (Scheme 3.1b). Moreover, it was found that the conversion improved using a 
substoichiometric amount of triethylamine (0.1 equiv), whereas the use of excess amine was 
detrimental. Evidently, in our case the base was not the stoichiometric reducing agent, as initially 
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shown by Watanabe et al.
11
 Thus, it was concluded that the turnover of the catalytic cycle was 
originating instead from the combined action of CO and H2O in the water-gas shift reaction. 
These remarkable findings opened up an entire new avenue of investigation in our group as we 
strived to extend this capacity of the CO/H2O couple to other reductive processes. 
 
Scheme 3.1. Catalytic allylation of aldehydes. 
3.1.2. C-C bond formation via reductive processes 
A large number of C-C bond forming reactions in the toolbox of the synthetic organic 
chemist are overall reductive and rely on pre-formed organometallic species or 
(super)stoichiometric amounts of reducing agents (Scheme 3.2). Addition of organometallic 
reagents to carbonyls (Grignard reagents, stannanes, organochromium reagents, for instance) 
require that the organometal species be pre-formed stoichiometrically from a precursor at a 
higher oxidation state (usually a halide). The metal is then discarded in its oxidized form at the 
end of the reaction. Reductive homocoupling and heterocoupling reactions can be carried out 
with a stoichiometric amount of Ni(0), which produces Ni(II) as a consequence of the reductive 
elimination step needed to forge the new C-C bond. The Wittig reaction employs a 
stoichiometric amount of a phosphine, which enables the olefination step and is converted into a 
phosphine oxide. Although extremely robust and practical for small scale applications, protocols 
of this type are not amenable to scale-up, because of the scarce atom economy and the large 
amount of waste (often toxic) that is generated.  
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Scheme 3.2. Examples of reductive processes in organic synthesis. 
In an effort to address the issue of waste generation and removal, protocols have been 
developed in which the active metal (or reagent) is used catalytically in combination with a 
stoichiometric reducing agent, whose only role is to ensure turnover of the catalytic cycle 
(Scheme 3.3). Thus, allylation reactions can be carried out under Nozaki-Hiyama-Kishi 
conditions using catalytic amounts of Cr(II) or Cr(III) and Mn(0) as the stoichiometric 
reductant.
12
 Catalytic reductive coupling reactions have become possible by combining a 
catalytic amount of Ni(0) with stoichiometric Zn(0).
13
 Wittig olefination reactions have been 
rendered catalytic in phosphine by the use of a silane as the terminal reducing agent.
14
 These 
strategies, which are commonly referred to as “catalytic variants”, are really not catalytic, 
because they merely replace a stoichiometric reducing agent with another, perhaps more 
tractable, stoichiometric reducing agent.  
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Scheme 3.3. Examples of pseudo-catalytic reductive processes in organic synthesis. 
The first of the “Grand Challenges” identified by the NRC report “Sustainability in the 
Chemical Industry” calls for the reduction of waste and the identification of environmentally 
benign strategies (“it is better to prevent waste than to clean it up after it is formed”).15 In line 
with these recommendations, alternative strategies have been proposed that are waste-free 
because of their overall redox-neutrality (Scheme 3.4). Krische and coworkers showed that the 
Ir-catalyzed allylation of carbonyls can be carried out starting from a benzylic alcohol, which 
serves both as the reagent and the source of reducing equivalents as it is oxidized in situ to the 
corresponding aldehyde.
16
 Similarly, Beller and coworkers described the alkylation of ketones 
with alcohols relying on the same hydrogen-transfer concept.
17
 Strategies of this kind are truly 
catalytic and are becoming increasingly popular.
 18,19
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Scheme 3.4. Examples of catalytic transformations based on a hydrogen-transfer approach. 
The finding that carbon monoxide could serve as a terminal reducing agent in the Ru-
catalyzed allylation reaction, resulting in an atom-economic process which is essentially waste-
free (the only byproducts are CO2 and acetic acid), led us to consider its potential applications in 
a variety of other reductive transformations. Although our intended approach is akin to the 
strategies shown in Scheme 3.3, and therefore not truly catalytic, CO stands out among other 
stoichiometric reducing agents because of the negligible impact of the waste that it produces. 
3.2. BACKGROUND 
3.2.1. The water-gas shift reaction 
3.2.1.1. Historical overview 
The WGSR was first reported by Ludwig Mond in 1888,
20
 but its importance was not 
recognized until the development of the Haber-Bosch process for the synthesis of ammonia.
3,21
 
The water gas (a mixture of CO and H2 obtained from steam and incandescent coal) was 
employed as the source of hydrogen. However, removal of excess CO by liquefaction proved to 
be challenging on a large scale. The WGSR provided an efficient method for the removal of CO  
by conversion to CO2 (more easily removed by dissolution in water), with the benefit of 
producing additional H2 for ammonia synthesis. In an attempt to optimize the process, 
researchers at BASF initiated an intensive research program in the early 1910s and eventually 
settled on a Fe2O3-Cr2O3 heterogeneous catalyst. This system, named the High Temperature 
(HT) shift catalyst, operated above 400 °C and could achieve CO levels of 2-4% at the exit of the 
reactor.
22
 In the early 1960s, the CO conversion was further improved by the discovery of a 
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series of Cu-ZnO catalysts, called Low Temperature (LT) shift catalysts, which operated at lower 
temperature (200 °C) and afforded an exit CO concentration of 0.1-0.3%.
23
 The higher efficiency 
observed at lower temperature is a direct consequence of the thermodynamics of the WGSR 
(vide infra). Consequently, further research efforts focused on the identification of more active 
catalysts that could operate at low temperature. 
In 1932 Hieber et al. reported that metal carbonyl complexes reacted with aqueous bases to 
form metal carbonyl hydrides. Following acidification, H2 and CO2 were released (Eq. 3.4).
24
  
  (3.4) 
In the 1970s, the analogy between these observations and the steps in the WGSR was 
eventually recognized. Thus, metal carbonyls were investigated as potential low-temperature, 
homogeneous WGSR catalysts, leading to a series of patents
25
 and four independent publications 
in 1977. Ford et al.
26
 and  Pettit et al.
27
 reported that several transition metal carbonyl complexes 
are active WGSR catalysts when combined with organic or inorganic bases at temperatures as 
low as 100 °C. In contrast, Eisenberg et al.
28
 and Zudin et al.
29
 were able to show that the WGSR 
can also take place in acidic media. These seminal reports launched decades of intensive research 
aimed at identifying more efficient homogeneous catalysts. Hundreds of soluble transition metal 
complexes, representing over 20 d-block elements, have been examined for their ability to 
catalyze the WGSR and the results have been thoroughly chronicled.
30
 
More recently, a renewed interest in heterogeneous WGSR catalysis led to the discovery of 
extremely active, supported gold catalysts. The initial investigations by Andreeva et al. showed 
that Fe2O3-supported Au catalyzes the WGSR in the 160-200 °C range, whereas Fe2O3 alone is 
poorly reactive.
31
 Titania (TiO2)-,
32
 ceria (CeO2)-,
33
 and zirconia (ZrO2)-
34
 supported gold 
catalysts are equally reliable. The activity of supported gold catalysts is highly dependent on the 
method of deposition, the structure and size of the nanoparticles. Investigation in the area is still 
ongoing, especially with regard to the reaction mechanism, the nature of active sites and their 
relationship to catalytic activity.
35
 
Remarkably mild conditions for the WGSR have been achieved through the use of 
photocatalysis.
36
 In 1980, Sato and White reported that UV-irradiated Pt/TiO2 catalyzed the 
WGSR at room temperature and below!
37
 Following this initial disclosure, a number of soluble 
transition metal complexes were found to be active photocatalysts for the WGSR at ambient 
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pressure and temperature.
38
 Ir-bipyridine complexes, which are widely utilized for their 
photocatalytic properties, have been investigated by Ziessel in their capacity to promote the 
WGSR.
39
 
Despite the advances in the low temperature WGSR brought about by the use of 
homogeneous and photocatalysis, these systems have yet to match the levels of performance and 
robustness of heterogeneous catalysts. Thus, the HT and LT shift catalysts, originally intended 
for the synthesis of ammonia and improved over the course of the years, still represent today the 
basis for the catalysis of the WGSR on an industrial scale. 
3.2.1.2. Thermodynamics and mechanism 
The WGSR is a reversible, moderately exothermic reaction (ΔH0 = ‒9.8 kcal/mol). As such, 
according to the Van’t Hoff equation, the equilibrium constant decreases with increasing 
temperature. This aspect, demonstrated experimentally by Haber as early as 1909,
40
 explains the 
higher efficiency of the LT shift catalysts, although at the expenses of the reaction rate. In 
accordance with Le Châtelier’s principle, the equilibrium constant is not affected by the pressure 
since the number of moles of reactant and products is independent of the position of the 
equilibrium. 
The kinetics and mechanism of the WGSR under heterogeneous catalysis have been widely 
investigated and have been the subject of debate over decades.
41
 Two limiting mechanisms have 
been proposed: (1) the associative mechanism, which involves the adsorption of H2O and CO, 
the formation of an intermediate on the surface of the catalyst and its decomposition into CO2 
and H2, and (2) the regenerative or redox mechanism, which entails reduction of H2O to H2 with 
concomitant oxidation of the catalytic surface, followed by oxidation of CO to CO2. Although 
the consensus mechanism for the HT catalysts is the regenerative, redox proposal, the 
mechanistic scenario for LT catalysts appears much less well understood and is highly dependent 
upon the metal and the experimental conditions.
42
  
The discovery of homogeneous catalysts has opened up the possibility for the detection and 
characterization of reactive intermediates, leading to a more refined and relatively well 
understood mechanistic picture.
30b
 The catalytic cycle shown in Scheme 3.5 represents the 
generally accepted mechanism for the WGSR catalyzed by a metal-carbonyl complex (i) under 
basic conditions. The cycle consists of five steps: (A) nucleophilic activation of coordinated CO 
to form hydroxycarbonyl complex ii, (B) decarboxylation to form metal hydride iii, (C) 
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protonation, (D) reductive elimination of H2 from the dihydrido complex iv, and (E) binding of 
CO to the coordinatively unsaturated intermediate v.  
 
Scheme 3.5. General catalytic cycle of the WGSR under basic conditions. 
In the Fe(CO)5 system investigated by King et al., the mechanism follows the general 
catalytic cycle with step A being turnover limiting.
43
 DFT studies also support this catalytic 
cycle, although alternative proposals have been formulated.
44
 The mechanism appears to be more 
complex with Ru, Os, Rh and Ir carbonyl complexes due to the formation of metal clusters.
45
 A 
different pathway has been suggested for Group 6 (Cr, Mo, W) metal-carbonyl complexes. 
Activation of free CO forms anionic formate (F), which coordinates to the metal (G). 
Decarboxylation then takes place from a formate-metal complex vi rather than a 
hydroxycarbonyl-metal complex ii.
46
  
The occurrence of the WGSR under acidic conditions is a much less general phenomenon. 
For instance, while Ir4(CO)12, Fe(CO)5 and Ru3(CO)12 are all active catalysts in alkaline solution, 
only the latter is active in the presence of H2SO4.
30a,47
 A plausible mechanism was proposed by 
Ford et al. using Ru3(CO)12, which generates the active Ru2(CO)9 catalyst vii in situ (Scheme 
3.6).
48
 Under acidic conditions, coordinated CO must be sufficiently activated toward 
nucleophilic attack by water rather than hydroxide (step J, as opposed to A). This activation can 
be achieved if protonation of the metal center (H) occurs prior to nucleophilic attack of CO. 
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Protonation raises the oxidation state by two, decreases the extent of CO back-bonding and 
therefore renders CO more susceptible to nucleophilic attack. Similar mechanistic proposals have 
been formulated for related acid-catalyzed processes.
49
 
 
Scheme 3.6. Catalytic cycle of the WGSR under acidic conditions using Ru3(CO)12/H2SO4. 
The mechanism of the WGSR under photocatalysis has been described for 
[Ir(bipy)Cp*Cl]
+
Cl
‒
 (xii, R=COOH) in a landmark study by Ziessel (Scheme 3.7).
[39c]
 Following 
the initial CO coordination and activation steps (M and N), turnover-limiting decarboxylation 
yields the neutral, coordinatively unsaturated complex xv, the intermediacy of which has been 
established by direct isolation. Protonation of the metal center furnishes the hydrido intermediate 
xvi, which is prone to photoexcitation and protonation of the excited state xvii, and reductive 
elimination of H2 thereby (R). The requirement for light in the final protonation step was 
demonstrated by the lack of reactivity of complex xvi in the dark. 
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Scheme 3.7. Catalytic cycle of the WGSR under photocatalysis using xii. 
3.2.2. Existing applications of the water-gas shift reaction in organic synthesis 
The vast amount of research done since the 1970s on homogeneous catalysis has 
demonstrated the possibility of harnessing the reduction potential of the WGSR to drive 
reductive organic transformations. The obvious advantages of this synergy include low impact of 
waste, scalability and availability of precursors. However, despite all of the research into 
improving the efficiency of the WGSR, the process nowadays is mainly utilized for the 
generation of hydrogen using heterogeneous catalysis, while its applications to the synthesis of 
fine chemicals remain underdeveloped. The following sections will illustrate the potential for 
application of the WGSR to a plethora of organic transformations and identify areas of future 
development. 
The reduction potential of the WGSR can be exploited in organic synthesis in two different 
ways. In the first approach, the WGSR provides reducing equivalents that can be directly 
incorporated into the final product (Figure 3.1a). Essentially, this corresponds to the delivery of 
H2 as would be achieved through a hydrogenation reaction, although free H2 is not directly 
involved. In the second approach, the reducing potential of the WGSR is applied to a metal 
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catalyst that has to be reduced to its active form to reenter the catalytic cycle (Figure 3.1b). In the 
absence of the WGSR, transformations of this type would require a stoichiometric amount of a 
reducing agent, usually a low-valent metal (Mn, Zn, SmI2, SnCl2, etc.). It should be highlighted 
that, whereas in the former case the WGSR offers modest to no practical advantage over a 
standard hydrogenation, the latter case eliminates the need for a stoichiometric amount of metal, 
thus reducing the waste stream and enhancing atom economy. 
 
Figure 3.1. WGSR in organic transformations. 
Another important distinction involves the type of transformation that is accomplished. The 
vast majority of reactions employing the WGSR entail the reduction of a functional group 
without a carbon-carbon bond forming event. These transformations usually fall into the 
category of incorporation of H2 (as in the reduction of nitro groups, imines, alkenes and 
carbonyls), although there are exceptions (deoxygenation of epoxides). Only a limited number of 
WGSR-promoted reactions accomplish the formation of a carbon-carbon bond. Among those, 
some rely on CO as both the reducing agent and the source of carbon (hydroformylation and 
other carbonylation reactions), whereas others utilize an external building block to forge the new 
carbon-carbon bond (allylation, alkylation). The following sections are arranged on the basis of 
this classification. This review covers only transformations that employ the CO/H2O couple as 
the reducing agent in the presence of a metal catalyst. Reductions carried out with CO alone 
(without water and/or hydroxide) will not be covered. Likewise, reactions that employ a metal 
carbonyl complex in stoichiometric amounts are not included in this review. 
3.2.2.1. Non-C-C bond forming reactions 
3.2.2.1.1. Nitro reduction 
The reduction of nitroarenes to anilines represents the most common application of the 
WGSR to organic synthesis. Traditionally, this transformation is carried out using stoichiometric 
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amounts of reducing agents (such as Fe or Zn powder, Na2S, SnCl2), or catalytic hydrogenation 
over Pd, Pt or Ni.
50
 The use of the WGSR as the source of reducing equivalents allows for a mild 
and chemoselective process. The nitro-to-amine transform is a 6e
‒
-reduction, therefore three 
equivalents of CO are required per mole of nitro compound (Eq. 3.5). 
  (3.5) 
The reduction of nitrobenzene to aniline with CO/H2O was first reported by Iqbal in 1971 
using Rh catalysts and organic bases (Scheme 3.8a).
51
 More systematic studies were undertaken 
by Pettit et al. in 1978 using Fe, Rh, Ru, Os, Ir carbonyl complexes and aqueous solutions of 
trialkylamines (Scheme 3.8b).
52
 
 
Scheme 3.8. Initial reports on nitroarene reduction using WGSR conditions. 
The metal complexes under examination are active catalysts for the WGSR and do generate 
H2 when exposed to CO/H2O. However, Pettit et al. suggested the involvement of a metal-
hydride intermediate [HM(CO)n]
‒
 as the reducing agent (formed via CO 
activation/decarboxylation, as iii in Scheme 3.5),
53
 as opposed to in situ generation of H2. This 
point was demonstrated by the incorporation of deuterium in the product when the reaction was 
carried out in the presence of CO/D2O/H2 (Eq. 3.6). From these results, it appears evident that H2 
is not causing the reduction of nitrobenzene, even though it may be generated under the reaction 
conditions. 
  (3.6) 
In 1980, Alper and Amaratunga described a system capable of operating under mild 
conditions (ambient pressure and temperature).
54
 The system is comprised of Ru3(CO)12 and 
BnEt3N
+
Cl
‒
 as the phase transfer catalyst in a mixture of 5 M aqueous NaOH/benzene/2-
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methoxyethanol (Eq. 3.7). The increased reactivity is attributed to the solubility of the putative 
ammonium-rutenate intermediate [BnEt3N]
+
[HRu3(CO)11]
‒
 in the organic phase. 
  (3.7) 
These initial reports stimulated dozens of further elaborations,
55
 and the topic is still an active 
field of research. A summary of catalysts and reaction conditions that have been reported is 
provided in Table 3.1. Most of the protocols employ basic or neutral conditions, although there 
are examples of acidic media (entries 12 and 14). Generally, the reaction conditions have been 
optimized for nitrobenzene as a benchmark and extended to a limited number of nitroarenes, 
making it impossible to come to conclusions regarding their generality. A few methods, 
however, possess remarkable generality and functional group tolerance, and will be discussed 
separately (entries 6, 17, 22, 35, 39). The most user-friendly protocols appear to be those that 
employ phase-transfer catalysis (entries 4 and 11) or additives such as amines and phosphines 
(entries 15 and 16), as they operate under mild conditions (room temperature and ambient 
pressure) with readily available reagents. The use of selenium as the catalyst, which generates 
H2Se under WGSR conditions, is also well established (entries 5, 26, 32). 
Table 3.1. Reaction conditions for the reduction of aromatic nitro groups. 
Entry Metal catalyst Additives T (°C) PCO (bar) Ref. 
1  
Rh2O3, RhCl3·3H2O,  
Rh carbonyl complexes 
pyridine,  
N-methylpyrrolidine 
50-150 50-121 51 
2  
Mn, Re, Fe, Ru, Os, Rh, Ir, Pt 
carbonyl complexes 
Me3N, Et3N 25-187 34-117 52,56 
3  Rh6(CO)16 
N,N-dimethylbenzylamine (DMBA), 
polymer-bound DMBA 
80-120 7-55 57 
4  Ru3(CO)12 NaOH / BnEt3N
+Cl‒ 25 1 54 
5  Se Et3N 80 30 58 
6  Rh carbonyl complexes 
aliphatic amines and diamines, 
pyridine, substituted pyridines, 
polymer-bound amines 
80 1-8 59,60,61 
7  [Ru(cod)py4](BPh4)2 - 80-145 15-61 62 
8  PtCl2(PPh3)2 Et3N / SnCl4 20-100 15-59 63,64 
9  Fe2O3/Al2O3 alkali metal carbonates 300-350 1 65 
10  Rh6(CO)16, Ru3(CO)12 
phenanthroline, substituted 
phenanthrolines, bipyridine, 
TMEDA 
165 30 66,67 
11  Co2(CO)8 / [Rh(1,5-hexadiene)Cl]2 NaOH / (C12H25)Me3N
+Cl‒ 25 1 68 
96 
 
Table 3.1. (cont.) 
Entry Metal catalyst Additives T (°C) PCO (bar) Ref. 
12  Ru and Os carbonyl complexes 
KOH, HCl, HBr, HBF4, CH3COOH, 
CF3COOH  
120 69 69 
13  Co carbonyl complexes NaOH / (C16H33)Me3N
+Br‒ 25 1 70 
14  (η4-Ph4C4C=O)Ru(CO)3 
Na2CO3, NaHCO2, CH3COOH, 
CF3COOH 
105 34 71 
15  
Rh carbonyl complexes /  
amines and diamines 
NaOH 25 1 72 
16  
Rh and Ru carbonyl complexes / 
phosphines and bis-phosphines 
NaOH 25-50 1 73 
17  Ru3(CO)12 alkyl amines 150-180 20 74,75,76 
18  
Ru3(CO)12 / N,N’-diaryl-
diiminoacenaphthene ligands 
- 150-180 30 77 
19  S, CS2, H2S, COS / V2O5, NH4VO3 NaOH, NH4OH, NaOCH3, Et3N 70-150 120-140 78 
20  
RhCl3·3H2O on PVP  
(PVP = poly(4-vinylpyridine)) 
- 100 1 79 
21  
Ru3(CO)12 / 
,-dimethylbis(2-
benzothiazolyl)methane 
- 150-200 10-50 80 
22  PdCl2 
NaOH / (3-C6H4SO3
‒Na+)3P 
(TPPTS), BINAS (see Figure 3.2) 
100 120 81 
23  Pd, PdCl2 / Fe, Fe2O3 / I2 pyridine 150-180 25-90 82 
24  K+, Cs+, (PPh3)2N
+ [Rh(CO)4]
‒ - 200 40-81 83 
25  
[Rh(nbd)(ppy)]ClO4 
(ppy = polypyridine chelating ligand) 
KOH 130 1 84 
26  Se pyridine, Et3N 180-200 4 85 
27  
[Rh(CO)2(amine)2]PF6, 
[Ir(cod)(amine)2]PF6 
pyridine, substituted pyridines 60-150 0.5-30 86,87 
28  
[Rh(CO)2(amine)2]PF6, 
[Ir(cod)(amine)2]PF6, 
[Rh(cod)(amine)2]PF6, Rh2(CO)4Cl2   
on PVP 
- 70-130 0.5-2 
88,89, 
90,91 
29  
Rh6(CO)16 / dimethylaminoethylated 
hydroxypropyl-chitosan 
- 80 10 92 
30  
Ru3(CO)9(PEO-DPPSA)3  
(PEO-DPPSA = poly(ethylene oxide)-
substituted 4-(diphenylphosphino) 
benzenesulfonamide) 
- 100-140 20-50 93 
31  RhCl3·3H2O alkyl amines, 2-picoline, TMEDA 100 1 94 
32  Se 
NaOAc, Na2CO3, NaOH, Et3N, 
DBU 
85-160 1-10 95 
33  CuCl2·2H2O on PVP - 100-150 7-27 96 
34  Au/Fe(OH)x - 100-120 5-15 97 
35  Au/TiO2 - 25 5 98 
36  Ag, Au, Pd, Rh, Pt on hydrotalcite - 150 9 99 
37  Ru/MgF2 - 175 20 100 
38  
dendrimer-encapsulated 
[Rh5(CO)15]
‒ 
- 80 10 101 
39  Co3O4/N-doped graphene - 125 30 102 
40  PdCl2(py)2 / Fe / I2 pyridine, substituted pyridines 100-180 40 103 
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One of the remarkable features of the nitro reduction under WGSR conditions is the high 
chemoselectivity, which often cannot be guaranteed using other reduction protocols.
104
 For 
example, all three reduction-susceptible functional groups of 4-chloro-3-nitroacetophenone are 
reduced unselectively by a standard hydrogenation over Pd/C (Eq. 3.8).
105
 Conversely, under 
WGSR conditions, reduction of the nitro group occurs selectively even in the presence of other 
functional groups prone to reduction (alkenes, alkynes, halides, nitriles, ketones, aldehydes, 
esters, etc., Figure 3.2).
61,76,81,98,102  
  (3.8) 
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Figure 3.2. Chemoselective reduction of nitroarenes. 
A noteworthy sequence of complementary reduction methods allows for the preparation of 
3.5, a tritiated photoaffinity ligand for the dopamine reuptake transporter protein (Scheme 
3.9).
106
 Reduction of the nitro group in 3.1 under Alper’s phase-transfer conditions affords amine 
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3.2 without reduction of the unsaturated amide. Lithium aluminum hydride was used to carry out 
the deoxygenation of the amide, followed by the introduction of the tritium label by 
hydrogenation of 3.3 (T2, Pd/C). 
 
Scheme 3.9. Sequential reduction reactions for the synthesis of 3.5. 
WGSR conditions display a marked preference for the reduction of aromatic as compared to 
aliphatic nitro groups; aliphatic nitro groups are normally unreactive (Figure 3.3a).
57,63
 However, 
conditions have been developed that can effect the reduction of aliphatic nitro groups to amines 
(Figure 3.3b),
54,98
 or the partial reduction to nitriles (Figure 3c).
60,107
 
 
Figure 3.3. Reduction of aliphatic nitro groups. 
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Mechanistic investigations of the  reduction of nitro groups by CO/H2O are abundant. From a 
qualitative standpoint, the participation of H2 is clearly excluded on the basis of important facts: 
(1) the reduction is often less efficient if H2 is used instead of CO/H2O;
69
 (2) some of the systems 
used for the nitro reduction are not active WGSR catalysts and do not produce CO2 and H2 in the 
absence of a nitro compound;
76,94,103
 (3) even for those systems that are capable of producing H2, 
competition/labelling experiments demonstrate that the nitro group is not directly reduced by 
H2;
52
 (4) functional groups that are susceptible to reduction by H2 do not react (Figure 3.2). 
The generally accepted catalytic cycle, supported by the isolation of some reactive 
intermediates,
[108]
 involves two sequential deoxygenation steps (Scheme 3.10). Following the 
formation of cycloadduct xviii between the nitro group and ligated CO, decarboxylation 
produces the η2-nitrosoarene complex xix. Insertion of CO leads to the four-membered 
cycloadduct xx which decarboxylates to form the nitrenoid complex xxi. The nitrenoid affords 
the aniline product after a further 2e
‒
-reduction, either WGSR-driven (via metal-hydride xxii),
109
 
or via formation of an isocyanate and its subsequent hydrolysis/decarboxylation.
64,76,110
 An 
exception to this general catalytic cycle is the reduction using the Se/amine system. The reaction 
of selenium with CO/aqueous amine produces H2Se,
111
 which is believed to be the actual 
reducing agent.
58,95b
 
 
Scheme 3.10. Catalytic cycle for the reduction of nitroarenes. 
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3.2.2.1.2. Downstream reactions from nitro reduction 
The reduction of nitro groups to amines represents only a small portion of the vast amount of 
reductive processes that can be accomplished from nitro compounds using CO as the reducing 
agent. As illustrated in Scheme 3.10, the reaction of a nitro group with CO generates a nitrenoid 
intermediate xxi which, in the absence of water, may undergo different reaction 
pathways.
105,112,113
 Thus, depending on the reaction conditions, nitro compounds can be 
converted into isocyanates, azo compounds, imines, ureas, or carbamates (Figure 3.4a). The 
nitrenoid can also react intramolecularly with a tethered functional group (olefinic or aromatic C-
H, alcohol, amine, etc.), lending itself to the synthesis of heterocycles (Figure 3.4b). 
 
Figure 3.4. Possible reaction pathways following the CO-mediated reduction of nitroarenes. 
These sets of reductive transformations, which do not rely on the CO/H2O couple, are outside 
the scope of this review. However, similar approaches have been used to combine the WGSR-
driven nitro reduction with a tandem transformation. 
The reductive amination reaction from nitroarenes and carbonyl compounds falls into this 
category, and proceeds through the in situ formation of an imine, which is reduced under WGSR 
conditions. The first example was reported by Watanabe et al. in 1980.
114
 In the presence of 
[Rh(cod)Cl]2 or [Rh(nbd)Cl]2, nitroarenes and linear, aliphatic aldehydes furnish reductive 
amination products in moderate yield (Eq. 3.9). Under these conditions, N,N-dialkylated anilines 
result. 
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  (3.9) 
An improved variant possessing increased synthetic utility was recently reported by Park and 
Chung.
115
 The use of a Co2Rh2/C heterogeneous catalyst enabled the synthesis of a number of 
secondary amines from nitroarenes, aromatic aldehydes and ketones (Figure 3.5). These 
conditions avoid double alkylation, but the substrate scope remains limited to aromatic nitro 
compounds and benzaldehydes. 
 
Figure 3.5. Reductive amination from nitroarenes and carbonyls. 
It might be tempting to assume that the nitro compound is reduced to the aniline first and 
condensation with the aldehyde follows, but this appears not to be the case. Indeed, imines form 
readily from nitroarenes and aldehydes by a CO-mediated reduction without the need for H2O.
116
 
In addition, control experiments wherein the aldehyde was combined directly with the aniline 
yielded no product, showing that the aniline is not a competent intermediate.
114b
 Therefore, it 
was suggested that the imine is formed directly from the nitrenoid intermediate xxiii (Scheme 
3.11) via oxaziridine xxiv and nitrone xxv, which is reduced by CO to the imine.
117
 The 
reductive amination product is then obtained via WGSR reduction (Section 3.2.2.1.3). 
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Scheme 3.11. Mechanism for the formation of an imine by CO reduction of a nitro compound. 
Over the course of their studies on reductive amination from nitroarenes, Watanabe et al. also 
found that, under modified conditions (RhCl(PPh3)3 and PdCl2), the formation of dialkylated 
anilines was suppressed and quinolines were obtained instead (Eq. 3.10).
114
 Although the 
transformation is overall redox-neutral, the aniline formed via WGSR reduction of the nitroarene 
is along the reaction pathway. Quinoline formation occurs by self-condensation of the aldehyde, 
conjugate addition of the aniline, and oxidative cyclization (Skraup quinoline synthesis). 
  (3.10) 
Similarly, the synthesis of phenanthrolines (Eq. 3.11)
118
 and quinolines from 2-
nitrochalcones (Eq. 3.12)
119,120
 have been reported. In the latter case, the intermediacy of the 
aniline obtained via WGSR reduction was suggested by a set of clever competition 
experiments.
121
 
  (3.11) 
  (3.12) 
Lastly, although ureas are generally synthesized from nitroarenes and amines under 
anhydrous conditions (Figure 3.4), symmetrical arylureas can be obtained directly from the 
corresponding nitroarenes via CO/H2O reduction/carbonylation, using selenium as the catalyst 
(Eq. 3.13).
122
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  (3.13) 
3.2.2.1.3. Reduction of imines and reductive amination 
The reductive amination employing nitroarenes and carbonyl compounds was discussed in 
Section 3.2.2.1.2. In addition to this approach, the synthesis of substituted amines by reductive 
amination can be achieved directly from an amine precursor and a carbonyl compound, thus 
bypassing the first nitro-to-amine reduction step. The obvious advantage is the wider range of 
products that can be produced. Whereas reductive amination from nitro compounds can lead only 
to secondary anilines (or tertiary anilines with two identical substituents), no such limitations 
exist when a primary or secondary amine is used as the starting material. 
As is the case with the reductive amination from nitro compounds, the reaction relies on the 
in situ generation of an imine (or iminium ion) that is reduced under WGSR conditions. This 
crucial step has been documented in the reduction of N-benzylideneaniline with catalytic 
amounts of Fe(CO)5 (Eq. 3.14).
123
  
  (3.14) 
The first example of reductive amination under WGSR conditions was reported by Watanabe 
et al. in 1978.
124
 A number of amines combined with formaldehyde or benzaldeyde to produce 
the corresponding methylated or benzylated amines in variable yield using Rh catalysts (Eq. 
3.15). The same process can be carried out in the presence of Co2(CO)8/dppe with comparable 
results.
125
 Ketones can participate in the reaction, as well (Eq. 3.16).
60
 
  (3.15) 
  (3.16) 
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The last two years have witnessed a renewed interest in the WGSR-driven reductive 
amination. Several improved variants have been developed that allow for the alkylation of 
primary and secondary amines with aldehydes and ketones, using homogeneous
126,127
 or 
heterogeneous catalysts.
115,128 
Quite surprisingly, none of the recent reports acknowledge the 
pioneering cases mentioned above. Reaction conditions and illustrative examples are provided in 
Figure 3.6. 
 
Figure 3.6. Reductive amination under WGSR conditions. 
Since the reaction protocols employ little to no water, the role of water deserves a comment. 
The condensation between a carbonyl compound and an amine liberates one equivalent of water, 
which in principle should suffice to carry out the subsequent reduction of the imine bond. The 
formation of reduction products even in the absence of added water is therefore justified (Figure 
3.6c). In the presence of molecular sieves, which sequester the water originating from imine 
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condensation, the reaction stops at the imine stage.
115
 On the other hand, addition of a 
superstoichiometric amount of water is detrimental.
126
 
By means of labeling and competition experiments, Chusov and List ruled out the 
involvement of free H2. The reaction proceeded at a much lower rate when CO was replaced by 
H2. Only 11% D incorporation was measured when D2 (1 bar) was added to the reaction mixture, 
whereas D incorporation reached 74% when N,N-deuterated aniline was used. In addition, a Rh-
hydride complex was detected by 
1
H NMR reaction monitoring. On the basis of these 
observations, the authors proposed a catalytic cycle involving oxidative addition of a Rh 
carbonyl complex into the C-OH bond of the intermediate hemiaminal.
126
 This step seems rather 
unlikely, given the tendency of hemiaminals to lose water and the fact that oxidative addition of 
Rh into C-OH bonds is unknown. It seems more reasonable that the intermediate imine would 
undergo reduction by a Rh-H complex (observed in situ!) generated via the WGSR. 
3.2.2.1.4. Reduction of heterocycles 
The reduction of nitrogen-containing heterocycles can be driven by the WGSR under forcing 
conditions. Murahashi et al. reported that quinolines and isoquinolines are reduced to the 
corresponding 1,2,3,4-tetrahydroquinolines and 1,2,3,4-tetrahydroisoquinolines (with 
concomitant N-formylation in the latter case) in the presence of Rh6(CO)16 at 150 °C and 55 bar 
of CO (Figure 3.7).
129
  
 
Figure 3.7. Reduction of quinolines and isoquinolines. 
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Only the N-containing ring undergoes reduction. This feature offers complementarity to 
direct hydrogenation methods, which provide 5,6,7,8-tetrahydroquinolines selectively (Eq. 3.17). 
  (3.17) 
Other nitrogen-containing heterocycles undergo reduction under WGSR conditions too, but 
the reported methods have little synthetic utility due to the low turnover numbers or complexity 
of the reaction mixtures.
130,131,132
 Oxygen- and sulfur-containing heterocycles, as well as 
polynuclear aromatic hydrocarbons, are unreactive or poorly reactive under WGSR 
conditions.
131,132 
3.2.2.1.5. Reduction of carbonyls 
The reduction of carbonyls to primary and secondary alcohols is a relatively facile 
transformation under WGSR conditions and several catalytic systems have been investigated in 
this capacity (Table 3.2). The early reports described harsh conditions with limited applicability 
(entries 1-4). While aromatic and branched aliphatic aldehydes were reduced to the 
corresponding alcohols, linear aldehydes underwent aldol condensation/1,2-reduction (entry 1). 
Improved results were obtained with the Rh6(CO)16/TMPDA system described by Kaneda et al., 
which allowed for a milder process compatible with several classes of aldehydes, but not as 
widely applicable in the case of ketones (entry 5 and Figure 3.8a). Recently, Beller et al. reported 
the efficient and scalable reduction of aldehydes using Knölker’s catalyst (entry 7 and Figure 
3.8b). Ketones are not reactive under these conditions. 
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Table 3.2. Reaction conditions for the reduction of carbonyls. 
Entry Metal catalyst Additives T (°C) PCO (bar) Substrates Ref. 
1  RhCl3·3H2O Et3N 200 51 aliphatic aldehydes 133 
2  
Fe, Ru, Rh carbonyl 
complexes 
KOH 125 55 
aromatic aldehydes, 
acetophenone 
45a 
3  Fe3(CO)12 Et3N 100 100 acetone 134 
4  RhH2(O2COH)[P(iPr)3]2 - 150 15 
benzaldehyde, 
acetophenone 
135 
5  Rh6(CO)16 
TMPDA 
(N,N,N',N'-tetramethyl-
1,3-propanediamine) 
30-80 5-20 
aliphatic and 
aromatic aldehydes, 
ketones 
136 
6  
Rh6(CO)16 / 
dimethylaminoethylated 
hydroxypropyl-chitosan 
- 80 10 benzaldehyde 92 
7  Knölker’s catalyst K2CO3 100 10 
aliphatic and 
aromatic aldehydes 
137 
8  Knölker’s catalyst Na2CO3 120 
in situ 
release 
aromatic aldehydes 138 
 
 
Figure 3.8. Reduction of aldehydes and ketones. 
The reduction of ,-unsaturated aldehydes is more challenging due to the competition 
between the 1,2- and 1,4-reduction modes (see Section 3.2.2.1.6). For example, the reduction of 
,-unsaturated aldehydes using Knölker’s catalyst afforded mixtures of saturated and allylic 
alcohols (Eq. 3.18).
137
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  (3.18) 
Kaneda et al. were able to obtain selective carbonyl reduction by fine tuning of the reaction 
conditions. In the case of Rh6(CO)16, it was shown that the site-selectivity is highly dependent on 
the base used in the reaction. The use of TMPDA is crucial for the achievement of 1,2-reduction 
(even the similar TMEDA gives poorer results), whereas 4-DMAP reverses the selectivity in 
favor of 1,4-reduction (Eq. 3.19).
136b
 Good 1,2-selectivity is also displayed by ceria-supported 
gold nanoparticle catalysts (Eq. 3.20).
139
 In contrast, direct hydrogenation using the same catalyst 
is unselective. 
  (3.19) 
  (3.20) 
3.2.2.1.6. Reduction of alkenes and alkynes 
The hydrogenation of unactivated olefins under WGSR conditions is rather unexplored and 
only two cases have been reported. Ethylene was hydrogenated to ethane using K2PtCl4/SnCl2 in 
acidic medium (HCl/acetic acid) under CO (0.4 bar) at 88 °C.
140
 However, the same conditions 
failed to provide clean hydrogenation of propylene. H2 added to the reaction mixture remained 
unconsumed, thus lending support to the intermediacy of a Pt-H intermediate formed from H2O. 
Styrene was reduced to ethylbenzene in good yields using Fe3(CO)12 and basic conditions, 
though with competing hydrohydroxymethylation (Section 3.2.2.2.1) depending upon the solvent 
mixture (Eq. 3.21).
141
 
  (3.21) 
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Conversely, the hydrogenation of activated olefins (,-unsaturated aldehydes, ketones, 
esters, amides, and nitriles) has been investigated more thoroughly. Already in 1973, Joh et al. 
had shown that the C-C double bond of a variety of unsaturated carbonyl compounds underwent 
selective 1,4-reduction, while unactivated olefins were unreactive.
142
 The initial conditions were 
quite harsh (98 bar, 130 °C, Figure 3.9a), but the addition of Et3N allowed for a milder process to 
be developed (1 bar, 30 °C, Figure 3.9b).
143
 Selenium, often used as an alternative to transition 
metals in WGSR-driven reductions, is also effective in the selective reduction of activated 
olefins (Figure 3.9c).
144
 
 
Figure 3.9. Selective 1,4-reduction of conjugated olefins. 
Other Rh-based catalytic systems were studied in the 1,4-reduction of conjugated olefins, 
however with limited exploration of the substrate scope.
66b,135,136b,145,146
 
The only reported example of alkyne hydrogenation under WGSR conditions involves 
heterogeneous catalysis. Using TiO2-supported gold nanoparticle catalysts, Cao et al. were able 
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to achieve the chemo- and stereoselective reduction of a wide range of alkynes to (Z)-alkenes in 
high yields and without overreduction. (Figure 3.10).
147
 
 
Figure 3.10. Selective reduction of alkynes to alkenes. 
3.2.2.1.7. Deoxygenation of epoxides 
The deoxygenation of epoxides to the corresponding alkenes under WGSR conditions has 
been known since 1968, when Watanabe et al. reported the reduction of styrene oxide with 
K2Fe(CO)4.
148
 However, the development of synthetically useful reduction protocols occurred 
only in the last decade with the advent of nanoparticle catalysts. Hydrotalcite-supported silver
149
 
and gold,
150
 as well as titania-supported gold nanoparticles,
151
 are efficient promoters of the 
reduction of a variety of epoxides (Figure 3.11). Thanks to these contributions, the use of WGSR 
conditions represents one of the mildest and most efficient catalytic methods to date for this 
transformation. 
 
Figure 3.11. Deoxygenation of epoxides with nanoparticle catalysts. 
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From a mechanistic standpoint, it should be emphasized that the deoxygenation of epoxides 
is conceptually different from the reactions discussed above because it does not lead to the 
incorporation of reducing equivalents (H) into the substrate. The reducing power provided by the 
CO/H2O couple ensures turnover of the catalytic cycle by reducing the putative metal-oxo 
intermediate xxvii to the active form of the metal xxvi (Scheme 3.12). Metal-oxo intermediates 
are believed to be involved in the deoxygenation of epoxides.
152
 However, their intermediacy in 
the deoxygenation reaction under WGSR conditions has not been explicitly documented and, 
therefore, alternative mechanisms cannot be discounted at this time.  
 
Scheme 3.12. WGSR in the deoxygenation of epoxides. 
Regardless of the mechanistic pathway, an important aspect concerns the role of water. 
Although water does not appear in the balanced equation, its presence is of course required for 
the occurrence of the WGSR. Control experiments demonstrated that the reaction did not 
proceed in the absence of water (Scheme 3.13a). However, only a catalytic amount of water is 
needed to initiate the reaction (Scheme 3.13b).
151 
 
Scheme 3.13. Control experiments with water. 
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3.2.2.1.8. Other deoxygenation reactions 
Several other deoxygenation reactions have been carried out using CO/H2O as the reducing 
agent. A summary is provided in Table 3.3. 
Table 3.3 Deoxygenation reactions using the CO/H2O couple. 
Entry Reaction Metal catalyst Ref. 
1 
Hydroxylamine to amine 
 
Rh6(CO)16 60,107 
2 
Amine N-oxide to amine 
 
Rh6(CO)16 60,107  
Au/TiO2 151 
[Ru(cod)py4](BPh4)2 153 
3 
-hydroxycarboxylic acid to carboxylic acid 
 
Pd/C, PdCl2(PPh3)2
 154 
4 
Sulfoxide to sulfide 
 
Au/TiO2 151 
 
3.2.2.1.9. Desulfurization 
The desulfurization of thiophenols and benzylic mercaptans was described by Alper et al. in 
1985 using Co2(CO)8 under rather forcing conditions (Eq. 3.22).
155
 Interestingly, the proposed 
mechanistic pathway involves generation of carbonyl sulfide rather than carbon dioxide, and is 
supported by its direct observation. 
  (3.22) 
3.2.2.1.10. Dehalogenation 
The examples shown in Figure 3.2 and thereafter illustrate the reluctance of carbon-halogen 
bonds to undergo reduction under WGSR conditions. Indeed, only a handful of cases of 
hydrodehalogenation have been reported. In 1990, Sonoda et al. described the use of Se/Et3N for 
the debromination/elimination of vicinal dibromides (Eq. 3.23), as well as the dehalogenation of 
114 
 
-halo ketones (Eq. 3.24).156 Similarly, -chloroacetophenone undergoes dechlorination in the 
presence of PdCl2(PPh3)2 (Eq. 25).
157
 
  (3.23) 
  (3.24) 
  (3.25) 
Ford et al. showed that 1,2-dichloroethane can be dechlorinated to a mixture of ethane and 
ethylene with RhCl3/4-picoline (Eq. 3.26).
158
 From the observation that the ethylene/ethane ratio 
decreases as the reaction progresses, it was suggested that ethylene forms first via a 
reduction/elimination pathway, and is then further reduced to ethane by the same catalytic 
system. 
  (3.26) 
Harsh conditions are needed for the dechlorination of chlorobenzene, which has been 
achieved, albeit in low yield, using CuCl2 supported on poly(4-vinylpyridine) (Scheme 3.14a).
159
 
In contrast, deiodination of aryl iodides occurs readily at 60 °C and 1 bar of CO (Scheme 
3.14b).
160
 
  
Scheme 3.14. Hydrodehalogenation of aryl halides. 
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3.2.2.2. C-C bond forming reactions 
3.2.2.2.1. Hydroformylation and hydrohydroxymethylation 
The hydroformylation reaction is a powerful C-C bond forming process with extensive 
industrial applications. The traditional Co- and Rh-based catalysts for this transformation are 
capable of converting alkenes into homologous aldehydes using syngas.
6
 The possibility of using 
the CO/H2O couple was investigated by Reppe and Vetter as early as 1953.
7
 Besides being one 
of the earliest applications of the WGSR to organic synthesis, the Reppe-type hydroformylation 
reaction represents an exception in the landscape of WGSR-driven organic reactions, because 
CO acts both as carbon source and reducing agent (Scheme 3.15). 
 
Scheme 3.15. Reducing equivalents in hydroformylation reactions. 
The seminal report by Reppe, part of a thorough study on the chemistry of hydrido-metal-
carbonyl complexes, illustrates the conversion of terminal alkenes into homologated alcohols 
(via the corresponding aldehydes) using Fe(CO)5 in combination with amines, H2O and CO (Eq. 
3.27). Strictly speaking, therefore, the term hydrohydroxymethylation would be more appropriate 
for this transformation. 
  (3.27) 
These results established the basis for further elaborations that took place beginning in the 
1970s, contemporaneous with the development of homogeneous catalysis for the WGSR. Thus, 
Pettit et al. investigated the use of other metal-carbonyl complexes in the Reppe-type 
hydroformylation of propylene and obtained higher efficiency and selectivity for the linear 
aldehyde 3.6 relative to the Fe(CO)5 system (Table 3.4).
27
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Table 3.4. Performance of metal carbonyls in the Reppe-type hydroformylation reaction. 
 
Entry Metal catalyst T (°C) TON
a 
6:7 ratio 
1  Fe(CO)5 110 5.2 1:1 
2  Ru3(CO)12 100 47 11.5:1 
3  H4Ru4(CO)12 100 79 11:1 
4  Os3(CO)12 180 13 1.9:1 
5  Rh6(CO)16 125 300 1.4:1 
6  Ir4(CO)12 125 250 1.8:1 
7  (Bu4N)[Pt3(CO)6]5 125 0.5 1.9:1 
a. Turnover number (TON) = [mmol(3.6) + mmol(3.7)]/mmol(catalyst) 
Similarly, Laine compared the performance of Ru and Rh carbonyls in alkaline solution and 
found that, whereas Ru carbonyls display a higher selectivity for the linear aldehyde, Rh 
carbonyls are less selective and capable of reducing the aldehyde product to the alcohol.
161
 
Numerous other variations of the Reppe-type hydroformylation reaction have been reported, 
encompassing a wide array of metal catalysts and using either basic, neutral, or acidic conditions 
(Table 3.5). However, unlike some other WGSR-driven reactions, the hydroformylation under 
WGSR conditions has not risen to the status of a well-established synthetic method. In most 
cases, harsh conditions are needed and the desired aldehyde is obtained in low yield even from 
simple, linear olefins. The process is fraught with multiple challenges, ranging from the control 
of the site selectivity, to the occurrence of hydrogenation of the alkene, overreduction of the 
aldehyde to the alcohol, or aldol condensation. In contrast, traditional hydroformylation 
approaches (with CO/H2) appear much more robust and synthetically useful.
162 
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Table 3.5. Reaction conditions for the hydroformylation reaction. 
Entry Metal catalyst Additives T (°C) PCO (bar) Ref. 
1  Rh2O3/Fe(CO)5 N-methylpyrrolidine 100-200 203 163 
2  
Fe, Ru, Os, Rh, Ir, Pt carbonyl 
complexes 
Me3N 100-180 24 27 
3  Ru3(CO)12, H4Ru4(CO)12, Rh6(CO)16 KOH 135-150 55 161 
4  Co2(CO)8 / dppe, other phosphines none, Et3N 135-195 12-150 164 
5  RhH2(O2COH)[P(iPr)3]2 - 115 15 135 
6  Rh6(CO)16 
aliphatic amines and diamines, 
pyridine, substituted pyridines 
80 5 145 
7  Rh2(CO)3(dppm)2 LiCl, p-TsOH 90 0.4 165 
8  Fe(CO)5 NaOH, Et3N 110-140 10-27 166 
9  
Rh2(StBu)2(CO)2(TPPTS)2, 
[Rh(cod)(TPPTS)2](ClO4), 
RhH(CO)(TPPTS)3 
(TPPTS = (3-C6H4SO3
‒Na+)3P) 
- 80 8 167 
10  K[Ru(EDTA-H)Cl]2H2O - 110-130 10-40 168 
11  
RhCl3·3H2O on PVP  
(PVP = poly(4-vinylpyridine)) 
- 85-120 0.3-1.7 169 
12  
[Rh(cod)(amine)2]PF6, 
[Rh(CO)2(amine)2]PF6 
on PVP 
- 100-140 10-56 170 
13  [Ru(OCOEt)(CO)2]n EtCOOH/EtCOONa 140 18-88 171 
14  [Rh2(-S2CBn2)(cod)2] - 80 1.3-22 172 
 
The boundary between hydroformylation and hydrohydroxymethylation is not clear-cut. The 
hydroformylation reaction is often accompanied by overreduction of the aldehyde to the alcohol. 
The ease of carbonyl reduction under the forcing conditions required for hydroformylation has 
been exploited in the formulation of protocols that yield hydrohydroxymethylation products 
predominantly. This is true for the original report by Reppe, as well as a number of other 
cases.
141,173,174
 For example, allyl alcohol can be converted to 1,4-butanediol under WGSR 
conditions in the presence of Rh6(CO)16 and TMPDA (Eq. 3.28).
173a
 Again, however, these 
methods are of little synthetic utility due to the limited substrate scope and poor efficiency. 
  (3.28) 
The mechanism of Reppe-type hydroformylation has been examined by means of 
identification of reactive intermediates and kinetic studies. The proposed mechanism parallels 
118 
 
the earlier proposal by Heck and Breslow for the hydroformylation with Co2(CO)8 and CO/H2,
175
 
the only difference being that the reactive metal hydride iii is generated via WGSR rather than by 
oxidative addition of H2 (Scheme 3.16).
27
 Besides being involved in the coordination/migratory 
insertion of the olefin to form xxx, intermediate iii is accountable for the reduction of the 
aldehyde to the alcohol.
161
 Intermediate iii can also react along the traditional WGSR manifold to 
produce H2, which is detected in the reaction mixtures.
169,170
 
 
 
Scheme 3.16. Catalytic cycle for the Reppe-type hydroformylation reaction. 
One of the key observations is that, in the case of Fe(CO)5, the reaction displays second order 
kinetic behavior with respect to Fe(CO)5.
166
 This fact is consistent with an alternative 
mechanistic proposal whereby the acyl iron intermediate xxxiii liberates the product not by 
means of protonation/reductive elimination (as in Scheme 3.16), but by attack of iron hydride 
xxxiv (Scheme 3.17).
176
 
 
Scheme 3.17. Alternative binuclear mechanism for hydroformylation. 
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3.2.2.2.2. Hydroaminomethylation 
When the aldehyde produced by hydroformylation is intercepted by an amine, the imine (or 
iminium ion) formed in situ can undergo reduction, resulting in an overall 
hydroaminomethylation process (Eq. 3.29). 
  (3.29) 
Interestingly, the hydroaminomethylation sequence was first reported by Reppe and Vetter in 
the context of their seminal work on the CO/H2O-mediated hydroformylation reaction,
7
 and only 
later on revisited (and vastly elaborated) using syngas.
177
 The initial conditions used by Reppe 
were quite harsh (Fe(CO)5, 105-145 °C, 100-200 bar) and the process was inefficient, but further 
studies identified more effective catalysts and reaction conditions. Iqbal obtained improved 
results with a mixed Fe(CO)5/Rh2O3 system (Eq. 3.30).
178
  
  (3.30) 
Other catalysts (metal carbonyls,
179,180
 and cationic Rh complexes
181
) behave similarly. 
However, the control of the site-selectivity (linerar vs. branched) and the forcing conditions 
remained the major issues which hampered further synthetic developments for decades. 
Significant advances have been achieved in the last two years thanks to the contributions of 
Beller and coworkers. Using a combination of Ru3(CO)12 and K2CO3, the 
hydroaminomethylation reaction proceeds cleanly with a wide range of olefins and 
primary/secondary amines (Figure 3.12a).
182
 Remarkably, the site-selectivity for the linear 
product is high (typically > 95:5) even in the absence of ligands. Under these conditions, the 
catalyst displays selectivity for terminal olefins, whereas internal olefins are unreactive. 
However, in a modified approach, which employs a phosphinoimidazole ligand, internal olefins 
become reactive and undergo isomerization to furnish the linear amine product when possible 
(Figure 3.12b).
183
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Figure 3.12. Hydroaminomethylation reaction under WGSR conditions. 
3.2.2.2.3. Other carbonylation reactions 
A large number of carbonylation reactions are carried out using mixtures of CO and H2O, 
namely hydroxycarbonylation of alkenes,
184
 alkynes,
185
 and halides
55b
 (including the Monsanto 
process).
186
 However, a careful distinction must be made as to the role of CO and H2O. The 
aforementioned transformations are redox-neutral and employ CO and H2O as reactants, not as a 
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reducing couple. Since the WGSR is not involved, those transformations will not be covered 
here. 
Besides hydroformylation and related processes, only a limited number of carbonylation 
reactions employing CO/H2O are reductive and rely on the WGSR. These include 
cyclocarbonylation reactions, as well as carbonylation of alkenes to symmetrical ketones. 
The reductive cyclocarbonylation under WGSR conditions was pioneered and considerably 
developed by Takahashi and coworkers. In an initial report, the reaction of internal alkynes with 
CO and Rh4(CO)12 under basic conditions afforded furanones (Figure 3.13a).
187
 The reaction was 
subsequently extended to terminal alkynes under modified conditions (Figure 3.13b).
188
 This 
pathway is a prerogative of the CO/H2O system, as the use of CO/H2 caused hydrogenation of 
the alkyne and hydrohydroxymethylation.
189
 The control over the site-selectivity under these 
conditions is minimal and mainly substrate-induced, but it was later shown that the selectivity 
could be significantly improved using more polar solvents, although at the expenses of the 
conversion.
190
  
 
Figure 3.13. Synthesis of furanones by reductive cyclocarbonylation. 
The involvement of the WGSR as the source of reducing equivalents was initially established 
by carrying out the reaction with D2O, which resulted in full incorporation of D at the 5-position 
of the furanone.
187
 A mechanistic proposal was then put forward which proceeds by double 
carbonylation of the alkyne and rearrangement to form xxxviii, generation of a Rh-hydride 
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intermediate xl via WGSR, and subsequent reductive elimination to the product (Scheme 
3.18).
[190]
 
 
Scheme 3.18. Catalytic cycle for the formation of furanones. 
Similar approaches to the synthesis of furanones were also described by other research 
groups, using PdI2,
191
 Co2Rh2/C,
192
 and Ru3(CO)12.
193
 Interestingly, Takahashi et al. found that, 
while Co2(CO)8 is inactive in the formation of furanones, at higher temperatures it promotes the 
formation of indanones from aryl-substituted alkynes, through a C-H insertion process (Eq. 
3.31).
[194]
 The reaction proceeds via the corresponding indenone, which undergoes reduction 
under WGSR conditions and was shown to be a competent intermediate.
195
 
  (3.31) 
The propensity of alkynes toward reductive cyclocarbonylation has been pivotal to achieve 
the synthesis of various other cyclic structures.
196
 In particular, by introducing a reactive, 
tethered functional group, fused cycles such as indolones,
197
 tricyclic lactones,
198
 
isocoumarins,
199
 benzofuranones,
200
 and isochromanones
201
 could be synthesized (Scheme 3.19). 
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Scheme 3.19. Synthesis of other fused cycles by cyclocarbonylation. 
The synthesis of symmetrical ketones from alkenes is another instance of reductive 
carbonylation reaction that can be carried out under WGSR conditions. The reaction represents 
an alternative pathway to hydroformylation that becomes predominant when operating in an 
excess of the olefin. Being related to hydroformylation, it suffers from limitations such as need 
for harsh conditions and poor control over site-selectivity. Indeed, the method is largely 
underdeveloped and only a few cases have been reported.
202
 For example, dimethyl-4-
oxopimelate has been synthesized from methyl acrylate using Co2(CO)8/dppe in 93% yield with 
respect to H2O (the limiting reagent, Eq. 3.32).
202d
 
  (3.32) 
3.2.2.2.4. Reductive alkylation 
As was illustrated for reductive amination reactions, stabilized carbanions can be alkylated 
with aldehydes under WGSR conditions. The reaction proceeds via formation of an aldol adduct, 
elimination of water, and reduction of the activated olefin (Eq. 3.33). 
  (3.33) 
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The first example of this transformation was reported by Watanabe et al. in 1978.
203
 Several 
ketones were -methylated with aqueous formaldehyde in the presence of RhCl33H2O. Yields 
were low and mixtures of mono- and dimethylated products were obtained (Scheme 3.20). 
 
Scheme 3.20. Reductive alkylation of ketones. 
In a similar fashion, picolines can be homologated with formaldehyde to afford 
ethylpyridines (Eq. 3.34),
204
 and arylacetonitriles are -methylated to arylpropionitriles (Eq. 
3.35).
205
 
  (3.34) 
  (3.35) 
In an attempt to streamline the synthesis of methyl isobutyl ketone from acetone, Rossi et al. 
discovered that WGSR conditions can be employed to this end using a Cu/Al2O3 catalyst (Eq. 
3.36).
206
 
  (3.36) 
A more useful synthetic protocol involves the reaction of active methylene compounds with 
carbonyls in what is formally a reductive Knoevenagel condensation. Chusov et al. reported that 
methyl cyanoacetate can be alkylated in good yield with aldehydes and ketones using 
homogeneous (Figure 3.14a)
207
 or heterogeneous (Figure 3.14b)
128
 Rh catalysts. As in the 
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reductive amination, addition of water is not necessary because one equivalent of water is 
liberated from the condensation reaction. Indeed, it was shown that decarboxylation of the ester 
moiety in the product takes place when water is added to the reaction mixture (Figure 3.14c). 
The authors again propose a catalytic cycle which involves oxidative addition of Rh into the C-
OH bond of the aldol adduct,
207
 but this proposal is arbitrary and lacks experimental evidence, as 
discussed in Section 3.2.2.1.3. More likely, the Knoevenagel condensation adduct undergoes 
reduction by a Rh-H species formed via WGSR. 
 
Figure 3.14. Reductive Knoevenagel condensation. 
3.2.2.2.5. Carbonyl allylation 
The allylation of carbonyl compounds is a fundamental reaction in organic synthesis owing 
to its versatility and capacity to build adjacent stereogenic centers with high levels of 
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stereocontrol.
208
 The reaction is generally conducted with a pre-formed allylmetal species, 
typically an allylic borane, silane, or stannane. Catalytic variants have also been developed. 
Some of the catalytic protocols employ an allylic halide or alcohol derivative in combination 
with a metal catalyst and a sacrificial metal reducing agent in stoichiometric amount. An 
example is represented by the allylation under Nozaki-Hiyama-Kishi/Fürstner conditions, which 
combines catalytic amounts of CrCl2 (or CrCl3) and superstoichiometric amounts of Mn.
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Although catalytic in the metal that carries out the allylation reaction itself, protocols of this kind 
are de facto not catalytic, given that a stoichiometric amount of metal reducing agent is still 
required. Truly catalytic methods include the transfer hydrogenation approach described by 
Krische.
18
 Given the prominence and abundant use of allylation reactions in total synthesis 
endeavors, the discovery that catalysis is possible by means of the WGSR represents an 
important advance, especially from the point of view of atom economy and environmental 
concerns. In fact, under WGSR conditions, the only byproducts are CO2 and the conjugate base 
of the allyl nucleofuge! 
The first report from these laboratories, in 2008, identified optimal reaction conditions for the 
allylation of  aldehydes with allyl acetate, using RuCl3 hydrate.
9
 Under mild conditions (70-80 
°C and 2 bar of CO), a variety of aromatic, aliphatic and ,-unsaturated aldehydes could be 
allylated with excellent functional group compatibility (Figure 3.15). 
 
Figure 3.15. Allylation of aldehydes. 
One of the key findings is that only a catalytic amount of Et3N was needed. The use of a 
stoichiometric or superstoichiometric amount of base is detrimental. On the other hand, the 
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reaction does not proceed in the absence of base. These results clearly rule out the participation 
of triethylamine as the reducing agent. Rather, it seems that the base may be involved in the 
reduction of RuCl3 to the catalytically active Ru(0), and/or act as a buffer for the acid liberated as 
the byproduct. Another important observation concerns the role of halide. The reaction proceeds 
at a much reduced rate when Ru3(CO)12 is employed instead of RuCl3·nH2O, but the rate is 
restored upon addition Bu4N
+
Cl
–
. It seems that the neutral Ru(0)-carbonyl complex is not 
effective in the formation of a -allylruthenium intermediate, but it can be converted into a more 
reactive anionic Ru(0)-Cl complex by the addition of a chloride source. On the basis of these 
observations, the catalytic cycle shown in Scheme 3.21 was formulated. The suggested 
catalytically active species xli is produced either by chloride displacement of CO in Ru3(CO)12, 
or reduction of RuCl3 to Ru(0) by WGSR or perhaps Et3N.
210
 Oxidative addition of allyl acetate 
into Ru(0) forms -allylruthenium(II) complex xlii, which adds to the aldehyde (xliii) and 
generates the product after protonolysis. This process leaves behind a Ru(II)-hydroxide complex 
xliv, which is prone to CO migratory insertion to form the Ru-hydroxycarbonyl intermediate xlv. 
From xlv, the usual WGSR steps (decarboxylation, reductive elimination) regenerate the active 
Ru(0) catalyst along with carbon dioxide and acetic acid as the byproducts.  
Recently, the scope of the allylation reaction has been expanded to include substituted allylic 
acetates. Under similar reaction conditions, allylic acetates bearing a variety of substituents at the 
2-position (methyl, phenyl, ester, ketone, acetal) react with aldehydes in good yield (Figure 
3.16).
211
 Unfortunately, ketones are not suitable electrophilic partners under these conditions. 
In addition, a recent report by Vasylyev and Alper describes the use of 
[Rh(TMEDA)(CO)2]
+
[RhCl2(CO)2]
‒
 as an allylation catalyst in the presence of Cs2CO3nH2O 
serving both as the base and the water source (Eq. 3.37).
212
 
  (3.37) 
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Scheme 3.21. Catalytic cycle for the allylation reaction. 
 
Figure 3.16. Extension to 2-substituted allylic acetates. 
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3.3. RESEARCH OBJECTIVES 
The present research project aimed at leveraging the reduction potential provided by the 
WGSR in a variety of reductive transformations currently carried out with pre-formed 
organometallic species or (super)stoichiometric amounts of reducing agents (as in Schemes 3.2 
and 3.3). In particular, the opportunities for catalysis of the following transformations were 
investigated: 
(a)  Organochromium addition to aldehydes (Nozaki-Hiyama-Kishi reaction), where the use 
of CO/H2O would provide an alternative to the stoichiometric use of air-sensitive and 
toxic Cr(II);  
(b)  Addition of other organometals to carbonyls, to develop what is formally a “catalytic 
Grignard reaction”; 
(c)  Aryl homocoupling reactions; 
(d)  The Wittig reaction, where the CO/H2O couple might be used to reduce a phosphine 
oxide to a phosphine, therefore enabling its use in catalytic amount. 
The proposed transformations were investigated through a Design of Experiment (DoE) 
approach to quickly screen and determine the impact of many reaction variables. 
3.4. RESULTS 
3.4.1.  Development of a catalytic variant of the Nozaki-Hyama-Kishi reaction 
On the basis of the well-established catalytic activity of Cr(0) and Cr(III) in the WGSR,
30
 we 
envisioned to exploit the reducing power of the WGSR in the Nozaki-Hiyama-Kishi (NHK) 
reaction to avoid the use of a stoichiometric amount of metal (either Cr or Mn).
209
  
The feasibility of the catalytic reaction was tested on a model reaction combining (E)-1-
iododecene (3.8, Scheme 3.22) and hydrocinnamaldehyde (3.9). Several parameters were varied 
for optimization purposes: 
(a)  Chromium source: readily available Cr salts and complexes at different oxidation states 
(0, II and III) were employed; a catalytic amount of NiCl2·DME was always added as it is 
known that traces of Ni(II) are necessary to facilitate the formation of the C-Cr(III) 
bond;
213
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(b)  Base: an assortment of organic and inorganic bases, nucleophilic and non-nucleophilic, 
were employed to ascertain the role of the base itself (promoter of the WGSR by 
generating OH
-
, aid in solubilizing the metal, or both); 
(c)  Solvent: solvents compatible with NHK conditions were chosen; 
(d)  Equivalents of H2O (1 to 3); 
(e)  Temperature (25 to 110 °C). 
With the aid of Design-Expert, a randomized assortment of reaction conditions was selected 
and executed (>100 permutations, details available in Chapter 6).  
 
Scheme 3.22. Reaction parameters for the optimization of the catalytic NHK reaction  
No product (3.10) was detected when Cr(0) and Cr(III) sources were used, regardless of the 
reaction conditions. Among the Cr(II) sources, only CrCl2 yielded 3.10, but in stoichiometric or 
substoichiometric amount with respect to Cr (< 4%), i.e., without turnover of the catalytic cycle. 
It appears that, after the first turnover, the reaction cannot proceed past the Cr(III)-alkoxide stage 
(i.e., the alkoxide formed after carbonyl addition), owing to the strength of the Cr-O bond. 
Naturally, the same issue arose in the development of the catalytic NHK with stoichiometric 
amounts of Mn and was resolved by the addition of TMSCl,
12 
 which guarantees turnover of the 
catalytic cycle through the formation of an alkoxysilane (featuring a strong Si-O bond). 
Unfortunately, this option is not available in our case due to the incompatibility of TMSCl with 
water. Nevertheless, we investigated the use of other water-compatible silanes as stoichiometric 
additives ((Me3Si)2O, (Me2HSi)2O, tBuMe2SiOH, PhMe2SiOH, Ph3SiOH) which, again, resulted 
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in only one turnover or less. These findings strengthen the conclusion that the process is 
unfeasible due to the inertness of the intermediate Cr(III)-alkoxide complex (see Section 3.5.1). 
3.4.2.  Development of catalytic nucleophilic addition reactions using other transition 
metals 
In an attempt to overcome the intrinsic limitations of chromium in the catalytic addition to 
aldehydes, the use of other transition metals was investigated. 
3.4.2.1. Manganese 
The addition of organomanganese(II) reagents to aldehydes is a well-known process.
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Organomanganese(II) reagents are usually prepared by transmetalation from 
organolithium/magnesium species and manganese(II) halides. Oxidative addition of Mn metal to 
organic halides is also possible, although more challenging. 
As previously done with chromium, a DoE approach was utilized to assess the competence of 
Mn in the catalytic addition to aldehydes driven by the WGSR. Mn(0), Mn(I) and Mn(II) sources 
were tested in the addition of 3.8 to 3.9, resulting in no reactivity (Scheme 3.23). 
 
Scheme 3.23. Reaction parameters for the optimization of the Mn-catalyzed addition reaction.  
3.4.2.2. Ruthenium 
Based on the observation made in these laboratories that allylruthenium species add to 
aldehydes in a process that can be catalyzed by CO/H2O, we investigated the feasibility of 
catalytic nucleophilic addition to aldehydes of other organoruthenium species (alkenyl and aryl 
halides). Using a DoE approach, Ru(0), Ru(II) and Ru(III) sources were screened for their 
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catalytic activity in the model reaction, with no 3.10 being observed and reactants remaining 
unconsumed even when low-valent Ru sources were used (Scheme 3.24). 
 
Scheme 3.24. Reaction parameters for the optimization of the Ru-catalyzed addition reaction.  
The lack of consumption of vinyl iodide pointed to the difficulty in accessing 
organoruthenium species via oxidative addition of carbon-halogen bonds. Indeed, very few 
reports detail the isolation of organoruthenium complexes from C-X oxidative addition, which 
also requires harsh conditions to occur. For instance, preparation of 3.12 (Scheme 3.25) from p-
bromotoluene and RuH2(CO)(PPh3)3 (3.11) requires refluxing at 130 °C!
215
 In addition, 3.12 was 
tested for its capacity of adding to p-CF3-benzaldehyde, resulting in no addition product 
formation. 
 
Scheme 3.25. Synthesis and reactivity of 3.12.  
It seems that the catalytic addition of organoruthenium species other than allylruthenium is 
complicated by the difficult oxidative addition to C-X bonds, and the inertness of the oxidative 
addition complex toward carbonyl addition. 
3.4.2.3. Palladium 
The challenging oxidative addition step may be overcome by employing a more electron-rich 
group 10 metal source, capable of undergoing facile oxidative addition to C-X bonds. To this 
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end, an array of palladium sources was investigated in the model reaction, resulting in 
stoichiometric consumption of alkenyl iodide (with respect to Pd) when Pd(0) sources were used, 
but no carbonyl addition (Scheme 3.26). Consumed 3.8 was reduced to 1-decene. 
 
Scheme 3.26. Reaction parameters for the optimization of the Pd-catalyzed addition reaction.  
3.4.2.4. Nickel 
Allylnickel complexes undergo addition to aldehydes and ketones to generate the 
corresponding homoallylic alcohols. Similarly to the NHK reaction, the reaction can be catalyzed 
by a stoichiometric metal reducing agent (Zn).216 This process offers an opportunity for WGSR 
catalysis, which would obviate the need for a stoichiometric amount of Zn. 
A set of exploratory experiments guided by a DoE approach was undertaken using the 
allylation of anisaldehyde with allyl carbonate or allyl pivalate as the model reaction (Scheme 
3.27, 97 reactions in total). A wide set of bases were investigated to promote WGSR reactivity 
and facilitate solubility of Ni complexes. Trace amounts of product 3.13 (i.e., less than one 
turnover) were detected when Ni(cod)2 was used; no product was detected with other Ni sources. 
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Scheme 3.27. Reaction parameters for the optimization of the Ni-catalyzed allylation reaction.  
Although a series of control experiments demonstrated that allylnickel species are compatible 
with superstoichiometric amounts of water (Scheme 3.28), turnover of the catalytic reaction of 
addition to the aldehyde could not be achieved. As in the case of chromium, it is likely that the 
strong Ni(II)-O bond that is generated after carbonyl addition does not allow for further 
reactivity. 
 
Scheme 3.28. Control experiments with water. 
3.4.3.  Development of a catalytic variant of the aryl homocoupling reaction 
Nickel-mediated reductive homocoupling reactions of halides have been extensively 
investigated, both under stoichiometric and catalytic conditions (the latter requiring a 
stoichiometric reducing agent, Zn or Mn).
217
 In order to test the feasibility of the catalytic 
reaction under WGSR conditions, the homocoupling of 4-bromobenzonitrile was attempted 
using Ni(0) and Ni(II) sources, in combination with organic and inorganic bases (Scheme 3.29). 
Trace amounts of product formed only when Ni(0) sources were employed. 
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Scheme 3.29. Reaction parameters for the optimization of the Ni-catalyzed aryl homocoupling reaction.  
Unlike the case of allylnickel complexes, control experiments demonstrated that the 
intermediate arylnickel is sensitive to water (Scheme 3.30). Indeed, addition of a 
superstoichiometric amount of water (which mimics the condition of WGSR catalysis) strongly 
inhibited the stoichiometric coupling reaction, presumably by protonating the arylnickel(II) 
intermediate. 
 
Scheme 3.30. Control experiments with water. 
3.4.4.  Development of a catalytic variant of the Wittig olefination reaction 
The synthetic approaches attempted thus far intended to exploit the CO/H2O couple as a 
terminal reducing agent for a metal catalyst that is directly implicated in the C-C bond forming 
event. In a different approach, the WGSR may be employed as the source of reducing 
equivalents to be transferred to an organocatalyst after the C-C bond event has taken place by an 
independent mechanism.  
The Wittig reaction represents a plausible candidate for WGSR catalysis. As in the Wittig 
variants that utilize stoichiometric amounts of silanes as the reducing agents,
218
 CO may carry 
out the deoxygenation of a phosphine oxide, thus regenerating the active phosphine needed for 
the olefination process. 
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The investigation began with the study of the crucial deoxygenation step. The strong P=O 
bond of triphenylphosphine oxide could not be deoxygenated under WGSR conditions using 
metal carbonyl complexes or selenium, even at high temperature and pressure of CO (Scheme 
3.31). Electron-rich aromatic phosphine oxides 3.15 and 3.16, which have a weaker P=O bond 
due to the lower extent of back-donation, were found to be unreactive as well. 
 
Scheme 3.31. Deoxygenation of phosphine oxides. 
Next, the deoxygenation of the As=O bond was attempted. Whereas triphenylarsine oxide 
could not be reduced under WGSR conditions, the weaker As=O bond in 3.17 (Scheme 3.32) 
was partially deoxygenated in the presence of Rh4(CO)12 (35%). Strikingly, the even weaker 
Sb=O bond in triphenylstibine oxide was reduced almost quantitatively (81%) under similar 
conditions (Table 3.6, entry 1). Deoxygenation also took place in the absence of added water 
(entry 2), but with lower yield. Although water does not appear in the balanced equation, a 
catalytic amount is still needed to initiate the WGSR. Likely, adventitious water in DMF is 
sufficient for this purpose. In runs without base, however, the reduction was significantly 
inhibited (entries 3 and 4). 
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Scheme 3.32. Deoxygenation of arsine oxides. 
Table 3.6. Deoxygenation of triphenylstibine oxide. 
 
Entry TMEDA (equiv) H2O (equiv) Product (%)
 
1  10 50 81 
2  10 0 49 
3  0 50 31 
4  0 0 15 
 
Having demonstrated that the crucial deoxygenation step occurs readily in the case of stibine 
oxides, we sought to apply these findings to the olefination reaction itself. The use of antimony 
in Wittig reactions is rather uncommon and has been documented only with tributylstibine.
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For this reason, tributylstibine was chosen for further optimization. Its catalytic role was 
investigated in the olefination reaction combining benzaldehyde and bromoacetophenone to 
provide (E)-chalcone (3.18, Table 3.7). Tributylstibine and Rh4(CO)12 were added in catalytic 
amounts to the reaction mixture. Screening of reaction conditions quickly revealed the feasibility 
of the intended catalytic process. 
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Table 3.7. Optimization of the catalytic olefination reaction. 
 
Entry Bu3Sb (mol%) H2O (equiv) Base Solvent T (°C) 3.18 (%)
 
1  30 0.2 - DMF 90 9 
2  30 1 - DMF 90 2 
3  30 0.2 - Toluene 90 6 
4  30 1 - Toluene 90 77 
5  30 1 - Toluene 70 54 
6  15 1 - Toluene 70 75 
7  10 1 - Toluene 70 88 
8  5 1 - Toluene 70 83 
9  5 0.5 - Toluene 70 79 
10  5 2 - Toluene 70 62 
11  30 1 Collidine Toluene 90 2 
12  30 1 DIPEA Toluene 90 15 
13  30 1 DBU Toluene 90 2 
14  30 1 Proton sponge Toluene 90 20 
15  5 1 Cs2CO3 Toluene 70 8 
16  5 1 K3PO4 Toluene 70 13 
17  - 2 - Toluene 70 0 
18a 15 2 - Toluene 70 0 
19b 15 2 - Toluene 70 0 
a. No Rh4(CO)12 was added to the reaction mixture; b. The reaction was run under an Ar atmosphere. 
 
Whereas the reaction proceeded sluggishly with 30 mol% of Bu3Sb in DMF at 90 °C and did 
not exhibit turnover (entries 1-2), changing the solvent to toluene allowed for catalyst turnover 
when a full equivalent of H2O was used (entry 4). The reaction worked less efficiently when the 
temperature was decreased to 70 °C (entry 5), but, surprisingly, a reduced loading of 
tributylstibine (5-15%) allowed for better conversion at that temperature (entries 6-8). The 
reaction proceeded even with a substoichimetric amount of water (0.5 equiv, entry 9). On the 
contrary, a higher amount of water was detrimental (entry 10). Addition of bases of different 
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pKas, which should facilitate the formation of the intermediate stibonium ylide, had an inhibitory 
effect on the reaction (entries 11-16). Finally, control experiments showed that the reaction did 
not proceed in the absence of Bu3Sb, Rh4(CO)12, or CO (entries 17-19), confirming the existence 
of a WGSR-mediated process at the stibine level. 
Analysis of the reaction mixtures also indicated that substantial amounts of acetophenone 
were being formed, and that the conversion to acetophenone was highly influenced by the H2O 
loading. A more thorough investigation of the impact of water content on the outcome of the 
reaction was therefore undertaken (Table 3.8).   
Table 3.8. Interplay of olefination and acetophenone formation. 
 
Entry Bu3Sb : Rh H2O : Bu3Sb 3.18 (%)
a 
3.19 (%)
b
 3.18 : 3.19
 
1  1 10 79 18 2.3 
2  1 20 83 23 1.8 
3  1 40 62 31 1.0 
4  2 5 77 19 2.0 
5  2 10 88 27 1.6 
6  2 20 35 37 0.5 
7  3 3.3 0 28 0.0 
8  3 6.7 75 28 1.3 
9  3 13.3 82 38 1.1 
10  6 1.7 0 34 0.0 
11  6 3.3 54 43 0.6 
12  6 6.7 71 54 0.7 
a. Relative to benzaldehyde; b. Relative to bromoacetophenone. 
 
Reactions were run at a constant Rh4(CO)12 loading (1.25 mol%) and varying amounts of 
Bu3Sb and H2O. It appears that the product:acetophenone ratio worsens at high Bu3Sb loadings 
(3-6-fold excess vs. Rh, corresponding to 15-30 mol%, entries 7-12), where the formation of 
acetophenone becomes predominant (3.18:3.19 ≤ 1). At lower stibine loadings (1-2-fold excess 
vs. Rh, 5-10 mol%, entries 1-6), the formation of product is enhanced (3.18:acetophenone ≥ 1), 
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provided that the amount of H2O is kept low (5-10-fold excess vs. Bu3Sb, corresponding to 0.5-1 
equiv). In absolute terms, the best conversion to product is obtained using Bu3Sb (10 mol%) and 
H2O (1 equiv) (88%, entry 5), whereas an improved product:acetophenone ratio is obtained with 
Bu3Sb (5 mol%) and H2O (0.5 equiv), yet with a slightly diminished conversion to product (79%, 
entry 1). 
In an attempt to expand the scope of the reaction, the optimized conditions were applied to 
other activated alkyl halides (Figure 3.17). Unfortunately, none of them yielded any olefination 
products, even when more forcing conditions were employed (T up to 100 °C). The alkyl halides 
and the aldehyde were found unreacted in the reaction mixtures. 
 
Figure 3.17. Unreactive alkyl halides. 
The lack of reactivity of the alkyl halides in Figure 3.17 compared to bromoacetophenone, 
and the observation that bases inhibit the reaction, prompted further investigation into the nature 
of the olefination step. Clearly, the inhibitory effect of the base suggests that the reaction may 
not proceed via ylide formation by deprotonation. Indeed, it has been suggested that the 
combination of bromoacetophenone and tributylstibine in equimolar amount leads to the 
displacement of the halide to form stibonium bromide 3.20 (Scheme 3.33), which rapidly 
equilibrates between its C-bound and O-bound isomers. Disproportionation of 3.20 yields 
acetophenone and stibonium ylide 3.21.
220
 
 
Scheme 3.33. Disproportionation of stibonium bromide 3.20. 
141 
 
Evidence for the disproportionation step was found in the stoichiometric reaction of 
bromoacetophenone and benzaldehyde with tributylstibine (Scheme 3.34). 
1
H NMR monitoring 
of the progress of the reaction showed that the rate of formation of 3.18 matched the rate of 
formation of acetophenone. Therefore, ylide 3.21, formed via disproportionation, is likely 
implicated in the olefination event. Small amounts of 3.22 were also detected, presumably 
formed by nucleophilic displacement of Br
-
 in the starting material by the nucleophilic stibonium 
enolate 3.20b. 
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Scheme 3.34. Progress of the stoichiometric olefination reaction as monitored by 
1
H NMR. 
In the catalytic reaction, the low concentration of 3.20 disfavors the disproportionation step 
(a bimolecular process). In fact, implication of 3.21 in the catalytic reaction is inconsistent with 
the experimental data, because the amount of product often exceeds that of acetophenone (Table 
3.8). Therefore, the observed olefination event seems to be the result of nucleophilic addition of 
3.20b to benzaldehyde, and subsequent elimination of a Sb(V) species (Scheme 3.35).  
142 
 
 
Scheme 3.35. Addition/elimination of stibonium bromide 3.20. 
3.5. DISCUSSION 
Our efforts toward the application of the WGSR in the catalysis of fundamental C-C bond 
forming reaction have identified two separate strategies (Figure 3.18). In a first approach, the 
CO/H2O couple serves as the terminal reducing agent for a metal catalyst that is directly 
involved in the formation of a new C-C bond. The ability of CO to act in this capacity was first 
disclosed by our laboratories in the case of the Ru-catalyzed allylation reaction (Section 
3.2.2.2.5), and its extension to other systems was then investigated. In a second approach, the 
CO/H2O couple provides reducing equivalents for an organocatalyst that is implicated in the C-C 
bond formation. In this case, the metal catalyst for the WGSR is not involved in the formation of 
the C-C bond, but only in the formation of a metal-hydride species that participates in the 
reduction of the organocatalyst. This strategy was used in the development of the catalytic Wittig 
reaction. The details and challenges associated with both approaches will be discussed herein. 
 
Figure 3.18. WGSR in C-C bond forming reactions. 
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3.5.1. Strategy I: reduction of a metal catalyst 
The development of the WGSR-driven, Ru-catalyzed allylation reaction in our laboratories 
led to the formulation of the catalytic cycle shown in Scheme 3.21. The same catalytic cycle can 
be envisioned for any metal-catalyzed carbonyl addition, and generalized in the form shown in 
Scheme 3.36. Oxidative addition of low-valent metal catalyst i leads to an organometallic species 
xlviii that can undergo nucleophilic addition to a carbonyl. Displacement of the alkoxyde by H2O 
forms metal-hydroxide complex xlix which, after CO insertion, decarboxylates to hydrido 
complex li. Reductive elimination of HX regenerates i. 
 
Scheme 3.36. Catalytic cycle for the carbonyl addition reaction. 
The role of CO and H2O can be postulated to be similar in the catalysis of the reductive 
homocoupling reaction, but the proposal of a catalytic cycle is not as straightforward because of 
the existence of one-electron processes.
217c,d
 
With the exception of the Ru-catalyzed allylation reaction, turnover of other carbonyl 
addition reactions (using other metals and nucleophiles, Sections 3.4.1 and 3.4.2) and the Ni-
catalyzed homocoupling reaction (Section 3.4.3) could not be achieved under WGSR conditions. 
These findings suggest the existence of one or more weak steps along the proposed catalytic 
pathway. Indeed, for the catalytic cycles shown in Scheme 3.36 to exhibit turnover, a number of 
conditions must be strictly met. 
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3.5.1.1. Electrochemical requirement 
In the design of methods that capitalize on the WGSR, the electrochemical limits posed by 
the CO/H2O couple must be considered. With an half-cell reduction potential E° = ‒0.53 V, CO 
has approximately the same reducing power as gallium(0). Therefore, it is not likely to be 
successful in regenerating highly electropositive metals (E° < 0 V). On the other hand, metals 
with positive reduction potentials are good candidates, as they generate an overall positive 
(hence thermodynamically favorable) electromotive force ΔE°. Figure 3.19 identifies metals that 
meet this electrochemical requirement based on the half-cell reduction potential of the M(II) → 
M(0) reduction (highlighted in green). In principle, WGSR catalysis should be possible using 
metals such as Ni, Pd and Ru. Although these electrochemical considerations are in agreement 
with the observed efficiency of the Ru-catalyzed allylation reaction, the lack of catalytic activity 
of Ni and Pd cannot be explained by electrochemical arguments alone. On the contrary, CO-
promoted reduction of metals such as Cr and Mn is thermodynamically unfavorable. Therefore, 
these metals are unlikely to be successful in a WGSR-mediated process, unless other oxidation 
states are involved (for example, E°Cr(III)/Cr(II) = ‒0.42 V, ΔE° = 0.11 V). 
Cr Mn Fe Co Ni Cu Zn 
‒0.91 ‒1.19 ‒0.45 ‒0.28 ‒0.26 0.34 ‒0.76 
‒0.38 ‒0.66 0.08 0.25 0.27 0.87 ‒0.23 
Mo Tc Ru Rh Pd Ag Cd 
  0.45 0.60 0.95  ‒0.40 
  0.98 1.13 1.48  0.13 
W Re Os Ir Pt Au Hg 
    1.18  0.85 
    1.71  1.38 
 
 
Figure 3.19. Electrochemical requisite for WGSR-driven reductions. 
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3.5.1.2. Ease of oxidative addition 
The formation of the organometallic intermediate xlvii proceeds via oxidative addition of the 
low-valent catalyst i into a R-X bond. The ease of oxidative addition is dictated by many factors, 
namely the metal and its oxidation state, the influence of the ligand sphere, the organic moiety R, 
the leaving group X, and the solvent. Our studies indicated that, across the range of metals that 
were investigated in the carbonyl addition reactions, only a handful were capable of oxidative 
addition. Among the Cr sources (Scheme 3.22), only CrCl2 yielded traces of products. Cr(0) 
sources were inert, perhaps due to the formation of metal carbonyl clusters. Chromium(III) 
sources were unreactive as well, arguably because their reduction to a low-valent oxidation state 
did not take place under WGSR conditions. A similar trend was identified when comparing 
Ni(0)/Ni(II) sources (Schemes 3.27 and 3.29), and Pd(0)/Pd(II) sources (Scheme 3.26): only the 
low-valent form underwent oxidative addition. Oxidative addition of Mn could not be achieved, 
regardless of the oxidation state (Scheme 3.23). Ruthenium(0), which promptly undergoes 
oxidative addition into allylic halides and pseudo-halides, did not exhibit the same propensity 
toward oxidative addition when the reaction was attempted with alkenyl or aryl halides (Schemes 
3.24 and 3.25). 
3.5.1.3. Ease of carbonyl addition 
Intermediate xlvii generated via oxidative addition needs to be capable of delivering the R 
moiety to the carbonyl in a nucleophilic addition step. Again, the feasibility of this step depends 
primarily on the metal, and might be limited for carbophilic metals. In the case of Pd, no 
carbonyl addition was observed after oxidative addition; rather, the Pd(II) complex xlvii 
underwent protodemetalation. This is surprising, as arylpalladium (prepared by oxidative 
addition of aryl halides) and alkenylpalladium species (prepared from carbopalladiation of 
alkynes) are known to undergo carbonyl addition in an intramolecular fashion.
221
 Likely, no 
carbonyl addition was observed in our case because of the intermolecular nature of the process, 
and the consequent entropic loss. With Ru, carbonyl addition occurred readily from π-
allylruthenium intermediate xlii (Scheme 3.21) thanks to the decreased activation barrier 
provided by a 6-membered transition state. However, no carbonyl addition was observed from 
the preformed arylruthenium complex 3.12 (Scheme 3.25). 
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3.5.1.4. Ease of alkoxide displacement and CO insertion 
Turnover of the catalytic cycle is contingent upon protonolysis of the metal alkoxide xlviii by 
water (with liberation of the desired product) and subsequent migratory insertion of CO in 
complex xlix. Ultimately, the likelihood of these steps is determined by the balance between 
oxophilicity and carbophilicity of the metal. Figure 3.20 compares the bond dissociation energies 
(BDE) for the M-O bond and the M-CH3 bond of the d-block transition metals.  
Sc Ti V Cr Mn Fe Co Ni Cu Zn 
163 161 150 103 96 93 92 91 65 65 
28 42 40 33 28 32 43 50 53 64 
          
Y Zr Nb Mo Tc Ru Rh Pd Ag Cd 
172 186 184 134 131 126 97 91 53 56 
- 66 - 49 - 34 57 - 32 56 
          
La Hf Ta W Re Os Ir Pt Au Hg 
192 192 191 161 150 143 99 94 53 51 
- 73 62 53 53 - 58 64 46 57 
          
 
 
Figure 3.20. Oxophilicity vs carbophilicity in transition metals
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. 
As a general trend, early transition metals are more oxophilic than late transition metals, 
whereas carbophilicity increases in the opposite direction. This analysis is extremely simplistic, 
because it does not take into consideration important factors that influence bond enthalpies such 
as metal oxidation state, ligand sphere, back-bonding, etc. Yet, the oxophilicity/carbophilicity 
trends may help interpret the experimental data. Due to the high oxophilicity of Cr, the 
conversion of xlviii into xlix and l therefrom is enthalpically disfavored. We suggest that, in the 
case of Cr, the turnover of the catalytic cycle is hampered by the difficulty of achieving CO 
migratory insertion in complex xlix, which requires breaking a strong Cr-O bond and forming a 
much weaker Cr-C bond. Similar arguments may apply to the Ni-catalyzed reactions. The case of 
Ru is puzzling because the allylation reaction is not inhibited by the high oxophilicity of the 
metal. This might be due to the high reduction potential of Ru(II), which favors the reduction of 
li to i, therefore acting as a thermodynamic driving force. 
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3.5.1.5. Compatibility with water 
Since the occurrence of the WGSR invariably requires the presence of water, the 
organometallic intermediates must be compatible with protic conditions. A weak C-M bond to a 
carbophilic metal may undergo protodemetalation, driven by the formation of a stronger M-OH 
bond. The ease of protodemetalation is also dependent on the R group. In the case of Ni, control 
experiments indicated that π-allylnickel complexes were stable in the presence of water, whereas 
arylnickel complexes were not (Schemes 3.28 and 3.30). 
3.5.2. Strategy II: reduction of an organocatalyst 
The implementation of WGSR catalysis in the Wittig reaction requires that a phosphine 
oxide lii be reduced to a phosphine liv by a metal-hydride lvii generated through the WGSR 
pathway (Scheme 3.37). As suggested for other metal-mediated reduction of phosphine 
oxides,
223
 the deoxygenation step forms a metal-hydroxyde complex lv which, under WGSR 
conditions, is prone to CO insertion and decarboxylation to reform lvii. Phosphine liv can 
participate in the classic steps of the Wittig reaction (halide displacement, deprotonation to ylide, 
addition to carbonyl and decomposition of oxaphosphetane), regenerating lii after the olefination 
has taken place. In this proposed catalytic cycle, H2O does not appear in the balanced equation. 
However, a catalytic amount of water is required to generate lvii at the onset of the reaction. 
 
Scheme 3.37. Catalytic cycle for the catalytic Wittig reaction under WGSR conditions. 
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The crucial phosphine oxide deoxygenation step was studied independently to assess its 
feasibility. Deoxygenation reactions of hydroxylamines, N-oxides, and sulfoxides have all been 
accomplished under WGSR conditions (Section 3.2.2.1.8), and are facilitated by the low BDEs 
of the corresponding N-O or S=O bonds (Figure 3.21).
222
 However, the strong P=O bond in 
triphenylphosphine oxide (130 kcal/mol) could not be reduced by CO with any metal even at 
high temperature , and neither could the As=O bond (102 kcal/mol) in triphenylarsine oxide. On 
the contrary, the weaker Sb=O bond (81 kcal/mol) was readily reduced by Rh4(CO)12 under CO 
atmosphere. In addition, computational analysis
224
 revealed a much lower BDE (88 kcal/mol) for 
the As=O bond in the electron-rich tris-(2-furyl)arsine oxide (compared to 102 kcal/mol for 
triphenylarsine oxide), which indeed could be deoxygenated, albeit in low yield. 
 
Figure 3.21. Deoxygenations under WGSR conditions. 
Given the ease of deoxygenation of the Sb=O bond and the convincing literature precedents 
for the use of Bu3Sb in olefination reactions (both with base and base-free),
219
 our investigation 
focused on the use of stibines to develop the catalytic variant. Catalytic conditions were quickly 
identified and optimized for the use of Bu3Sb in molar ratio as low as 5% (Table 3.7, entry 8). As 
expected, the reaction worked efficiently even with a substoichiometric amount of water (entry 
9). However, the use of a stoichiometric amount of water is beneficial, probably because of the 
competitive participation of lvii in the traditional WGSR manifold (to form H2, which consumes 
H2O unproductively).  
The reaction did not proceed in the absence of CO (entry 19) or Rh (entry 18), lending 
support to the existence of a Rh-catalyzed WGSR process. However, the inhibitory effect of 
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bases (entries 11-16) cast doubt on the implication of a classic Wittig mechanism, because a base 
should be necessary to generate the intermediate ylide lix. Thus, alternative mechanism were 
proposed, namely formation of an organorhodium complex by oxidative addition into 
bromoacetophenone, and its subsequent addition to benzaldehyde/elimination, or Rh-catalyzed 
reduction of bromoacetophenone to acetophenone, followed by aldol condensation with 
benzaldehyde. Both mechanisms can be ruled out based on the observation that no reaction 
occurs in the absence of Bu3Sb (entry 17). 
Analysis of the stoichiometric reaction (Scheme 3.34) showed that the intermediate 
stibonium salt 3.20 is involved in a disproportionation process that yields 3.21 and 3.19 (Scheme 
3.33). Thus, the stoichiometric reaction proceeds by addition of ylide 3.21 to benzaldehyde, and 
is always accompanied by a stoichiometric amount of 3.19 as the byproduct. These observations 
are consistent with previous studies of reduction
220
 and olefination
219b
 of α-bromoketones.  
In the case of the catalytic reaction, the concentration of 3.20 is low. We propose that, rather 
than engaging in a kinetically unfavorable bimolecular disproportionation, the nucleophilic 
stibonium enolate 3.20b reacts with benzaldehyde to form adduct 3.23 (Scheme 3.38). 
Elimination of Bu3Sb(OH)Br provides chalcone. The Sb(V) byproduct undergoes WGSR-driven 
reduction to Bu3Sb, plausibly via Bu3Sb=O.  
 
Scheme 3.38. Catalytic cycle for the Bu3Sb-catalyzed olefination under WGSR conditions. 
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The proposed catalytic cycle is consistent with our experimental observations. The amount of 
chalcone often exceeds that of acetophenone, which rules out the disproportionation/ylide 
addition pathway (although disproportionation might occur to a small extent). Moreover, the 
amount of acetophenone increases at higher H2O loading, as a result of H2O being a competitive 
electrophile for 3.20b. 
3.6. CONCLUSION 
The water-gas shift reaction has found application in a diverse set of organic reactions, 
mainly as an alternative source of H2 for hydrogenative transformations. One of the most 
intriguing, yet underdeveloped aspects is the capacity of the CO/H2O couple to act as a terminal 
reductant in C-C bond forming reactions, therefore enabling turnover of catalytic cycles. We 
have attempted to exploit the WGSR in this capacity with two separate strategies: first, in the 
regeneration of a metal catalyst involved in a C-C bond forming event; second, in the 
regeneration of an organocatalyst.  
The first strategy was studied in the context of carbonyl addition and reductive 
homocoupling reactions. There are multiple conditions that must be strictly met for this approach 
to be successful, ranging from electrochemical requirements to properly balanced bond 
enthalpies of the complexes along the catalytic pathway. Needless to say, the multiple 
requirements made the development of new catalytic methods based on the WGSR quite 
challenging. Indeed, success was obtained only with the Ru-catalyzed allylation reaction. 
On the other hand, the second strategy poses fewer challenges because it consists of two 
independent catalytic processes: a metal-catalyzed one for the WGSR, and an organo-catalyzed 
one for the formation of the C-C bond. In this case, the major requirement is that the 
organocatalyst be successfully reduced to its active form by a metal-hydride generated via 
WGSR. We demonstrated that the use of Bu3Sb enabled the development of a catalytic 
olefination reaction under WGSR conditions. However, the reaction did not proceed through the 
envisioned Wittig pathway, but through an addition/elimination pathway, and the substrate scope 
could not be extended to other nucleophiles (bromoacetate, bromoacetonitrile). The use of 
electron-rich arsines might help restore Wittig-type reactivity and allow for further extensions of 
the catalytic olefination reaction. 
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Chapter 4:  
The reductive Knoevenagel condensation driven by the Water-Gas 
Shift Reaction 
 
4.1. INTRODUCTION 
Since its original discovery over a century ago, the Water-Gas Shift Reaction (WGSR) has 
played a crucial role in industrial chemistry, providing a source of hydrogen to feed fundamental 
industrial transformations such as the Haber-Bosch synthesis of ammonia. Although the 
production of hydrogen remains nowadays the major application of the WGSR, the advent of 
homogeneous catalysis in the 1970s marked the beginning of a synergy between WGSR and 
organic chemistry.
1
 Thus, the reducing power provided by the CO/H2O couple has been 
exploited in the synthesis of fine chemicals, mainly in hydrogenation-type reactions (nitro 
reduction, reductive amination, hydrogenation of alkenes and carbonyls, etc.). On the other hand, 
the use of the WGSR to drive C-C bond forming processes remains underdeveloped. 
Following the serendipitous discovery that the Ru-catalyzed allylation reaction of aldehydes 
can be driven by CO/H2O as the terminal reductant,
2
 our group became interested in expanding 
the range of applicability of the WGSR to the catalysis of other fundamental reductive C-C bond 
forming reactions. The efforts made to this end were presented and discussed in Chapter 3. Our 
investigations initially identified two different strategies to exploit the WGSR in the formation of 
a C-C bond: the regeneration of a metal catalyst, or the regeneration of an organocatalyst (Figure 
4.1a and b). Due to the intrinsic challenges associated with both strategies, only marginal success 
was achieved. However, a third, simpler approach to engage the WGSR in a reductive C-C bond 
formation relies on the well-established capacity of CO/H2O to act as a H2 surrogate (Figure 
4.1c). In this approach, an independent C-C bond forming event leads to a functional group that 
can be reduced (hydrogenated) by CO/H2O. The metal catalyst for the WGSR is not involved in 
the formation of the C-C bond, but only in the generation of a metal-hydride species that will 
hydrogenate the substrate. The outcome is an overall reductive, tandem transformation that 
combines two steps in one, therefore enhancing step- and redox economy.
3
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Figure 4.1. WGSR in C-C bond forming reactions. 
Tandem, WGSR-based approaches have been described for the reductive amination reaction, 
a non-C-C bond forming process that entails formation of an imine and its reduction by CO/H2O 
(Section 3.2.2.1.3). As early as 1978, Watanabe et al. employed WGSR conditions to carry out 
the methylation or benzylation of amines with aldehydes.
4
 More recently, the scope and 
applicability of the reductive amination reaction under WGSR conditions have been significantly 
expanded by the independent contributions of List, Chusov, Chung and coworkers.
5
 
A similar strategy has been adopted in the formation of C-C bonds via tandem aldol 
condensation/WGSR-mediated alkene reduction (reductive alkylation, Section 3.2.2.2.4). In this 
context, Watanabe et al. reported the methylation of ketones and methylpyridines with 
formaldehyde.
6
 In addition, relying on their studies of the reductive amination reaction, Chusov 
et al. disclosed two protocols for the reductive alkylation of active methylene compounds 
(reductive Knoevenagel condensation, Figure 4.2). The transformation was achieved using either 
homogenous (Rh2(OAc)4)
7
 or heterogenous (Rh/C)
5d
 catalysis, and allowed for the successful 
alkylation of methyl cyanoacetate with aldehydes and ketones. However, several drawbacks are 
associated with the reported protocols. First, the reaction requires impractical high temperatures 
(110-160 °C) and pressures of CO (50-90 bar). Second, the forcing conditions cause unwanted 
side reactions, such as transesterification, hydrolysis and decarboxylation of esters. Third, the 
protocol seems to be only applicable to cyanoacetates as the Knoevenagel nucleophiles.  
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Figure 4.2. Reductive Knoevenagel condensation under WGSR conditions. 
The reductive variant of the Knoevenagel condensation represents an alternative to the direct 
alkylation of active methylene compounds with alkyl halides. This traditional method suffers 
from the need for a (super)stoichiometric amount of base (usually inorganic), as well as the 
occurrence of overalkylation and O-alkylation.
8
 Key benefits of a reductive alkylation approach 
include the smooth C-monoalkylation, the larger availability of aldehydes and ketones compared 
to halides, their lower cost ($4/mol for benzaldehyde, $38/mol for benzyl bromide, for example)
9
 
and toxicity. Moreover, the use of WGSR conditions is more mass-efficient than regular 
alkylation reactions (CO2 vs. M
+
Br
−
 as the byproducts), and it allows for a chemoselective 
reduction of the intermediate alkene that is compatible with a variety of other reduction-
susceptible functional groups. Yet, the protocols developed by Chusov et al. are far from being 
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synthetically useful because of the harshness of the reaction conditions. The identification of 
more user-friendly reaction conditions and the expansion of the substrate scope are essential for 
the further development of this strategic WGSR-driven, C-C bond forming reaction. 
4.2. BACKGROUND 
4.2.1. The Knoevenagel condensation and its reductive variants 
With over 120 years’ worth of history and applications in synthetic endeavors, the 
Knoevenagel condensation reaction represents an indispensible tool in organic synthesis.
10
 The 
reaction entails the addition of an active methylene compound to an aldehyde or ketone in the 
presence of a weak base, followed by the elimination of water (Scheme 4.1a). The pKa of the 
active methylene compound must be sufficiently low to allow for deprotonation by a weak base. 
Thus, cyclic and acyclic 1,3-dicarbonyl compounds are a privileged class of substrates in the 
Knoevenagel condensations, although reactions with heteroatom-, aryl-, or nitro-stabilized enol 
equivalents are not uncommon. 
 
Scheme 4.1. Knoevenagel condensation and its reductive variant. 
Because of its operational simplicity and expedited access to α,β–unsaturated motifs, the 
Knoevenagel condensation has found multiple applications in organic synthesis, including in 
industrial settings.
11
 One of its key features is the possibility to engage the resulting alkene in 
tandem processes, such as Michael, Diels-Alder, or sigmatropic reactions.
10
 In this context, the 
reductive variant of the Knoevenagel reaction, in which the alkene is hydrogenated immediately 
following the condensation (Scheme 4.1b), has also received significant attention. For example, 
the synthesis of the top-selling anti-diabetic drug pioglitazone (4.4, Scheme 4.2) involves the 
Knoevenagel condensation of 2,4-thiazolidinedione (4.1) with aldehyde 4.2. The resulting 
Knoevenagel adduct 4.3 affords pioglitazone after a standard hydrogenation over Pd/C.
12
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Scheme 4.2. Synthesis of pioglitazone. 
Reductive Knoevenagel protocols of this kind, consisting of the reduction of a pre-formed 
Knoevenagel adduct in a separate step, are numerous. In addition to the widespread use of H2, 
several other hydrogen sources have been employed in the reduction step, including sodium 
borohydride,
13
 borane,
14
 formic acid/triethylamine,
15
 formate,
16
 the Hantzsch ester,
17
 2-
phenylbenzimidazoline,
18
 and 2-phenylbenzothiazoline.
19
 However, the need for a two-step 
process is impractical and limits the step-economy. 
Consequently, efforts have been made to combine the condensation and reduction steps into a 
tandem (one-pot) process, using mutually compatible reagents and reaction conditions. Tandem 
protocols were successfully described with several reducing agents (Scheme 4.3): H2,
20
 formic 
acid/triethylamine,
21
 the Hantzsch ester (4.5),
22
 2-phenylbenzimidazoline,
23
 and, of course, the 
CO/H2O-based systems discussed above (Figure 4.2).
5d,7
 Both aldehydes and ketones can be 
engaged as the electrophiles. 
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Scheme 4.3. Selected examples of one-pot, reductive Knoevenagel condensation. 
Although these methods are efficient from a step-economy standpoint, the use of reducing 
agents other than the simple H2, H2O/CO, or HCOOH/Et3N is highly wasteful and atom-
uneconomic. However, the range of applicability of H2 is limited because of its incompatibility 
with functional groups such as alkenes, alkynes, carbonyls, halides, nitro groups, and S-bearing 
functionalities. On the other hand, CO/H2O and HCOOH/Et3N have fewer compatibility issues, 
but are still unpractical because of the harsh conditions needed, or the long incubation time for 
the condensation to take place, respectively. Therefore, it is not surprising that, for applications 
of the reductive Knoevenagel condensation with sensitive substrates in a total synthesis context, 
the use of the mild (yet wasteful) Hantzsch ester has been preferred (Scheme 4.4).
24
 
 
Scheme 4.4. Reductive Knoevenagel condensation in the total synthesis of atropurpuran.  
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4.2.2. Methods based on hydrogen-transfer 
An alternative to the use of external reducing agents is represented by the hydrogen-transfer 
technology.
25
 In methods relying on hydrogen-transfer, the electrophile (aldehyde) is replaced by 
a primary alcohol, which acts both as the reactant and the source of reducing equivalents. A 
suitable metal catalyst allows for the in situ oxidation of the alcohol to the carbonyl, as well as 
the reduction of the alkene after the Knoevenagel condensation has taken place (hence the term 
hydrogen-transfer or hydrogen-borrowing). Although known since 1955,
26
 the hydrogen-transfer 
alkylation of active methylene compounds has been considerably developed only in the last 
decade. Recent reports have described protocols for the alkylation of several classes of active 
methylene precursors, including arylacetonitriles,
27
 barbituric acids,
28
 cyanoacetates,
29
 
oxindoles,
30
 1,3-diketones,
31
 ketonitriles,
32
 and malonates
33
, using group 8 and 9 transition metal 
catalysts (Scheme 4.5).
34
  
 
Scheme 4.5. Selected examples of hydrogen-transfer, reductive Knoevenagel condensation. 
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Despite the benefit of their catalytic nature, hydrogen-transfer alkylation protocols are still 
limited by the need for high temperatures (which, in conjunction with basic conditions, may 
cause transesterification or decarboxylation of esters),
29,33
 and by the fact that only primary 
alcohols (mostly benzylic) are compatible. Therefore, the reductive alkylation of ketones (from 
secondary alcohols) cannot be achieved under these conditions.  
4.3. RESEARCH OBJECTIVES 
Within the context of our overarching goal to expand the applications of the WGSR in 
organic synthesis, the present investigation intended to provide a robust and general protocol for 
the reductive Knoevenagel condensation using CO/H2O as the reducing agent. The development 
of our synthetic method involved the following steps: 
1. Identification of milder and more practical reaction conditions than previously reported; 
2. Application of the optimized reaction conditions to a wide range of electrophiles and 
nucleophiles, thus demonstrating the generality and versatility of the approach; 
3. Clarification of the observed reactivity trends through a mechanistic proposal, which may 
guide further optimization. 
4.4. RESULTS 
4.4.1. Optimization and substrate scope 
Relying on the previous reports by Chusov et al. on the reductive Knoevenagel condensation 
under WGSR conditions,
5d,7
 we speculated that the addition of a base to the reaction mixture 
would be beneficial and remove the requirement for high temperature. The role of the base 
would be twofold: first, allow for a fast condensation between the active methylene compound 
and the carbonyl (the Knoevenagel reaction does require at least a catalytic amount of base); 
second, facilitate the formation of the active reducing agent (a metal-hydride species) through a 
base-catalyzed, WGSR mechanism (see Section 3.2.1.2). 
The reaction between ethyl cyanoacetate (4.6a) and benzaldehyde (4.7a) was chosen for the 
optimization of reaction conditions (Scheme 4.6). Extensive evaluation of metal catalysts 
(homogeneous and heterogeneous), bases and solvents quickly revealed that the reaction could 
be conveniently carried out at room temperature when an amine was added, in agreement with 
our expectations. The optimized reaction conditions, involving the use of RhCl3·3H2O (2 mol%), 
172 
 
triethylamine (2.5 equiv), H2O (2 equiv) in acetonitrile (0.5 M) under CO atmosphere (10 bar), 
yielded the reductive alkylation product 4.8aa almost quantitatively, with only traces of 
unreduced alkene (4.9aa), decarboxylated product (4.10aa) and benzyl alcohol (4.11a).
35
 
 
Scheme 4.6. Optimized reaction conditions. 
With the optimized conditions in hand, the substrate scope with respect to the nucleophile 
and the electrophile was evaluated. Initially, ethyl cyanoacetate was combined with a number of 
aliphatic and aromatic aldehydes (Table 4.1). During the exploration of the aldehyde scope, we 
made the observation that the rate of the reaction (and therefore the product yield) was highly 
dependent on the electronic properties of the aldehyde, with aliphatic and electron-rich aromatic 
aldehydes reacting faster than the electron-poor ones, as a general trend. The difference in rate is 
due to efficiency of the reduction step. Indeed, with slow-reacting aldehydes, significant amounts 
of alkene 4.9 were detected in the reaction mixtures. To account for the different reactivity of the 
electrophiles and facilitate the reduction of 4.9, small adjustments of the optimized conditions 
had to be made.
36
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Table 4.1. Aldehyde substrate scope. 
 
Entry Aldehyde 
RhCl3 
(mol%) 
H2O 
(equiv) 
Time  
(h) 
Product 
Yield 
(%)
a
 
1  
 
2 3 24 
 
89 
2  
 
2 3 24 
 
88 
3  
 
2 3 24 
 
92 
4  
 
2 3 24 
 
92 
5  
 
2 3 24 
 
73 
6  
 
2 2 18 
 
93 
7  
 
2 2 18 
 
91 
8  
 
2 2 18 
 
87 
9  
 
2 2 18 
 
90 
10  
 
2 2 18 
 
81 
11  
 
2 2 18 
 
95 
 
174 
 
Table 4.1. (cont.) 
Entry Aldehyde 
RhCl3 
(mol%) 
H2O 
(equiv) 
Time  
(h) 
Product 
Yield 
(%)
a
 
12 
 
2 2 18 
 
87 
13 
 
3 5 36 
 
82 
14 
 
3 5 36 
 
54 
15b 
 
3 5 36 
 
69 
16c 
 
3 5 36 
 
traces 
17 
 
2 2 18 
 
90 
18 
 
2 2 18 
 
97 
19 
 
2 2 18 
 
91 
20 
 
2 2 18 
 
95 
21 
 
2 3 24 
 
71 
22 
 
2 3 24 
 
19d 
23 
 
2 2 18 
 
0 
a. Yield of isolated, purified product; b. 1 M in CH3CN; c. The reaction afforded                             
as the main product; d. Determined by 
1
H NMR. 
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Thus, benzaldehyde and other nearly electron-neutral aromatic aldehydes reacted efficiently 
when the reactions were conducted with H2O (3 equiv) for 24 hours (Table 1, entries 1-5). 
Ortho-substituents (methyl, fluoro) were well tolerated. A meta-vinyl substituent was not 
reduced over the course of the reaction; however, the product 4.8ad rapidly polymerized after 
isolation. The Lewis-basic methylthio substituent in 4.7e did not significantly inhibit the 
reaction, nor did it undergo hydrodesulfurization.  
Electron-rich aromatic aldehydes required a lower H2O loading (2 equiv) and shorter reaction 
time (18 h) to reach completion (entries 6-9). 4-Methoxy, 4-allyloxy, 4-dimethylamino, and 
2,4,6-trimethoxybenzaldehyde all afforded the reductive Knoevenagel products in high yield. 
The allyl group in 4.7h did not undergo competitive reduction or deallylation. The same reaction 
conditions could also be applied to a number of heteroaromatic aldehydes (entries 10-12), which 
worked efficiently regardless of their π-rich (4.7j, 4.7k) or π-deficient (4.7l) character. 
On the contrary, electron-poor aromatic aldehydes and 2-naphthaldehyde performed poorly 
when exposed to the same conditions as benzaldehyde. To facilitate the reduction of the 
corresponding adducts 4.9, the water loading and the reaction time were increased (5 equiv, 36 h, 
entries 13-15). Under those conditions, decarboxylation of the ester moiety became competitive, 
accounting for the lower isolated yields for 4.7n and 4.7o. Remarkably, the 4-bromo substituent 
in 4.7m remained intact. However, the nitro group in 4.7p underwent fast reduction to the 
corresponding aniline, such that only traces of product 4.8ap were observed (entry 16). The 
reaction afforded alkene 4.9ap’ primarily, which did not undergo further reduction. The 
reluctance of 4.9ap’ toward rhodium-catalyzed hydrogenation has already been noted,20g and 
might be due to the Lewis-basic character of the amino substituent and its consequent affinity for 
the rhodium center. On the contrary, the less Lewis-basic dimethylamino group in 4.7i did not 
inhibit the reaction. 
Aliphatic aldehydes also reacted smoothly under the conditions used for electron-rich 
aromatic aldehydes (entries 17-20). α-Trisubstituted (4.7q), α-disubstituted (4.7r and 4.7s) and β-
branched (4.7t) aldehydes afforded reductive Knoevenagel products in nearly quantitative yield. 
The compatibility with 4.7q is remarkable because the corresponding product 4.8aq cannot be 
generated by simple alkylation of a neopentyl halide.
37
 With the linear aldehyde 4.7u (entry 21), 
self-condensation became competitive and a slightly diminished yield was obtained. Also, 
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reaction of 4.7u required a higher water loading and longer reaction time compared to other 
aliphatic aldehydes, because of the lower rate of reduction of the intermediate alkene. 
Finally, the compatibility with alkynyl moieties was explored (entries 22-23). 
Trimethylsilylethynyl-substituted benzaldehyde 4.7v reacted poorly due to the difficulty in 
reducing the corresponding Knoevenagel adduct 4.9av. A propargyloxy substituent (4.7w) 
inhibited the reaction completely, and only 4.9aw was observed in the reaction mixture. This 
observation is in contrast with the smooth reactivity of the similar, allyloxy-subtituted 
benzaldehyde 4.7h. Although the alkynyl groups themselves did not suffer from reduction under 
the reaction conditions, these data indicate that alkynes are incompatible because they may act as 
competitive ligands for the rhodium catalyst. In particular, the terminal alkyne in 4.7w, in the 
presence of triethylamine, is prone to form a Rh-acetylide complex.
38
 
The promising results obtained with aldehydes prompted us to shift our attention to ketones 
as a more challenging class of electrophiles (Table 4.2). In general, the reactivity of ketones was 
limited by their slow rate of Knoevenagel condensation under the standard reaction conditions. 
Accordingly, adjustments had to be made to overall concentration, H2O and Et3N loading. Cyclic 
ketones were successfully engaged in the reductive alkylation reaction when the H2O and Et3N 
loading was increased to 5 and 7 equivalents, resp. (entries 1-3). However, the isolated yield 
decreased upon reducing the ring size from 6- to 5- and 4-membered ketones. This trend reflects 
the higher propensity of cyclopentanone and cyclobutanone toward enolization and self-
condensation,
39
 thus depleting the electrophile. On the contrary, non-cyclic ketones did not 
participate in the reaction. The increased steric bulk in ketones 4.7a’, 4.7b’ and 4.7c’ thwarted 
the condensation step to an extent that the corresponding reduced products 4.8 were only 
observed in trace amounts, if any (entries 4-6). Further optimization (perhaps through the use of 
stronger bases) is needed to ensure compatibility with non-cyclic ketones. 
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Table 4.2. Ketone substrate scope. 
 
Entry Ketone 
Et3N 
(equiv) 
Time  
(h) 
Product 
Yield 
(%)
a
 
1  
 
7 30 
 
93 
2  
 
7 30 
 
79 
3  
 
7 30 
 
47 
4  
 
1 42 
 
traces 
5  
 
1 42 
 
0 
6  
 
1 42 
 
0 
a. Yield of isolated, purified product. 
 
Lastly, we endeavored to expand the substrate scope of the reductive Knoevenagel reaction 
to include other active methylene compounds (Table 4.3). This task turned out to be particularly 
challenging, due to the different behavior of other carbon acids compared to 4.6a. Malononitrile 
4.6b and N,N-dimethylbarbituric acid 4.6c (entries 1-2) afforded complex reaction mixtures 
because of their tendency to undergo 1,4-addition to Knoevenagel adducts 4.9 (whose reduction 
was slow). Side reactivity was unavoidable even when conditions that favor alkene reduction 
were employed (higher Rh and H2O loading). On the contrary, benzoylacetonitrile 4.6d and 
cyanoacetamide 4.6e reacted smoothly after proper tuning of the reaction conditions, and the 
corresponding alkylated products were isolated in high yield (entries 3-4). The less acidic 2-
pyridylacetonitrile 4.6f afforded the alkylated product when the H2O loading was increased to 50 
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equivalents (entry 5). In this case, the lower yield is due to competitive reduction of 4.7a to 
benzyl alcohol at high water loading. 
Table 4.3. Nucleophile substrate scope. 
 
Entry Nucleophile Electrophile 
RhCl3 
(mol%) 
Et3N 
(equiv) 
H2O 
(equiv) 
CH3CN 
(M) 
Product 
Yield 
(%)
a
 
1   4.7f 3 3 10 0.75 
 
ndb 
2  
 
4.7f 2 2.5 5 0.5 
 
ndb 
3  
 
4.7f 3 4 5 1 
 
87 
4  
 
4.7f 2 4 5 0.5 
 
84 
5c 
 
4.7a 3 2.5 50 2 
 
68 
a. Yield of isolated, purified product; b. Complex reaction mixture containing small amounts of product; c. Run for 
72 h. 
 
4.4.2. Deuterium incorporation 
In consideration of the superstoichiometric amount of triethylamine needed to carry out the 
reaction, as well as its known role as a hydride donor,
40
 a deuteration experiment was performed 
to ascertain the involvement of CO/H2O as the source of reducing equivalents. Thus, the pre-
formed condensation adduct 4.9af was exposed to modified reaction conditions using Rh4(CO)12 
and D2O (Scheme 4.7). The choice of the starting material and the Rh catalyst was dictated by 
the need to remove potential H2O sources (the condensation forms one equivalent of H2O, and 
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RhCl3 is supplied as a trihydrate complex). Under these conditions, 92% deuterium incorporation 
was measured at C(3) by mass spectrometry. The incomplete incorporation might be due to 
adventitious water in acetonitrile and/or CO. No deuterium incorporation was observed at C(2), 
presumably because of the fast D/H exchange upon exposure to moisture or silica gel . 
 
Scheme 4.7. Deuterium incorporation experiment.  
4.5. DISCUSSION 
4.5.1. Comparison with existing methods 
Our investigation of the rhodium-catalyzed, WGSR-driven reductive Knoevenagel 
condensation has identified triethylamine as a key component to allow for the reaction to proceed 
smoothly at room temperature. These findings are in sharp contrast with the base-free conditions 
developed by Chusov et al., which require temperatures in the range of 110-160 °C.
5d,7
 The 
drastic acceleration caused by triethylamine likely arises from its capacity to catalyze the 
Knoevenagel condensation and, at the same time, promote the WGSR by a base-catalyzed 
mechanism.
1,41
 Moreover, the amine may act as a ligand to help solubilize the Rh catalyst and 
disrupt the Rh-CO clusters that are formed under a CO atmosphere.
42
 
The mild conditions and the use of CO as the reducing agent brought about several 
improvements compared to traditional alkylation methods, and other reductive Knoevenagel 
condensation protocols. In particular, the following improvements were achieved:  
 Use of a cheap, non-wasteful reducing agent, amenable to scale-up;  
 The tandem, one-pot nature of the process, which does not require isolation of the 
intermediate alkene;  
 Suppression of dialkylation and O-alkylation, common issues when using alkyl halides;  
 Suppression of decarboxylation, which occurs with methods that require high 
temperature;  
 Compatibility with functional groups that are not tolerated when using H2 (unactivated 
alkenes, allyl ethers, halides, thioethers);  
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 Compatibility with electrophiles that are prone to self-condensation under basic 
conditions (linear aldehydes, cyclic ketones);  
 Possibility of installing a neopentyl group by alkylation. 
Yet, some limitations of the reductive Knoevenagel condensation under WGSR conditions 
also became apparent. First of all, the use of carbon monoxide, though desirable for its low cost 
and waste impact, poses severe safety concerns because of its toxicity and flammability. CO can 
certainly be handled safely by means of specialized techniques and equipment, but these 
handling restrictions limit its use in research laboratories. 
Moreover, the following aspects also detract from the widespread application of our method: 
 Difficulty to optimize conditions for some classes of ketones that do not undergo 
condensation easily, and for active methylene precursors that are prone to conjugate 
addition; 
 Incompatibility of nitro groups, anilines, and alkynes; 
 The use of an expensive rhodium catalyst in high molar amount (2-3 mol%). 
4.5.2. Mechanistic scenario 
The exploration of the substrate scope generated a wealth of mechanistic information that 
helped us formulate a plausible catalytic cycle (Scheme 4.8) and revise a previous mechanistic 
proposal. Over the course of their studies of the Rh-catalyzed reductive Knoevenagel 
condensation, Chusov et al. proposed a catalytic cycle that involves Rh insertion into the C-OH 
bond of an intermediate β-hydroxy ester (4.12).7 The occurrence of the WGSR was not directly 
invoked, but the proposed mechanism clearly shows intermediates (Rh-hydroxycarbonyls, Rh-
hydrides) that would be expected for a WGSR-based process. Intermediates such as 4.12 are 
fleeting, and prone to dehydrate to form a Knoevenagel adduct (4.9). Indeed, our studies 
indicated that 4.9 rapidly accumulated in the reaction mixtures and, as noted in deuteration 
experiments, was kinetically competent. Therefore, we wish to reformulate the mechanistic 
picture of the reductive Knoevenagel condensation as follows. 
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Scheme 4.8. Proposed catalytic cycle. 
The catalytically active, low-valent Rh-carbonyl complex i (generated by reduction of the 
precursor RhCl3) undergoes nucleophilic addition of hydroxide (from triethylamine and water) to 
a CO ligand. The resulting Rh-hydroxycarbonyl complex ii decarboxylates to form Rh-hydride 
iii. These steps are in agreement with those proposed for the WGSR under basic conditions.
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The involvement of the CO/H2O system as the hydride source, and not triethylamine, was clearly 
established on the basis of deuterium incorporation when D2O was used. Loss of a CO ligand 
from iii opens a coordination site (iv) that enables coordination of 4.9. The need for ligand 
dissociation prior to olefin coordination, already suggested for the Rh-catalyzed 
hydroformylation reaction,
43
 is consistent with our observation that the efficiency of the reaction 
decreases at higher pressure of CO.
35
 Moreover, the strong inhibitory effect of Lewis-basic 
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functional groups, such as anilines and terminal alkynes, reinforces the importance of 
coordinative unsaturation to enable olefin binding. From v, migratory insertion of the olefin and 
protonation of the anionic Rh complex vi affords vii. Reductive elimination generates the 
product 4.8 and the coordinatively unsaturated complex viii, which can reenter the catalytic cycle 
upon CO coordination. 
During the exploration of the aldehyde substrate scope, we made the puzzling observation 
that aromatic aldehydes bearing electron-donating groups reacted faster than those bearing 
electron-withdrawing groups. At a first glance, this observation is difficult to fit in our proposed 
mechanistic picture. Reasonably, an electron-poor arene should lower the LUMO of 4.9 and 
thus: (1) facilitate the coordination of 4.9 to the anionic complex iv (a metal-to-ligand 
interaction); (2) promote hydride delivery (migratory insertion) to the electron-depleted π-
system. These arguments are in agreement with Hammett studies performed on the reduction of 
styrene derivatives.
44
 However, it should be considered that 4.9 already possesses a low-lying 
LUMO because of the contribution of the ester and nitrile groups. Therefore, further lowering of 
the LUMO energy (and consequent acceleration) by an electron-poor aryl substituent is expected 
to be minimal.  
The accelerating capacity of electron-rich arenes could be explained as a push-pull effect,
45
 
whereby the electron-donating substituent enhances the polarization of the alkene and lowers its 
bond order by favoring resonance structures 4.9’ and 4.9’’ (Scheme 4.9). The consequent 
weakening of the double bond would account for a more facile hydride delivery in the formation 
of vi, and explain the observed rates if formation of vi were turnover-limiting. A similar 
manifestation of the push-pull effect has been documented in the Ni-catalyzed hydrogenation of 
styrene derivatives, for which the application of the Yukawa-Tsuno correlation furnished 
negative ρ values.46 
 
Scheme 4.9. Resonance structures of 4.9. 
The proposal that step v to vi is turnover limiting, and slow in the case of electron-poor 
aldehydes, is also consistent with the need for higher water loadings for such substrates. When 
hydride delivery is slow, olefin coordination to Rh might be reversible. Thus, the Rh-hydride 
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intermediate iii can participate in a traditional WGSR process, which consumes water 
unproductively by forming dihydrogen through complex ix. 
4.6. CONCLUSION 
Among the strategies identified by our group for the application of the WGSR in organic 
synthesis, the use of CO/H2O as a H2 surrogate in the reduction of a pre-formed C-C bond has 
been so far the most successful approach. The use of CO/H2O as a terminal reducing agent in 
catalytic C-C bond formation poses inherent challenges that were discussed in Chapter 3. 
However, such challenges can be overcome when the C-C bond forming event is relegated to a 
separate, WGSR-independent process. 
This strategy has been successfully illustrated in the tandem Knoevenagel 
condensation/reduction reaction, in which the alkene formed by Knoevenagel condensation is 
readily reduced under WGSR conditions. The use of an amine base has been pivotal to the 
development of mild and widely-applicable reaction conditions. The compatibility with several 
classes of electrophiles and nucleophiles has been demonstrated, resulting in a method that is 
comparable and, for certain aspects, even superior to established alkylation or reductive 
alkylation protocols. In particular, the major benefits of our approach include the use of a cheap 
and atom-economic reducing agent, the compatibility with hydrogenation-susceptible functional 
groups, and the fact that reactions can be run at room temperature. Further investigation is 
needed to enable extension to other classes of challenging electrophiles (acyclic ketones) and 
nucleophiles (high-acidity active methylene compounds). 
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Chapter 5:  
Experimental section 
 
5.1. GENERAL EXPERIMENTAL 
All reactions were performed in oven (120 °C) and/or flame dried glassware (including NMR 
tubes for kinetic experiments) under an atmosphere of dry nitrogen or argon, unless noted. 
Reaction solvents tetrahydrofuran (Fisher, HPLC grade) and diethyl ether (Fisher, BHT 
stabilized ACS grade) were dried by percolation through two columns packed with neutral 
alumina under a positive pressure of argon. Reaction solvents hexanes (Fisher, OPTIMA grade) 
and toluene (Fisher, ACS grade) were dried by percolation through a column packed with neutral 
alumina and a column packed with Q5 reactant, a supported copper catalyst for scavenging 
oxygen, under a positive pressure of argon. Reaction solvents dioxane, dimethoxyethane and 
benzene (Fisher, ACS grade) were distilled over sodium prior to use. Reaction solvents 
acetonitrile and benzotrifluoride (Aldrich, ACS grade) were distilled from CaH2. Acetonitrile 
was further dried over  4 Å molecular sieves. Reaction solvent acetone (Aldrich) was dried over 
4 Å molecular sieves prior to use. Solvents for filtration and chromatography were certified ACS 
grade. “Brine” refers to a saturated solution of sodium chloride. All reaction temperatures 
correspond to internal temperatures measured with Teflon coated thermocouples unless 
otherwise noted.  
1
H and 
13
C NMR spectra were recorded on Varian Unity 500, Varian VXR 500, Varian Unity 
Inova 500 NB, or Bruker Avance III HD 500 spectrometers (500 MHz, 
1
H; 126 MHz, 
13
C). 
Spectra are referenced to residual chloroform ( 7.26 ppm, 1H;  77.0 ppm, 13C), residual 
benzene ( 7.16 ppm, 1H;  128.0 ppm, 13C), residual CD2Cl2 (5.32 ppm, 
1
H; 53.8 ppm, 
13
C), 
CFCl3 (10% in CDCl3) as an external reference for 
19
F NMR ( 0.00 ppm 19F), and phosphoric 
acid (40% in H2O) as an external reference for 
31
P NMR ( 0.00 ppm 31P). Chemical shifts are 
reported in ppm, multiplicities are indicated by s (singlet), d (doublet), t (triplet), q (quartet), p 
(pentet), h (hextet), sept (septet), m (multiplet) and br (broad). Coupling constants, J, are 
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reported in Hertz. All assignments are corroborated by 
13
C APT and/or 2D experiments (COSY, 
HSQC).  
Elemental analyses were performed by the University of Illinois Microanalytical Service 
Laboratory, or by Robertson Microlit Laboratories. Mass Spectrometry was performed by the 
University of Illinois Mass Spectrometer Center. Electron Impact (EI) spectra were recorded on a 
Waters 70-VSE spectrometer. Electrospray Ionization (ESI) spectra were recorded on Waters Q-
TOF Ultima or Waters Synapt G2-Si spectrometers. Data are reported in the form of m/z. 
Infrared spectra (IR) were recorded on a Perkin Elmer Spectrum Two ATR spectrometer using 
neat sample. Peaks are reported in cm
-1
 with indicated relative intensities: s (strong, 67-100%); m 
(medium, 34-66%), w (weak, 0-33%). Kugelrohr distillations were performed on a Büchi GKR-
50 Kugelrohr and boiling points correspond to uncorrected air bath temperatures (ABT). Melting 
points were obtained in a vacuum-sealed capillary tube using a Thomas Hoover melting point 
apparatus and are corrected. Analytical thin-layer chromatography was performed on Merck 
silica gel plates with QF-254 indicator. Visualization was accomplished with UV (254). Column 
chromatography was performed using 230-400 mesh silica gel purchased from Silicycle.   
Analytical gas chromatography (GC) was performed using a Hewlett Packard 5890 Series II 
Gas Chromatograph fitted with a flame ionization detector (H2 carrier gas, 1 mL/min) Injections 
were made on a Hewlett-Packard HP-1 (30 meter) capillary column. The injector temperature 
was 250 °C, the detector temperature was 300 °C, with a split ratio of 100:1. Retention times (tR) 
and integrated ratios were obtained using Agilent Chemstation Software. 
2-Iodotoluene (Aldrich), 1-bromo-4-fluorobenzene (Aldrich), TMEDA (Aldrich), 2-butanone 
(Aldrich), dichlorodimethylsilane (Gelest), dichlorodiethylsilane (Gelest), 
dichlorodiisopropylsilane (Gelest), acetophenone (Aldrich), mesyl chloride (Aldrich), 2-butyn-1-
ol (Aldrich), hydrocinnamaldehyde (Alfa), pyridine (Fisher), triethylamine (Fisher), allyl methyl 
carbonate (Aldrich), benzaldehyde (Aldrich), furfural (Alfa), 4-(trifluoromethyl)benzaldehyde 
(Oakwood), isobutyraldehyde (Aldrich), isovaleraldehyde (Aldrich) were distilled prior to use. 
CeCl3 (Aldrich) was dried according to the procedure described by Imamoto et al.
1
 NaH and KH 
(Aldrich, 30% in mineral oil) were washed repeatedly with hexanes and dried under vacuum 
prior to use. Commercial solutions of organometallic reagents were titrated prior to use 
according to the procedure described by Hoye et al.
2
 Cs
0
, CuTC, t-Bu3P,  (t-Bu3P)2Pd, CrCl2, 
Cr(OAc)2 hydrate, bis(benzene)chromium, chromocene, Ni(cod)2 and all metal-carbonyl 
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complexes were purchased from Strem, stored and handled in a drybox, and used as received. All 
other reagents were purchased from Aldrich, Fisher, Oakwood, or Strem and used as received. 
5.2. LITERATURE PREPARATIONS 
The following compounds were prepared according to published procedures: 
allylpalladium(II) chloride dimer,
3
 Pd(dba)2,
4
 1,3-bis(diphenylphosphino)butane dioxide,
5
 KTC,
6
 
(E)-2-phenylethylenyldimethyl silanol 1.17,
7
 (4-methoxyphenyl)dimethylsilanol 1.19,
8
 
potassium (4-methoxyphenyl)dimethylsilanolate K
+
(1.19)
−
,
9
 cesium (4-
methoxyphenyl)dimethylsilanolate Cs
+
(1.19)
−
,
9 
 4-methoxy-4’-fluorobiphenyl 1.16,10 
compounds 2.21,
11
 2.38,
12
 2.40,
13
 2.41,
13
 2.56,
14
 Ligands A and B,
15
 Cp2Zr(H)Cl (Schwartz’s 
reagent)
16
, compounds 3.8,
17
 3.10,
18
 3.12,
19
 3.13,
20
 CrCl3·3THF,
21
 allyl pivalate,
22
 tris(2,4-
dimethoxyphenyl)phosphine,
23
 tri(furan-2-yl)arsine,
24
 compounds 4.7h,
25
 4.7v,
26
 and 4.7w.
27
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5.3. EXPERIMENTS FOR CHAPTER 1 
Cesium (E)-Dimethyl(styryl)silanolate (Cs
+
(1.17)
−
) [RCS] 
 
In a drybox, a flame-dried 100-mL round bottomed flask was charged dry benzene (25 mL).  
Cs
0
 (1.66 g, 12.5 mmol) was added as a liquid via a pipette. The suspension was diluted further 
with dry benzene (25 mL). To a separate flame-dried 25-mL conical flask was charged 1.17 
(2.25 g, 12.6 mmol, 1.01 equiv), 4-chlorostyrene (2.25 g, 16.3 mmol) and dry benzene (10 mL) 
affording a colorless solution. The solution was then added via pipette dropwise to the 
vigorously stirring Cs suspension over a 10 min interval, resulting in an orange/yellow mixture. 
The mixture was filtered through a M porosity-fritted funnel into a 100-mL Schlenk flask. The 
solvent was removed under vacuum (0.1 mmHg). The resulting viscous material was treated with 
hexanes (10 mL) to induce precipitation, followed by concentration. This procedure was repeated 
three times to afford 2.44 g (63%) of Cs
+
(1.17)
−
 as a white powder. The product was found to 
contain ca. 3% of the fully saturated silanolate as determined by 
1
H NMR.
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Data for Cs
+
(1.17)
−
: 
 
1
H NMR: (500 MHz, C6D6) 
δ 7.57 (d, J = 8.0 Hz, 2H), 7.24 (t, J = 7.6 Hz, 2H), 7.14 – 7.07 (m, 1H), 7.06 – 
6.99 (m, 1H), 6.92 – 6.83 (m, 1H), 0.33 (s, 6H) 
 
Bromo(4-fluorophenyl)(tri-tert-butylphosphine)palladium (1.23) [AA-14-CV0687] 
 
In a drybox, an oven-dried, 100-mL Schlenk flask was charged with Pd(t-Bu3P)2 (600 mg, 
1.17 mmol, 1.0 equiv) and t-Bu3P•HBr (10.0 mg, 0.035 mmol, 0.03 equiv) as solids. Degassed 2-
butanone (24 mL) was then added, followed by 4-fluorobromobenzene (5.2 mL, 46.9 mmol, 40 
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equiv). The flask was sealed and removed from the drybox. The flask was then purged with Ar 
and submerged into a preheated 70 °C oil bath. After 45 min, the flask was removed from the oil 
bath and the reaction mixture was cooled to room temperature. The volatiles were removed in 
vacuo (0.1 mmHg) to afford an orange solid. The flask was again sealed and returned to a 
drybox. Toluene (10 mL) was added to the solid residue, resulting in a heterogeneous mixture. 
The mixture was added to vigorously stirring pentane (60 mL), which resulted in the 
precipitation of a yellow solid. The solid was collected on an oven-dried M porosity fritted 
funnel and washed with additional pentane (10 mL). The solid was dried under vacuum (0.1 
mmHg) for 6 h to afford 465 mg (82%) of 1.23 as a yellow powder. The data for 1.23 matched 
those reported in the literature.
29
 
Data for 1.23: 
 
1
H NMR:      (500 MHz, C6D6) 
 δ 7.25 (m, 2H), 6.65 (t, J = 8.9 Hz, 2H), 1.05 (d, J = 12.5 Hz, 27H) 
 
19
F NMR:      (470 MHz, C6D6) 
 δ ‒122.4 
 
31
P NMR:      (202 MHz, C6D6) 
 δ 66.5 
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Kinetic experiments for the cross-coupling of Cs
+
(1.17)
− 
with 1.18 
General Procedure I 
 
In a drybox, a one-necked, 5-mL round-bottomed flask equipped with a magnetic stir bar, a 
reflux condenser and three-way stop-cock (fitted with an argon inlet and a rubber septum) was 
charged with naphthalene, APC, dppp(O)2, 2-iodotoluene (1.18) and dry benzotrifluoride. To this 
solution was added Cs
+
(1.17)
−
 as a solid. The flask was removed from the drybox, the stopcock 
evacuated and purged with argon. The flask was placed in a 40 °C oil bath. The reaction progress 
was monitored by GC analysis. Sampling of the reaction was performed by removing 50 L 
aliquots of the mixture by syringe and quenching the aliquots at regular intervals.
30
 The quench 
was performed as follows: the aliquot was injected into 100 L of a 10% aqueous solution of 2-
dimethylaminoethanethiol hydrochloride. This yellow solution was diluted with 1.0 mL of ethyl 
acetate and the organic phase was filtered through a 0.5 x 1.0 cm plug of silica gel. The filtrate 
was analyzed by GC: naphthalene, tR 1.70 min; 1.14, tR 7.25 min (HP-1, 160 °C for 5 min, then 
50
 
°C /min to 225 °C, then 2 min at 225 °C). 
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Order in Cs
+
(1.17)
−
 with APC/dppp(O)2 at 40 °C (60 mM) (Table 1.2, entry 1) 
Cs
+
(1.17)
−
  60 mM 
2-iodotoluene  80 mM 
APC   3.6 mM (Pd) 
dppp(O)2  3.6 mM 
 
Following General Procedure I, a mixture of silanolate Cs
+
(1.17)
− 
 (39 mg, 0.12 mmol, 0.75 
equiv), APC (1.3 mg, 0.0036 mmol, 0.0225 equiv), dppp(O)2 (3.2 mg, 0.0072 mmol, 0.045 
equiv), naphthalene (9.5 mg), and 2-iodotoluene (21 L, 0.16 mmol, 1.0 equiv) were dissolved in 
dry benzotrifluoride (2 mL) at room temperature followed by stirring at 40 °C. Aliquots of the 
mixture were then taken for GC analysis. rate = 4.35 x 10
-2
 mM/s [RCS] 
 
time mmol naph area naph area 1.14 mol 1.14 mol cross % conversion 
2 0.0741 45268 10263 10.65   
2 0.0741 45069 10209 10.64 10.65 8.87 
2 0.0741 45227 10255 10.65   
3 0.0741 41365 15442 17.54   
3 0.0741 41105 15083 17.24 17.38 14.49 
3 0.0741 41087 15197 17.38   
4 0.0741 51977 25816 23.33   
4 0.0741 52101 25963 23.41 23.51 19.59 
4 0.0741 52052 26343 23.78   
5 0.0741 40060 24128 28.30   
5 0.0741 39554 23928 28.42 28.41 23.67 
5 0.0741 40161 24368 28.51   
6 0.0741 43309 30189 32.75   
6 0.0741 42786 30270 33.24 32.99 27.49 
6 0.0741 42753 30024 32.99   
7 0.0741 38342 29838 36.56   
7 0.0741 38223 30285 37.22 36.86 30.72 
7 0.0741 38001 29774 36.81   
 
  
y = 5.2229x + 1.4641 
R² = 0.9895 
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Following General Procedure I, a mixture of silanolate Cs
+
(1.17)
− 
 (39 mg, 0.12 mmol, 0.75 
equiv), APC (1.3 mg, 0.0036 mmol, 0.0225 equiv), dppp(O)2 (3.2 mg, 0.0072 mmol, 0.045 
equiv), naphthalene (10.6 mg), and 2-iodotoluene (21 L, 0.16 mmol, 1.0 equiv) were dissolved 
in dry benzotrifluoride (2 mL) at room temperature followed by stirring at 40 °C. Aliquots of the 
mixture were then taken for GC analysis. rate = 4.30 x 10
-2
 mM/s [RCS] 
 
time 
mmol 
naph 
area naph 
area 
1.14 
mol 
1.14 
mol 
cross 
% 
conversion 
2 0.0827 39839 6983 9.19   
2 0.0827 39844 6885 9.06 2 9.16 
2 0.0827 39800 7003 9.23   
3 0.0827 43715 12895 15.47   
3 0.0827 43941 12860 15.34 3 15.37 
3 0.0827 43682 12758 15.31   
4 0.0827 43018 17173 20.93   
4 0.0827 42704 16953 20.81 4 20.82 
4 0.0827 42615 16832 20.71   
5 0.0827 43278 21469 26.01   
5 0.0827 43429 21493 25.95 5 25.96 
5 0.0827 43769 21628 25.91   
6 0.0827 44355 26259 31.04   
6 0.0827 43973 25613 30.54 6 30.73 
6 0.0827 43930 25642 30.60   
7 0.0827 47192 31841 35.38   
7 0.0827 46539 31108 35.05 7 35.01 
7 0.0827 47054 31070 34.62   
 
  
  
y = 5.1565x - 0.3625 
R² = 0.9961 
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Following General Procedure I, a mixture of silanolate Cs
+
(1.17)
− 
 (39 mg, 0.12 mmol, 0.75 
equiv), APC (1.3 mg, 0.0036 mmol, 0.0225 equiv), dppp(O)2 (3.2 mg, 0.0072 mmol, 0.045 
equiv), naphthalene (12.5 mg), and 2-iodotoluene (21 L, 0.16 mmol, 1.0 equiv) were dissolved 
in dry benzotrifluoride (2 mL) at room temperature followed by stirring at 40 °C. Aliquots of the 
mixture were then taken for GC analysis. rate = 4.18 x 10
-2
 mM/s [RCS] 
 
time 
mmol 
naph 
area naph 
area 
1.14 
mol 
1.14 
mol 
cross 
% 
conversion 
2 0.0975 49797 7247 9.00   
2 0.0975 49859 7198 8.92 8.97 7.48 
2 0.0975 50053 7290 9.00   
3 0.0975 58641 13003 13.71   
3 0.0975 58044 12916 13.76 13.76 11.47 
3 0.0975 58507 13084 13.82   
4 0.0975 52678 15916 18.68   
4 0.0975 52967 15905 18.56 18.59 15.49 
4 0.0975 52805 15827 18.53   
5 0.0975 53344 20472 23.72   
5 0.0975 53380 20596 23.85 23.70 19.75 
5 0.0975 53355 20314 23.53   
6 0.0975 50910 23443 28.46   
6 0.0975 50612 23273 28.42 28.62 23.85 
6 0.0975 50595 23704 28.96   
7 0.0975 54518 30172 34.21   
7 0.0975 54344 30076 34.21 34.12 28.43 
7 0.0975 54651 30007 33.94   
 
  
avg. rate = 4.28 x 10
-2
 mM/s 
  
y = 5.0117x - 1.2584 
R² = 0.9995 
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Order in Cs
+
(1.17)
− 
with APC/dppp(O)2 at 40 °C (80 mM) (Table 1.2, entry 2) 
Cs
+
(1.17)
−
  80 mM 
2-iodotoluene  80 mM 
APC   3.6 mM (Pd) 
dppp(O)2  3.6 mM 
 
Following General Procedure I, a mixture of silanolate Cs
+
(1.17)
−
 (103 mg, 0.32 mmol, 2.0 
equiv), APC (1.3 mg, 0.0036 mmol, 0.0225 equiv), dppp(O)2 (3.2 mg, 0.0072 mmol, 0.045 
equiv), naphthalene (11.2 mg), and 2-iodotoluene (21 L, 0.16 mmol, 1.0 equiv) were dissolved 
in dry benzotrifluoride (2 mL) at room temperature followed by stirring at 40 °C. Aliquots of the 
mixture were then taken for GC analysis. rate = 5.61 x 10
-2
 mM/s [RCS] 
 
time mmol naph area naph area 1.14 
mol 
1.14 
mol cross % conversion 
2 0.0874 52339 11671 12.36   
2 0.0874 52321 11625 12.31 12.31 7.70 
2 0.0874 51656 11440 12.27   
3 0.0874 56320 20739 20.40   
3 0.0874 56594 20975 20.54 20.51 12.82 
3 0.0874 56371 20936 20.58   
4 0.0874 50080 25080 27.75   
4 0.0874 49517 24506 27.42 27.58 17.24 
4 0.0874 49800 24782 27.57   
5 0.0874 52453 32486 34.32   
5 0.0874 52295 32580 34.52 34.32 21.45 
5 0.0874 52030 32047 34.13   
6 0.0874 53715 38732 39.96   
6 0.0874 53125 38640 40.30 40.28 25.17 
6 0.0874 52630 38535 40.57   
7 0.0874 50868 42504 46.30   
7 0.0874 50944 42416 46.14 46.20 28.87 
7 0.0874 51440 42854 46.16   
 
  
y = 6.7281x - 0.0759 
R² = 0.9961 
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Following General Procedure I, a mixture of silanolate Cs
+
(1.17)
− 
 (103 mg, 0.32 mmol, 2.0 
equiv), APC (1.3 mg, 0.0036 mmol, 0.0225 equiv), dppp(O)2 (3.2 mg, 0.0072 mmol, 0.045 
equiv), naphthalene (9.4 mg), and 2-iodotoluene (21 L, 0.16 mmol, 1.0 equiv) were dissolved in 
dry benzotrifluoride (2 mL) at room temperature followed by stirring at 40 °C. Aliquots of the 
mixture were then taken for GC analysis. rate = 5.77 x 10
-2
 mM/s [RCS] 
 
time 
mmol 
naph 
area naph 
area 
1.14 
mol 
1.14 
mol 
cross 
% 
conversion 
2 0.0733 41990 13297 14.72   
2 0.0733 46194 13561 13.64 14.29 8.93 
2 0.0733 41727 13034 14.52   
3 0.0733 41322 21030 23.65   
3 0.0733 41655 21310 23.77 23.75 14.84 
3 0.0733 41491 21259 23.81   
4 0.0733 43117 29518 31.81   
4 0.0733 43048 29434 31.78 31.87 19.92 
4 0.0733 43042 29644 32.01   
5 0.0733 42924 35619 38.56   
5 0.0733 42711 35761 38.91 39.05 24.41 
5 0.0733 42999 36709 39.67   
6 0.0733 40774 38177 43.51   
6 0.0733 40847 39189 44.59 44.14 27.59 
6 0.0733 40588 38717 44.33   
7 0.0733 42719 45030 48.99   
7 0.0733 42616 45159 49.25 49.11 30.70 
7 0.0733 42621 45038 49.11   
 
  
 
 
  
y = 6.928x + 2.5251 
R² = 0.9831 
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Following General Procedure I, a mixture of silanolate Cs
+
(1.17)
−
 (103 mg, 0.32 mmol, 2.0 
equiv), APC (1.3 mg, 0.0036 mmol, 0.0225 equiv), dppp(O)2 (3.2 mg, 0.0072 mmol, 0.045 
equiv), naphthalene (9.3 mg), and 2-iodotoluene (21 L, 0.16 mmol, 1.0 equiv) were dissolved in 
dry benzotrifluoride (2 mL) at room temperature followed by stirring at 40 °C. Aliquots of the 
mixture were then taken for GC analysis. rate = 4.32 x 10
-2
 mM/s [RCS] 
 
time 
mmol 
naph 
area naph 
area 
1.14 
mol 
1.14 
mol 
cross 
% 
conversion 
2 0.0726 41928 8954 9.83   
2 0.0726 42084 8510 9.31 9.50 5.94 
2 0.0726 42027 8555 9.37   
3 0.0726 37739 12869 15.70   
3 0.0726 37625 12110 14.81 15.10 9.44 
3 0.0726 37861 12173 14.80   
4 0.0726 44323 19956 20.72   
4 0.0726 44797 19946 20.49 20.62 12.89 
4 0.0726 44870 20129 20.65   
5 0.0726 38724 21685 25.78   
5 0.0726 39021 21714 25.61 25.89 16.18 
5 0.0726 39087 22313 26.28   
6 0.0726 40309 26420 30.17   
6 0.0726 40552 27262 30.94 30.62 19.13 
6 0.0726 40328 26927 30.73   
7 0.0726 40748 31382 35.45   
7 0.0726 40356 30961 35.31 35.40 22.13 
7 0.0726 40638 31301 35.45   
 
  
 
avg. rate = 5.23 x 10
-2
 mM/s 
  
y = 5.1804x - 0.4559 
R² = 0.9986 
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Order in Cs
+
(1.17)
− 
with APC/dppp(O)2 at 40 °C (120 mM) (Table 1.2, entry 3) 
Cs
+
(1.17)
−
  120 mM 
2-iodotoluene  80 mM 
APC   3.6 mM (Pd) 
dppp(O)2  3.6 mM 
 
Following General Procedure I, a mixture of silanolate Cs
+
(1.17)
−
 (78 mg, 0.24 mmol, 1.5 
equiv), APC (1.3 mg, 0.0036 mmol, 0.0225 equiv), dppp(O)2 (3.2 mg, 0.0072 mmol, 0.045 
equiv), naphthalene (13.2 mg), and 2-iodotoluene (21 L, 0.16 mmol, 1.0 equiv) were dissolved 
in dry benzotrifluoride (2 mL) at room temperature followed by stirring at 40 °C. Aliquots of the 
mixture were then taken for GC analysis. rate = 6.41 x 10
-2
 mM/s [RCS] 
 
time 
mmol 
naph 
area naph 
area 
1.14 
mol 
1.14 
mol 
cross 
% 
conversion 
2 0.103 62167 20602 21.64   
2 0.103 61647 20783 22.02 22.34 13.96 
2 0.103 61451 21972 23.35   
3 0.103 52521 26805 33.33   
3 0.103 52169 25210 31.56 32.15 20.10 
3 0.103 52135 25207 31.57   
4 0.103 50973 32954 42.22   
4 0.103 50175 31508 41.01 41.49 25.93 
4 0.103 51020 32230 41.25   
5 0.103 49576 36711 48.36   
5 0.103 49686 38012 49.96 48.97 30.61 
5 0.103 49472 36825 48.61   
6 0.103 58708 49285 54.82   
6 0.103 57976 48686 54.84 54.83 34.27 
6 0.103 58306 48960 54.83   
7 0.103 53523 50590 61.72   
7 0.103 53810 50192 60.91 61.09 38.18 
7 0.103 53295 49475 60.62   
 
  
y = 7.6934x + 8.8581 
R² = 0.988 
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Following General Procedure I, a mixture of silanolate Cs
+
(1.17)
−
 (78 mg, 0.24 mmol, 1.5 
equiv), APC (1.3 mg, 0.0036 mmol, 0.0225 equiv), dppp(O)2 (3.2 mg, 0.0072 mmol, 0.045 
equiv), naphthalene (9.8 mg), and 2-iodotoluene (21 L, 0.16 mmol, 1.0 equiv) were dissolved in 
dry benzotrifluoride (2 mL) at room temperature followed by stirring at 40 °C. Aliquots of the 
mixture were then taken for GC analysis. rate = 6.34 x 10
-2
 mM/s [RCS] 
 
time 
mmol 
naph 
area naph 
area 
1.14 
mol 
1.14 
mol 
cross 
% 
conversion 
2 0.0765 44909 18481 19.96   
2 0.0765 44993 17762 19.15 19.46 12.16 
2 0.0765 44804 17802 19.27   
3 0.0765 39301 24150 29.80   
3 0.0765 39367 25023 30.83 30.14 18.84 
3 0.0765 39284 24123 29.78   
4 0.0765 40547 33046 39.53   
4 0.0765 40961 32591 38.59 38.91 24.32 
4 0.0765 41203 32807 38.62   
5 0.0765 39285 37139 45.85   
5 0.0765 39123 36769 45.58 45.90 28.69 
5 0.0765 39113 37318 46.28   
6 0.0765 41861 44509 51.57   
6 0.0765 42687 46153 52.44 51.96 32.48 
6 0.0765 42139 45071 51.88   
7 0.0765 50467 60566 58.21   
7 0.0765 50412 60786 58.48 58.26 36.41 
7 0.0765 50708 60741 58.10   
 
  
 
  
  
y = 7.6135x + 6.5117 
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Following General Procedure I, a mixture of silanolate Cs
+
(1.17)
−
 (78 mg, 0.24 mmol, 1.5 
equiv), APC (1.3 mg, 0.0036 mmol, 0.0225 equiv), dppp(O)2 (3.2 mg, 0.0072 mmol, 0.045 
equiv), naphthalene (10.2 mg), and 2-iodotoluene (21 L, 0.16 mmol, 1.0 equiv) were dissolved 
in dry benzotrifluoride (2 mL) at room temperature followed by stirring at 40 °C. Aliquots of the 
mixture were then taken for GC analysis. rate = 6.36 x 10
-2
 mM/s [RCS] 
 
time 
mmol 
naph 
area naph 
area 
1.14 
mol 
1.14 
mol 
cross 
% 
conversion 
2 0.0796 54158 13139 12.24   
2 0.0796 53906 13014 12.18 12.18 7.61 
2 0.0796 54308 13038 12.12   
3 0.0796 41822 17777 21.45   
3 0.0796 41735 17725 21.43 21.51 13.44 
3 0.0796 41934 17988 21.65   
4 0.0796 49021 29512 30.38   
4 0.0796 48173 29199 30.59 30.46 19.04 
4 0.0796 48847 29442 30.42   
5 0.0796 45148 33990 37.99   
5 0.0796 45152 33967 37.96 38.12 23.82 
5 0.0796 45405 34542 38.39   
6 0.0796 28312 24320 43.35   
6 0.0796 28338 24770 44.11 44.06 27.54 
6 0.0796 28544 25288 44.71   
7 0.0796 43053 43059 50.47   
7 0.0796 43468 43711 50.75 50.56 31.60 
7 0.0796 43220 43216 50.46   
       
 
  
 
avg. rate = 6.37 x 10
-2
 mM/s 
 
  
y = 7.6342x - 1.5386 
R² = 0.9916 
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Order in Cs
+
(1.17)
− 
with APC/dppp(O)2 at 40 °C (160 mM) (Table 1.2, entry 4) 
Cs
+
(1.17)
−
  160 mM 
2-iodotoluene  80 mM 
APC   3.6 mM (Pd) 
dppp(O)2  3.6 mM 
 
Following General Procedure I, a mixture of silanolate Cs
+
(1.17)
−
 (99 mg, 0.32 mmol, 2.0 
equiv), APC (1.3 mg, 0.0036 mmol, 0.0225 equiv), dppp(O)2 (3.2 mg, 0.0072 mmol, 0.045 
equiv), naphthalene (10.8 mg), and 2-iodotoluene (21 L, 0.16 mmol, 1.0 equiv) were dissolved 
in dry benzotrifluoride (2 mL) at room temperature followed by stirring at 40 °C. Aliquots of the 
mixture were then taken for GC analysis. rate = 8.37 x 10
-2
 mM/s [RCS] 
 
time mmol naph area naph area 1.14 
mol 
1.14 
mol cross % conversion 
2 0.0843 41061 15063 19.61   
2 0.0843 41043 15015 19.55 19.57 12.23 
2 0.0843 40858 14956 19.56   
3 0.0843 40901 24529 32.05   
3 0.0843 40806 24375 31.93 31.91 19.95 
3 0.0843 41308 24547 31.76   
4 0.0843 28349 21981 41.44   
4 0.0843 28401 21866 41.15 41.36 25.85 
4 0.0843 28753 22326 41.50   
5 0.0843 37151 35711 51.37   
5 0.0843 37130 36289 52.24 51.78 32.37 
5 0.0843 37215 36030 51.74   
6 0.0843 39750 45737 61.50   
6 0.0843 39747 45679 61.42 61.37 38.36 
6 0.0843 39447 45163 61.19   
7 0.0843 45222 57983 68.53   
7 0.0843 43616 58766 72.01 70.13 43.83 
7 0.0843 44894 58677 69.85   
 
  
y = 10.045x + 0.8198 
R² = 0.9975 
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Following General Procedure I, a mixture of silanolate Cs
+
(1.17)
−
 (99 mg, 0.32 mmol, 2.0 
equiv), APC (1.3 mg, 0.0036 mmol, 0.0225 equiv), dppp(O)2 (3.2 mg, 0.0072 mmol, 0.045 
equiv), naphthalene (10.2 mg), and 2-iodotoluene (21 L, 0.16 mmol, 1.0 equiv) were dissolved 
in dry benzotrifluoride (2 mL) at room temperature followed by stirring at 40 °C. Aliquots of the 
mixture were then taken for GC analysis. rate = 8.11 x 10
-2
 mM/s [RCS] 
 
time 
mmol 
naph 
area naph 
area 
1.14 
mol 
1.14 
mol 
cross 
% 
conversion 
2 0.0796 42778 12546 14.80   
2 0.0796 43254 12661 14.77 14.76 9.23 
2 0.0796 43406 12658 14.72   
3 0.0796 41198 21514 26.35   
3 0.0796 41396 21021 25.63 25.88 16.18 
3 0.0796 41412 21064 25.67   
4 0.0796 41877 30846 37.17   
4 0.0796 42330 31233 37.24 37.03 23.15 
4 0.0796 42106 30611 36.69   
5 0.0796 47586 44519 47.21   
5 0.0796 47713 44203 46.75 46.96 29.35 
5 0.0796 48115 44735 46.92   
6 0.0796 45255 49631 55.35   
6 0.0796 45657 50377 55.68 55.51 34.69 
6 0.0796 45904 50486 55.50   
7 0.0796 46752 58501 63.15   
7 0.0796 46522 58368 63.32 63.11 39.45 
7 0.0796 46513 57950 62.88   
 
  
 
  
y = 9.7304x - 3.2424 
R² = 0.9942 
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Following General Procedure I, a mixture of silanolate Cs
+
(1.17)
−
 (99 mg, 0.32 mmol, 2.0 
equiv), APC (1.3 mg, 0.0036 mmol, 0.0225 equiv), dppp(O)2 (3.2 mg, 0.0072 mmol, 0.045 
equiv), naphthalene (9.8 mg), and 2-iodotoluene (21 L, 0.16 mmol, 1.0 equiv) were dissolved in 
dry benzotrifluoride (2 mL) at room temperature followed by stirring at 40 °C. Aliquots of the 
mixture were then taken for GC analysis. rate = 7.39 x 10
-2
 mM/s [AA-14-CZ8690] 
 
 
  
 
avg. rate = 7.96 x 10
-2
 mM/s 
 
  
 mmol area area mmol (%) average mM
0.076 2.00E+07 1.39E+07 2.13E-02 13.3
0.076 2.64E+07 1.67E+07 1.94E-02 12.1
0.076 2.36E+07 1.61E+07 2.08E-02 13.0
0.076 1.73E+07 1.66E+07 2.94E-02 18.4
0.076 1.72E+07 1.95E+07 3.46E-02 21.6
0.076 1.87E+07 1.80E+07 2.95E-02 18.4
0.076 2.20E+07 2.51E+07 3.49E-02 21.8
0.076 2.12E+07 2.58E+07 3.72E-02 23.3
0.076 1.86E+07 2.72E+07 4.47E-02 27.9
0.076 1.82E+07 2.66E+07 4.47E-02 27.9
0.076 2.12E+07 2.88E+07 4.16E-02 26.0
0.076 1.59E+07 2.82E+07 5.42E-02 33.9
0.076 1.91E+07 3.72E+07 5.94E-02 37.1
0.076 1.78E+07 3.50E+07 6.02E-02 37.6
0.076 2.05E+07 3.43E+07 5.13E-02 32.0
23.42
28.49
300
360
product
10.24
15.58
19.48
time (s)
naphthalene
120
240
180
y = 0.0739x + 1.7103
R² = 0.9965
0.00
5.00
10.00
15.00
20.00
25.00
30.00
0 60 120 180 240 300 360 420 480
[product]
(μmol/mL)
time (s)
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Order in Cs
+
(1.17)
− 
with APC/dppp(O)2 at 40 °C (240 mM) (table 1.2, entry 5) 
Cs
+
(1.17)
−
  240 mM 
2-iodotoluene  80 mM 
APC   3.6 mM (Pd) 
dppp(O)2  3.6 mM 
 
Following General Procedure I, a mixture of silanolate Cs
+
(1.17)
−
 (149 mg, 0.48 mmol, 3.0 
equiv), APC (1.3 mg, 0.0036 mmol, 0.0225 equiv), dppp(O)2 (3.2 mg, 0.0072 mmol, 0.045 
equiv), naphthalene (12.6 mg), and 2-iodotoluene (21 L, 0.16 mmol, 1.0 equiv) were dissolved 
in dry benzotrifluoride (2 mL) at room temperature followed by stirring at 40 °C. Aliquots of the 
mixture were then taken for GC analysis. rate = 8.20 x 10
-2
 mM/s [AA-14-CZ8691] 
 
 
  
 mmol area area mmol (%) average mM
0.098 3.30E+07 2.61E+07 3.11E-02 19.5
0.098 3.19E+07 2.76E+07 3.41E-02 21.3
0.098 2.98E+07 2.72E+07 3.59E-02 22.4
0.098 2.04E+07 2.50E+07 4.82E-02 30.2
0.098 2.54E+07 2.94E+07 4.56E-02 28.5
0.098 2.34E+07 2.65E+07 4.47E-02 27.9
0.098 8.05E+06 1.10E+07 5.38E-02 33.6
0.098 1.98E+07 2.64E+07 5.24E-02 32.7
0.098 1.61E+07 2.49E+07 6.08E-02 38.0
0.098 3.35E+07 5.27E+07 6.19E-02 38.7
0.098 3.37E+07 5.40E+07 6.32E-02 39.5
0.098 3.10E+07 5.23E+07 6.64E-02 41.5
0.098 2.92E+07 5.28E+07 7.11E-02 44.5
0.098 2.49E+07 5.06E+07 8.01E-02 50.1
0.098 2.90E+07 5.23E+07 7.10E-02 44.4
180 23.09
time (s)
naphthalene product
120 16.85
240 27.83
300 31.92
360 37.04
y = 0.0820x + 7.6638
R² = 0.9949
0.00
10.00
20.00
30.00
40.00
0 60 120 180 240 300 360 420 480
[product]
(μmol/mL)
time (s)
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Following General Procedure I, a mixture of silanolate Cs
+
(1.17)
−
 (149 mg, 0.48 mmol, 3.0 
equiv), APC (1.3 mg, 0.0036 mmol, 0.0225 equiv), dppp(O)2 (3.2 mg, 0.0072 mmol, 0.045 
equiv), naphthalene (10.2 mg), and 2-iodotoluene (21 L, 0.16 mmol, 1.0 equiv) were dissolved 
in dry benzotrifluoride (2 mL) at room temperature followed by stirring at 40 °C. Aliquots of the 
mixture were then taken for GC analysis. rate = 9.40 x 10
-2
 mM/s [AA-14-CZ8693] 
 
 
 
  
 
 
 
 
 mmol area area mmol (%) average mM
0.080 2.04E+07 1.81E+07 2.82E-02 17.6
0.080 1.83E+07 1.61E+07 2.81E-02 17.6
0.080 1.74E+07 1.90E+07 3.48E-02 21.8
0.080 2.07E+07 2.54E+07 3.91E-02 24.4
0.080 2.34E+07 3.04E+07 4.14E-02 25.9
0.080 2.47E+07 3.08E+07 3.98E-02 24.9
0.080 2.33E+07 3.84E+07 5.24E-02 32.8
0.080 2.43E+07 3.90E+07 5.11E-02 31.9
0.080 2.58E+07 4.08E+07 5.04E-02 31.5
0.080 2.19E+07 4.20E+07 6.12E-02 38.2
0.080 2.26E+07 4.36E+07 6.16E-02 38.5
0.080 2.06E+07 4.73E+07 7.34E-02 45.9
0.080 2.36E+07 5.34E+07 7.20E-02 45.0
0.080 2.36E+07 5.07E+07 6.84E-02 42.7
0.080 2.05E+07 5.27E+07 8.21E-02 51.3
time (s)
naphthalene product
120 15.19
360 37.07
180 20.05
240 25.65
300 32.69
y = 0.0940x + 3.5759
R² = 0.9953
0.00
10.00
20.00
30.00
40.00
0 60 120 180 240 300 360 420 480
[product]
(μmol/mL)
time (s)
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Following General Procedure I, a mixture of silanolate Cs
+
(1.17)
−
 (74 mg, 0.24 mmol, 3.0 
equiv), APC (0.7 mg, 0.0018 mmol, 0.0225 equiv), dppp(O)2 (1.6 mg, 0.0036 mmol, 0.045 
equiv), naphthalene (5.4 mg), and 2-iodotoluene (10 L, 0.08 mmol, 1.0 equiv) were dissolved in 
dry benzotrifluoride (1 mL) at room temperature followed by stirring at 40 °C. Aliquots of the 
mixture were then taken for GC analysis. rate = 9.56 x 10
-2
 mM/s [AA-14-CZ8695] 
 
 
 
  
 
avg. rate = 9.05 x 10
-2
 mM/s 
  
 mmol area area mmol (%) average mM
0.042 1.80E+07 2.47E+07 2.32E-02 29.0
0.042 2.46E+07 2.69E+07 1.85E-02 23.1
0.042 2.17E+07 2.54E+07 1.98E-02 24.7
0.042 1.86E+07 2.87E+07 2.60E-02 32.5
0.042 2.12E+07 3.20E+07 2.54E-02 31.8
0.042 1.99E+07 3.05E+07 2.59E-02 32.4
0.042 2.07E+07 3.97E+07 3.23E-02 40.4
0.042 2.01E+07 3.83E+07 3.22E-02 40.2
0.042 2.13E+07 3.80E+07 3.01E-02 37.7
0.042 2.05E+07 4.73E+07 3.91E-02 48.8
0.042 2.19E+07 4.75E+07 3.66E-02 45.8
0.042 1.95E+07 4.45E+07 3.87E-02 48.3
0.042 1.90E+07 5.11E+07 4.55E-02 56.9
0.042 1.96E+07 4.55E+07 3.92E-02 49.0
0.042 1.99E+07 5.22E+07 4.43E-02 55.4
time (s)
naphthalene product
120 20.50
360 43.01
180 25.78
240 31.55
300 38.12
y = 0.0956x + 8.8448
R² = 0.9982
0.00
10.00
20.00
30.00
40.00
50.00
0 60 120 180 240 300 360 420 480
[product]
(μmol/mL)
time (s)
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Order in Cs
+
(1.17)
− 
with APC/dppp(O)2 at 40 °C (320 mM) (Table 1.2, entry 6) 
Cs
+
(1.17)
−
  320 mM 
2-iodotoluene  80 mM 
APC   3.6 mM (Pd) 
dppp(O)2  3.6 mM 
 
Following General Procedure I, a mixture of silanolate Cs
+
(1.17)
−
 (199 mg, 0.64 mmol, 4.0 
equiv), APC (1.3 mg, 0.0036 mmol, 0.0225 equiv), dppp(O)2 (3.2 mg, 0.0072 mmol, 0.045 
equiv), naphthalene (12.8 mg), and 2-iodotoluene (21 L, 0.16 mmol, 1.0 equiv) were dissolved 
in dry benzotrifluoride (2 mL) at room temperature followed by stirring at 40 °C. Aliquots of the 
mixture were then taken for GC analysis. rate = 1.03 x 10
-1
 mM/s [AA-14-CZ8692] 
 
 
  
 mmol area area mmol (%) average mM
0.100 2.64E+07 2.03E+07 3.07E-02 19.2
0.100 2.33E+07 2.08E+07 3.56E-02 22.3
0.100 2.36E+07 2.04E+07 3.45E-02 21.6
0.100 2.14E+07 2.41E+07 4.51E-02 28.2
0.100 2.32E+07 2.85E+07 4.91E-02 30.7
0.100 2.39E+07 2.71E+07 4.53E-02 28.3
0.100 2.27E+07 3.36E+07 5.93E-02 37.1
0.100 2.51E+07 3.89E+07 6.20E-02 38.7
0.100 2.40E+07 3.62E+07 6.03E-02 37.7
0.100 2.50E+07 4.83E+07 7.74E-02 48.4
0.100 2.80E+07 4.85E+07 6.93E-02 43.3
0.100 2.80E+07 4.82E+07 6.90E-02 43.1
0.100 3.47E+07 6.81E+07 7.85E-02 49.0
0.100 3.17E+07 6.56E+07 8.27E-02 51.7
0.100 2.88E+07 6.31E+07 8.76E-02 54.7
240 30.26
300 35.95
360 41.46
180 23.25
time (s)
naphthalene product
120 16.82
y = 0.1033x + 4.7575
R² = 0.9976
0.00
10.00
20.00
30.00
40.00
50.00
0 60 120 180 240 300 360 420 480
[product]
(μmol/mL)
time (s)
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Following General Procedure I, a mixture of silanolate Cs
+
(1.17)
−
 (99 mg, 0.32 mmol, 4.0 
equiv), APC (0.7 mg, 0.0018 mmol, 0.0225 equiv), dppp(O)2 (1.6 mg, 0.0036 mmol, 0.045 
equiv), naphthalene (5.4 mg), and 2-iodotoluene (10 L, 0.08 mmol, 1.0 equiv) were dissolved in 
dry benzotrifluoride (1 mL) at room temperature followed by stirring at 40 °C. Aliquots of the 
mixture were then taken for GC analysis. rate = 1.13 x 10
-1
 mM/s [AA-14-CZ8696] 
 
 
  
 
 
 
  
 mmol area area mmol (%) average mM
0.042 1.07E+07 1.18E+07 1.86E-02 23.3
0.042 9.86E+06 1.24E+07 2.13E-02 26.6
0.042 9.35E+06 1.21E+07 2.18E-02 27.3
0.042 1.61E+07 2.59E+07 2.73E-02 34.1
0.042 1.68E+07 2.85E+07 2.86E-02 35.8
0.042 1.59E+07 2.93E+07 3.12E-02 38.9
0.042 1.71E+07 3.47E+07 3.44E-02 43.0
0.042 1.56E+07 3.62E+07 3.92E-02 49.0
0.042 1.55E+07 3.40E+07 3.70E-02 46.3
0.042 1.10E+07 2.94E+07 4.53E-02 56.6
0.042 1.25E+07 3.07E+07 4.17E-02 52.1
0.042 1.30E+07 3.25E+07 4.21E-02 52.6
0.042 2.01E+07 5.46E+07 4.60E-02 57.5
0.042 1.99E+07 5.48E+07 4.65E-02 58.2
0.042 1.78E+07 5.11E+07 4.84E-02 60.5
time (s)
naphthalene product
120 20.58
360 46.97
180 29.02
240 36.87
300 43.01
y = 0.1113x + 8.5862
R² = 0.9816
0.00
10.00
20.00
30.00
40.00
50.00
60.00
0 60 120 180 240 300 360 420 480
[product]
(μmol/mL)
time (s)
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Following General Procedure I, a mixture of silanolate Cs
+
(1.17)
−
 (99 mg, 0.32 mmol, 4.0 
equiv), APC (0.7 mg, 0.0018 mmol, 0.0225 equiv), dppp(O)2 (1.6 mg, 0.0036 mmol, 0.045 
equiv), naphthalene (5.4 mg), and 2-iodotoluene (10 L, 0.08 mmol, 1.0 equiv) were dissolved in 
dry benzotrifluoride (1 mL) at room temperature followed by stirring at 40 °C. Aliquots of the 
mixture were then taken for GC analysis. rate = 1.17 x 10
-1
 mM/s [AA-14-CZ8699] 
 
 
  
 
avg. rate = 1.11 x 10
-1
 mM/s 
 
  
 mmol area area mmol (%) average mM
0.042 1.52E+07 1.58E+07 1.76E-02 22.0
0.042 1.54E+07 1.67E+07 1.83E-02 22.9
0.042 1.45E+07 1.72E+07 2.00E-02 25.0
0.042 2.19E+07 3.93E+07 3.04E-02 38.0
0.042 2.22E+07 3.79E+07 2.88E-02 36.0
0.042 2.12E+07 3.83E+07 3.06E-02 38.3
0.042 2.37E+07 4.83E+07 3.44E-02 43.0
0.042 2.57E+07 5.08E+07 3.34E-02 41.7
0.042 2.20E+07 4.86E+07 3.73E-02 46.7
0.042 2.61E+07 6.37E+07 4.12E-02 51.5
0.042 2.64E+07 6.19E+07 3.96E-02 49.6
0.042 2.61E+07 6.21E+07 4.02E-02 50.2
0.042 3.10E+07 8.84E+07 4.81E-02 60.2
0.042 3.23E+07 9.01E+07 4.72E-02 59.0
0.042 3.10E+07 9.21E+07 5.02E-02 62.8
time (s)
naphthalene product
120 18.64
360 48.53
180 29.92
240 35.04
300 40.35
y = 0.1170x + 6.4097
R² = 0.9784
0.00
10.00
20.00
30.00
40.00
50.00
60.00
0 60 120 180 240 300 360 420 480
[product]
(μmol/mL)
time (s)
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Order in Cs
+
(1.17)
−
 with APC/dppp(O)2 at 40 °C (400 mM) (Table 1.2, entry 7) 
Cs
+
(1.17)
−
  400 mM 
2-iodotoluene  80 mM 
APC   3.6 mM (Pd) 
dppp(O)2  3.6 mM 
 
Following General Procedure I, a mixture of silanolate Cs
+
(1.17)
−
 (124 mg, 0.40 mmol, 5.0 
equiv), APC (0.7 mg, 0.0018 mmol, 0.0225 equiv), dppp(O)2 (1.6 mg, 0.0036 mmol, 0.045 
equiv), naphthalene (5.4 mg), and 2-iodotoluene (10 L, 0.08 mmol, 1.0 equiv) were dissolved in 
dry benzotrifluoride (1 mL) at room temperature followed by stirring at 40 °C. Aliquots of the 
mixture were then taken for GC analysis. rate = 1.16 x 10
-1
 mM/s [AA-14-CZ8697] 
 
 
  
 mmol area area mmol (%) average mM
0.042 2.09E+07 2.23E+07 1.80E-02 22.5
0.042 2.05E+07 1.76E+07 1.45E-02 18.2
0.042 1.87E+07 2.22E+07 2.01E-02 25.2
0.042 2.04E+07 3.15E+07 2.60E-02 32.5
0.042 2.16E+07 3.15E+07 2.47E-02 30.8
0.042 1.98E+07 3.03E+07 2.59E-02 32.4
0.042 1.90E+07 3.70E+07 3.29E-02 41.2
0.042 1.87E+07 3.60E+07 3.26E-02 40.7
0.042 1.86E+07 3.92E+07 3.55E-02 44.4
0.042 2.57E+07 6.07E+07 3.99E-02 49.9
0.042 2.72E+07 6.46E+07 4.01E-02 50.2
0.042 2.66E+07 6.21E+07 3.95E-02 49.3
0.042 1.65E+07 4.39E+07 4.50E-02 56.3
0.042 1.99E+07 5.26E+07 4.47E-02 55.8
0.042 1.89E+07 5.09E+07 4.55E-02 56.9
180 25.53
time (s)
naphthalene product
120 17.55
240 33.68
300 39.84
360 45.08
y = 0.1156x + 4.5842
R² = 0.9913
0.00
10.00
20.00
30.00
40.00
50.00
0 60 120 180 240 300 360 420 480
[product]
(μmol/mL)
time (s)
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Following General Procedure I, a mixture of silanolate Cs
+
(1.17)
−
 (124 mg, 0.40 mmol, 5.0 
equiv), APC (0.7 mg, 0.0018 mmol, 0.0225 equiv), dppp(O)2 (1.6 mg, 0.0036 mmol, 0.045 
equiv), naphthalene (5.4 mg), and 2-iodotoluene (10 L, 0.08 mmol, 1.0 equiv) were dissolved in 
dry benzotrifluoride (1 mL) at room temperature followed by stirring at 40 °C. Aliquots of the 
mixture were then taken for GC analysis. rate = 1.09 x 10
-1
 mM/s [AA-14-CZ8698] 
 
 
  
 
avg. rate = 1.12 x 10
-2
 mM/s 
 
  
 mmol area area mmol (%) average mM
0.042 1.59E+07 1.41E+07 1.50E-02 18.7
0.042 1.48E+07 1.27E+07 1.46E-02 18.3
0.042 1.41E+07 1.37E+07 1.65E-02 20.6
0.042 2.08E+07 3.02E+07 2.45E-02 30.6
0.042 2.06E+07 2.78E+07 2.29E-02 28.6
0.042 2.00E+07 2.74E+07 2.31E-02 28.9
0.042 1.94E+07 3.71E+07 3.23E-02 40.4
0.042 2.01E+07 3.61E+07 3.04E-02 38.0
0.042 2.15E+07 3.87E+07 3.04E-02 38.0
0.042 3.07E+07 6.72E+07 3.69E-02 46.2
0.042 2.36E+07 5.34E+07 3.83E-02 47.8
0.042 3.65E+07 7.55E+07 3.49E-02 43.7
0.042 2.03E+07 5.06E+07 4.22E-02 52.8
0.042 1.98E+07 4.81E+07 4.12E-02 51.4
0.042 2.04E+07 4.98E+07 4.12E-02 51.5
time (s)
naphthalene product
120 15.35
360 41.52
180 23.49
240 31.04
300 36.71
y = 0.1093x + 3.4011
R² = 0.9878
0.00
10.00
20.00
30.00
40.00
50.00
0 60 120 180 240 300 360 420 480
[product]
(μmol/mL)
time (s)
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Kinetic experiments for the transmetalation of in-situ generated arylpalladium 
arylsilanolate complex 1.13 
General Procedure II: K
+
(1.19)
−
 at 50 °C 
 
In a drybox, an oven-dried, 4-mL vial was charged with 1.23 (8.5 mg, 0.0175 mmol) and 
toluene, resulting in an orange solution. Then, a stock solution of K
+
(1.19)
−
 and 1,4-
difluorobenzene in toluene was added to a total volume of 0.7 mL (0.025 M in 1.23) and the 
mixture was vigorously mixed. The resulting solution was transferred via syringe into an oven-
dried, 5-mm NMR tube. The tube was sealed with a cap and wrapped with Parafilm to exclude 
any oxygen or moisture. The NMR tube was removed from the drybox and inserted into a 
preheated 50 °C NMR probe. The temperature of the reaction solution was allowed to equilibrate 
for ca. 60 seconds prior to data collection. The reaction progress was monitored via 
19
F NMR 
spectroscopy by the appearance of the product 1.16 (δ = ‒117.2 ppm) as compared to an internal 
reference (1,4-difluorobenzene, δ = ‒119.9 ppm) using the following parameters: at = 0.5 s, d1 = 
1 s, pw90 = 15 μs, pw = pw90/2, sw = ‒115 to ‒130 ppm, nt and sampling as specified in each 
individual experiment. Experiments were repeated in triplicate. 
  
214 
 
0.5 equivalents (Table 1.4, entry 1) 
Following General Procedure II, 1.23 (8.5 mg, 0.0175 mmol) was dissolved in toluene (0.55 
mL). A stock solution of K
+
(1.19)
−
 (0.00875 mmol, 0.5 equiv) and 1,4-difluorobenzene (0.00875 
mmol, 0.5 equiv) in toluene (0.15 mL) was added. The tube was inserted into a preheated 50 °C 
NMR probe and the reaction progress was monitored via 
19
F NMR spectroscopy; nt = 64, 
sampling every 300 s. rate = 7.15 · 10
-4
 mM/s [AA-14-CV0671] 
 
 
Following General Procedure II, 1.23 (8.5 mg, 0.0175 mmol) was dissolved in toluene (0.58 
mL). A stock solution of K
+
(1.19)
−
 (0.00875 mmol, 0.5 equiv) and 1,4-difluorobenzene (0.00730 
mmol, 0.42 equiv) in toluene (0.12 mL) was added. The tube was inserted into a preheated 50 °C 
NMR probe and the reaction progress was monitored via 
19
F NMR spectroscopy; nt = 64, 
sampling every 300 s. rate = 7.54 · 10
-4
 mM/s [AA-14-CV0672] 
 
 
Following General Procedure II, 1.23 (8.5 mg, 0.0175 mmol) was dissolved in toluene (0.58 
mL). A stock solution of K
+
(1.19)
−
 (0.00875 mmol, 0.5 equiv) and 1,4-difluorobenzene (0.00730 
600 59.0 7899.0 0.19
900 99.7 7966.5 0.31
1200 160.9 7829.2 0.51
1500 198.7 7933.3 0.63
1800 347.3 7859.8 1.10
2100 397.5 7946.9 1.25
2400 431.9 7906.8 1.37
time (s)
product 
integral
standard 
integral
[product] 
(μmol/mL)
y = 0.000715x - 0.306034
R² = 0.965436
0.00
0.50
1.00
1.50
2.00
0 1000 2000 3000
[product]
(μmol/mL)
time (s)
600 102.6 14177.6 0.15
900 334.1 14094.4 0.49
1200 631.4 14110.1 0.93
1500 788.8 14293.8 1.15
1800 867.0 14161.5 1.28
2100 1000.3 14293.6 1.46
2400 1041.1 14417.1 1.50
time (s)
product 
integral
standard 
integral
[product] 
(μmol/mL)
y = 0.000754x - 0.135882
R² = 0.927385
0.00
0.50
1.00
1.50
2.00
0 1000 2000 3000
[product]
(μmol/mL)
time (s)
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mmol, 0.42 equiv) in toluene (0.12 mL) was added. The tube was inserted into a preheated 50 °C 
NMR probe and the reaction progress was monitored via 
19
F NMR spectroscopy; nt = 64, 
sampling every 300 s. rate = 8.46 · 10
-4
 mM/s [AA-14-CV0673] 
 
avg. rate = 7.72 · 10
-4
 ± 6.73 · 10
-5 
mM/s 
 
  
600 255.5 14532.6 0.37
900 314.8 14764.6 0.44
1200 617.6 14458.0 0.89
1500 783.0 14555.5 1.12
1800 895.5 14591.5 1.28
2100 1109.3 14424.9 1.60
2400 1268.6 14409.6 1.83
time (s)
product 
integral
standard 
integral
[product] 
(μmol/mL) y = 0.000846x - 0.192712
R² = 0.984905
0.00
0.50
1.00
1.50
2.00
0 1000 2000 3000
[product]
(μmol/mL)
time (s)
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0.6 equivalents (Table 1.4, entry 2) 
Following General Procedure II, 1.23 (8.5 mg, 0.0175 mmol) was dissolved in toluene (0.2 
mL). A stock solution of K
+
(1.19)
−
 (0.0105 mmol, 0.6 equiv) and 1,4-difluorobenzene (0.0175 
mmol, 1 equiv) in toluene (0.5 mL) was added. The tube was inserted into a preheated 50 °C 
NMR probe and the reaction progress was monitored via 
19
F NMR spectroscopy; nt = 64, 
sampling every 200 s. rate = 1.07 · 10
-3
 mM/s [AA-14-CV0691] 
 
 
Following General Procedure II, 1.23 (8.5 mg, 0.0175 mmol) was dissolved in toluene (0.2 
mL). A stock solution of K
+
(1.19)
−
 (0.0105 mmol, 0.6 equiv) and 1,4-difluorobenzene (0.0175 
mmol, 1 equiv) in toluene (0.5 mL) was added. The tube was inserted into a preheated 50 °C 
NMR probe and the reaction progress was monitored via 
19
F NMR spectroscopy; nt = 64, 
sampling every 200 s. rate = 8.29 · 10
-4
 mM/s [AA-14-CV0692] 
 
 
 
400 182.7 40901.4 0.22
600 418.3 41623.2 0.50
800 548.5 41909.7 0.65
1000 744.9 42188.0 0.88
1200 860.8 42290.1 1.02
1400 1082.6 42423.6 1.28
1600 1280.4 42381.0 1.51
1800 1543.4 42453.8 1.82
2000 1725.8 42716.9 2.02
2200 1809.6 43114.8 2.10
time (s)
product 
integral
standard 
integral
[product] 
(μmol/mL)
y = 0.00107x - 0.19642
R² = 0.99330
0.00
0.50
1.00
1.50
2.00
2.50
0 1000 2000 3000
[product]
(μmol/mL)
time (s)
400 219.5 37101.6 0.30
600 322.0 37290.4 0.43
800 517.8 37115.9 0.70
1000 549.7 37343.0 0.74
1200 756.1 37306.8 1.01
1400 801.4 37049.9 1.08
1600 988.8 37495.5 1.32
1800 1090.7 37843.8 1.44
2000 1211.6 37135.3 1.63
2200 1333.0 37258.7 1.79
standard 
integral
[product] 
(μmol/mL)
time (s)
product 
integral
y = 0.000829x - 0.034502
R² = 0.993442
0.00
0.50
1.00
1.50
2.00
2.50
0 1000 2000 3000
[product]
(μmol/mL)
time (s)
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Following General Procedure II, 1.23 (8.5 mg, 0.0175 mmol) was dissolved in toluene (0.2 
mL). A stock solution of K
+
(1.19)
−
 (0.0105 mmol, 0.6 equiv) and 1,4-difluorobenzene (0.0175 
mmol, 1 equiv) in toluene (0.5 mL) was added. The tube was inserted into a preheated 50 °C 
NMR probe and the reaction progress was monitored via 
19
F NMR spectroscopy; nt = 64, 
sampling every 200 s. rate = 8.63 · 10
-4
 mM/s [AA-14-CV0693] 
 
avg. rate = 9.17 · 10
-4
 ± 1.25 · 10
-4 
mM/s 
 
  
400 221.7 37633.7 0.29
600 477.6 37596.4 0.64
800 505.9 37811.5 0.67
1000 755.0 37680.4 1.00
1200 838.6 37654.6 1.11
1400 943.2 37459.2 1.26
1600 1105.5 37456.8 1.48
1800 1198.2 37590.1 1.59
2000 1315.7 37703.2 1.74
2200 1443.6 37855.6 1.91
time (s)
product 
integral
standard 
integral
[product] 
(μmol/mL)
y = 0.000863x + 0.047954
R² = 0.986652
0.00
0.50
1.00
1.50
2.00
2.50
0 1000 2000 3000
[product]
(μmol/mL)
time (s)
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0.75 equivalents (Table 1.4, entry 3) 
Following General Procedure II, 1.23 (8.5 mg, 0.0175 mmol) was dissolved in toluene (0.4 
mL). A stock solution of K
+
(1.19)
−
 (0.0131 mmol, 0.75 equiv) and 1,4-difluorobenzene (0.0175 
mmol, 1 equiv) in toluene (0.3 mL) was added. The tube was inserted into a preheated 50 °C 
NMR probe and the reaction progress was monitored via 
19
F NMR spectroscopy; nt = 64, 
sampling every 300 s. rate = 1.57 · 10
-3
 mM/s [AA-14-CV0666] 
 
 
Following General Procedure II, 1.23 (8.5 mg, 0.0175 mmol) was dissolved in toluene (0.4 
mL). A stock solution of K
+
(1.19)
−
 (0.0131 mmol, 0.75 equiv) and 1,4-difluorobenzene (0.0175 
mmol, 1 equiv) in toluene (0.3 mL) was added. The tube was inserted into a preheated 50 °C 
NMR probe and the reaction progress was monitored via 
19
F NMR spectroscopy; nt = 64, 
sampling every 300 s. rate = 1.51 · 10
-3
 mM/s [AA-14-CV0667] 
 
 
Following General Procedure II, 1.23 (8.5 mg, 0.0175 mmol) was dissolved in toluene (0.4 
mL). A stock solution of K
+
(1.19)
−
 (0.0131 mmol, 0.75 equiv) and 1,4-difluorobenzene (0.0175 
300 506.2 33125.3 0.76
600 714.0 34233.5 1.04
900 1183.2 35837.1 1.65
1200 1589.1 36782.7 2.16
1500 2037.4 37108.5 2.75
1800 2391.3 37110.4 3.22
2100 2813.9 37213.5 3.78
2400 3118.2 37483.1 4.16
2700 3481.4 37378.4 4.66
3000 3650.7 37185.8 4.91
3300 3889.8 37279.0 5.22
time (s)
product 
integral
standard 
integral
[product] 
(μmol/mL)
y = 0.00157x + 0.29443
R² = 0.99199
0.00
1.00
2.00
3.00
4.00
5.00
6.00
0 1000 2000 3000 4000
[product]
(μmol/mL)
time (s)
300 340.9 32395.1 0.53
600 788.6 31889.8 1.24
900 1030.4 31632.8 1.63
1200 1387.2 32326.3 2.15
1500 1710.1 32808.3 2.61
1800 2004.6 33804.8 2.96
2100 2476.3 35157.7 3.52
2400 2764.0 36349.2 3.80
2700 3214.9 36949.6 4.35
3000 3582.7 36881.0 4.86
3300 3756.5 36866.4 5.09
standard 
integral
[product] 
(μmol/mL)
time (s)
product 
integral
y = 0.00151x + 0.26388
R² = 0.99585
0.00
1.00
2.00
3.00
4.00
5.00
6.00
0 1000 2000 3000 4000
[product]
(μmol/mL)
time (s)
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mmol, 1 equiv) in toluene (0.3 mL) was added. The tube was inserted into a preheated 50 °C 
NMR probe and the reaction progress was monitored via 
19
F NMR spectroscopy; nt = 64, 
sampling every 300 s. rate = 1.37 · 10
-3
 mM/s [AA-14-CV0668] 
 
avg. rate = 1.48 · 10
-3
 ± 1.03 · 10
-4 
mM/s 
 
  
300 392.3 35774.8 0.55
600 950.6 36069.4 1.32
900 1287.5 36078.9 1.78
1200 1502.2 35472.6 2.12
1500 1860.4 35895.8 2.59
1800 2101.8 35346.7 2.97
2100 2495.8 35719.4 3.49
2400 2624.2 35181.5 3.73
2700 3065.9 35528.3 4.31
3000 3177.2 35063.6 4.53
3300 3355.3 35631.0 4.71
time (s)
product 
integral
standard 
integral
[product] 
(μmol/mL)
y = 0.00137x + 0.44427
R² = 0.98701
0.00
1.00
2.00
3.00
4.00
5.00
6.00
0 1000 2000 3000 4000
[product]
(μmol/mL)
time (s)
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1 equivalent (Table 1.4, entry 4) 
Following General Procedure II, 1.23 (8.5 mg, 0.0175 mmol) was dissolved in toluene (0.4 
mL). A stock solution of K
+
(1.19)
−
 (0.0175 mmol, 1 equiv) and 1,4-difluorobenzene (0.0175 
mmol, 1 equiv) in toluene (0.3 mL) was added. The tube was inserted into a preheated 50 °C 
NMR probe and the reaction progress was monitored via 
19
F NMR spectroscopy; nt = 64, 
sampling every 300 s. rate = 2.45 · 10
-3
 mM/s [AA-14-CV0665] 
 
 
Following General Procedure II, 1.23 (8.5 mg, 0.0175 mmol) was dissolved in toluene (0.4 
mL). A stock solution of K
+
(1.19)
−
 (0.0175 mmol, 1 equiv) and 1,4-difluorobenzene (0.0175 
mmol, 1 equiv) in toluene (0.3 mL) was added. The tube was inserted into a preheated 50 °C 
NMR probe and the reaction progress was monitored via 
19
F NMR spectroscopy; nt = 64, 
sampling every 300 s. rate = 2.73 · 10
-3
 mM/s [AA-14-CV0669] 
 
 
Following General Procedure II, 1.23 (8.5 mg, 0.0175 mmol) was dissolved in toluene (0.4 
mL). A stock solution of K
+
(1.19)
−
 (0.0175 mmol, 1 equiv) and 1,4-difluorobenzene (0.0175 
300 585.0 35268.7 0.83
600 1093.2 36554.3 1.50
900 1611.3 36673.9 2.20
1200 2085.5 36313.3 2.87
1500 2563.1 35911.3 3.57
1800 3319.3 37187.5 4.46
2100 4004.4 37041.9 5.41
2400 4721.6 37079.1 6.37
2700 5247.0 37091.5 7.07
3000 5672.8 36970.9 7.67
3300 6110.2 36865.8 8.29
3600 6472.0 36842.4 8.78
3900 6648.4 36624.4 9.08
standard 
integral
[product] 
(μmol/mL)
time (s)
product 
integral
y = 0.00245x + 0.09923
R² = 0.99185
0.00
2.00
4.00
6.00
8.00
10.00
12.00
0 1000 2000 3000 4000 5000
[product]
(μmol/mL)
time (s)
300 223.3 15332.2 0.73
600 596.4 15308.3 1.95
900 838.9 15433.4 2.72
1200 1209.7 15441.8 3.92
1500 1530.2 15086.7 5.07
1800 1825.7 15454.1 5.91
2100 2181.0 15451.2 7.06
2400 2378.2 15581.3 7.63
2700 2594.3 15555.2 8.34
3000 2735.6 15472.1 8.84
3300 2885.3 15381.3 9.38
3600 3065.5 15301.2 10.02
3900 3184.2 15075.6 10.56
time (s)
product 
integral
standard 
integral
[product] 
(μmol/mL)
y = 0.00273x + 0.58506
R² = 0.97948
0.00
2.00
4.00
6.00
8.00
10.00
12.00
0 1000 2000 3000 4000 5000
[product]
(μmol/mL)
time (s)
221 
 
mmol, 1 equiv) in toluene (0.3 mL) was added. The tube was inserted into a preheated 50 °C 
NMR probe and the reaction progress was monitored via 
19
F NMR spectroscopy; nt = 64, 
sampling every 300 s. rate = 2.16 · 10
-3
 mM/s [AA-14-CV0670] 
 
avg. rate = 2.45 · 10
-3
 ± 2.85 · 10
-4 
mM/s 
 
  
300 342.2 15288.3 1.12
600 480.0 15539.0 1.54
900 734.7 15436.4 2.38
1200 965.7 15267.6 3.16
1500 1163.2 15411.7 3.77
1800 1483.5 15411.8 4.81
2100 1532.4 15142.0 5.06
2400 1840.3 15175.7 6.06
2700 2006.5 15249.5 6.58
3000 2200.6 15222.3 7.23
3300 2397.9 15295.6 7.84
3600 2508.9 15311.0 8.19
3900 2561.6 15148.1 8.46
time (s)
product 
integral
standard 
integral
[product] 
(μmol/mL)
y = 0.00216x + 0.54879
R² = 0.99032
0.00
2.00
4.00
6.00
8.00
10.00
12.00
0 1000 2000 3000 4000 5000
[product]
(μmol/mL)
time (s)
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1 equivalent - with added P(t-Bu)3 (2 equivalents) (Table 1.3, entry 2) 
Following General Procedure II, 1.23 (8.5 mg, 0.0175 mmol) was dissolved in toluene (0.4 
mL). A stock solution of K
+
(1.19)
−
 (0.0175 mmol, 1 equiv), P(t-Bu)3 (0.035 mmol, 2 equiv) and 
1,4-difluorobenzene (0.0289 mmol, 1.65 equiv) in toluene (0.3 mL) was added. The tube was 
inserted into a preheated 50 °C NMR probe and the reaction progress was monitored via 
19
F 
NMR spectroscopy; nt = 64, sampling every 300 s. rate = 2.56 · 10
-3
 mM/s [AA-14-CZ8644] 
 
 
Following General Procedure II, 1.23 (8.5 mg, 0.0175 mmol) was dissolved in toluene (0.4 
mL). A stock solution of K
+
(1.19)
−
 (0.0175 mmol, 1 equiv), P(t-Bu)3 (0.035 mmol, 2 equiv) and 
1,4-difluorobenzene (0.0289 mmol, 1.65 equiv) in toluene (0.3 mL) was added. The tube was 
inserted into a preheated 50 °C NMR probe and the reaction progress was monitored via 
19
F 
NMR spectroscopy; nt = 64, sampling every 300 s. rate = 2.65 · 10
-3
 mM/s [AA-14-CZ8645] 
 
 
Following General Procedure II, 1.23 (8.5 mg, 0.0175 mmol) was dissolved in toluene (0.4 
mL). A stock solution of K
+
(1.19)
−
 (0.0175 mmol, 1 equiv), P(t-Bu)3 (0.035 mmol, 2 equiv) and 
300 513.5 36786.5 1.15
600 753.7 36919.8 1.69
900 1167.3 37076.9 2.60
1200 1613.4 36981.7 3.60
1500 1880.8 37044.1 4.19
1800 2285.7 37294.1 5.06
2100 2746.7 37602.4 6.03
2400 3045.3 37733.2 6.66
2700 3519.5 37649.9 7.72
3000 3774.8 37994.7 8.20
3300 4125.6 37766.7 9.02
3600 4393.8 37928.2 9.57
3900 4538.5 37990.3 9.86
time (s)
product 
integral
standard 
integral
[product] 
(μmol/mL) y = 0.00256x + 0.41965
R² = 0.99396
0.00
2.00
4.00
6.00
8.00
10.00
12.00
0 1000 2000 3000 4000 5000
[product]
(μmol/mL)
time (s)
300 307.4 39198.0 0.65
600 829.8 39050.9 1.75
900 1204.0 39172.5 2.54
1200 1621.8 38923.6 3.44
1500 2021.6 39023.1 4.28
1800 2446.0 39035.5 5.17
2100 2864.8 38972.4 6.07
2400 3231.8 38993.9 6.84
2700 3413.2 38672.1 7.29
3000 3932.7 38299.5 8.48
3300 4113.0 38703.3 8.77
3600 4431.6 38440.2 9.52
3900 4773.1 38300.6 10.29
standard 
integral
[product] 
(μmol/mL)
time (s)
product 
integral
y = 0.00265x + 0.22156
R² = 0.99478
0.00
2.00
4.00
6.00
8.00
10.00
12.00
0 1000 2000 3000 4000 5000
[product]
(μmol/mL)
time (s)
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1,4-difluorobenzene (0.0289 mmol, 1.65 equiv) in toluene (0.3 mL) was added. The tube was 
inserted into a preheated 50 °C NMR probe and the reaction progress was monitored via 
19
F 
NMR spectroscopy; nt = 64, sampling every 300 s. rate = 2.76 · 10
-3
 mM/s [AA-14-CZ8646] 
 
avg. rate = 2.66 · 10
-3
 ± 1.00 · 10
-4 
mM/s 
 
1 equivalent - with added P(t-Bu)3 (5 equivalents) (Table 1.3, entry 3) 
Following General Procedure II, 1.23 (8.5 mg, 0.0175 mmol) was dissolved in toluene (0.3 
mL). A stock solution of K
+
(1.19)
−
 (0.0175 mmol, 1 equiv), P(t-Bu)3 (0.0875 mmol, 5 equiv) 
and 1,4-difluorobenzene (0.0175 mmol, 1 equiv) in toluene (0.3 mL) was added. The tube was 
inserted into a preheated 50 °C NMR probe and the reaction progress was monitored via 
19
F 
NMR spectroscopy; nt = 64, sampling every 300 s. rate = 2.42 · 10
-3
 mM/s [AA-14-CZ8647] 
 
 
  
300 454.4 49073.0 0.76
600 988.2 49325.2 1.65
900 1563.8 49560.7 2.61
1200 2160.1 49479.6 3.60
1500 2771.6 49579.2 4.62
1800 3443.7 49698.7 5.72
2100 4028.4 49826.9 6.68
2400 4550.2 49548.2 7.58
2700 4880.3 49615.2 8.12
3000 5243.7 49421.8 8.76
3300 5704.9 49420.1 9.53
3600 5973.9 49424.6 9.98
3900 6143.3 49403.9 10.27
time (s)
product 
integral
standard 
integral
[product] 
(μmol/mL)
y = 0.00276x + 0.34923
R² = 0.98333
0.00
2.00
4.00
6.00
8.00
10.00
12.00
0 1000 2000 3000 4000 5000
[product]
(μmol/mL)
time (s)
300 416.0 37751.5 0.55
600 1113.1 37573.6 1.48
900 1622.2 38065.5 2.13
1200 2334.0 37724.4 3.09
1500 2989.6 37602.8 3.98
1800 3620.4 37713.6 4.80
2100 4203.9 37678.7 5.58
2400 4799.8 37731.4 6.36
2700 5345.0 37809.6 7.07
3000 5810.3 37592.0 7.73
3300 6047.7 37741.1 8.01
3600 6499.5 37651.4 8.63
3900 6871.9 37630.5 9.13
time (s)
product 
integral
standard 
integral
[product] 
(μmol/mL)
y = 0.00242x + 0.17991
R² = 0.98899
0.00
2.00
4.00
6.00
8.00
10.00
12.00
0 1000 2000 3000 4000 5000
[product]
(μmol/mL)
time (s)
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1.5 equivalents (Table 1.4, entry 5) 
Following General Procedure II, 1.23 (8.5 mg, 0.0175 mmol) was dissolved in toluene (0.2 
mL). A stock solution of K
+
(1.19)
−
 (0.0263 mmol, 1.5 equiv) and 1,4-difluorobenzene (0.0145 
mmol, 0.83 equiv) in toluene (0.5 mL) was added. The tube was inserted into a preheated 50 °C 
NMR probe and the reaction progress was monitored via 
19
F NMR spectroscopy; nt = 16, 
sampling every 45 s. rate = 1.56 · 10
-2
 mM/s [AA-14-CV0688] 
 
 
Following General Procedure II, 1.23 (8.5 mg, 0.0175 mmol) was dissolved in toluene (0.2 
mL). A stock solution of K
+
(1.19)
−
 (0.0263 mmol, 1.5 equiv) and 1,4-difluorobenzene (0.0145 
mmol, 0.83 equiv) in toluene (0.5 mL) was added. The tube was inserted into a preheated 50 °C 
NMR probe and the reaction progress was monitored via 
19
F NMR spectroscopy; nt = 16, 
sampling every 45 s. rate = 1.78 · 10
-2
 mM/s [AA-14-CV0689] 
 
 
 
0 108.2 4783.5 0.94
45 202.9 4998.0 1.69
90 313.6 4862.9 2.69
135 421.8 4844.8 3.63
180 472.8 4844.9 4.07
225 578.8 4831.3 5.00
270 640.2 4864.7 5.49
315 710.6 4844.6 6.12
360 749.8 4877.9 6.41
time (s)
product 
integral
standard 
integral
[product] 
(μmol/mL)
y = 0.0156x + 1.1976
R² = 0.9841
0.00
1.00
2.00
3.00
4.00
5.00
6.00
7.00
8.00
0 50 100 150 200 250 300 350 400
[product]
(μmol/mL)
time (s)
0 85.3 5150.9 0.69
45 171.8 5200.6 1.38
90 250.5 5103.2 2.05
135 340.8 5041.9 2.82
180 416.8 5071.8 3.43
225 533.6 5085.0 4.38
270 660.2 5097.1 5.40
315 790.3 5124.6 6.43
360 840.2 5098.4 6.87
time (s)
product 
integral
standard 
integral
[product] 
(μmol/mL) y = 0.0178x + 0.5056
R² = 0.9933
0.00
1.00
2.00
3.00
4.00
5.00
6.00
7.00
8.00
0 50 100 150 200 250 300 350 400
[product]
(μmol/mL)
time (s)
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Following General Procedure II, 1.23 (8.5 mg, 0.0175 mmol) was dissolved in toluene (0.2 
mL). A stock solution of K
+
(1.19)
−
 (0.0263 mmol, 1.5 equiv) and 1,4-difluorobenzene (0.0145 
mmol, 0.83 equiv) in toluene (0.5 mL) was added. The tube was inserted into a preheated 50 °C 
NMR probe and the reaction progress was monitored via 
19
F NMR spectroscopy; nt = 16, 
sampling every 45 s. rate = 1.81 · 10
-2
 mM/s [AA-14-CV0690] 
 
avg. rate = 1.72 · 10
-2
 ± 1.37 · 10
-3 
mM/s 
 
  
0 39.6 4813.9 0.34
45 164.8 5052.9 1.36
90 252.6 4977.8 2.12
135 356.3 4912.6 3.02
180 410.5 4913.9 3.48
225 533.2 4927.4 4.51
270 664.3 4946.8 5.60
315 744.2 4942.9 6.28
360 798.4 4939.9 6.74
time (s)
product 
integral
standard 
integral
[product] 
(μmol/mL) y = 0.0181x + 0.4644
R² = 0.9944
0.00
1.00
2.00
3.00
4.00
5.00
6.00
7.00
8.00
0 50 100 150 200 250 300 350 400
[product]
(μmol/mL)
time (s)
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2 equivalents (Table 1.4, entry 6) 
Following General Procedure II, 1.23 (8.5 mg, 0.0175 mmol) was dissolved in toluene (0.2 
mL). A stock solution of K
+
(1.19)
−
 (0.035 mmol, 2 equiv) and 1,4-difluorobenzene (0.0292 
mmol, 1.67 equiv) in toluene (0.5 mL) was added. The tube was inserted into a preheated 50 °C 
NMR probe and the reaction progress was monitored via 
19
F NMR spectroscopy; nt = 16, 
sampling every 60 s. rate = 1.90 · 10
-2
 mM/s [AA-14-CV0675] 
 
 
Following General Procedure II, 1.23 (8.5 mg, 0.0175 mmol) was dissolved in toluene (0.2 
mL). A stock solution of K
+
(1.19)
−
 (0.035 mmol, 2 equiv) and 1,4-difluorobenzene (0.0292 
mmol, 1.67 equiv) in toluene (0.5 mL) was added. The tube was inserted into a preheated 50 °C 
NMR probe and the reaction progress was monitored via 
19
F NMR spectroscopy; nt = 16, 
sampling every 45 s. rate = 1.93 · 10
-2
 mM/s [AA-14-CV0676] 
 
 
Following General Procedure II, 1.23 (8.5 mg, 0.0175 mmol) was dissolved in toluene (0.2 
mL). A stock solution of K
+
(1.19)
−
 (0.035 mmol, 2 equiv) and 1,4-difluorobenzene (0.0292 
0 380.9 19209.5 1.65
60 665.0 18546.6 2.99
120 1008.2 18249.1 4.61
180 1309.5 18146.7 6.02
240 1528.4 18204.2 7.00
300 1677.0 18211.8 7.68
360 1818.6 18147.7 8.36
time (s)
product 
integral
standard 
integral
[product] 
(μmol/mL) y = 0.0190x + 2.0573
R² = 0.9728
0.00
1.00
2.00
3.00
4.00
5.00
6.00
7.00
8.00
9.00
10.00
0 50 100 150 200 250 300 350 400
[product]
(μmol/mL)
time (s)
0 388.0 19101.6 1.69
45 523.9 17880.9 2.44
90 738.9 17534.6 3.52
135 997.6 17633.7 4.72
180 1203.2 17413.4 5.76
225 1409.3 17513.9 6.71
270 1573.5 17551.0 7.48
315 1653.1 17633.1 7.82
360 1732.2 17636.5 8.19
time (s)
product 
integral
standard 
integral
[product] 
(μmol/mL) y = 0.0193x + 1.9020
R² = 0.9747
0.00
1.00
2.00
3.00
4.00
5.00
6.00
7.00
8.00
9.00
10.00
0 50 100 150 200 250 300 350 400
[product]
(μmol/mL)
time (s)
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mmol, 1.67 equiv) in toluene (0.5 mL) was added. The tube was inserted into a preheated 50 °C 
NMR probe and the reaction progress was monitored via 
19
F NMR spectroscopy; nt = 16, 
sampling every 45 s. rate = 2.18 · 10
-2
 mM/s [AA-14-CV0677] 
 
avg. rate = 2.00 · 10
-2
 ± 1.54 · 10
-3 
mM/s 
 
  
0 328.8 19678.2 1.39
45 543.5 18834.1 2.41
90 753.2 18260.6 3.44
135 934.5 18427.2 4.23
180 1217.1 18244.6 5.57
225 1444.4 18600.6 6.48
270 1701.9 18602.9 7.63
315 1879.1 18754.0 8.36
360 1994.1 18568.2 8.96
time (s)
product 
integral
standard 
integral
[product] 
(μmol/mL) y = 0.0218x + 1.4689
R² = 0.9951
0.00
1.00
2.00
3.00
4.00
5.00
6.00
7.00
8.00
9.00
10.00
0 50 100 150 200 250 300 350 400
[product]
(μmol/mL)
time (s)
228 
 
3 equivalents (Table 1.4, entry 7) 
Following General Procedure II, 1.23 (8.5 mg, 0.0175 mmol) was dissolved in toluene (0.2 
mL). A stock solution of K
+
(1.19)
−
 (0.0524 mmol, 3 equiv) and 1,4-difluorobenzene (0.0175 
mmol, 1 equiv) in toluene (0.5 mL) was added. The tube was inserted into a preheated 50 °C 
NMR probe and the reaction progress was monitored via 
19
F NMR spectroscopy; nt = 8, 
sampling every 30 s. rate = 2.51 · 10
-2
 mM/s [AA-14-CV0678] 
 
 
Following General Procedure II, 1.23 (8.5 mg, 0.0175 mmol) was dissolved in toluene (0.2 
mL). A stock solution of K
+
(1.19)
−
 (0.0524 mmol, 3 equiv) and 1,4-difluorobenzene (0.0175 
mmol, 1 equiv) in toluene (0.5 mL) was added. The tube was inserted into a preheated 50 °C 
NMR probe and the reaction progress was monitored via 
19
F NMR spectroscopy; nt = 8, 
sampling every 30 s. rate = 2.55 · 10
-2
 mM/s [AA-14-CV0679] 
 
 
 
0 216.5 6977.0 1.55
30 289.6 6727.1 2.15
60 374.3 6472.9 2.89
90 488.1 6344.0 3.85
120 612.2 6359.1 4.81
150 726.7 6410.5 5.67
180 787.9 6387.3 6.17
210 865.7 6329.2 6.84
240 919.8 6344.9 7.25
time (s)
product 
integral
standard 
integral
[product] 
(μmol/mL) y = 0.0251x + 1.5607
R² = 0.9897
0.00
1.00
2.00
3.00
4.00
5.00
6.00
7.00
8.00
0 50 100 150 200 250 300
[product]
(μmol/mL)
time (s)
0 201.4 6757.7 1.49
30 250.5 6612.9 1.89
60 353.5 6351.5 2.78
90 462.3 6324.7 3.65
120 571.6 6274.4 4.56
150 699.0 6249.8 5.59
180 788.0 6207.7 6.35
210 832.2 6258.4 6.65
240 896.0 6279.3 7.13
time (s)
product 
integral
standard 
integral
[product] 
(μmol/mL) y = 0.0255x + 1.3950
R² = 0.9850
0.00
1.00
2.00
3.00
4.00
5.00
6.00
7.00
8.00
0 50 100 150 200 250 300
[product]
(μmol/mL)
time (s)
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Following General Procedure II, 1.23 (8.5 mg, 0.0175 mmol) was dissolved in toluene (0.2 
mL). A stock solution of K
+
(1.19)
−
 (0.0524 mmol, 3 equiv) and 1,4-difluorobenzene (0.0175 
mmol, 1 equiv) in toluene (0.5 mL) was added. The tube was inserted into a preheated 50 °C 
NMR probe and the reaction progress was monitored via 
19
F NMR spectroscopy; nt = 8, 
sampling every 30 s. rate = 2.63 · 10
-2
 mM/s [AA-14-CV0681] 
 
avg. rate = 2.56 · 10
-2
 ± 6.11 · 10
-4 
mM/s 
 
  
0 155.0 6616.8 1.17
30 255.4 6477.6 1.97
60 361.8 6272.3 2.88
90 473.5 6199.7 3.82
120 587.2 6182.7 4.75
150 692.2 6254.7 5.53
180 780.5 6211.8 6.28
210 851.3 6255.9 6.80
240 899.8 6202.7 7.25
time (s)
product 
integral
standard 
integral
[product] 
(μmol/mL) y = 0.0263x + 1.3406
R² = 0.9894
0.00
1.00
2.00
3.00
4.00
5.00
6.00
7.00
8.00
0 50 100 150 200 250 300
[product]
(μmol/mL)
time (s)
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5 equivalents (Table 1.4, entry 8) 
Following General Procedure II, 1.23 (8.5 mg, 0.0175 mmol) was dissolved in toluene (0.2 
mL). A stock solution of K
+
(1.19)
−
 (0.0875 mmol, 5 equiv) and 1,4-difluorobenzene (0.0175 
mmol, 1 equiv) in toluene (0.5 mL) was added. The tube was inserted into a preheated 50 °C 
NMR probe and the reaction progress was monitored via 
19
F NMR spectroscopy; nt = 8, 
sampling every 30 s. rate = 2.92 · 10
-2
 mM/s [AA-14-CV0680] 
 
 
Following General Procedure II, 1.23 (8.5 mg, 0.0175 mmol) was dissolved in toluene (0.2 
mL). A stock solution of K
+
5
–
 (0.0875 mmol, 5 equiv) and 1,4-difluorobenzene (0.0175 mmol, 1 
equiv) in toluene (0.5 mL) was added. The tube was inserted into a preheated 50 °C NMR probe 
and the reaction progress was monitored via 
19
F NMR spectroscopy; nt = 8, sampling every 30 s. 
rate = 2.86 · 10
-2
 mM/s [AA-14-CV0682] 
 
 
 
0 264.8 6784.2 1.95
30 297.1 6694.8 2.22
60 401.6 6439.2 3.12
90 527.9 6311.3 4.18
120 648.3 6305.7 5.14
150 749.2 6328.0 5.92
180 856.3 6236.8 6.86
210 979.7 6259.7 7.83
time (s)
product 
integral
standard 
integral
[product] 
(μmol/mL) y = 0.0292x + 1.5815
R² = 0.9921
0.00
1.00
2.00
3.00
4.00
5.00
6.00
7.00
8.00
9.00
0 50 100 150 200 250
[product]
(μmol/mL)
time (s)
0 184.4 6143.2 1.50
30 231.6 6586.5 1.76
60 353.4 6324.4 2.79
90 466.8 6249.2 3.73
120 584.6 6207.2 4.71
150 712.6 6258.1 5.69
180 802.0 6127.8 6.54
210 877.1 6255.3 7.01
time (s)
product 
integral
standard 
integral
[product] 
(μmol/mL)
y = 0.0286x + 1.2110
R² = 0.9898
0.00
1.00
2.00
3.00
4.00
5.00
6.00
7.00
8.00
9.00
0 50 100 150 200 250
[product]
(μmol/mL)
time (s)
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Following General Procedure II, 1.23 (8.5 mg, 0.0175 mmol) was dissolved in toluene (0.2 
mL). A stock solution of K
+
(1.19)
−
 (0.0875 mmol, 5 equiv) and 1,4-difluorobenzene (0.0175 
mmol, 1 equiv) in toluene (0.5 mL) was added. The tube was inserted into a preheated 50 °C 
NMR probe and the reaction progress was monitored via 
19
F NMR spectroscopy; nt = 8, 
sampling every 30 s. rate = 2.95 · 10
-2
 mM/s [AA-14-CV0683] 
 
avg. rate = 2.91 · 10
-2
 ± 4.58 · 10
-4 
mM/s 
 
  
0 231.2 6761.3 1.71
30 313.3 6710.2 2.33
60 418.8 6482.2 3.23
90 565.1 6426.5 4.40
120 678.5 6438.0 5.27
150 809.4 6460.6 6.26
180 862.0 6456.4 6.68
210 991.3 6365.0 7.79
time (s)
product 
integral
standard 
integral
[product] 
(μmol/mL) y = 0.0295x + 1.6160
R² = 0.9939
0.00
1.00
2.00
3.00
4.00
5.00
6.00
7.00
8.00
9.00
0 50 100 150 200 250
[product]
(μmol/mL)
time (s)
232 
 
7.5 equivalents (Table 1.4, entry 9) 
Following General Procedure II, 1.23 (8.5 mg, 0.0175 mmol) was dissolved in toluene (0.1 
mL). A stock solution of K
+
(1.19)
−
 (0.131 mmol, 7.5 equiv) and 1,4-difluorobenzene (0.021 
mmol, 1.2 equiv) in toluene (0.6 mL) was added. The tube was inserted into a preheated 50 °C 
NMR probe and the reaction progress was monitored via 
19
F NMR spectroscopy; nt = 8, 
sampling every 30 s. rate = 3.03 · 10
-2
 mM/s [AA-14-CV0684] 
 
  
Following General Procedure II, 1.23 (8.5 mg, 0.0175 mmol) was dissolved in toluene (0.1 
mL). A stock solution of K
+
(1.19)
−
 (0.131 mmol, 7.5 equiv) and 1,4-difluorobenzene (0.021 
mmol, 1.2 equiv) in toluene (0.6 mL) was added. The tube was inserted into a preheated 50 °C 
NMR probe and the reaction progress was monitored via 
19
F NMR spectroscopy; nt = 8, 
sampling every 30 s. rate = 2.98 · 10
-2
 mM/s [AA-14-CV0685] 
 
 
 
0 153.1 7712.0 1.19
30 349.0 7431.6 2.82
60 452.2 7255.1 3.74
90 542.9 7190.1 4.53
120 688.0 7333.6 5.63
150 773.1 7279.6 6.37
180 878.7 7264.8 7.26
210 934.0 7321.8 7.65
time (s)
product 
integral
standard 
integral
[product] 
(μmol/mL) y = 0.0303x + 1.7140
R² = 0.9819
0.00
1.00
2.00
3.00
4.00
5.00
6.00
7.00
8.00
9.00
0 50 100 150 200 250
[product]
(μmol/mL)
time (s)
0 51.2 3167.2 0.97
30 64.2 3276.1 1.18
60 108.2 3172.3 2.05
90 191.5 3156.0 3.64
120 234.0 3154.4 4.45
150 283.1 3154.1 5.39
180 306.4 3121.6 5.89
210 354.1 3124.0 6.80
time (s)
product 
integral
standard 
integral
[product] 
(μmol/mL)
y = 0.0298x + 0.6608
R² = 0.9816
0.00
1.00
2.00
3.00
4.00
5.00
6.00
7.00
8.00
9.00
0 50 100 150 200 250
[product]
(μmol/mL)
time (s)
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Following General Procedure II, 1.23 (8.5 mg, 0.0175 mmol) was dissolved in toluene (0.1 
mL). A stock solution of K
+
(1.19)
−
 (0.131 mmol, 7.5 equiv) and 1,4-difluorobenzene (0.021 
mmol, 1.2 equiv) in toluene (0.6 mL) was added. The tube was inserted into a preheated 50 °C 
NMR probe and the reaction progress was monitored via 
19
F NMR spectroscopy; nt = 8, 
sampling every 30 s. rate = 3.06 · 10
-2
 mM/s [AA-14-CV0686] 
 
avg. rate = 3.02 · 10
-2
 ± 4.04 · 10
-4 
mM/s 
 
  
0 47.3 3166.7 0.90
30 79.1 3307.8 1.43
60 153.0 3208.7 2.86
90 188.8 3164.8 3.58
120 243.6 3133.1 4.66
150 283.4 3145.3 5.41
180 333.2 3149.8 6.35
210 377.2 3158.9 7.16
time (s)
product 
integral
standard 
integral
[product] 
(μmol/mL)
y = 0.0306x + 0.8291
R² = 0.9951
0.00
1.00
2.00
3.00
4.00
5.00
6.00
7.00
8.00
9.00
0 50 100 150 200 250
[product]
(μmol/mL)
time (s)
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General Procedure III: K
+
(1.19)
−
 at 25 °C 
 
In a drybox, an oven-dried, 4-mL vial was charged with 1.23 (8.5 mg, 0.0175 mmol) and 
toluene, resulting in an orange solution. Then, a stock solution of K
+
(1.19)
−
 and 1,4-
difluorobenzene in toluene was added to a total volume of 0.7 mL (0.025 M in 1.23) and the 
mixture was vigorously mixed. The resulting solution was transferred via syringe into an oven-
dried, 5-mm NMR tube. The tube was sealed with a cap and wrapped with Parafilm to exclude 
any oxygen or moisture. The NMR tube was removed from the drybox and inserted into a pre-
warmed 25 °C NMR probe. The temperature of the reaction solution was allowed to equilibrate 
for ca. 60 seconds prior to data collection. The reaction progress was monitored via 
19
F NMR 
spectroscopy by the appearance of the product 1.16 (δ = ‒117.2 ppm) as compared to an internal 
reference (1,4-difluorobenzene, δ = ‒119.9 ppm) using the following parameters: at = 0.5 s, d1 = 
1 s, pw90 = 15 μs, pw = pw90/2, sw = ‒115 to ‒130 ppm, nt and sampling as specified in each 
individual experiment. Experiments were repeated in triplicate. 
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7.5 equivalents 
Following General Procedure III, 1.23 (8.5 mg, 0.0175 mmol) was dissolved in toluene (0.1 
mL). A stock solution of K
+
(1.19)
−
 (0.131 mmol, 7.5 equiv) and 1,4-difluorobenzene (0.0175 
mmol, 1 equiv) in toluene (0.6 mL) was added. The tube was inserted into a preheated 25 °C 
NMR probe and the reaction progress was monitored via 
19
F NMR spectroscopy; nt = 16, 
sampling every 60 s. rate = 2.68 · 10
-3
 mM/s [AA-14-CZ8615] 
 
 
Following General Procedure III, 1.23 (8.5 mg, 0.0175 mmol) was dissolved in toluene (0.1 
mL). A stock solution of K
+
(1.19)
−
 (0.131 mmol, 7.5 equiv) and 1,4-difluorobenzene (0.0175 
mmol, 1 equiv) in toluene (0.6 mL) was added. The tube was inserted into a preheated 25 °C 
NMR probe and the reaction progress was monitored via 
19
F NMR spectroscopy; nt = 16, 
sampling every 120 s. rate = 2.78 · 10
-3
 mM/s [AA-14-CZ8616] 
0 345.7 13627.8 1.27
60 381.3 13510.1 1.41
120 408.6 13489.6 1.51
180 436.1 13471.7 1.62
240 500.6 13449.0 1.86
300 564.1 13485.2 2.09
360 619.4 13503.4 2.29
420 615.5 13521.9 2.28
480 672.1 13414.4 2.51
540 747.2 13473.8 2.77
600 802.4 13451.7 2.98
660 852.7 13494.8 3.16
720 868.1 13399.5 3.24
780 907.5 13461.8 3.37
840 961.7 13412.9 3.59
900 973.5 13489.6 3.61
960 1044.0 13416.4 3.89
1020 1034.8 13576.8 3.81
1080 1139.5 13504.2 4.22
1140 1158.4 13464.4 4.30
1200 1252.3 13387.3 4.68
1260 1253.7 13418.4 4.67
1320 1236.0 13426.3 4.60
1380 1370.8 13469.0 5.09
1440 1331.0 13436.2 4.95
1500 1408.6 13532.9 5.20
1560 1467.2 13414.8 5.47
1620 1463.7 13360.0 5.48
1680 1569.9 13469.5 5.83
time (s)
product 
integral
standard 
integral
[product] 
(μmol/mL)
y = 0.00268x + 1.26145
R² = 0.99470
0.00
1.00
2.00
3.00
4.00
5.00
6.00
7.00
0 500 1000 1500 2000
[product]
(μmol/mL)
time (s)
236 
 
 
 
Following General Procedure III, 1.23 (8.5 mg, 0.0175 mmol) was dissolved in toluene (0.1 
mL). A stock solution of K
+
(1.19)
−
 (0.131 mmol, 7.5 equiv) and 1,4-difluorobenzene (0.0175 
mmol, 1 equiv) in toluene (0.6 mL) was added. The tube was inserted into a preheated 25 °C 
NMR probe and the reaction progress was monitored via 
19
F NMR spectroscopy; nt = 16, 
sampling every 120 s. rate = 2.66 · 10
-3
 mM/s [AA-14-CZ8617] 
 
avg. rate = 2.71 · 10
-3
 ± 6.43 · 10
-5 
mM/s 
 
 
  
0 318.2 13324.9 1.19
120 444.2 14137.5 1.57
240 513.0 14417.8 1.78
360 610.7 14149.4 2.16
480 713.3 14354.6 2.48
600 822.3 14165.6 2.90
720 905.2 14102.3 3.21
840 1023.8 14024.5 3.65
960 1143.8 14035.7 4.07
1080 1156.7 14004.5 4.13
1200 1310.9 13997.0 4.68
1320 1424.2 14023.6 5.08
1440 1453.5 14068.4 5.17
1560 1544.6 13974.1 5.53
1680 1607.9 14211.4 5.66
time (s)
product 
integral
standard 
integral
[product] 
(μmol/mL)
y = 0.00278x + 1.21325
R² = 0.99415
0.00
1.00
2.00
3.00
4.00
5.00
6.00
7.00
0 500 1000 1500 2000
[product]
(μmol/mL)
time (s)
0 318.5 13897.9 1.15
120 377.0 14101.8 1.34
240 475.7 14134.2 1.68
360 623.5 14187.6 2.20
480 687.8 14128.9 2.43
600 750.0 14049.8 2.67
720 866.4 14183.1 3.05
840 926.3 14054.8 3.30
960 1012.8 14174.1 3.57
1080 1138.6 14085.6 4.04
1200 1294.2 14073.0 4.60
1320 1342.0 14050.4 4.78
1440 1394.9 14088.7 4.95
1560 1413.6 14048.3 5.03
1680 1562.1 14067.2 5.55
time (s)
product 
integral
standard 
integral
[product] 
(μmol/mL) y = 0.00266x + 1.12049
R² = 0.99263
0.00
1.00
2.00
3.00
4.00
5.00
6.00
0 500 1000 1500 2000
[product]
(μmol/mL)
time (s)
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General Procedure IV: Cs
+
(1.19)
−
 at 50 °C 
 
In a drybox, an oven-dried, 5-mm NMR tube was charged with 1.23 (9.4 mg, 0.0194 mmol), 
1,4-difluorobenzene (1 L, 0.00974 mmol, 0.5 equiv) and toluene (0.4 mL) resulting in an 
orange solution upon vigorous mixing. Then, Cs
+
(1.19)
−
 (6.0 mg, 0.0192 mmol, 0.98 equiv) was 
added as a solid and the sides of the tube were rinsed with toluene (0.4 mL). The mixture was 
vigorously mixed using a vortex mixer for ca. 2 min to ensure complete dissolution. The tube 
was sealed with a septum and wrapped with Parafilm to exclude any oxygen or moisture. The 
NMR tube was removed from the drybox and inserted into a preheated 50 °C NMR probe. The 
temperature of the reaction solution was allowed to equilibrate for ca. 90 s prior to data 
collection. The reaction progress was monitored via 
19
F NMR spectroscopy by the appearance of 
the product 1.16 (δ = ‒117.2 ppm) as compared to an internal reference (1,4-difluorobenzene, δ = 
‒119.9 ppm) using the following parameters: at = 0.328, d1 = 0, pw90 = 8.85, pw = pw90/2, nt = 
128, sampling every 300 s. Experiments were repeated in triplicate. 
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1 equivalent (Table 1.5, entry 1) 
Following General Procedure IV, a mixture of 1.23 (9.4 mg, 0.0194 mmol) and 1,4-
difluorobenzene (1 L) was dissolved in toluene (0.4 mL), followed by the addition of 
Cs
+
(1.19)
−
 (6.2 mg, 0.0192 mmol, 0.98 equiv) and toluene (0.4 mL) to afford an orange solution. 
The tube was placed into a preheated 50 °C NMR probe and the reaction progress was monitored 
by 
19
F NMR spectroscopy. rate = 2.97 · 10
-3
 mM/s [RCS] 
 
 
Following General Procedure IV, a mixture of 1.23 (9.4 mg, 0.0194 mmol) and 1,4-
difluorobenzene (1 L) was dissolved in toluene (0.4 mL), followed by the addition of 
Cs
+
(1.19)
−
 (6.2 mg, 0.0192 mmol, 0.98 equiv) and toluene (0.4 mL) to afford an orange solution. 
The tube was placed into a preheated 50 °C NMR probe and the reaction progress was monitored 
by 
19
F NMR spectroscopy. rate = 3.09 · 10
-3
 mM/s [RCS] 
 
 
300 493.4 7397.3 1.62
600 717.4 6934.6 2.51
900 981.3 6733.7 3.53
1200 1471.5 6950.8 5.13
1500 1876.7 6963.7 6.54
1800 2201.5 7049.4 7.57
2100 2406.6 6901.6 8.46
2400 2749.4 7003.2 9.52
2700 2848.2 7131.6 9.68
3000 2925.1 7136.3 9.94
3300 3062.9 7132.8 10.41
3600 3215.2 6900.0 11.30
time (s)
product 
integral
standard 
integral
[product] 
(μmol/mL) y = 0.00297x + 1.38740
R² = 0.95400
0.00
2.00
4.00
6.00
8.00
10.00
12.00
14.00
0 1000 2000 3000 4000
[product]
(μmol/mL)
time (s)
300 805.2 7863.9 2.48
600 1220.5 8997.9 3.29
900 1774.2 9456.3 4.55
1200 2171.5 9228.6 5.71
1500 2447.8 9020.8 6.58
1800 2832.9 8731.2 7.87
2100 3042.2 8431.4 8.75
2400 3334.1 8181.4 9.88
2700 3480.4 7965.8 10.60
3000 3656.3 7938.6 11.17
3300 3799.0 7802.5 11.81
3600 3872.4 7712.3 12.18
time (s)
product 
integral
standard 
integral
[product] 
(μmol/mL) y = 0.00309x + 1.88537
R² = 0.98474
0.00
2.00
4.00
6.00
8.00
10.00
12.00
14.00
0 1000 2000 3000 4000
[product]
(μmol/mL)
time (s)
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Following General Procedure IV, a mixture of 1.23 (9.4 mg, 0.0194 mmol) and 1,4-
difluorobenzene (1 L) was dissolved in toluene (0.4 mL), followed by the addition of 
Cs
+
(1.19)
−
 (6.2 mg, 0.0192 mmol, 0.98 equiv) and toluene (0.4 mL) to afford an orange solution. 
The tube was placed into a preheated 50 °C NMR probe and the reaction progress was monitored 
by 
19
F NMR spectroscopy. rate = 3.13 · 10
-3
 mM/s [RCS] 
 
avg. rate = 3.06 · 10
-3
 ± 8.24 · 10
-5 
mM/s 
  
300 480.2 11494.1 1.01
600 837.0 10369.9 1.96
900 1238.6 9564.7 3.14
1200 1587.1 9422.2 4.08
1500 2059.5 9275.3 5.38
1800 2461.0 9140.5 6.53
2100 2700.4 9201.7 7.12
2400 2983.0 9151.5 7.90
2700 3466.2 9062.0 9.28
3000 3834.8 9035.9 10.29
3300 3852.0 9153.4 10.21
3600 4140.2 9077.1 11.06
time (s)
product 
integral
standard 
integral
[product] 
(μmol/mL)
y = 0.00313x + 0.38524
R² = 0.98716
0.00
2.00
4.00
6.00
8.00
10.00
12.00
14.00
0 1000 2000 3000 4000
[product]
(μmol/mL)
time (s)
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General Procedure V: Cs
+
(1.19)
−
 at 25 °C 
 
In a drybox, an oven-dried, 4-mL vial was charged with 1.23 (8.5 mg, 0.0175 mmol) and 
toluene, resulting in an orange solution. Then, a stock solution of Cs
+
(1.19)
−
 and 1,4-
difluorobenzene in toluene was added to a total volume of 0.7 mL (0.025 M in 1.23) and the 
mixture was vigorously mixed. The resulting solution was transferred via syringe into an oven-
dried, 5-mm NMR tube. The tube was sealed with a cap and wrapped with Parafilm to exclude 
any oxygen or moisture. The NMR tube was removed from the drybox and immediately inserted 
into a pre-warmed 25 °C NMR probe. The reaction progress was monitored via 
19
F NMR 
spectroscopy by the appearance of the product 1.16 (δ = ‒117.2 ppm) as compared to an internal 
reference (1,4-difluorobenzene, δ = ‒119.9 ppm) using the following parameters: at = 0.5 s, d1 = 
1 s, pw90 = 15 μs, pw = pw90/2, sw = ‒115 to ‒130 ppm, nt and sampling as specified in each 
individual experiment. Experiments were repeated in triplicate. 
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1.5 equivalents (Table 1.5, entry 2) 
Following General Procedure V, 1.23 (8.5 mg, 0.0175 mmol) was dissolved in toluene (0.2 
mL). A stock solution of Cs
+
(1.19)
−
 (0.0263 mmol, 1.5 equiv) and 1,4-difluorobenzene (0.0175 
mmol, 1 equiv) in toluene (0.5 mL) was added. The tube was inserted into a preheated 25 °C 
NMR probe and the reaction progress was monitored via 
19
F NMR spectroscopy; nt = 16, 
sampling every 45 s. rate = 6.29 · 10
-3
 mM/s [AA-14-CV0694] 
 
 
Following General Procedure V, 1.23 (8.5 mg, 0.0175 mmol) was dissolved in toluene (0.2 
mL). A stock solution of Cs
+
(1.19)
−
 (0.0263 mmol, 1.5 equiv) and 1,4-difluorobenzene (0.0175 
mmol, 1 equiv) in toluene (0.5 mL) was added. The tube was inserted into a preheated 25 °C 
NMR probe and the reaction progress was monitored via 
19
F NMR spectroscopy; nt = 16, 
sampling every 45 s. rate = 6.30 · 10
-3
 mM/s [AA-14-CV0695] 
 
 
Following General Procedure V, 1.23 (8.5 mg, 0.0175 mmol) was dissolved in toluene (0.2 
mL). A stock solution of Cs
+
(1.19)
−
 (0.0263 mmol, 1.5 equiv) and 1,4-difluorobenzene (0.0175 
45 133.6 5445.5 1.23
90 215.1 5399.7 1.99
135 231.7 5411.0 2.14
180 271.1 5378.6 2.52
225 295.0 5401.2 2.73
270 351.0 5397.2 3.25
315 346.5 5409.8 3.20
360 389.8 5393.0 3.61
405 439.4 5386.7 4.08
450 438.8 5367.7 4.09
495 466.4 5346.6 4.36
540 492.7 5388.5 4.57
time (s)
product 
integral
standard 
integral
[product] 
(μmol/mL)
y = 0.00638x + 1.28121
R² = 0.97571
0.00
1.00
2.00
3.00
4.00
5.00
6.00
0 100 200 300 400 500 600
[product]
(μmol/mL)
time (s)
45 257.3 5642.6 2.28
90 308.5 5596.6 2.76
135 320.3 5578.2 2.87
180 350.0 5554.6 3.15
225 408.2 5581.1 3.66
270 438.6 5562.4 3.94
315 487.2 5561.2 4.38
360 464.9 5533.2 4.20
405 516.7 5556.6 4.65
450 537.1 5572.1 4.82
495 595.2 5585.6 5.33
540 605.4 5567.9 5.44
time (s)
product 
integral
standard 
integral
[product] 
(μmol/mL) y = 0.00630x + 2.11359
R² = 0.98168
0.00
1.00
2.00
3.00
4.00
5.00
6.00
0 100 200 300 400 500 600
[product]
(μmol/mL)
time (s)
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mmol, 1 equiv) in toluene (0.5 mL) was added. The tube was inserted into a preheated 25 °C 
NMR probe and the reaction progress was monitored via 
19
F NMR spectroscopy; nt = 16, 
sampling every 45 s. rate = 6.70 · 10
-3
 mM/s [AA-14-CV0696] 
 
avg. rate = 6.46 · 10
-3
 ± 2.12 · 10
-4 
mM/s 
 
  
45 254.7 5490.0 2.32
90 264.9 5469.0 2.42
135 299.0 5442.5 2.75
180 323.8 5469.4 2.96
225 372.4 5444.6 3.42
270 402.3 5423.0 3.71
315 438.6 5458.0 4.02
360 483.4 5405.9 4.47
405 514.0 5432.3 4.73
450 523.8 5445.3 4.81
495 574.5 5470.1 5.25
540 590.1 5451.3 5.41
time (s)
product 
integral
standard 
integral
[product] 
(μmol/mL) y = 0.00670x + 1.89589
R² = 0.99179
0.00
1.00
2.00
3.00
4.00
5.00
6.00
0 100 200 300 400 500 600
[product]
(μmol/mL)
time (s)
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2 equivalents (Table 1.5, entry 3) 
Following General Procedure V, 1.23 (8.5 mg, 0.0175 mmol) was dissolved in toluene (0.1 
mL). A stock solution of Cs
+
(1.19)
−
 (0.035 mmol, 2 equiv) and 1,4-difluorobenzene (0.0175 
mmol, 1 equiv) in toluene (0.6 mL) was added. The tube was inserted into a preheated 25 °C 
NMR probe and the reaction progress was monitored via 
19
F NMR spectroscopy; nt = 16, 
sampling every 45 s. rate = 9.29 · 10
-3
 mM/s [AA-14-CV0697] 
 
 
Following General Procedure V, 1.23 (8.5 mg, 0.0175 mmol) was dissolved in toluene (0.1 
mL). A stock solution of Cs
+
(1.19)
−
 (0.035 mmol, 2 equiv) and 1,4-difluorobenzene (0.0175 
mmol, 1 equiv) in toluene (0.6 mL) was added. The tube was inserted into a preheated 25 °C 
NMR probe and the reaction progress was monitored via 
19
F NMR spectroscopy; nt = 16, 
sampling every 45 s. rate = 1.03 · 10
-2
 mM/s [AA-14-CV0698] 
 
 
Following General Procedure V, 1.23 (8.5 mg, 0.0175 mmol) was dissolved in toluene (0.1 
mL). A stock solution of Cs
+
(1.19)
−
 (0.035 mmol, 2 equiv) and 1,4-difluorobenzene (0.0175 
45 302.3 5576.7 2.71
90 392.3 5452.6 3.60
135 402.8 5442.1 3.70
180 479.1 5459.9 4.39
225 504.5 5432.7 4.64
270 542.1 5422.8 5.00
315 567.6 5449.6 5.21
360 651.2 5457.5 5.97
405 686.6 5448.7 6.30
time (s)
product 
integral
standard 
integral
[product] 
(μmol/mL)
y = 0.00929x + 2.52105
R² = 0.97919
0.00
1.00
2.00
3.00
4.00
5.00
6.00
7.00
8.00
0 100 200 300 400 500
[product]
(μmol/mL)
time (s)
45 328.7 5516.4 2.98
90 394.7 5445.7 3.62
135 446.5 5452.1 4.10
180 505.0 5451.8 4.63
225 525.9 5457.0 4.82
270 610.0 5452.5 5.59
315 649.6 5374.8 6.04
360 680.3 5403.4 6.29
405 726.9 5390.9 6.74
time (s)
product 
integral
standard 
integral
[product] 
(μmol/mL)
y = 0.0103x + 2.6531
R² = 0.9909
0.00
1.00
2.00
3.00
4.00
5.00
6.00
7.00
8.00
0 100 200 300 400 500
[product]
(μmol/mL)
time (s)
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mmol, 1 equiv) in toluene (0.6 mL) was added. The tube was inserted into a preheated 25 °C 
NMR probe and the reaction progress was monitored via 
19
F NMR spectroscopy; nt = 16, 
sampling every 45 s. rate = 1.08 · 10
-2
 mM/s [AA-14-CV0699] 
 
avg. rate = 1.01 · 10
-2
 ± 7.69 · 10
-4 
mM/s 
 
  
45 327.6 5545.0 2.95
90 419.5 5449.4 3.85
135 462.0 5457.6 4.23
180 504.0 5435.8 4.64
225 573.9 5439.9 5.27
270 608.3 5426.0 5.61
315 662.0 5451.8 6.07
360 717.7 5380.3 6.67
405 760.6 5447.3 6.98
time (s)
product 
integral
standard 
integral
[product] 
(μmol/mL) y = 0.0108x + 2.7068
R² = 0.9911
0.00
1.00
2.00
3.00
4.00
5.00
6.00
7.00
8.00
0 100 200 300 400 500
[product]
(μmol/mL)
time (s)
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3 equivalents (Table 1.5, entry 4) 
Following General Procedure V, 1.23 (8.5 mg, 0.0175 mmol) was dissolved in toluene (0.1 
mL). A stock solution of Cs
+
(1.19)
−
 (0.0525 mmol, 3 equiv) and 1,4-difluorobenzene (0.0175 
mmol, 1 equiv) in toluene (0.6 mL) was added. The tube was inserted into a preheated 25 °C 
NMR probe and the reaction progress was monitored via 
19
F NMR spectroscopy; nt = 16, 
sampling every 45 s. rate = 1.40 · 10
-2
 mM/s [AA-14-CZ8601] 
 
 
Following General Procedure V, 1.23 (8.5 mg, 0.0175 mmol) was dissolved in toluene (0.1 
mL). A stock solution of Cs
+
(1.19)
−
 (0.0525 mmol, 3 equiv) and 1,4-difluorobenzene (0.0175 
mmol, 1 equiv) in toluene (0.6 mL) was added. The tube was inserted into a preheated 25 °C 
NMR probe and the reaction progress was monitored via 
19
F NMR spectroscopy; nt = 8, 
sampling every 30 s. rate = 1.54 · 10
-2
 mM/s [AA-14-CZ8602] 
 
 
Following General Procedure V, 1.23 (8.5 mg, 0.0175 mmol) was dissolved in toluene (0.1 
mL). A stock solution of Cs
+
(1.19)
−
 (0.0525 mmol, 3 equiv) and 1,4-difluorobenzene (0.0175 
45 1033.4 13229.2 3.91
90 1210.3 12968.6 4.67
135 1337.3 12954.6 5.16
180 1511.5 13071.3 5.78
225 1665.9 13010.7 6.40
270 1842.5 13080.9 7.04
315 2031.2 13041.4 7.79
time (s)
product 
integral
standard 
integral
[product] 
(μmol/mL) y = 0.0140x + 3.3013
R² = 0.9979
0.00
1.00
2.00
3.00
4.00
5.00
6.00
7.00
8.00
9.00
0 50 100 150 200 250 300 350
[product]
(μmol/mL)
time (s)
30 441.6 7866.9 2.81
60 467.1 7706.8 3.03
90 575.0 7620.2 3.77
120 619.2 7590.5 4.08
150 665.3 7582.8 4.39
180 778.7 7561.5 5.15
210 827.8 7654.4 5.41
240 895.0 7573.2 5.91
270 970.2 7606.7 6.38
300 1051.7 7576.6 6.94
time (s)
product 
integral
standard 
integral
[product] 
(μmol/mL) y = 0.0154x + 2.2507
R² = 0.9939
0.00
1.00
2.00
3.00
4.00
5.00
6.00
7.00
8.00
0 50 100 150 200 250 300 350
[product]
(μmol/mL)
time (s)
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mmol, 1 equiv) in toluene (0.6 mL) was added. The tube was inserted into a preheated 25 °C 
NMR probe and the reaction progress was monitored via 
19
F NMR spectroscopy; nt = 8, 
sampling every 30 s. rate = 1.41 · 10
-2
 mM/s [AA-14-CZ8603] 
 
avg. rate = 1.45 · 10
-2
 ± 7.81 · 10
-4 
mM/s 
 
  
30 424.6 7804.1 2.72
60 460.9 7703.9 2.99
90 529.7 7578.0 3.49
120 590.1 7604.8 3.88
150 651.6 7564.9 4.31
180 740.0 7576.9 4.88
210 786.5 7593.1 5.18
240 821.4 7549.2 5.44
270 919.8 7551.4 6.09
300 976.1 7530.7 6.48
time (s)
product 
integral
standard 
integral
[product] 
(μmol/mL)
y = 0.0141x + 2.2221
R² = 0.9959
0.00
1.00
2.00
3.00
4.00
5.00
6.00
7.00
8.00
0 50 100 150 200 250 300 350
[product]
(μmol/mL)
time (s)
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5 equivalents (Table 1.5, entry 5) 
Following General Procedure V, 1.23 (8.5 mg, 0.0175 mmol) was dissolved in toluene (0.1 
mL). A stock solution of Cs
+
(1.19)
−
 (0.0875 mmol, 5 equiv) and 1,4-difluorobenzene (0.0175 
mmol, 1 equiv) in toluene (0.6 mL) was added. The tube was inserted into a preheated 25 °C 
NMR probe and the reaction progress was monitored via 
19
F NMR spectroscopy; nt = 8, 
sampling every 30 s. rate = 2.03 · 10
-2
 mM/s [AA-14-CZ8604] 
 
 
Following General Procedure V, 1.23 (8.5 mg, 0.0175 mmol) was dissolved in toluene (0.1 
mL). A stock solution of Cs
+
(1.19)
−
 (0.0875 mmol, 5 equiv) and 1,4-difluorobenzene (0.0175 
mmol, 1 equiv) in toluene (0.6 mL) was added. The tube was inserted into a preheated 25 °C 
NMR probe and the reaction progress was monitored via 
19
F NMR spectroscopy; nt = 8, 
sampling every 30 s. rate = 2.00 · 10
-2
 mM/s [AA-14-CZ8605] 
 
 
Following General Procedure V, 1.23 (8.5 mg, 0.0175 mmol) was dissolved in toluene (0.1 
mL). A stock solution of Cs
+
(1.19)
−
 (0.0875 mmol, 5 equiv) and 1,4-difluorobenzene (0.0175 
30 623.0 7574.0 4.11
60 654.1 7433.0 4.40
90 733.0 7375.4 4.97
120 888.9 7344.1 6.05
150 950.4 7377.7 6.44
180 1013.2 7324.2 6.92
210 1127.1 7374.0 7.64
240 1209.2 7356.0 8.22
time (s)
product 
integral
standard 
integral
[product] 
(μmol/mL) y = 0.0203x + 3.3521
R² = 0.9888
0.00
1.00
2.00
3.00
4.00
5.00
6.00
7.00
8.00
9.00
0 50 100 150 200 250 300
[product]
(μmol/mL)
time (s)
30 496.9 7587.7 3.27
60 550.8 7511.7 3.67
90 629.1 7295.0 4.31
120 752.6 7274.9 5.17
150 804.3 7319.7 5.49
180 920.1 7307.0 6.30
210 1002.0 7332.1 6.83
240 1069.9 7322.2 7.31
time (s)
product 
integral
standard 
integral
[product] 
(μmol/mL)
y = 0.0200x + 2.5980
R² = 0.9940
0.00
1.00
2.00
3.00
4.00
5.00
6.00
7.00
8.00
9.00
0 50 100 150 200 250 300
[product]
(μmol/mL)
time (s)
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mmol, 1 equiv) in toluene (0.6 mL) was added. The tube was inserted into a preheated 25 °C 
NMR probe and the reaction progress was monitored via 
19
F NMR spectroscopy; nt = 8, 
sampling every 30 s. rate = 1.91 · 10
-2
 mM/s [AA-14-CZ8606] 
 
avg. rate = 1.98 · 10
-2
 ± 6.24 · 10
-4 
mM/s 
 
  
30 445.3 7608.6 2.93
60 499.0 7467.8 3.34
90 592.8 7449.7 3.98
120 676.0 7398.8 4.57
150 765.5 7397.4 5.17
180 832.7 7438.7 5.60
210 957.2 7428.2 6.44
240 1000.3 7344.0 6.81
time (s)
product 
integral
standard 
integral
[product] 
(μmol/mL)
y = 0.0191x + 2.2752
R² = 0.9961
0.00
1.00
2.00
3.00
4.00
5.00
6.00
7.00
8.00
9.00
0 50 100 150 200 250 300
[product]
(μmol/mL)
time (s)
249 
 
7.5 equivalents (Table 1.5, entry 6) 
Following General Procedure V, 1.23 (8.5 mg, 0.0175 mmol) was dissolved in toluene (0.1 
mL). A stock solution of Cs
+
(1.19)
−
 (0.131 mmol, 7 equiv) and 1,4-difluorobenzene (0.035 
mmol, 2 equiv) in toluene (0.6 mL) was added. The tube was inserted into a preheated 25 °C 
NMR probe and the reaction progress was monitored via 
19
F NMR spectroscopy; nt = 8, 
sampling every 30 s. rate = 1.92 · 10
-2
 mM/s [AA-14-CZ8607] 
 
 
Following General Procedure V, 1.23 (8.5 mg, 0.0175 mmol) was dissolved in toluene (0.1 
mL). A stock solution of Cs
+
(1.19)
−
 (0.131 mmol, 7 equiv) and 1,4-difluorobenzene (0.035 
mmol, 2 equiv) in toluene (0.6 mL) was added. The tube was inserted into a preheated 25 °C 
NMR probe and the reaction progress was monitored via 
19
F NMR spectroscopy; nt = 8, 
sampling every 30 s. rate = 2.06 · 10
-2
 mM/s [AA-14-CZ8608] 
 
avg. rate = 1.99 · 10
-2
 ± 9.90 · 10
-4 
mM/s 
  
30 559.3 15283.0 3.66
60 683.9 15208.7 4.50
90 773.6 15084.2 5.13
120 818.2 14867.6 5.50
150 897.3 14950.9 6.00
180 979.0 14933.0 6.56
210 1103.2 14986.0 7.36
time (s)
product 
integral
standard 
integral
[product] 
(μmol/mL) y = 0.0192x + 3.2301
R² = 0.9890
0.00
1.00
2.00
3.00
4.00
5.00
6.00
7.00
8.00
0 50 100 150 200 250
[product]
(μmol/mL)
time (s)
30 380.6 12445.8 3.06
60 478.4 12374.0 3.87
90 493.9 12358.5 4.00
120 554.9 12368.0 4.49
150 680.7 12384.7 5.50
180 760.3 12372.1 6.15
210 847.7 12442.2 6.81
time (s)
product 
integral
standard 
integral
[product] 
(μmol/mL)
y = 0.0206x + 2.3626
R² = 0.9754
0.00
1.00
2.00
3.00
4.00
5.00
6.00
7.00
8.00
0 50 100 150 200 250
[product]
(μmol/mL)
time (s)
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5.4. EXPERIMENTS FOR CHAPTER 2 
Ethynyl(isopropoxy)dimethylsilane (2.22) [AA-02-084] 
 
In a 250-mL, 3-neck, round-bottom flask (equipped with an addition funnel, an Ar inlet and a 
septum), a solution of 2.21 (3.3 mL, 20 mmol) in THF (10 mL) at 0 °C  was treated with 0.5 M 
ethynylmagnesium bromide in THF (40 mL, 20 mmol, 1 equiv) by dropwise addition via 
addition funnel over 20 min. The reaction mixture was warmed to room temperature and stirred 
for 2 h. The white precipitate was removed by filtration through a pad of celite and the pad was 
washed with Et2O (40 mL). The solvent was removed under reduced pressure and the residual 
liquid was purified by short-path distillation (bp = 83-87 °C, 760 mmHg) to afford 2.22 (1.31 g, 
46%) as a colorless liquid. The experimental data matched those from the literature.
31
 
 
Ethynyldimethyl(2,4,6-trimethoxyphenyl)silane (2.24) [AA-03-028/29] 
 
In a 250-mL, 3-neck, round-bottom flask (equipped with an addition funnel, an Ar inlet and a 
septum), TMEDA (7.7 mL, 51.5 mmol, 1.03 equiv) was added to a suspension of 2,4,6-
trimethoxybenzene (8.4 g, 50 mmol) in hexane (20 mL) at room temperature. A 2.3 M solution 
of BuLi in hexane (22.9 mL, 52.5 mmol, 1.05 equiv) was added via addition funnel over 10 min 
and the mixture stirred for 20 h. The resulting suspension was cannulated into a solution of 
dichlorodimethylsilane (6.1 mL, 50 mmol, 1 equiv) in hexane (25 mL) at room temperature. The 
original flask was rinsed with THF (2 × 5 mL) and the resulting mixture was stirred for 2 h. The 
white precipitate was removed by vacuum filtration through a medium glass frit and the solvent 
removed under reduced pressure. TMEDA was removed under high vacuum over 20 h. The 
resulting chlorosilane was used in the next step without further purification. 
In a 500-mL, 3-neck, round-bottom flask (equipped with an addition funnel, an Ar inlet and a 
septum), a solution of the intermediate chlorosilane in THF (125 mL) at room temperature was 
251 
 
treated with 0.5 M ethynylmagnesium bromide in THF (115 mL, 57.5 mmol, 1.15 equiv) by 
dropwise addition via addition funnel over 30 min. The mixture was stirred for 4 h, then 
quenched with water (50 mL) and diluted with Et2O (50 mL). The layers were separated and the 
aqueous layer was washed with Et2O (2 × 50 mL). The combined organic extracts were washed 
with brine (30 mL), dried (Na2SO4) and filtered. The solvent was then removed under reduced 
pressure. The residual yellow oil was dissolved in hexane (200 mL) and heated to reflux for 5 
min after adding activated carbon. The suspension was filtered through a pad of celite, which 
was washed with hexane (100 mL). The resulting clear solution was concentrated to ca. 100 mL 
under reduced pressure and refrigerated (‒18 °C) for 48 h. The resulting white solid was 
collected by vacuum filtration. A second and a third crop were obtained from the mother liquor 
after refrigeration for additional 24 h. The combined crops afforded 7.10 g of 2.24 (57%). 
Data for 2.24: 
 
1
H NMR: (500 MHz, CDCl3) 
δ 6.08 (s, 2H, C(6)H), 3.82 (s, 3H, C(9)H3), 3.77 (s, 6H, C(8)H3), 2.38 (s, 1H, 
C(1)H), 0.46 (s, 6H, C(3)H3) 
 
13
C NMR: (126 MHz, CDCl3) 
δ 166.45 (C5), 163.83 (C7), 102.16 (C4), 91.31 (C2), 91.08 (C1), 90.77 (C6), 
55.30 (C8), 55.21 (C7), 1.46 (C3) 
 TLC: Rf 0.50 (hexane/EtOAc 8:2) 
 
4-(dimethyl(2,4,6-trimethoxyphenyl)silyl)-2-phenylbut-3-yn-2-ol (2.25) [AA-03-054] 
 
In a 50-mL Schlenk flask, dry CeCl3 (1.15 g, 4.67 mmol, 1 equiv) and THF (7.8 mL) were 
combined and stirred overnight at room temperature, then cooled to  ‒78 °C. In a separate 25-mL 
Schlenk flask, a solution of 2.24 (1.17 g, 4.67 mmol) in THF (5 mL) at ‒78 °C was treated with  
2.4 M BuLi in hexane (1.95 mL, 4.67 mmol, 1 equiv) via syringe. After stirring for 30 min at     
‒78 °C, the resulting suspension was cannula-transferred into the suspension of CeCl3 in THF. 
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The mixture was stirred for 30 min at ‒78 °C, then acetophenone (0.55 mL, 4.67 mmol, 1 equiv) 
was added dropwise. The resulting reaction mixture was stirred for 30 min, then warmed to room 
temperature and quenched with saturated aqueous NH4Cl (10 mL). The layers were separated 
and the aqueous layer was washed with Et2O (2 × 10 mL). The combined organic extracts were 
washed with brine (10 mL), dried (Na2SO4), filtered and the solvent removed under reduced 
pressure. The residual oil was purified by silica gel column chromatography (hexane/EtOAc 
85:15) to afford 2.25 (1.40 g, 81%) as a colorless oil. 
Data for 2.25: 
 1
H NMR: (500 MHz, CDCl3) 
δ 7.69 (d, J = 9.0 Hz, 2H, C(13)H), 7.33 (t, J = 7.5 Hz, 2H, C(14)H), 7.27 (t, J = 
7.5 Hz, 1H, C(15)H), 6.08 (s, 2H, C(8)H), 3.82 (s, 3H, C(11)H3), 3.74 (s, 6H, 
C(10)H3), 2.31 (s, 1H, OH), 1.75 (s, 3H, C(1)H3), 0.50 – 0.40 (m, 6H, C(5)H3) 
 
13
C NMR: (126 MHz, CDCl3) 
δ 166.36 (C7), 163.65 (C9), 145.92 (C12), 128.02 (C14), 127.39 (C15), 125.12 
(C13), 106.81 (C6), 102.57 (C3), 90.71 (C4), 90.57 (C8), 70.17 (C2), 55.24 
(C10), 55.16 (C11), 33.38 (C1), 1.51 (C5) 
 TLC: Rf 0.25 (hexane/EtOAc 8:2) 
 
Dimethyl(3-phenylbuta-1,2-dien-1-yl)(2,4,6-trimethoxyphenyl)silane (2.26) [AA-03-033] 
 
In a 10-mL, 2-neck, round-bottom flask (equipped with an Ar inlet and a septum), a solution 
of 2.25 (150 mg, 0.405 mmol) in toluene (2 mL) at 0 °C was treated with 1.81 M EtMgCl in 
Et2O (0.22 mL, 0.405 mmol, 1 equiv) and stirred for 10 min. The mixture was warmed to room 
temperature and stirred for additional 10 min. The Schwartz’s reagent (157 mg, 0.608 mmol, 1.5 
equiv) was quickly added in one portion and the resulting suspension stirred at room temperature 
for 20 h. The reaction was quenched with saturated aqueous NaHCO3 (2 mL). The layers were 
separated and the aqueous layer was washed with Et2O (2 × 5 mL). The combined organic 
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extracts were washed with brine (5 mL), dried (Na2SO4), filtered and the solvent removed under 
reduced pressure. The residue was purified by silica gel column chromatography (hexane/EtOAc 
9:1) to afford 2.26 (104 mg, 72%) as a yellow oil. 
Data for 2.26: 
 1
H NMR: (500 MHz, CDCl3) 
δ 7.37 (d, J = 7.9 Hz, 2H, C(13)H), 7.28 (t, J = 7.7 Hz, 2H, C(14)H), 7.13 (t, J = 
7.3 Hz, 1H, C(15)H), 6.10 (s, 2H, C(8)H), 5.64 (q, J = 3.5 Hz, 1H, C(4)H), 3.84 
(s, 3H, C(11)H3), 3.75 (s, 3H, C(10)H3), 2.06 (d, J = 3.6 Hz, 3H, C(1)H3), 0.39 
(s, 1H, 3H, C(5)H3), 0.39 (s, 1H, 3H, C(5’)H3) 
 
13
C NMR: (126 MHz, CDCl3) 
δ 209.63 (C3), 166.30 (C7), 163.44 (C9), 138.18 (C12), 128.09 (C13), 125.27 
(C15), 125.01 (C14), 104.06 (C6), 93.51 (C2), 90.38 (C8), 86.80 (C4), 55.16 
(C10), 55.14 (C11), 16.04 (C1), 0.57 (C5) 
 TLC: Rf 0.46 (hexane/EtOAc 8:2) 
 
Dimethyl(3-phenylbuta-1,2-dien-1-yl)silanol (2.20) [AA-03-056] 
 
In a 25-mL, 2-neck, round-bottom flask (equipped with an Ar inlet and a septum), 2.06 M 
HCl in Et2O (0.72 mL, 1.58 mmol, 1 equiv) was added dropwise to a solution of 2.26 (560 mg, 
1.58 mmol) in THF (8 mL) at 0 °C. The mixture was stirred at 0 °C for 40 min, then transferred 
via cannula into a mixture of pH = 5, 1 M aqueous acetate buffer (20 mL) and CH3CN (10 mL) 
at 0 °C, and stirred for 5 min. After diluting with Et2O (20 mL), the layers were separated and the 
aqueous layer was washed with Et2O (2 × 10 mL). The combined organic extracts were washed 
with saturated aqueous NaHCO3 (20 mL), dried (Na2SO4), filtered and the solvent removed 
under reduced pressure. The residue was purified by silica gel chromatography on a 
Chromatotron apparatus (hexane/EtOAc 9:1) to afford 2.20 (255 mg, 79%) as a colorless oil. 
Data for 2.20: 
 1
H NMR: (500 MHz, C6D6) 
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δ 7.40 (d, J = 7.6 Hz, 2H, C(7)H), 7.20 (t, J = 7.8 Hz, 2H, C(8)H), 7.04 (t, J = 7.4 
Hz, 1H, C(9)H), 5.35 (q, J = 3.6 Hz, 1H, C(4)H), 2.10 (br s, 1H, OH), 1.96 (d, J 
= 3.7 Hz, 3H, C(1)H3), 0.20 (s, 1H, 3H, C(5)H3), 0.20 (s, 1H, 3H, C(5’)H3) 
 
13
C NMR: (126 MHz, C6D6) 
δ 211.90 (C3), 137.44 (C6), 128.70 (C8), 126.29 (C9), 125.55 (C7), 94.72 (C2), 
85.85 (C4) 16.03 (C1), 0.60 (C5), 0.55 (C5’) 
 TLC: Rf 0.17 (hexane/EtOAc 9:1) 
 
Diethyl(ethynyl)(2,4,6-trimethoxyphenyl)silane (2.28) [AA-03-059/060] 
 
In a 100-mL, 3-neck, round-bottom flask (equipped with an addition funnel, an Ar inlet and a 
septum), TMEDA (3.9 mL, 25.8 mmol, 1.03 equiv) was added to a suspension of 2,4,6-
trimethoxybenzene (4.2 g, 25 mmol) in hexane (10 mL) at room temperature. A 2.38 M solution 
of BuLi in hexane (11.0 mL, 26.3 mmol, 1.05 equiv) was added via addition funnel over 10 min 
and the mixture stirred for 20 h. The resulting suspension was cannulated into a solution of 
dichlorodiethylsilane (3.7 mL, 25 mmol, 1 equiv) in hexane (13 mL) at room temperature. The 
original flask was rinsed with hexane (2 × 5 mL) and the resulting mixture was stirred for 2 h. 
The white precipitate was removed by vacuum filtration through a medium glass frit and the 
solvent removed under reduced pressure. TMEDA was removed under high vacuum over 18 h. 
The resulting chlorosilane was used in the next step without further purification. 
In a 250-mL, 3-neck, round-bottom flask (equipped with an addition funnel, an Ar inlet and a 
septum), a solution of the intermediate chlorosilane in THF (60 mL) at room temperature was 
treated with 0.5 M ethynylmagnesium bromide in THF (58 mL, 28.8 mmol, 1.15 equiv) by 
dropwise addition via addition funnel over 30 min. The mixture was stirred for 4 h, then 
quenched with water (25 mL) and diluted with Et2O (25 mL). The layers were separated and the 
aqueous layer was washed with Et2O (2 × 25 mL). The combined organic extracts were washed 
with brine (20 mL), dried (Na2SO4) and filtered. The solvent was then removed under reduced 
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pressure. The residual yellow oil was dissolved in hexane (100 mL) and heated to reflux for 5 
min after adding activated carbon. The suspension was filtered through a pad of celite, which 
was washed with hexane (50 mL). The resulting clear solution was concentrated and the residue 
was purified by silica gel column chromatography (hexane/DCM 1:1) to afford 2.28 (2.30 g, 
33%) as a colorless oil. 
Data for 2.28: 
 1
H NMR: (500 MHz, CDCl3) 
δ 1H NMR (499 MHz, CDCl3) δ 6.09 (s, 2H, C(7)H), 3.82 (s, 3H, C(10)H3), 3.76 
(s, 6H, C(9)H3), 2.39 (s, 1H, C(1)H), 1.03 (t, J = 7.5 Hz, 6H, C(4)H3), 0.99 – 
0.83 (m, 4H, C(3)H2) 
 
13
C NMR: (126 MHz, CDCl3) 
δ 166.64 (C6), 163.73 (C8), 100.77 (C5), 91.78 (C1), 90.69 (C7), 89.44 (C2), 
55.20 (C9), 55.15 (C10), 7.60 (C4), 6.85 (C3) 
 TLC: Rf 0.36 (hexane/DCM 1:1) 
 
 
(3,5-dimethoxyphenyl)diethyl(ethynyl)silane (2.31) [AA-03-063/064] 
 
In a 100-mL, 3-neck, round-bottom flask (equipped with an addition funnel, an Ar inlet and a 
septum), a solution of 1-bromo-3,5-dimethoxybenzene (4.34 g, 20 mmol) in THF (30 mL) at ‒78 
°C was treated with 2.38 M BuLi in hexane (8.8 mL, 21 mmol, 1.05 equiv) and stirred for 30 
min. The resulting suspension was cannulated into a solution of dichlorodiethylsilane (3.0 mL, 
20 mmol, 1 equiv) in hexane (10 mL) at ‒78 °C. The original flask was rinsed with THF (2 × 5 
mL). The resulting mixture was warmed to room temperature and stirred for 4 h. The solvent was 
removed under reduced pressure and the residual dichlorodiethylsilane was removed under high 
vacuum overnight. The resulting chlorosilane was used in the next step without further 
purification. 
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In a 250-mL, 3-neck, round-bottom flask (equipped with an addition funnel, an Ar inlet and a 
septum), a solution of the intermediate chlorosilane in THF (50 mL) at room temperature was 
treated with 0.5 M ethynylmagnesium bromide in THF (48 mL, 24 mmol, 1.2 equiv) by 
dropwise addition via addition funnel over 30 min. The mixture was stirred for 5 h, then 
quenched with water (20 mL). The layers were separated and the aqueous layer was washed with 
Et2O (2 × 30 mL). The combined organic extracts were washed with brine (20 mL), dried 
(Na2SO4) and filtered. The solvent was then removed under reduced pressure. The residual 
yellow oil was dissolved in hexane (70 mL) and heated to reflux for 5 min after adding activated 
carbon. The suspension was filtered through a pad of celite, which was washed with hexane (50 
mL). The resulting clear solution was concentrated and the residue was purified by silica gel 
column chromatography (hexane/DCM 7:3) to afford 2.31 (2.88 g, 58%) as a colorless oil. 
Data for 2.31: 
 1
H NMR: (500 MHz, CDCl3) 
δ 6.76 (d, J = 2.3 Hz, 2H, C(6)H), 6.49 (t, J = 2.3 Hz, 1H, C(8)H), 3.81 (s, 6H, 
C(9)H3), 2.52 (s, 1H, C(1)H), 1.04 (t, J = 7.8 Hz, 6H, C(4)H3), 0.93 – 0.77 (m, 
4H, C(3)H2) 
 
13
C NMR: (126 MHz, CDCl3) 
δ 160.42 (C7), 136.54 (C5), 111.74 (C6), 101.36 (C8), 95.66 (C1), 85.97 (C2), 
55.22 (C9), 7.25 (C4), 5.28 (C3) 
 TLC: Rf 0.67 (hexane/DCM 1:1) 
 
4-((3,5-dimethoxyphenyl)diethylsilyl)-2-phenylbut-3-yn-2-ol (2.32) [AA-03-065]
 
  
In a 25-mL Schlenk flask, dry CeCl3 (488 mg, 1.98 mmol, 1 equiv) and THF (3.3 mL) were 
combined and stirred for 2 h at room temperature, then cooled to  ‒78 °C. In a separate 10-mL 
Schlenk flask, a solution of 2.31 (490 mg, 1.98 mmol) in THF (2.2 mL) at ‒78 °C was treated 
with  2.38 M BuLi in hexane (0.83 mL, 1.98 mmol, 1 equiv) via syringe. After stirring for 30 
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min at ‒78 °C, the resulting suspension was cannulated into the suspension of CeCl3 in THF. The 
mixture was stirred for 30 min at ‒78 °C, then acetophenone (0.23 mL, 1.98 mmol, 1 equiv) was 
added dropwise. The resulting reaction mixture was stirred for 30 min, then warmed to room 
temperature and quenched with saturated aqueous NH4Cl (5 mL). The layers were separated and 
the aqueous layer was washed with Et2O (2 × 10 mL). The combined organic extracts were 
washed with brine (10 mL), dried (Na2SO4), filtered and the solvent removed under reduced 
pressure. The residual oil was purified by silica gel column chromatography (hexane/EtOAc 9:1) 
to afford 2.32 (660 mg, 90%) as a colorless oil. 
Data for 2.32: 
 1
H NMR: (500 MHz, CDCl3) 
δ 7.71 (d, J = 7.1 Hz, 2H, C(13)H), 7.37 (t, J = 7.4 Hz, 2H, C(14)H), 7.30 (t, J = 
7.3 Hz, 1H, C(15)H), 6.77 (d, J = 2.3 Hz, 2H, C(8)H), 6.49 (t, J = 2.3 Hz, 1H, 
C(10)H), 3.78 (s, 6H, C(11)H3), 2.41 (s, 1H, OH), 1.83 (s, 3H, C(1)H3), 1.15 – 
0.97 (m, 6H, C(6)H3), 0.98 – 0.78 (m, 4H, C(5)H2) 
 
13
C NMR: (126 MHz, CDCl3) 
δ 160.37 (C9), 145.30 (C12), 137.09 (C7), 128.25 (C14), 127.69 (C15), 124.92 
(C13), 111.73 (C8), 101.46 (C10), 85.33 (C4), 70.33 (C2), 55.18 (C11), 33.44 
(C1), 7.47 (C6), 5.49 (C5) 
 TLC: Rf 0.17 (hexane/EtOAc 9:1) 
 
(3,5-dimethoxyphenyl)diethyl(3-phenylbuta-1,2-dien-1-yl)silane (53) [AA-03-066] 
 
In a 25-mL Schlenk flask, a solution of 2.32 (400 mg, 1.09 mmol) in toluene (5.5 mL) at ‒20 
°C was treated with 1.70 M EtMgCl in Et2O (0.63 mL, 1.09 mmol, 1 equiv) and stirred for 20 
min. The Schwartz’s reagent (420 mg, 1.63 mmol, 1.5 equiv) was quickly added in one portion 
and the resulting suspension stirred at ‒20 °C for 10 min, then warmed to room temperature and 
stirred for 16 h. The reaction was quenched with saturated aqueous NaHCO3 (5 mL). The layers 
were separated and the aqueous layer was washed with Et2O (3 × 10 mL). The combined organic 
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extracts were washed with brine (10 mL), dried (Na2SO4), filtered and the solvent removed under 
reduced pressure. The residue was purified by silica gel column chromatography (pentane/Et2O 
95:5) to afford 2.33 (270 mg, 70%) as a yellow oil. 
Data for 2.33: 
 1
H NMR: (500 MHz, CDCl3) 
δ 7.39 (d, J = 7.9 Hz, 2H, C(13)H), 7.32 (t, J = 7.8 Hz, 2H, C(14)H), 7.17 (t, J = 
7.3 Hz, 1H, C(15)H), 6.72 (d, J = 2.3 Hz, 2H, C(8)H), 6.49 (t, J = 2.3 Hz, 1H, 
C(10)H), 5.48 (q, J = 3.6 Hz, 1H, C(4)H), 3.78 (s, 6H, C(11)H3), 2.10 (d, J = 3.7 
Hz, 3H, C(1)H3), 1.09 – 0.96 (m, 6H, C(6)H3), 0.96 – 0.80 (m, 4H, C(5)H2). 
 
13
C NMR: (126 MHz, CDCl3) 
δ 222.10 (C3), 160.37 (C9), 138.75 (C12), 137.25 (C7), 128.28 (C14), 125.78 
(C15), 125.17 (C13), 111.72 (C8), 101.15 (C10), 93.78 (C2), 81.11 (C4), 55.17 
(C11), 16.10 (C1), 7.34 (C6), 4.66 (C5), 4.61 (C5’) 
 TLC: Rf 0.43 (hexane/EtOAc 9:1) 
 
(2,4-dimethoxyphenyl)diethyl(ethynyl)silane (2.34) [AA-03-071/072] 
 
In a 250-mL, 3-neck, round-bottom flask (equipped with an addition funnel, an Ar inlet and a 
septum), a solution of 1-bromo-2,4-dimethoxybenzene (2.2 mL, 15 mmol) in THF (22.5 mL) at ‒
78 °C was treated with 1.57 M t-BuLi in pentane (20 mL, 31.5 mmol, 2.1 equiv) and stirred for 
30 min. The resulting suspension was cannulated into a solution of dichlorodiethylsilane (3.4 
mL, 22.5 mmol, 1.5 equiv) in hexane (7.5 mL) at ‒78 °C. The original flask was rinsed with 
THF (2 × 5 mL). The mixture was warmed to room temperature and stirred for 2 h. The resulting 
suspension was filtered on a glass frit and the solvent was removed under reduced pressure. The 
residual dichlorodiethylsilane was removed under high vacuum over 4 h. The resulting 
chlorosilane was used in the next step without further purification. 
In a 250-mL, 3-neck, round-bottom flask (equipped with an addition funnel, an Ar inlet and a 
septum), a solution of the intermediate chlorosilane in THF (38 mL) at room temperature was 
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treated with 0.5 M ethynylmagnesium bromide in THF (36 mL, 18 mmol, 1.2 equiv) by 
dropwise addition via addition funnel over 30 min. The mixture was stirred for 4 h, then 
quenched with water (20 mL). The layers were separated and the aqueous layer was washed with 
Et2O (2 × 30 mL). The combined organic extracts were washed with brine (20 mL), dried 
(Na2SO4) and filtered. The solvent was then removed under reduced pressure. The residual 
yellow oil was dissolved in hexane (50 mL) and heated to reflux for 5 min after adding activated 
carbon. The suspension was filtered through a pad of celite, which was washed with hexane (50 
mL). The resulting clear solution was concentrated and the residue was purified by silica gel 
column chromatography (hexane/DCM 7:3) to afford 2.34 (1.73 g, 47%) as a colorless oil. 
Data for 2.34: 
 1
H NMR: (500 MHz, CDCl3) 
δ 7.64 (d, J = 8.1 Hz, 1H, C(10)H), 6.53 (dd, J = 8.1, 2.2 Hz, 1H, C(9)H), 6.40 
(d, J = 2.1 Hz, 1H, C(7)H), 3.82 (s, 3H, C(11or 12)H3), 3.77 (s, 3H, C(11or 
12)H3), 2.52 (s, 1H, C(1)H), 0.99 (t, J = 7.7 Hz, 6H, C(4)H3), 0.88 – 0.84 (m, 4H, 
C(3)H2) 
 
13
C NMR: (126 MHz, CDCl3) 
δ 165.60 (C6 or C8), 162.92 (C6 or C8), 138.06 (C10), 113.31 (C5), 104.68 
(C9), 97.50 (C7), 95.01 (C1), 87.48 (C2), 55.20 (C11 or C12), 55.00 (C11 or 
C12), 7.58 (C4), 5.68 (C3) 
 TLC: Rf 0.61 (hexane/DCM 1:1) 
 
4-((2,4-dimethoxyphenyl)diethylsilyl)-2-phenylbut-3-yn-2-ol (2.35) [AA-03-074]
 
  
In a 50-mL Schlenk flask, dry CeCl3 (986 mg, 4.0 mmol, 1 equiv) and THF (6.6 mL) were 
combined and stirred for 2 h at room temperature, then cooled to  ‒78 °C. In a separate 25-mL 
Schlenk flask, a solution of 2.34 (993 mg, 4.0 mmol) in THF (4.4 mL) at ‒78 °C was treated 
with  2.38 M BuLi in hexane (1.7 mL, 4.0 mmol, 1 equiv) via syringe. After stirring for 30 min 
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at ‒78 °C, the resulting suspension was cannulated into the suspension of CeCl3 in THF. The 
mixture was stirred for 30 min at ‒78 °C, then acetophenone (0.47 mL, 4.0 mmol, 1 equiv) was 
added dropwise. The resulting reaction mixture was stirred for 30 min, then warmed to room 
temperature and quenched with saturated aqueous NH4Cl (5 mL). The layers were separated and 
the aqueous layer was washed with Et2O (2 × 20 mL). The combined organic extracts were 
washed with brine (20 mL), dried (Na2SO4), filtered and the solvent removed under reduced 
pressure. The residual oil was purified by silica gel column chromatography (pentane/Et2O 
85:15) to afford 2.35 (956 mg, 65%) as a colorless oil. 
Data for 2.35: 
 1
H NMR: (500 MHz, CDCl3) 
δ 7.74 (d, J = 7.7 Hz, 2H, C(16)H), 7.62 (d, J = 8.1 Hz, 1H, C(12)H), 7.38 (t, J = 
7.6 Hz, 2H, C(17)H), 7.31 (t, J = 7.3 Hz, 1H, C(18)H), 6.52 (dd, J = 8.1, 2.0 Hz, 
1H, C(11)H), 6.40 (d, J = 2.0 Hz, 1H, C(9)H), 3.82 (s, 3H, C(13 or 14)H3), 3.77 
(s, 3H, C(13 or 14)H3), 2.40 (br s, 1H, OH), 1.84 (s, 3H, C(1)H3), 1.00 (t, J = 7.7 
Hz, 6H, C(6)H3), 0.95 – 0.82 (m, 4H, C(5)H2) 
 
13
C NMR: (126 MHz, CDCl3) 
δ 165.57 (C8 or C10), 162.79 (C8 or C10), 145.57 (C15), 138.01 (C12), 128.17 
(C17), 127.56 (C18), 125.01 (C16), 113.80 (C7), 111.08 (C3), 104.60 (C11), 
97.23 (C9), 86.77 (C4), 70.35 (C2), 55.15 (C13 or C14), 54.94 (C13 or C14), 
33.54 (C1), 7.78 (C6), 5.82 (C5) 
 TLC: Rf 0.23 (pentane/Et2O 8:2) 
 
(2,4-dimethoxyphenyl)diethyl(3-phenylbuta-1,2-dien-1-yl)silane (2.36) [AA-03-076, AA-04-
022/023] 
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In a 5-mL Schlenk flask, a solution of 2.35 (40 mg, 0.109 mmol) in toluene (0.55 mL) at 0 
°C was treated with 1.70 M EtMgCl in Et2O (64 μL, 0.109 mmol, 1 equiv) and stirred for 15 
min. The Schwartz’s reagent (112 mg, 0.436 mmol, 4 equiv) was quickly added in one portion 
and the resulting suspension was warmed to room temperature and stirred for 4 h. The reaction 
was quenched with saturated aqueous NaHCO3 (1 mL). The layers were separated and the 
aqueous layer was washed with Et2O (2 × 5 mL). The combined organic extracts were washed 
with brine (5 mL), dried (Na2SO4), filtered and the solvent removed under reduced pressure. The 
residue was purified by silica gel column chromatography (pentane/Et2O 95:5) to afford 56 (13 
mg, 34%) as a yellow oil. 
Alternatively, in a 100-mL Schlenk flask, a solution of 2.45 and 2.46 (1.43 g, 4.86 mmol, 
actual 4.26 mmol of 2.45 based on NMR integration) in DCM (30 mL) at ‒78 °C was treated 
with Et3N (0.92 mL, 6.60 mmol, 1.35 equiv) and MsCl (0.47 mL, 6.11 mmol, 1.25 equiv) and 
stirred for 30 min. The mixture was then warmed to room temperature and quenched with 
saturated aqueous NaHCO3 (10 mL). The layers were separated and the aqueous layer was 
washed with Et2O (2 × 30 mL). The combined organic extracts were washed with brine (20 mL), 
dried (Na2SO4), filtered and the solvent removed under reduced pressure. The resulting mesylate 
2.47 was used in the next step without further purification. 
In a 100-mL Schlenk flask, a solution of the intermediate mesylate in Et2O (32 mL) at ‒78 
°C was treated with a freshly prepared 1 M solution of CuBr2PBu3 in Et2O (0.73 mL, 0.73 
mmol, 0.15 equiv). A 2.78 M solution of PhMgBr in Et2O (4.4 mL, 12.2 mmol, 2.5 equiv) was 
then added and the mixture warmed to 0 °C. The resulting yellow suspension was quenched by 
the addition of saturated aqueous NH4Cl (15 mL). The layers were separated and the aqueous 
layer was washed with Et2O (2 × 20 mL). The combined organic extracts were washed with 
brine (20 mL), dried (Na2SO4), filtered and the solvent removed under reduced pressure. The 
residual oil was purified by silica gel column chromatography (pentane/DCM 8:2) to afford 2.36 
(1.03 g, 69% based on the actual amount of 2.45) as a colorless oil. 
Data for 2.36: 
 1
H NMR: (500 MHz, CDCl3) 
δ 7.40 (d, J = 8.0 Hz, 1H, C(12)H), 7.37 (d, J = 7.4 Hz, 2H, C(16)H), 7.29 (t, J = 
7.8 Hz, 2H, C(17)H), 7.14 (t, J = 7.3 Hz, 1H, C(18)H), 6.52 (dd, J = 8.1, 2.2 Hz, 
1H, C(11)H), 6.42 (d, J = 2.1 Hz, 1H, C(9)H), 5.51 (q, J = 3.6 Hz, 1H, C(4)H), 
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3.83 (s, 3H, C(13 or 14)H3), 3.76 (s, 3H, C(13 or 14)H3), 2.07 (d, J = 3.7 Hz, 3H, 
C(1)H3), 1.01 – 0.93 (m, 6H, C(6)H3), 0.93 – 0.83 (m, 4H, C(5)H2) 
 
13
C NMR: (126 MHz, CDCl3) 
δ 165.84 (C8 or C10), 162.62 (C8 or C10), 137.75 (C15), 137.00 (C12), 128.17 
(C17), 125.48 (C18), 125.14 (C16), 115.48 (C7), 104.45 (C11), 97.62 (C9), 
93.24 (C2), 82.13 (C4), 55.21 (C13 or C14), 54.94 (C13 or C14), 16.10 (C1), 
7.58 (C6), 7.52 (C6’), 4.90 (C5), 4.78 (C5’) 
 TLC: Rf 0.31 (pentane/DCM 8:2) 
 
(2-cyclohexylidenevinyl)diethylsilanol (2.39) [AA-03-090] 
 
In a 5-mL Schlenk flask, a solution of 2.38 (127 mg, 0.542 mmol) in Et2O (1.4 mL) at ‒78 
°C was treated with 1.53 M t-BuLi in pentane (0.75 mL, 1.14 mmol, 2.1 equiv) by dropwise 
addition and stirred for 1 h. The solution was then cannulated into a solution of 
dichlorodiethylsilane (0.24 mL, 1.63 mmol, 3 equiv) in Et2O (4.0 mL) at ‒78 °C. The original 
flask was rinsed with Et2O (1 mL). The mixture was stirred at ‒78 °C for 15 min, then warmed to 
room temperature, cannulated into a mixture of pH = 5, 1 M aqueous acetate buffer (5 mL) and 
CH3CN (2.5 mL) at 0 °C, and stirred for 5 min. After diluting with Et2O (10 mL), the layers were 
separated and the aqueous layer was washed with Et2O (2 × 10 mL). The combined organic 
extracts were washed with saturated aqueous NaHCO3 (10 mL), dried (Na2SO4), filtered and the 
solvent removed under reduced pressure. The residue was purified by silica gel column 
chromatography (pentane/Et2O 9:1) to afford 2.39 (71 mg, 62%) as a colorless oil. 
Data for 2.39: 
 1
H NMR: (500 MHz, CDCl3) 
δ 4.86 – 4.79 (m, 1H, C(1)H), 2.22 – 2.02 (m, 4H, C(4)H2), 1.66 (br s, 1H, OH), 
1.64 – 1.37 (m, 6H, C(5)H2 and C(6)H2), 0.98 (t, J = 7.9 Hz, 6H, C(8)H3), 0.77 – 
0.57 (m, 4H, C(7)H2) 
 
13
C NMR: (126 MHz, CDCl3) 
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δ 222.14 (C2), 95.19 (C3), 77.93 (C1), 30.57 (C4), 27.23 (C5), 26.12 (C6), 6.64 
(C8), 6.49 (C7) 
 TLC: Rf 0.23 (pentane/Et2O 9:1) 
 
Chloro(2,4-dimethoxyphenyl)diethylsilane (2.43) [AA-04-040] 
 
In a 250-mL, 3-neck, round-bottom flask (equipped with an addition funnel, an Ar inlet and a 
septum), a solution of 1-bromo-2,4-dimethoxybenzene (4.32 mL, 30 mmol) in hexane (30 mL) at 
‒78 °C was treated with 1.51 M t-BuLi in pentane (42 mL, 63 mmol, 2.1 equiv) and stirred for 
30 min. TMEDA (4.72 mL, 31.5 mmol, 1.05 equiv) was slowly added and the resulting 
suspension was cannulated into a solution of dichlorodiethylsilane (6.73 mL, 45 mmol, 1.5 
equiv) in hexane (22.5 mL) at ‒78 °C. The original flask was rinsed with hexane (3 × 10 mL). 
The mixture was warmed to room temperature and stirred for 30 min. The resulting suspension 
was filtered twice on a medium glass frit to partially remove the Li salts. The solvent was 
removed under reduced pressure; the residual dichlorodiethylsilane and TMEDA were removed 
under high vacuum over 2 h. The residue was purified by Kugelrohr distillation to afford 2.43 
(6.40 mg, 82%) as a yellow oil. 
Data for 2.43: 
 bp: 180 °C (ABT, 0.5 mmHg) 
 1
H NMR: (500 MHz, CDCl3) 
δ 7.55 (d, J = 8.2 Hz, 1H, C(8)H), 6.55 (dd, J = 8.2, 2.1 Hz, 1H, C(7)H), 6.41 (d, 
J = 2.1 Hz, 1H, C(5)H), 3.83 (s, 3H, C(9 or 10)H3), 3.79 (s, 3H, C(9 or 10)H3), 
1.12 – 0.92 (m, 10H, C(2)H3 and C(1)H2) 
 
13
C NMR: (126 MHz, CDCl3) 
δ 165.11 (C4 or C6), 163.37 (C4 or C6), 137.60 (C8), 113.14 (C3), 105.01 (C7), 
97.49 (C5), 55.21 (C9 or C10), 55.04 (C9 or C10), 8.93 (C1), 6.79 (C2) 
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1-((2,4-dimethoxyphenyl)diethylsilyl)but-2-yn-1-ol (2.45) [AA-15-DJ5147]
 
 
In a 250-mL Schlenk flask, 1.52 M BuLi in hexane (14.1 mL, 21.4 mmol, 1.1 equiv) was 
added to a solution of 2-butyn-1-ol (1.46 mL, 19.5 mmol) in THF (30 mL) at ‒78 °C and the 
mixture stirred for 10 min. A solution of 2.43 (5.29 g, 20.4 mmol, 1.05 equiv) in THF (10 mL) 
was then slowly added via syringe. The resulting yellow solution was warmed to room 
temperature and stirred for 16 h. The mixture was then re-cooled to ‒78 °C and treated with 1.51 
M t-BuLi in pentane (14.6 mL, 23.4 mmol, 1.2 equiv). The mixture was warmed to ‒45 °C and 
stirred for 2 h, then quenched by the addition of saturated aqueous NH4Cl (10 mL). After 
warming to room temperature, the layers were separated and the aqueous layer was washed with 
Et2O (2 × 20 mL). The combined organic extracts were washed with brine (20 mL), dried 
(Na2SO4), filtered and the solvent removed under reduced pressure. The residual oil was purified 
by silica gel column chromatography (pentane/Et2O 75:25) to afford 4.38 g of an inseparable 
mixture of 2.45 (13.63 mmol, 70%) and 2.46 (1.64 mmol, 8%) as a colorless oil. 
Data for 2.45: 
 1
H NMR: (500 MHz, CDCl3) 
δ 7.36 (d, J = 8.1 Hz, 1H, C(12)H), 6.54 (dd, J = 8.1, 2.2 Hz, 1H, C(11)H), 6.45 
(d, J = 2.1 Hz, 1H, C(9)H), 4.39 (dq, J = 5.3, 2.6 Hz, 1H, C(4)H), 3.82 (s, 3H, 
C(13 or 14)H3), 3.81 (s, 3H, C(13 or 14)H3), 2.41 (d, J = 5.2 Hz, 1H, OH), 1.82 
(d, J = 2.6 Hz, 3H, C(1)H3), 1.12 – 0.88 (m, 10H, C(6)H3 and C(5)H2) 
 
13
C NMR: (126 MHz, CDCl3) 
δ 165.27 (C8 or C10), 162.73 (C8 or C10), 137.34 (C12), 113.15 (C7), 105.18 
(C11), 97.96 (C9), 83.34 (C3), 79.73 (C2), 71.64 (C4), 55.23 (C13 or C14), 
54.85 (C13 or C14), 7.47 (C1), 2.73 (C6), 2.04 (C5) 
 TLC: Rf 0.24 (pentane/Et2O 75:25) 
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Diethyl(3-phenylbuta-1,2-dien-1-yl)silanol (2.27) [AA-04-025] 
 
In a 10-mL Schlenk flask, 2.2 M HCl in Et2O (0.13 mL, 0.284 mmol, 1 equiv) was added 
dropwise to a solution of 2.36 (100 mg, 0.284 mmol) in DCM (2.8 mL) at 0 °C. The mixture was 
stirred at 0 °C for 40 min, then transferred via cannula into a mixture of pH = 5, 1 M aqueous 
acetate buffer (6 mL) and CH3CN (2 mL) at 0 °C, and stirred for 5 min. After diluting with Et2O 
(10 mL), the layers were separated and the aqueous layer was washed with Et2O (2 × 10 mL). 
The combined organic extracts were washed with saturated aqueous NaHCO3 (10 mL), dried 
(Na2SO4), filtered and the solvent removed under reduced pressure. The residue was purified by 
silica gel column chromatography (pentane/Et2O 8:2) to afford 2.27 (54 mg, 86%) as a colorless 
oil. 
Data for 2.27: 
 1
H NMR: (500 MHz, C6D6) 
δ 7.42 (d, J = 7.8 Hz, 2H, C(8)H), 7.21 (t, J = 7.8 Hz, 2H, C(9)H), 7.04 (t, J = 7.3 
Hz, 1H, C(10)H), 5.29 (q, J = 3.6 Hz, 1H, C(4)H), 1.97 (d, J = 3.7 Hz, 3H, 
C(1)H3), 1.36 (s, 1H, OH), 0.99 (t, J = 7.9 Hz, 3H, C(6)H3), 0.98 (t, J = 7.9 Hz, 
3H, C(6’)H3), 0.75 – 0.54 (m, 4H, C(5)H2) 
 
13
C NMR: (126 MHz, C6D6) 
δ 212.14 (C3), 137.53 (C7), 128.73 (C9), 126.31 (C10), 125.65 (C8), 94.38 (C2), 
83.36 (C4), 16.20 (C1), 7.37 (C5), 7.31 (C5’), 6.78 (C6) 
 TLC: Rf 0.36 (pentane/Et2O 8:2) 
 
  
 
 
 
 
 
266 
 
(2,4-dimethoxyphenyl)diethyl(3-methyl-4-phenylbuta-1,2-dien-1-yl)silane (2.49)  
[AA-04-072/073] 
 
In a 100-mL Schlenk flask, a solution of 2.45 and 2.46 (1.83 g, 6.25 mmol, actual 4.24 mmol 
of 2.45 based on NMR integration) in DCM (41 mL) at ‒78 °C was treated with Et3N (1.18 mL, 
8.43 mmol, 1.35 equiv) and MsCl (0.60 mL, 7.81 mmol, 1.25 equiv) and stirred for 30 min. The 
mixture was then warmed to room temperature and quenched with saturated aqueous NaHCO3 
(10 mL). The layers were separated and the aqueous layer was washed with Et2O (2 × 50 mL). 
The combined organic extracts were washed with brine (30 mL), dried (Na2SO4), filtered and the 
solvent removed under reduced pressure. The resulting mesylate 2.47 was used in the next step 
without further purification. 
In a 250-mL, 3-neck, round-bottom flask (equipped with an addition funnel, an Ar inlet and a 
septum), 1.05 M BnMgCl in Et2O (17.9 mL, 18.8 mmol, 3 equiv) was gradually added to a 
suspension of CuCN (1.68 g, 18.8 mmol, 3 equiv) and LiCl (1.59 g, 37.5 mmol, 6 equiv) in THF 
(32 mL) at ‒78 °C. The resulting suspension was warmed to room temperature to dissolve most 
of the solids, then re-cooled to ‒78 °C. A solution of the mesylate 2.47 in THF (32 mL) was then 
added via syringe and the reaction mixture stirred for 1 h. After warming to room temperature, 
the reaction was quenched by the addition of saturated aqueous NH4Cl (20 mL). The mixture 
was filtered through a pad of celite which was washed repeatedly with Et2O (100 mL). The 
filtrate was washed with brine (50 mL), dried (Na2SO4), filtered and the solvent removed under 
reduced pressure. The residual oil was purified by silica gel column chromatography 
(pentane/DCM 8:2) to afford 2.49 (1.38 g, 89% based on the actual amount of 2.45) as a 
colorless oil. 
Data for 2.49: 
 1
H NMR: (500 MHz, CDCl3) 
δ 7.29 (d, J = 8.0 Hz, 1H, C(12)H), 7.25 (t, J = 7.3 Hz, 2H, C(18)H), 7.21 – 7.15 
(m, 3H, C(17)H and C(19)H), 6.48 (dd, J = 8.1, 2.2 Hz, 1H, C(11)H), 6.40 (d, J 
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= 2.1 Hz, 1H, C(9)H), 5.10 – 5.00 (m, 1H, C(4)H), 3.82 (s, 3H, C(13 or 14)H3), 
3.75 (s 3H, C(13 or 14)H3), 3.34 – 3.21 (m, 2H, C(15)H2), 1.60 (d, J = 3.7 Hz, 
3H, C(1)H3), 0.97 – 0.88 (m, 6H, C(6)H3), 0.87 – 0.78 (m, 4H, C(5)H2) 
 
13
C NMR: (126 MHz, CDCl3) 
δ 210.19 (C3), 165.81 (C8 or C10), 162.45 (C8 or C10), 139.96 (C16), 137.19 
(C12), 128.92 (C18), 128.11 (C17), 125.95 (C19), 115.82 (C7), 104.39 (C11), 
97.57 (C9) 90.77 (C2), 78.18 (C4), 55.17 (C13 or C14), 54.91 (C13 or C14), 
40.45 (C15), 17.48 (C1), 7.56 (C6), 4.99 (C5), 4.80 (C5’) 
 TLC: Rf 0.37 (pentane/DCM 8:2) 
 
Diethyl(3-methyl-4-phenylbuta-1,2-dien-1-yl)silanol (2.48) [AA-04-050] 
 
In a 50-mL Schlenk flask, 2.08 M HCl in Et2O (0.79 mL, 1.64 mmol, 1 equiv) was added 
dropwise to a solution of 2.49 (600 mg, 1.64 mmol) in DCM (16.4 mL) at 0 °C. The mixture was 
stirred at 0 °C for 40 min, then transferred via cannula into a mixture of pH = 5, 1 M aqueous 
acetate buffer (32 mL) and CH3CN (10 mL) at 0 °C, and stirred for 5 min. After diluting with 
Et2O (30 mL), the layers were separated and the aqueous layer was washed with Et2O (2 × 20 
mL). The combined organic extracts were washed with saturated aqueous NaHCO3 (30 mL), 
dried (Na2SO4), filtered and the solvent removed under reduced pressure. The residue was 
purified by silica gel column chromatography (pentane/Et2O 9:1) to afford 2.48 (371 mg, 92%) 
as a colorless oil. 
Data for 2.48: 
 1
H NMR: (500 MHz, C6D6) 
δ 7.17 (d, J = 4.5 Hz, 2H, C(9)H), 7.10 – 7.04 (m, 3H, C(10)H and C(11)H), 4.99 
– 4.89 (m, 1H, C(4)H), 3.19 (dd, J = 14.6, 3.3 Hz, 1H, C(7)H), 3.14 (dd, J = 
14.6, 3.2 Hz, 1H, C(7’)H), 1.59 (d, J = 3.8 Hz, 3H, C(1)H3), 1.31 (br s, 1H, OH), 
1.01 (t, J = 7.9 Hz, 3H, C(6)H3), 1.00 (t, J = 7.9 Hz, 3H, C(6’)H3), 0.70 – 0.57 
(m, 4H, C(5)H2) 
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13
C NMR: (126 MHz, C6D6) 
δ 210.68 (C3), 139.96 (C8), 129.16 (C10), 128.42 (C9), 126.41 (C11), 92.20 
(C2), 79.93 (C4), 40.41 (C7), 17.60 (C1), 7.16 (C5), 7.03 (C5’), 6.73 (C6), 6.68 
(C6’) 
 TLC: Rf 0.50 (pentane/Et2O 9:1) 
 
Chloro(2,4-dimethoxyphenyl)diisopropylsilane (2.51) [AA-05-018] 
 
In a 500-mL, 3-neck, round-bottom flask (equipped with an addition funnel, an Ar inlet and a 
septum), a solution of 1-bromo-2,4-dimethoxybenzene (5.8 mL, 40 mmol) in hexane (60 mL) at 
‒78 °C was treated with 1.52 M t-BuLi in pentane (55 mL, 84 mmol, 2.1 equiv) and stirred for 
30 min. TMEDA (6.3 mL, 42 mmol, 1.05 equiv) was slowly added and the resulting suspension 
was cannulated into a solution of dichlorodiisopropylsilane (10.8 mL, 60 mmol, 1.5 equiv) in 
hexane (30 mL) at ‒78 °C. The original flask was rinsed with hexane (3 × 30 mL). The mixture 
was warmed to room temperature and stirred for 30 min. The resulting suspension was filtered 
twice on a medium glass frit to partially remove the Li salts. The solvent was removed under 
reduced pressure; the residual dichlorodiethylsilane and TMEDA were removed under high 
vacuum over 4 h. The residue was purified by Kugelrohr distillation to afford 2.51 (10.0 mg, 
87%) as a yellow oil. 
Data for 2.51: 
 bp: 204 °C (ABT, 0.5 mmHg) 
 1
H NMR: (500 MHz, CDCl3) 
δ 7.58 (d, J = 8.2 Hz, 1H, C(6)H), 6.55 (dd, J = 8.2, 2.1 Hz, 1H, C(5)H), 6.40 (d, 
J = 2.0 Hz, 1H, C(3)H), 3.83 (s, 3H, C(7 or 8)H3), 3.77 (s, 3H, C(7 or 8)H3), 1.45 
(hept, J = 7.3 Hz, 2H, C(9)H), 1.06 (d, J = 7.3 Hz, 6H, C(10)H3), 0.94 (d, J = 7.4 
Hz, 6H, C(10’)H3) 
 
13
C NMR: (126 MHz, CDCl3) 
269 
 
δ 164.68 (C2 or C4), 163.14 (C2 or C4), 138.44 (C6), 112.18 (C1), 104.91 (C5), 
97.24 (C3), 55.23 (C7 or C8), 54.79 (C7 or C8), 17.45 (C9), 17.25 (C9’), 14.75 
(C10) 
 
1-((2,4-dimethoxyphenyl)diisopropylsilyl)but-2-yn-1-ol (2.52) [AA-05-021]
 
 
In a 50-mL Schlenk flask, 2.38 M BuLi in hexane (3.0 mL, 7.30 mmol, 1.15 equiv) was 
added to a solution of 2-butyn-1-ol (0.47 mL, 6.34 mmol) in THF (9.5 mL) at ‒78 °C and the 
mixture stirred for 10 min. A solution of 2.51 (2.0 g, 6.97 mmol, 1.1 equiv) in THF (3.5 mL) was 
then slowly added via syringe. The resulting yellow solution was warmed to room temperature 
and stirred for 16 h. The mixture was then re-cooled to ‒78 °C and treated with 1.60 M t-BuLi in 
pentane (4.8 mL, 7.61 mmol, 1.2 equiv). The mixture was warmed to ‒45 °C and stirred for 2 h, 
then quenched by the addition of saturated aqueous NH4Cl (5 mL). After warming to room 
temperature, the layers were separated and the aqueous layer was washed with Et2O (2 × 20 mL). 
The combined organic extracts were washed with brine (20 mL), dried (Na2SO4), filtered and the 
solvent removed under reduced pressure. The residual oil was purified by silica gel column 
chromatography (pentane/Et2O 75:25) to afford 1.18 g of an inseparable mixture of 2.52 (1.73 
mmol, 25%) and 2.53 (2.33 mmol, 37%) as a colorless oil. 
Data for 2.52: 
 1
H NMR: (500 MHz, CDCl3) 
δ 7.45 (d, J = 8.1 Hz, 1H, C(12)H), 6.55 (dd, J = 8.2, 2.2 Hz, 1H, C(11)H), 6.45 
(d, J = 2.1 Hz, 1H, C(9)H), 4.56 (dq, J = 5.4, 2.6 Hz, 1H, C(4)H), 3.83 (s, 3H, 
C(13 or 14)H3), 3.80 (s, 3H, C(13 or 14)H3), 2.33 (d, J = 5.6 Hz, 1H, OH), 1.82 
(d, J = 2.7 Hz, 3H, C(1)H3), 1.55 – 1.36 (m, 2H, C(5)H), 1.15 (d, J = 7.5 Hz, 3H, 
C(6)H3), 1.11 (d, J = 7.5 Hz, 3H, C(6’)H3), 1.08 (d, J = 7.4 Hz, 3H, C(6’’)H3), 
1.07 (d, J = 7.5 Hz, 3H, C(6’’’)H3) 
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 TLC: Rf 0.34 (pentane/Et2O 75:25) 
 
(2,4-dimethoxyphenyl)diisopropyl(3-methyl-4-phenylbuta-1,2-dien-1-yl)silane (2.55)  
[AA-05-022/023]
 
 
In a 50-mL Schlenk flask, a solution of 2.52 and 2.53 (1.18 g, 3.68 mmol, actual 1.73 mmol 
of 2.52 based on NMR integration) in DCM (25 mL) at ‒78 °C was treated with Et3N (0.69 mL, 
4.97 mmol, 1.35 equiv) and MsCl (0.36 mL, 4.60 mmol, 1.25 equiv) and stirred for 30 min. The 
mixture was then warmed to room temperature and quenched with saturated aqueous NaHCO3 (5 
mL). The layers were separated and the aqueous layer was washed with Et2O (2 × 25 mL). The 
combined organic extracts were washed with brine (20 mL), dried (Na2SO4), filtered and the 
solvent removed under reduced pressure. The resulting mesylate 2.54 was used in the next step 
without further purification. 
In a 100-mL, 3-neck, round-bottom flask (equipped with an addition funnel, an Ar inlet and a 
septum), 1.0 M BnMgCl in Et2O (11.0 mL, 11.0 mmol, 3 equiv) was gradually added to a 
suspension of CuCN (989 mg, 11.0 mmol, 3 equiv) and LiCl (936 mg, 22.1 mmol, 6 equiv) in 
THF (18.5 mL) at ‒78 °C. The resulting suspension was warmed to room temperature to dissolve 
most of the solids, then re-cooled to ‒78 °C. A solution of the mesylate 2.54 in THF (18.5 mL) 
was then added via syringe and the reaction mixture stirred for 1 h. After warming to room 
temperature, the reaction was quenched by the addition of saturated aqueous NH4Cl (10 mL). 
The mixture was filtered through a pad of celite which was washed repeatedly with Et2O (70 
mL). The filtrate was washed with brine (30 mL), dried (Na2SO4), filtered and the solvent 
removed under reduced pressure. The residual oil was purified by silica gel column 
chromatography (pentane/DCM 9:1) to afford 2.55 (566 mg, 83% based on the actual amount of 
2.52) as a colorless oil. 
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Data for 2.55: 
 1
H NMR: (500 MHz, CDCl3) 
δ 7.37 (d, J = 8.1 Hz, 1H, C(12)H), 7.34 – 7.28 (m, 2H, C(18)H), 7.28 – 7.22 (m, 
3H, C(17)H and C(19)H), 6.52 (dd, J = 8.1, 2.0 Hz, 1H, C(11)H), 6.45 (d, J = 2.0 
Hz, 1H, C(9)H), 5.16 – 5.00 (m, 1H, C(4)H), 3.86 (s, 3H, C(13 or 14)H3), 3.79 
(s, 3H, C(13 or 14)H3), 3.42 (dd, J = 14.6, 3.0 Hz, 1H, C(7)H), 3.31 (dd, J = 
14.7, 2.9 Hz, 1H, C(7’)H), 1.67 (d, J = 3.8 Hz, 3H, C(1)H3), 1.38 (hept, J = 7.4 
Hz, 2H, C(5)H), 1.09 – 0.94 (m, 12H, C(6)H3) 
 
13
C NMR: (126 MHz, CDCl3) 
δ 210.84 (C3), 165.68 (C8 or C10), 162.30 (C8 or C10), 139.92 (C16), 138.42 
(C12), 128.95 (C18), 128.15 (C17), 125.99 (C19), 114.35 (C7), 104.26 (C11), 
97.41 (C9), 90.23 (C2), 75.81 (C4), 55.13 (C13 or C14), 54.64 (C13 or C14), 
40.45 (C15), 18.14 (C6), 18.09 (C6’), 17.51 (C1), 11.79 (C5), 11.73 (C5’) 
 TLC: Rf 0.23 (pentane/DCM 9:1) 
 
Diisopropyl(3-methyl-4-phenylbuta-1,2-dien-1-yl)silanol (2.50) [AA-05-025] 
 
In a 50-mL Schlenk flask, 2.08 M HCl in Et2O (1.35 mL, 2.8 mmol, 2 equiv) was added 
dropwise to a solution of 2.55 (553 mg, 1.40 mmol) in DCM (14 mL) at room temperature. The 
mixture was stirred for 30 min, then transferred via cannula into a mixture of pH = 5, 1 M 
aqueous acetate buffer (28 mL) and CH3CN (9 mL) at 0 °C, and stirred for 10 min. After diluting 
with Et2O (20 mL), the layers were separated and the aqueous layer was washed with Et2O (2 × 
20 mL). The combined organic extracts were washed with saturated aqueous NaHCO3 (30 mL), 
dried (Na2SO4), filtered and the solvent removed under reduced pressure. The residue was 
purified by silica gel column chromatography (pentane/Et2O 9:1) to afford 2.50 (325 mg, 85%) 
as a colorless oil. 
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Data for 2.50: 
 1
H NMR: (500 MHz, C6D6) 
δ 7.16 – 7.11 (m, 4H, C(9)H and C(10)H), 7.09 – 7.01 (m, 1H, C(11)H), 4.96 – 
4.79 (m, 1H, C(4)H), 3.24 – 3.07 (m, 2H, C(7)H2), 1.57 (d, J = 3.8 Hz, 3H, 
C(1)H3), 1.26 (s, 1H, OH), 1.07 (d, J = 7.1 Hz, 1H, C(6)H3), 1.05 (d, J = 7.2 Hz, 
1H, C(6’)H3), 1.03 (d, J = 7.0 Hz, 1H, C(6’’)H3), 1.02 (d, J = 7.0 Hz, 1H, 
C(6’’’)H3), 0.99 – 0.88 (m, 2H, C(5)H) 
 
13
C NMR: (126 MHz, C6D6) 
δ 211.14 (C3), 140.12 (C8), 129.29 (C10), 128.63 (C9), 126.61 (C11), 92.15 
(C2), 77.78 (C4), 40.59 (C7), 17.79 (C1), 17.38 (C6), 17.27 (C6’), 13.45 (C5), 
13.39 (C5’) 
 TLC: Rf 0.45 (pentane/Et2O 9:1) 
 
1-(3-methyl-4-phenylbuta-1,2-dien-1-yl)-4-(trifluoromethyl)benzene (2.67) and  
1-(2-methyl-1-phenylbut-3-yn-2-yl)-4-(trifluoromethyl)benzene (2.68) [AA-04-077/078] 
 
A 10-mL Schlenk flask was charged with NaH (34 mg, 1.43 mmol, 1.1 equiv) inside a glove 
box. The flask was transferred outside the glove box and toluene (1 mL) was added. A solution 
of 2.48 (320 mg, 1.3 mmol) in toluene (2 mL) was added dropwise and the resulting suspension 
stirred until bubbling subsided (1 h). Stirring was interrupted to let the residual NaH settle. 
In a separate 25-mL Schlenk flask, Pd(dba)2 (29 mg, 0.05 mmol, 0.05 equiv) and Ph3As (31 
mg, 0.1 mmol, 0.1 equiv) were combined and dissolved in toluene (7 mL). 2.66 (0.15 mL, 1.0 
mmol) was added and the solution warmed to 40 °C. The decanted solution of Na
+
(2.48)
−
 was 
added via syringe and the mixture stirred for 18 h. The reaction was quenched by adding acetate 
buffer (pH = 5, 1 M, 5 mL). The layers were separated and the aqueous layer was washed with 
pentane (2 × 10 mL). The combined organic extracts were treated with 30% H2O2 (0.1 mL), 
followed by saturated aqueous Na2S2O3 (3 mL). The aqueous layer was removed and the organic 
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layer was washed with brine (10 mL), dried (Na2SO4), filtered and the solvent removed under 
reduced pressure. The residue was purified by silica gel column chromatography (pentane) to 
afford 2.67 (115 mg, 40%) and 2.68 (37 mg, 13%) as colorless oils. 
Data for 2.67: 
 1
H NMR: (500 MHz, CDCl3) 
δ 7.53 (d, J = 7.7 Hz, 2H, C(7)H), 7.35 (d, J = 7.8 Hz, 2H, C(6)H), 7.31 (t, J = 
7.3 Hz, 2H, C(13)H), 7.27 – 7.19 (m, 3H, C(12)H and C(14)H), 6.09 (br s, 1H, 
C(4)H), 3.51 – 3.37 (m, 2H, C(10)H2), 1.80 (d, J = 2.4 Hz, C(1)H3) 
 
13
C NMR: (126 MHz, CDCl3) 
δ 204.63 (C3), 139.60 (C5), 138.88 (C11), 128.91 (C13), 128.40 (q, J = 32.3 Hz, 
C8), 128.38 (C12), 126.65 (C6), 126.47 (C14), 125.40 (q, J = 3.8 Hz, C7), 
124.32 (q, J = 271.6 Hz, C9), 103.92 (C2), 92.89 (C4), 41.02 (C10), 18.00 (C1) 
 MS: (EI)  
  288 (M
+
), 273, 233, 219, 204, 197, 177, 128, 91 
 TLC: Rf 0.43 (pentane) 
 
Data for 2.68: 
 1
H NMR: (500 MHz, CDCl3) 
δ 7.54 (d, J = 8.1 Hz, 2H, C(8)H), 7.45 (d, J = 8.1 Hz, 2H, C(2)H), 7.37 – 7.30 
(m, 2H, C(13)H), 7.30 – 7.21 (m, 3H, C(12)H and C(14)H), 3.01 – 2.86 (m, 2H, 
C(1)H and C(4)H), 2.82 (dd, J = 12.6, 6.3 Hz, 1H, C(4’)H), 1.30 (d, J = 6.7 Hz, 
C(5)H3) 
 
13
C NMR: (126 MHz, CDCl3) 
δ 139.36 (C11), 131.71 (C7), 129.32 (q, J = 32.6 Hz, C9), 129.30 (C13), 128.20 
(C12), 127.76 (C6), 126.40 (C14), 124.50 (q, J = 272.0 Hz, C10), 125.06 (q, J = 
3.8 Hz, C8), 96.81 (C3), 80.56 (C2), 42.98 (C4), 28.66 (C1), 20.41 (C5) 
 IR: (NaCl, DCM) 
  2931, 2232, 1614, 1495, 1453, 1376, 1324, 1169, 1127, 1106, 1067, 1017 
 MS: (EI)  
  288 (M
+
), 273, 233, 219, 197, 177, 128, 91 
 TLC: Rf 0.33 (pentane) 
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General procedure for the deprotonation of silanols 2.20, 2.27, 2.39, 2.48, and 2.50 
 
 
A Schlenk flask was charged with the base and the solvent. A solution of the silanol in the 
reaction solvent was added at the indicated temperature. The reaction mixture was stirred for the 
indicated time (for NaH and KH, the reaction was interrupted when bubbling subsided). For 
reactions run in deuterated solvents, a 0.6-mL aliquot was taken by syringe, transferred into an 
oven-dried NMR tube sealed under Ar atmosphere, and analyzed by 
1
H NMR. For reactions run 
in protiated solvents, a 100-μL aliquot was taken by syringe and transferred into a vial containing 
a known amount of biphenyl. The resulting mixture was quenched with a few drops of acetate 
buffer, diluted with EtOAc (1 mL), filtered through a silica plug and analyzed by GC. The 
original reaction mixture was used in cross-coupling experiments after determining the title of 
the silanolate by integration of GC peaks. 
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General procedure for cross-coupling experiments (Tables 2.1 – 2.10) 
 
In a glove box, the Pd source and the ligand were added to a dram vial containing a stir bar. 
A stock solution of the aromatic halide and biphenyl in the reaction solvent was added and the 
mixture stirred to homogenize. The vial was sealed with a septum screw cap, transferred outside 
the glove box and warmed to the indicated temperature. A solution of the silanolate in toluene 
(0.3 – 0.4 M) was then added via syringe. 50 μL aliquots were taken after the indicated time 
points, diluted with EtOAc (1 mL), quenched with a few drops of acetate buffer (pH=5), filtered 
through a silica plug and analyzed by GC. The column oven temperature program was as 
follows: 125 °C for 1 minute, 125 °C to 260 °C at 30 °C /min, then 260 ºC for 9.5 minutes (total 
run time: 15 minutes). 
GC response factors were established by the following equation using biphenyl as the 
internal standard:  
  
Three samples containing a known amount of the desired compound and biphenyl were 
prepared and dissolved in EtOAc. A small portion of each sample was diluted further to 1 mL. 
An aliquot of each sample was injected into GC in triplicates. The average of 9 response factors 
was used to monitor cross-coupling reactions. 
 
compound response factor tR (min) 
2.48 0.849 6.60 
2.50 0.610 7.37 
2.56 1.204 3.60 
2.60 1.994 3.83 
2.63 1.993 4.44 
2.65 1.871 2.58 
2.66 1.912 3.02 
2.67 0.633 7.08 
2.68 0.638 6.99 
biphenyl - 4.88 
276 
 
5.5. EXPERIMENTS FOR CHAPTER 3 
Study of the catalytic NHK reaction (Scheme 3.22) 
 
Inside the glove box, the Cr source (5 mol%), NiCl2·DME (3 mol%) and the base (10 mol%) 
were added to a 4-mL Dram vial. A stir bar was added and the vial was sealed with a septum 
screw cap. A stock solution of the vinyl iodide (0.1 mmol), hydrocinnamaldehyde (1 equiv) and 
biphenyl in the designated solvent (1 mL) was added via syringe. Additives and H2O were 
subsequently added. A needle was inserted through the septum and the vial was placed in an 
autoclave, where the reaction was stirred under CO atmosphere (10 bar) for 6 h at the indicated 
temperature. After purging the autoclave with nitrogen, the reaction was quenched with water 
(0.2 mL). The mixture was diluted with EtOAc (2 mL). A 0.2 mL aliquot was withdrawn, 
filtered through a silica plug and analyzed by GC using the following method: 2.5 min at 110 °C, 
then 40 °C/min to 210 °C, then 16 min at 210 °C.  
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Factor 1 Factor 2 Factor 3 Factor 5 Factor 6 Response 1
A: H2O (equiv) B: Cr(III) source C: base E: solvent F: Temp (°C) product (%)
1 Cr(OAc)3 basic Et3N CH3CN 25 0
2.5 CrCl3 pyridine CH3CN 25 0
1.5 Cr(acac)3 pyridine CH3CN 25 0
2.5 CrBr3 N-methylpyrrolidine CH3CN 25 0
3 Cr(acac)3 Et3N CH3CN 25 0
3 CrCl3·3THF pyridine CH3CN 25 0
2.5 CrCl3 Et3N CH3CN 75 0
3 CrCl3·3THF TMEDA CH3CN 75 0
2.5 CrCl3·3THF 2-picoline CH3CN 75 0
3 CrBr3 pyridine CH3CN 75 0
2 Cr(acac)3 phenantroline CH3CN 75 0
1.5 Cr(acac)3 TMEDA DMF 25 0
2 CrCl3 phenantroline DMF 25 0
2.5 Cr(acac)3 N-methylpyrrolidine DMF 25 0
1.5 CrBr3 2-picoline DMF 25 0
2 Cr(acac)3 TMEDA DMF 75 0
1 CrCl3·3THF pyridine DMF 75 0
1 Cr(acac)3 phenantroline DMF 75 0
3 CrCl3·3THF TMEDA DMF 75 0
2.5 Cr(OAc)3 basic phenantroline DMF 75 0
3 CrBr3 Et3N DMF 75 0
2 CrCl3 TMEDA DMF 75 0
1.5 Cr(acac)3 2-picoline DMF 75 0
1.5 CrBr3 N-methylpyrrolidine DMF 75 0
2.5 CrCl3 N-methylpyrrolidine DMF 75 0
1 CrBr3 Et3N dioxane 25 0
3 CrCl3 N-methylpyrrolidine dioxane 25 0
1 Cr(OAc)3 basic phenantroline dioxane 25 0
1.5 Cr(OAc)3 basic pyridine dioxane 25 0
1.5 CrBr3 2-picoline dioxane 75 0
3 CrCl3·3THF TMEDA dioxane 75 0
3 CrCl3·3THF phenantroline dioxane 75 0
2.5 Cr(acac)3 N-methylpyrrolidine dioxane 75 0
2.5 CrCl3 Et3N dioxane 75 0
1 Cr(OAc)3 basic N-methylpyrrolidine DME 25 0
2 CrCl3·3THF TMEDA DME 25 0
3 CrBr3 phenantroline DME 25 0
1 Cr(acac)3 phenantroline DME 25 0
3 bis(benzene)Cr Et3N DME 25 0
3 bis(benzene)Cr N-methylpyrrolidine DME 25 0
3 Chromocene phenantroline DME 25 0
1 Chromocene Et3N DME 25 0
1 Chromocene pyridine DME 25 0
2.5 Cr(CO)6 pyridine DME 25 0
3 CrCl2 TMEDA DME 25 0
1 CrCl2 phenantroline DME 25 0
1.5 Cr(CO)6 2-picoline DME 25 0
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Factor 1 Factor 2 Factor 3 Factor 5 Factor 6 Response 1
A: H2O (equiv) B: Cr(III) source C: base E: solvent F: Temp (°C) product (%)
1 CrBr3 2-picoline DME 75 0
1.5 Cr(OAc)3 basic 2-picoline DME 75 0
1 CrCl3 TMEDA DME 75 0
3 Cr(acac)3 TMEDA DME 75 0
1.5 CrCl3·3THF phenantroline DME 75 0
2.5 CrCl2 TMEDA DMSO 25 0
1.5 bis(benzene)Cr N-methylpyrrolidine DMSO 25 0
1 Chromocene TMEDA DMSO 25 0
1 CrCl2 Et3N DMSO 25 1
3 Chromocene Et3N DMSO 25 0
3 bis(benzene)Cr phenantroline DMSO 25 0
3 Cr(CO)6 pyridine DMSO 25 0
Factor 1 Factor 2 Factor 3 Factor 5 Factor 6
A: H2O (equiv) B: Cr source C: silane E: solvent F: Temp (°C)
0 CrCl2 none DMF 110 5
0 CrCl2 tBuMe2SiOH DMF 110 3
0 CrCl2 PhMe2SiOH DMF 110 4
0 CrCl2 Ph3SiOH DMF 110 4
0 CrCl2 (Me3Si)2O DMF 110 5
1 CrCl2 none DMF 110 5
1 CrCl2 (Me3Si)2O DMF 110 5
0 CrCl2 tBuMe2SiOH DMF 75 2
0 CrCl2 PhMe2SiOH DMF 75 2
0 CrCl2 Ph3SiOH DMF 75 2
product (%)
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Factor 1 Factor 2 Factor 3 Factor 5 Factor 6 Response 1
A: H2O (equiv) B: Cr source C: base E: solvent F: Temp (°C) product (%)
2.5 CrCl2 2,4,6-tBu-pyridine CH3CN 25 0
3 Chromocene 2,4,6-collidine CH3CN 25 0
1 Chromocene none CH3CN 25 0
1 Cr(CO)6 2,4,6-collidine CH3CN 25 0
1 Cr(OAc)2 hydrate 2,4,6-tBu-pyridine CH3CN 25 0
1 bis(benzene)Cr none CH3CN 25 0
1 Cr(OAc)2 hydrate none CH3CN 25 0
1 Cr(OAc)2 hydrate 2,4,6-tBu-pyridine DMF 25 0
1 Chromocene none DMF 25 0
2 bis(benzene)Cr 2,4,6-collidine DMF 25 0
1 Cr(OAc)2 hydrate 2,4,6-tBu-pyridine DMF 25 0
3 Cr(CO)6 2,4,6-collidine DMF 25 0
1.5 CrCl2 2,4,6-collidine DMF 25 2
2.5 bis(benzene)Cr none DMF 25 0
2.5 Cr(CO)6 2,4,6-collidine DMF 75 0
1 Cr(OAc)2 hydrate 2,4,6-collidine DMF 75 0
2.5 CrCl2 none DMF 75 3
1 Chromocene 2,4,6-tBu-pyridine DMF 75 0
2.5 Cr(OAc)2 hydrate 2,4,6-tBu-pyridine DMF 75 0
1.5 CrCl2 2,4,6-collidine DMF 75 1
2.5 bis(benzene)Cr none DMF 75 0
1 CrCl2 2,4,6-tBu-pyridine dioxane 25 0
3 Chromocene none dioxane 25 0
1.5 Cr(CO)6 none dioxane 25 0
1.5 bis(benzene)Cr 2,4,6-collidine dioxane 25 0
3 bis(benzene)Cr none DME 25 0
3 Cr(CO)6 none DME 25 0
3 CrCl2 none DME 25 0
1 CrCl2 none DME 25 0
3 Cr(CO)6 2,4,6-tBu-pyridine DME 25 0
1.5 Chromocene 2,4,6-tBu-pyridine DME 25 1
1 bis(benzene)Cr 2,4,6-collidine DME 25 0
3 Chromocene 2,4,6-tBu-pyridine DME 75 0
2.5 Cr(OAc)2 hydrate none DME 75 0
1.5 CrCl2 none DME 75 0
2.5 CrCl2 2,4,6-collidine DME 75 0
3 CrCl2 none DMSO 25 2
2.5 Chromocene 2,4,6-tBu-pyridine DMSO 25 0
2 Cr(CO)6 2,4,6-tBu-pyridine DMSO 25 0
2 CrCl2 2,4,6-collidine DMSO 25 1
3 CrCl2 2,4,6-tBu-pyridine DMSO 75 3
1.5 CrCl2 none DMSO 75 4
1 Chromocene none DMSO 75 0
1.5 Cr(OAc)2 hydrate 2,4,6-collidine DMSO 75 0
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Study of the Mn-catalyzed carbonyl addition reaction (Scheme 3.23) 
 
In the glove box, the Mn source (5 mol%) and the base (10 mol%) were added to a 4-mL 
Dram vial. A stir bar was added and the vial was sealed with a septum screw cap. A stock 
solution of the vinyl iodide (0.1 mmol), the aldehyde (1 equiv) and biphenyl in DME (1 mL) was 
added via syringe. H2O was subsequently added. A needle was inserted through the septum and 
the vial was placed in an autoclave, where the reaction was stirred under CO atmosphere (10 bar) 
for 18 h at the indicated temperature. After purging the autoclave with nitrogen, the reaction was 
quenched with water (0.2 mL). The mixture was diluted with EtOAc (2 mL). A 0.2 mL aliquot 
was withdrawn, filtered through a silica plug and analyzed by GC using the following method: 
2.5 min at 110 °C, then 40 °C/min to 210 °C, then 16 min at 210 °C. 
 
   
 
Factor 1 Factor 2 Factor 3 Factor 5 Factor 6 Response 1
A: H2O (equiv) B: Mn source C: base E: solvent F: Temp (°C) product (%)
3 CpMn(CO)3 2,4,6-collidine DME 75 0
1 MnI2 2,4,6-collidine DME 75 0
1 Cp2Mn 2,4,6-tBu-pyridine DME 75 0
3 MnI2 2,4,6-tBu-pyridine DME 75 0
1 MnI2 none DME 75 0
1 Mn2(CO)10 none DME 75 0
1 CpMn(CO)3 2,4,6-tBu-pyridine DME 75 0
2.5 MnI2 2,4,6-collidine DME 75 0
3 Mn(acac)2 none DME 75 0
3 Mn(acac)2 2,4,6-tBu-pyridine DME 75 0
2 Mn2(CO)10 2,4,6-tBu-pyridine DME 75 0
1 MnCl2 2,4,6-collidine DME 75 0
2.5 Cp2Mn none DME 75 0
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Study of the Ru-catalyzed carbonyl addition reaction (Scheme 3.24) 
 
Inside the glove box, the Ru source (6 mol%) and the base (10 mol%) were added to a 4-mL 
Dram vial. A stir bar was added and the vial was sealed with a septum screw cap. A stock 
solution of the vinyl iodide (0.1 mmol), the aldehyde (1 equiv) and biphenyl in the designated 
solvent (0.5 mL) was added via syringe. H2O was subsequently added. A needle was inserted 
through the septum and the vial was placed in an autoclave, where the reaction was stirred under 
CO atmosphere (10 bar) for 18 h at the indicated temperature. After purging the autoclave with 
nitrogen, the reaction was quenched with water (0.2 mL). The mixture was diluted with EtOAc 
(2 mL). A 0.2 mL aliquot was withdrawn, filtered through a silica plug and analyzed by GC 
using the following method: 2.5 min at 110 °C, then 40 °C/min to 210 °C, then 16 min at 210 °C. 
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Factor 1 Factor 2 Factor 3 Factor 5 Factor 6 Response 1
A: H2O (equiv) B: Ru source C: base E: solvent F: Temp (°C) product (%)
1 [RuCl2(CO)3]2 2,4,6-collidine dioxane 75 0
1 [RuCl2(CO)3]2 Et3N dioxane 75 0
3 [RuCl2(CO)3]2 TMEDA dioxane 75 0
3 [RuCl2(CO)3]2 phenantroline dioxane 75 0
1.5 [RuCl2(cod)]x none dioxane 75 0
1 [RuCl2(cod)]x 2,4,6-collidine dioxane 75 0
3 [RuCl2(cod)]x phenantroline dioxane 75 0
3 [RuCl2(cod)]x Et3N dioxane 75 0
3 [RuCl2(cymene)]2 2,4,6-collidine dioxane 75 0
1 [RuCl2(cymene)]2 Et3N dioxane 75 0
1 [RuCl2(cymene)]2 phenantroline dioxane 75 0
3 Ru3(CO)12 2,4,6-collidine dioxane 75 0
3 Ru3(CO)12 none dioxane 75 0
2 Ru3(CO)12 phenantroline dioxane 75 0
1 Ru3(CO)12 TMEDA dioxane 75 0
2 RuCl3 xH2O TMEDA dioxane 75 0
1 RuCl3 xH2O none dioxane 75 0
1.5 RuCl3 xH2O Et3N dioxane 75 0
3 [RuCl2(CO)3]2 2,4,6-collidine DMF 100 0
1 [RuCl2(CO)3]2 TMEDA DMF 100 0
2.5 [RuCl2(CO)3]2 TMEDA DMF 100 0
3 [RuCl2(CO)3]2 none DMF 100 0
1 [RuCl2(CO)3]2 Et3N DMF 100 0
1 [RuCl2(cod)]x phenantroline DMF 100 0
2 [RuCl2(cod)]x 2,4,6-collidine DMF 100 0
1.5 [RuCl2(cod)]x none DMF 100 0
1 [RuCl2(cymene)]2 TMEDA DMF 100 0
1.5 [RuCl2(cymene)]2 none DMF 100 0
3 [RuCl2(cymene)]2 Et3N DMF 100 0
3 Ru3(CO)12 phenantroline DMF 100 0
1.5 Ru3(CO)12 2,4,6-collidine DMF 100 0
1 Ru3(CO)12 none DMF 100 0
1 RuCl3 xH2O 2,4,6-collidine DMF 100 0
3 RuCl3 xH2O TMEDA DMF 100 0
2.5 RuCl3 xH2O Et3N DMF 100 0
1.5 RuCl3 xH2O phenantroline DMF 100 0
2.5 [RuCl2(CO)3]2 Et3N toluene 100 0
1 [RuCl2(CO)3]2 phenantroline toluene 100 0
3 [RuCl2(CO)3]2 2,4,6-collidine toluene 100 0
3 [RuCl2(cod)]x none toluene 100 0
1 [RuCl2(cod)]x 2,4,6-collidine toluene 100 0
1 [RuCl2(cod)]x Et3N toluene 100 0
2.5 [RuCl2(cod)]x TMEDA toluene 100 0
1 [RuCl2(cymene)]2 2,4,6-collidine toluene 100 0
2.5 [RuCl2(cymene)]2 none toluene 100 0
3 [RuCl2(cymene)]2 TMEDA toluene 100 0
3 [RuCl2(cymene)]2 phenantroline toluene 100 0
1 Ru3(CO)12 phenantroline toluene 100 0
3 Ru3(CO)12 TMEDA toluene 100 0
3 Ru3(CO)12 Et3N toluene 100 0
1 Ru3(CO)12 none toluene 100 0
1 RuCl3 xH2O TMEDA toluene 100 0
2 RuCl3 xH2O 2,4,6-collidine toluene 100 0
3 RuCl3 xH2O Et3N toluene 100 0
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Carbonyl addition of pre-formed oxidative addition complex 3.12 (Scheme 3.25) 
 
In the glove box, a 5-mL round bottom flask equipped with a reflux condenser the flask was 
charged with the Ru complex 3.12 (15 mg, 18.2 µmol)  and the solvent (toluene or DMF, 0.5 
mL). The flask was sealed with a 3-way glass joint and taken out of the glove box, where p-
trifluoromethylbenzaldehyde (2.5 µL, 1 equiv) was added at room temperature via syringe. The 
mixture was heated to reflux for 4 h, then cooled to at room temperature and quenched with 
water. An aliquot was taken, diluted with EtOAc, filtered through a silica plug and analyzed by 
GC-MS. No addition product was detected. 
 
Study of the Pd-catalyzed carbonyl addition reaction (Scheme 3.26) 
 
In the glove box, the Pd source (5 mol%) and the base (10 mol%) were added to a 4-mL 
Dram vial. A stir bar was added and the vial was sealed with a septum screw cap. A stock 
solution of the vinyl iodide (0.1 mmol), the aldehyde (1 equiv) and biphenyl in toluene (0.5 mL) 
was added via syringe. H2O was subsequently added. A needle was inserted through the septum 
and the vial was placed in an autoclave, where the reaction was stirred under CO atmosphere (10 
bar) for 18 h at the indicated temperature. After purging the autoclave with nitrogen, the reaction 
was quenched with water (0.2 mL). The mixture was diluted with EtOAc (2 mL). A 0.2 mL 
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aliquot was withdrawn, filtered through a silica plug and analyzed by GC using the following 
method: 2.5 min at 110 °C, then 40 °C/min to 210 °C, then 16 min at 210 °C. 
 
 
Study of the Ni-catalyzed carbonyl addition reaction (Scheme 3.27) 
 
Allyl carbonate 
Inside the glove box, the Ni source (5 mol%) and the base (10 mol%) were added to a 4-mL 
Dram vial. A stir bar was added and the vial was sealed with a septum screw cap. A stock 
solution of allyl carbonate (0.1 mmol), p-anisaldehyde (1 equiv) and biphenyl in the designated 
solvent (1 mL) was added via syringe. H2O was subsequently added. A needle was inserted 
Factor 1 Factor 2 Factor 3 Factor 5 Factor 6 Response 1
A: H2O (equiv) B: Pd source C: base E: solvent F: Temp (°C) product (%)
2.5 Pd(OAc)2 none toluene 100 0
3 Pd(OAc)2 Et3N toluene 100 0
1 APC Et3N toluene 100 0
2.5 APC NaOAc toluene 100 0
2 APC none toluene 100 0
3 PdBr2 NaOAc toluene 100 0
1 PdBr2 Cs2CO3 toluene 100 0
1 PdBr2 Et3N toluene 100 0
1.5 PdCl2(PPh3)2 none toluene 100 0
3 PdCl2(PPh3)2 Cs2CO3 toluene 100 0
1 PdCl2(PPh3)2 NaOAc toluene 100 0
3 Pd(PtBu3)2 NaOAc toluene 100 0
1 Pd(PtBu3)2 none toluene 100 0
2.5 Pd(PPh3)4 Et3N toluene 100 0
1.5 Pd(PPh3)4 NaOAc toluene 100 0
2 Pd2(dba)3 none toluene 100 0
2.5 Pd2(dba)3 Cs2CO3 toluene 100 0
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through the septum and the vial was placed in an autoclave, where the reaction was stirred under 
CO atmosphere (10 bar) for 18 h at the indicated temperature. After purging the autoclave with 
nitrogen, the reaction was quenched with water (0.2 mL). The mixture was diluted with EtOAc 
(2 mL). A 0.2 mL aliquot was withdrawn, filtered through a silica plug and analyzed by GC 
using the following method: 3 min at 100 °C, then 30 °C/min to 250 °C, then 2 min at 250 °C. 
 
Factor 1 Factor 2 Factor 3 Factor 4 Factor 6 Response 1
A: H2O (equiv) B:  Ni source C: base D: solvent E: Temp (°C) product (%)
3 Ni(cod)2 NaOAc CH3CN 25 1
3 Ni(PPh3)4 Cs2CO3 CH3CN 25 0
3 Ni(PPh3)2(CO)2 Et3N CH3CN 25 0
1 Ni(PPh3)2(CO)2 none CH3CN 25 0
1 NiBr2 none CH3CN 25 0
1 NiCl2(DME) Cs2CO3 CH3CN 25 0
2 Ni(acac)2 none CH3CN 25 0
3 NiCl2(dppe) collidine CH3CN 25 0
2 NiBr2 Et3N CH3CN 25 1
1.5 Ni(cod)2 Cs2CO3 CH3CN 75 3
1 Ni(PPh3)4 collidine CH3CN 75 0
1 NiCl2(DME) Et3N CH3CN 75 0
1 NiCl2(dppe) NaOAc CH3CN 75 0
1 Ni(cod)2 none CH3CN 75 0
3 NiCl2(dppe) collidine CH3CN 75 0
2 Ni(acac)2 collidine CH3CN 75 0
2 Ni(PPh3)4 Et3N CH3CN 75 0
2.5 NiBr2 Et3N CH3CN 75 0
2.5 Ni(cod)2 NaOAc DMF 25 1
1.5 Ni(PPh3)2(CO)2 NaOAc DMF 25 0
2.5 NiCl2(DME) none DMF 25 0
1 NiCl2(dppe) collidine DMF 25 0
1 Ni(cod)2 Et3N DMF 25 1
1 Ni(acac)2 Cs2CO3 DMF 25 0
3 NiCl2(DME) NaOAc DMF 75 0
2.5 Ni(PPh3)4 Cs2CO3 DMF 25 0
1 Ni(cod)2 Et3N DMF 110 0
1 Ni(cod)2 collidine DMF 110 0
1 Ni(cod)2 NaOAc DMF 110 0
1 Ni(cod)2 Cs2CO3 DMF 110 0
3 Ni(PPh3)2(CO)2 Cs2CO3 dioxane 25 0
1.5 NiCl2(DME) collidine dioxane 25 0
3 NiCl2(DME) NaOAc dioxane 25 0
1 NiCl2(dppe) NaOAc dioxane 25 0
3 NiCl2(dppe) none dioxane 25 0
1 Ni(cod)2 NaOAc dioxane 25 3
2 Ni(PPh3)4 Cs2CO3 dioxane 25 1
2.5 NiBr2 NaOAc dioxane 25 0
3 Ni(acac)2 Et3N dioxane 25 0
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Factor 1 Factor 2 Factor 3 Factor 4 Factor 6 Response 1
A: H2O (equiv) B:  Ni source C: base D: solvent E: Temp (°C) product (%)
1 NiBr2 Cs2CO3 dioxane 75 0
1 NiCl2(DME) none dioxane 75 0
3 Ni(cod)2 Cs2CO3 dioxane 75 2
2 Ni(PPh3)4 collidine dioxane 75 0
1 Ni(cod)2 collidine dioxane 75 1
1 Ni(cod)2 Et3N dioxane 75 1
3 Ni(PPh3)2(CO)2 NaOAc dioxane 75 0
3 NiBr2 none dioxane 75 0
1 NiCl2(dppe) Cs2CO3 dioxane 75 0
2 NiCl2(dppe) collidine DME 25 0
3 Ni(acac)2 NaOAc DME 25 0
1 Ni(acac)2 none DME 25 0
2.5 Ni(PPh3)2(CO)2 Et3N DME 25 0
3 Ni(PPh3)4 collidine DME 25 1
3 Ni(cod)2 collidine DME 25 2
3 NiCl2(dppe) Et3N DME 25 0
1 NiBr2 collidine DME 25 0
1.5 NiBr2 Cs2CO3 DME 25 0
3 Ni(PPh3)4 none toluene 25 1
2.5 Ni(acac)2 Cs2CO3 toluene 25 0
3 Ni(PPh3)4 collidine toluene 25 1
3 Ni(cod)2 Et3N toluene 25 0
1 NiCl2(dppe) NaOAc toluene 25 0
3 NiCl2(DME) collidine toluene 25 0
2 Ni(PPh3)2(CO)2 none toluene 25 0
2 Ni(cod)2 Cs2CO3 toluene 25 2
2.5 NiBr2 Et3N toluene 25 0
2.5 Ni(PPh3)2(CO)2 Et3N toluene 75 0
3 NiCl2(dppe) Et3N toluene 75 0
1 Ni(cod)2 NaOAc toluene 75 2
3 Ni(acac)2 NaOAc toluene 75 0
3 NiBr2 NaOAc toluene 75 0
1 Ni(PPh3)2(CO)2 none toluene 75 0
1 Ni(PPh3)4 Cs2CO3 toluene 75 0
2 NiCl2(DME) collidine toluene 75 0
1 Ni(PPh3)4 Et3N toluene 75 0
1 Ni(cod)2 Et3N xylenes 110 1
1 Ni(cod)2 collidine xylenes 110 1
1 Ni(cod)2 NaOAc xylenes 110 1
1 Ni(cod)2 Cs2CO3 xylenes 110 1
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Allyl pivalate 
Inside the glove box, the Ni source (10 mol%) and the base (20 mol%) were added to a 4-mL 
Dram vial. A stir bar was added and the vial was sealed with a septum screw cap. A stock 
solution of allyl pivalate (0.1 mmol), p-anisaldehyde (1 equiv) and biphenyl in the designated 
solvent (1 mL) was added via syringe. H2O was subsequently added. A needle was inserted 
through the septum and the vial was placed in an autoclave, where the reaction was stirred under 
CO atmosphere (20 bar) for 18 h at the indicated temperature. After purging the autoclave with 
nitrogen, the reaction was quenched with water (0.2 mL). The mixture was diluted with EtOAc 
(2 mL). A 0.2 mL aliquot was withdrawn, filtered through a silica plug and analyzed by GC 
using the following method: 3 min at 100 °C, then 30 °C/min to 250 °C, then 2 min at 250 °C. 
 
 
 
 
 
 
 
Factor 1 Factor 2 Factor 3 Factor 4 Factor 6 Response 1
A: H2O (equiv) B:  Ni source C: base D: solvent E: Temp (°C) product (%)
1 Ni(cod)2 phenantroline DMF 100 6
1 Ni(cod)2 pyridine DMF 100 4
1 Ni(cod)2 2,4,6-tBu-pyridine DMF 100 6
1 Ni(cod)2 ethylenediamine DMF 100 5
1 Ni(cod)2 DABCO DMF 100 6
1 Ni(cod)2 KOH DMF 100 7
1 Ni(cod)2 CsOH DMF 100 6
1 Ni(cod)2 NaHCO3 DMF 100 6
1 Ni(cod)2 CuTc DMF 100 6
1 Ni(cod)2 phenantroline dioxane 80 8
1 Ni(cod)2 pyridine dioxane 80 3
1 Ni(cod)2 2,4,6-tBu-pyridine dioxane 80 1
1 Ni(cod)2 ethylenediamine dioxane 80 6
1 Ni(cod)2 DABCO dioxane 80 3
1 Ni(cod)2 KOH dioxane 80 2
1 Ni(cod)2 CsOH dioxane 80 1
1 Ni(cod)2 NaHCO3 dioxane 80 1
1 Ni(cod)2 CuTc dioxane 80 1
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Control experiments with water (Scheme 3.28) 
 
In the glove box, a 5-mL Schlenk flask was charged with Ni(cod)2 (34.4 mg, 0.125 mmol, 0.5 
equiv), biphenyl (19.2 mg), DMF (2.5 mL), allyl pivalate (35.5 mg, 0.25 mmol), water (0-15 
equiv), and p-anisaldehyde (30 µL, 1 equiv). The flask was sealed and removed from the glove 
box. The mixture was stirred at room temperature. After 3 h, an aliquot was taken, diluted with 
EtOAc, filtered through a silica plug and analyzed by GC using the following method: 3 min at 
100 °C, then 30 °C/min to 250 °C, then 2 min at 250 °C. 
 
Study of the Ni-catalyzed aryl homocoupling reaction (Scheme 3.29) 
 
In the glove box, the Ni source (5 mol%) and the base (10 mol%) were added to a 4-mL 
Dram vial. A stir bar was added and the vial was sealed with a septum screw cap. A stock 
solution of the bromide (0.2 mmol), biphenyl, and water (1 equiv) in the designated solvent (1 
mL) was added via syringe. A needle was inserted through the septum and the vial was placed in 
an autoclave, where the reaction was stirred under CO atmosphere (20 bar) for 20 h at the 
indicated temperature. After purging the autoclave with nitrogen, the reaction was quenched with 
water (0.2 mL). The mixture was diluted with EtOAc (2 mL). A 0.2 mL aliquot was withdrawn, 
filtered through a silica plug and analyzed by GC using the following method: 2.5 min at 100 °C, 
then 50 °C/min to 260 °C, then 5 min at 260 °C. 
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Control experiments with water (Scheme 3.30) 
 
In the glove box, a 5-mL Schlenk flask was charged with Ni(cod)2 (41 mg, 0.15 mmol, 0.5 
equiv), biphenyl (23 mg), DMF (1 mL), p-bromobenzonitrile (55 mg, 0.3 mmol), and water (0-5 
equiv). The flask was sealed and removed from the glove box. The mixture was stirred at room 
temperature. After 20 h, an aliquot was taken, diluted with EtOAc, filtered through a silica plug 
and analyzed by GC using the following method: 2.5 min at 100 °C, then 50 °C/min to 260 °C, 
then 5 min at 260 °C. 
 
  
Factor 2 Factor 3 Factor 4 Factor 6 Response 1 Response 2 Response 3
B:  Ni source C: base D: solvent E: Temp (°C) product (%) Ar-Br (%) Ph-CN (%)
NiCl2(dppe) phenantroline DMF 100 0 96 5
Ni(PPh3)2(CO)2 Cs2CO3 DMF 100 0 91 4
NiBr2(diglyme) collidine DMF 100 0 93 1
Ni(PPh3)2(CO)2 none DMF 100 1 88 1
Ni(PPh3)2(CO)2 collidine DMF 100 1 92 1
Ni(cod)2 collidine DMF 100 2 91 1
NiBr2(diglyme) Et3N DMF 100 0 95 1
Ni(cod)2 NaOAc DMF 100 2 89 1
NiCl2(dppe) none DMF 100 0 94 0
Ni(cod)2 none dioxane 90 2 93 2
NiBr2(diglyme) none dioxane 90 0 97 1
Ni(cod)2 phenantroline dioxane 90 4 93 1
Ni(PPh3)2(CO)2 Et3N dioxane 90 0 97 1
Ni(PPh3)2(CO)2 NaOAc dioxane 90 1 97 1
NiBr2(diglyme) Cs2CO3 dioxane 90 0 98 1
NiCl2(dppe) collidine dioxane 90 0 98 0
NiCl2(dppe) Cs2CO3 dioxane 90 0 99 0
NiCl2(dppe) phenantroline dioxane 90 0 99 0
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Tri(furan-2-yl)phosphine oxide [AA-16-DU9281] 
 
Tri(2-furyl)phosphine (400 mg, 1.72 mmol) was dissolved in DCM (20 mL) in a 250-mL, 
round-bottom flask. H2O2 (30%, 10 mL, 88 mmol, 51 equiv) was then added. The mixture was 
stirred at room temperature for 2 h. The layers were separated; the organic layer was washed 
with water (2 x 50 mL), dried over Na2SO4, filtered, and concentrated (after testing for peroxide 
content). The resulting semisolid was washed with pentane and dried under vacuum, to provide 
3.15 (425 mg, 99%) as a white solid. 
Data for 3.15: 
 1
H NMR: (500 MHz, CDCl3) 
  δ 7.74 (br s, 3H), 7.19 – 7.15 (m, 3H), 6.58 – 6.53 (m, 3H) 
 31
P NMR: (202 MHz, CDCl3) 
  δ -11.02  
 
Tris(2,4-dimethoxyphenyl)phosphine oxide [AA-16-DU9285] 
 
Tris(2,4-dimethoxyphenyl)phosphine (700 mg, 1.58 mmol) was dissolved in DCM (20 mL) 
in a 250-mL, round-bottom flask. H2O2 (30%, 10 mL, 88 mmol, 56 equiv) was then added. The 
mixture was stirred at room temperature for 2 h. The layers were separated; the organic layer was 
washed with water (2 x 50 mL), dried over Na2SO4, filtered, and concentrated (after testing for 
peroxide content). The resulting semisolid was washed with pentane and dried under vacuum, to 
provide 3.16 (722 mg, 100%) as a white solid. 
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Data for 3.16: 
 1
H NMR: (500 MHz, CDCl3) 
δ 7.38 (dd, J = 14.4, 8.5 Hz, 3H), 6.47 (d, J = 8.5 Hz, 3H), 6.43 – 6.40 (m, 3H), 
3.82 (s, 9H), 3.57 (s, 9H) 
 31
P NMR: (202 MHz, CDCl3) 
  δ 24.80 
 
Tri(furan-2-yl)arsine oxide (3.17) [DGD] 
 
Tri(2-furyl)arsine (5.00 g, 18.2 mmol) was dissolved in CH3CN (60 mL) in a 250-mL, round-
bottom flask. H2O2 (30%, 30 mL, 264 mmol, 14.5 equiv) was then added. The mixture was 
stirred at room temperature for 2 h. Water (10 mL) and DCM (100 mL) were added. The layers 
were separated and the water layer was extracted with DCM (3 x 30 mL). The combined organic 
extracts were washed with brine (2 x 30 mL), dried over Na2SO4, filtered, and concentrated (after 
testing for peroxide content). The resulting semisolid was washed with pentane and dried under 
vacuum, to provide 3.17 (5.22 g, 98%) as a white solid. 
Data for 3.17: 
 1
H NMR: (500 MHz, CDCl3) 
δ 7.76 (dd, J = 1.7, 0.6 Hz, 3H), 7.20 (dd, J = 3.5, 0.6 Hz, 3H), 6.60 (dd, J = 3.5, 
1.7 Hz, 1H) 
 
Triphenylstibine oxide [AA-16-DU9292] 
 
Triphenylstibine (1.0 g, 2.83 mmol) was dissolved in acetone (20 mL) in a 100-mL, round-
bottom flask. H2O2 (30%, 1.0 mL, 8.8 mmol, 3.1 equiv) was added dropwise. The mixture was 
stirred at room temperature for 20 min. The white precipitate was collected by filtration, washed 
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with Et2O and dried under high vacuum. The resulting white solid (967 mg, 93%) was insoluble 
in any solvent, and was identified as triphenylstibine oxide from its diagnostic IR bands (665 and 
488 cm
-1
).
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Tributylstibine [AA-16-EO7724] 
 
In the glove box, a 250-mL, 3-neck round-bottom was charged with antimony trichloride 
(4.56 g, 20 mmol). The flask was sealed with septa, removed from the glove box, and an addition 
funnel was installed under a stream of Ar. Diethyl ether (40 mL) was added via syringe. BuLi 
(1.59 M in hexanes, 39.0 mL, 62 mmol, 3.1 equiv) was cannula-transferred into the addition 
funnel. The flask was cooled to -78 °C and BuLi was added dropwise over 30 min. After 
completing the addition, the mixture was allowed to warm to room temperature. A suspension 
resulted, with traces of antimony accumulated on the wall of the flask. The mixture was stirred 
for 1 h, and the solvents were then removed under high vacuum. A short-path distillation head 
was installed under a stream of Ar. The product was recovered by vacuum distillation as a clear 
liquid (4.46 g, 76%). 
Data: 
 bp: 90-93 °C/1 mmHg 
 1
H NMR: (500 MHz, CD2Cl2) 
δ 1.56 – 1.48 (m, 6H), 1.42 – 1.32 (m, 12H), 0.90 (t, J = 7.3 Hz, 9H) 
 13
C NMR: (126 MHz, CD2Cl2) 
  δ 30.45, 26.86, 14.65, 13.87 
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Study of the deoxygenation of phosphine oxides (Scheme 3.31) 
 
The metal carbonyl catalyst (or selenium) was added to an oven-dried dram vial in the glove 
box, followed by the phosphine oxide (0.25 mmol), the base, and the solvent (1 mL). The vial 
was sealed with a septum screw cap and removed from the glove box. Deoxygenated water was 
added via syringe. A needle was inserted through the septum and the vial placed in an autoclave. 
The autoclave was pressurized with CO (30 bar) and heated to the indicated temperature. The 
reaction was stirred for 16 h. After cooling and venting the autoclave, 0.2 mL of the reaction 
mixture were transferred into an NMR tube containing 0.5 mL of CDCl3, and the conversion 
determined by 
31
P NMR. 
 
 
 
 
 
M cat. base solvent Temp (°C) product (%)
Cr(CO)6 NaOH dioxane 90 0
Mn2(CO)10 NaOH dioxane 90 0
Fe3(CO)12 NaOH dioxane 90 0
Ru3(CO)12 NaOH dioxane 90 0
Co2(CO)8 NaOH dioxane 90 0
Rh4(CO)12 NaOH dioxane 90 0
Cr(CO)6 Et3N dioxane 90 0
Mn2(CO)10 Et3N dioxane 90 0
Fe3(CO)12 Et3N dioxane 90 0
Ru3(CO)12 Et3N dioxane 90 0
Co2(CO)8 Et3N dioxane 90 0
Rh4(CO)12 Et3N dioxane 90 0
Se none DMF 120 0
Se Et3N DMF 120 0
Se Py DMF 120 0
Se NaOAc DMF 120 0
Se KOH DMF 120 0
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With 3.15: 
 
 
With 3.16: 
 
 
Study of the deoxygenation of arsine oxides (Scheme 3.32) 
 
The metal carbonyl catalyst (5 mol%) was added to an oven-dried dram vial in the glove box, 
followed by the arsine oxide (0.15 mmol), the base (5 equiv) and the solvent (1 mL). The vial 
was sealed with a septum screw cap and removed from the glove box. Water (10 equiv) was 
added via syringe. A needle was inserted through the septum and the vial placed in an autoclave. 
The autoclave was pressurized with CO (30 bar) and heated to 100 °C for 16 h. After cooling and 
venting the autoclave, an aliquot was taken, diluted with i-PrOH, filtered through a silica plug 
and analyzed by HPLC. 
  
M(CO)n base solvent Temp (°C) product (%)
Fe3(CO)12 Et3N diglyme 120 0
Ru3(CO)12 Et3N diglyme 120 0
Rh4(CO)12 Et3N diglyme 120 0
Fe3(CO)12 KOH diglyme 120 0
Ru3(CO)12 KOH diglyme 120 0
Rh4(CO)12 KOH diglyme 120 0
M(CO)n base solvent Temp (°C) product (%)
Fe3(CO)12 Et3N diglyme 100 0
Ru3(CO)12 Et3N diglyme 100 0
Rh4(CO)12 Et3N diglyme 100 0
Fe3(CO)12 KOH diglyme 100 0
Ru3(CO)12 KOH diglyme 100 0
Rh4(CO)12 KOH diglyme 100 0
M(CO)n base solvent Temp (°C) product (%)
Fe3(CO)12 Et3N diglyme 100 0
Ru3(CO)12 Et3N diglyme 100 0
Rh4(CO)12 Et3N diglyme 100 0
Fe3(CO)12 KOH diglyme 100 0
Ru3(CO)12 KOH diglyme 100 0
Rh4(CO)12 KOH diglyme 100 trace
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The metal carbonyl catalyst was added to an oven-dried dram vial in the glove box, followed 
by the arsine oxide 3.17 (0.2 mmol), the base (10 equiv) and the solvent (0.5 mL). The vial was 
sealed with a septum screw cap and removed from the glove box. Water (50 equiv) was added 
via syringe. A needle was inserted through the septum and the vial placed in an autoclave. The 
autoclave was pressurized with CO (30 bar) and heated to 90 °C for 16 h. After cooling and 
venting the autoclave, 0.2 mL of the reaction mixture were transferred into an NMR tube, and 
the volatiles were removed under vacuum. CDCl3 was added, and the conversion determined by 
31
H NMR. 
 
 
Study of the deoxygenation of triphenylstibine oxide (Table 3.6) 
 
The metal carbonyl catalyst (1.25 mol%) was added to an oven-dried dram vial in the glove 
box, followed by the stibine oxide (0.1 mmol), the base (10 equiv) and the solvent (0.8 mL). The 
vial was sealed with a septum screw cap and removed from the glove box. Water was added via 
M(CO)n base solvent Temp (°C) product (%)
Rh4(CO)12 KOH DMF 90 31
Rh4(CO)12 TMEDA DMF 90 35
Rh4(CO)12 KOH 2-ethoxyehtanol 90 0
Rh4(CO)12 TMEDA 2-ethoxyehtanol 90 12
Rh4(CO)12 KOH diglyme 90 0
Rh4(CO)12 TMEDA diglyme 90 0
Ru3(CO)12 KOH DMF 90 0
Ru3(CO)12 TMEDA DMF 90 17
Ru3(CO)12 KOH 2-ethoxyehtanol 90 0
Ru3(CO)12 TMEDA 2-ethoxyehtanol 90 14
Ru3(CO)12 KOH diglyme 90 0
Ru3(CO)12 TMEDA diglyme 90 0
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syringe. A needle was inserted through the septum and the vial placed in an autoclave. The 
autoclave was pressurized with CO (30 bar) and heated to the indicated temperature for 16 h. 
After cooling and venting the autoclave, an aliquot from the reaction mixture was analyzed by 
HPLC. Quantitative data were obtained by comparison of the absorbance with samples at known 
concentration. 
 
 
Study of the olefination reaction catalyzed by Bu3Sb (Tables 3.7 and 3.8) 
 
In the glove box, a stock solution of Rh4(CO)12 (1.25 mol%), benzaldehyde (0.15 mmol), 
bromoacetophenone (2 equiv), tributylstibine, and t-Bu-benzene (internal standard) in the solvent 
was added to an oven-dried dram vial. The base was then added. The vial was sealed with a 
septum screw cap and removed from the glove box. Deoxygenated water was added via syringe. 
A needle was inserted through the septum and the vial placed in an autoclave. The autoclave was 
pressurized with CO (30 bar) and heated to the indicated temperature for 16 h. After cooling and 
venting the autoclave, the reaction mixture was quenched with water (1 mL) and diluted with 
EtOAc (1 mL). A 0.2 mL aliquot was withdrawn, filtered through a silica plug, and analyzed by 
GC-MS. 
M(CO)n TMEDA (equiv) solvent Temp (°C) H2O (equiv) product (%)
Rh4(CO)12 10 diglyme 90 50 82
Rh4(CO)12 10 diglyme 90 0 46
Rh4(CO)12 0 diglyme 90 50 21
Rh4(CO)12 0 diglyme 90 0 23
Rh4(CO)12 10 DMF 90 50 81
Rh4(CO)12 10 DMF 90 0 49
Rh4(CO)13 0 DMF 90 50 31
Rh4(CO)14 0 DMF 90 0 15
Rh4(CO)12 10 dioxane 60 50 35
Rh4(CO)12 10 DMF 60 50 14
Rh4(CO)12 10 DMF 60 0 28
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Bu3Sb (mol%) base solvent Temp (°C) H2O (equiv) product (%) acetophenone (%)
30 collidine DMF 90 - 12 35
30 collidine DMF 90 0.2 11 38
30 collidine DMF 90 1 4 38
30 - DMF 90 - 13 31
30 - DMF 90 0.2 9 32
30 - DMF 90 1 2 38
30 collidine toluene 90 - 16 31
30 collidine toluene 90 0.2 12 35
30 collidine toluene 90 1 2 44
30 - toluene 90 - 9 29
30 - toluene 90 0.2 6 33
30 - toluene 90 1 77 35
30 - toluene 90 2 74 44
30 DIPEA toluene 90 1 15 67
30 DBU toluene 90 1 2 21
30 proton sponge toluene 90 1 20 59
5 K2CO3 toluene 70 0.5 0 13
5 Cs2CO3 toluene 70 0.5 26 69
5 K3PO4 toluene 70 0.5 17 42
5 K2CO3 toluene 70 1 0 15
5 Cs2CO3 toluene 70 1 8 65
5 K3PO4 toluene 70 1 13 27
15 - toluene 70 0.5 0 28
15 - toluene 70 1 75 28
15 - toluene 70 2 82 38
30 - toluene 70 0.5 0 34
30 - toluene 70 1 54 43
30 - toluene 70 2 71 54
5 - toluene 70 0.5 79 18
5 - toluene 70 1 83 23
5 - toluene 70 2 62 31
10 - toluene 70 0.5 77 19
10 - toluene 70 1 88 27
10 - toluene 70 2 35 37
Rh4(CO)12 Bu3Sb (mol%) CO solvent Temp (°C) H2O (equiv) product (%) acetophenone (%)
 -  toluene 70 2 0 0
- 15  toluene 70 2 0 13
 15 - toluene 70 2 0 23
(based on aldehyde) (based on bromide)
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Stoichiometric olefination reaction monitored by 
1
H NMR (Scheme 3.34) [AA-16-EO7742] 
 
Bromoacetophenone (20.0 mg, 0.1 mmol), benzaldehyde (10.6 mg, 0.1 mmol) and 1,1,2,2-
tetrachloroethane (8.3 mg, 0.05 mmol, internal standard) were dissolved in dry d8-toluene. 
Tributylstibine (29.3 mg, 0.1 mmol, 1 equiv) was added. The mixture was transferred into an 
oven-dried NMR tube. The sealed tube was inserted into a pre-heated (70 °C) NMR probe. 
1
H 
NMR spectra were recorded every 10 min (nt = 4, d1 = 10 s, at = 4.096 s). 
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5.6. EXPERIMENTS FOR CHAPTER 4 
General Procedure VI: Reaction of ethyl cyanoacetate with aldehydes (Table 4.1) 
 
RhCl3·3H2O was added to a 40-mL glass vial, followed by acetonitrile, ethyl cyanoacetate 
4.6a, the aldehyde 4.7, deionized water, and triethylamine. A stir bar was added, and the vial was 
placed in an autoclave. The autoclave was pressurized with CO and vented three times, and then 
pressurized to 10 bar. The reaction was stirred at room temperature for the indicated time. After 
venting and purging the autoclave with nitrogen, the vial was removed. The volatiles were 
removed under reduced pressure, the residue was dissolved in CH2Cl2, and loaded on silica gel 
(1 g). The crude mixture was purified by silica gel column chromatography (2.5 x 20-25 cm), 
followed by distillation or recrystallization. 
 
Ethyl 2-cyano-3-phenylpropanoate (4.8aa) [AA-16-EW3708] 
 
Following General Procedure VI, RhCl3·3H2O (10.5 mg, 0.04 mmol, 2 mol%), CH3CN (4.0 
mL), ethyl cyanoacetate (0.213 mL, 2.0 mmol), benzaldehyde (0.214 mL, 2.1 mmol, 1.05 equiv), 
H2O (0.108 mL, 6.0 mmol, 3.0 equiv), and Et3N (0.70 mL, 5.0 mmol, 2.5 equiv) were 
sequentially added to a 40-mL vial. The reaction was stirred at room temperature for 24 h. 
Purification by silica gel column chromatography (pentane/Et2O 8:2), followed by Kugelrohr 
distillation, afforded 4.8aa (363 mg, 89%) as a colorless oil. The spectral data matched those 
previously reported in the literature.
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Data for 4.8aa: 
 bp: 192 °C (ABT, 0.5 mmHg) 
 1
H NMR: (500 MHz, CDCl3) 
δ 7.38 – 7.26 (m, 5H, C(ar)H), 4.24 (q, J = 7.1 Hz, 2H, C(4)H2), 3.72 (dd, J = 
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8.4, 5.8 Hz, 1H, C(2)H), 3.28 (dd, J = 13.8, 5.8 Hz, 1H, C(6)H), 3.20 (dd, J = 
13.8, 8.4 Hz, 1H, C(6)H’), 1.27 (t, J = 7.1 Hz, 3H, C(5)H3) 
 
13
C NMR: (126 MHz, CDCl3) 
δ 165.5 C(3), 135.4 C(7), 129.0, 128.8, 127.7 C(10), 116.0 C(1), 62.8 C(4), 39.6 
C(2), 35.9 C(6), 13.9 C(5) 
 HRMS: (EI)  
  m/z: [M]
+
 Calcd for C12H13NO2: 203.0946; Found: 203.0950 
 TLC: Rf 0.21 (pentane/Et2O 8:2) [silica gel, UV, iodine] 
 
Ethyl 2-cyano-3-(o-tolyl)propanoate (4.8ab) [AA-16-EW3723] 
 
Following General Procedure VI, RhCl3·3H2O (10.5 mg, 0.04 mmol, 2 mol%), CH3CN (4.0 
mL), ethyl cyanoacetate (0.213 mL, 2.0 mmol), o-tolualdehyde (0.243 mL, 2.1 mmol, 1.05 
equiv), H2O (0.108 mL, 6.0 mmol, 3.0 equiv), and Et3N (0.70 mL, 5.0 mmol, 2.5 equiv) were 
sequentially added to a 40-mL vial. The reaction was stirred at room temperature for 24 h. 
Purification by silica gel column chromatography (pentane/Et2O 85:15), followed by Kugelrohr 
distillation, afforded 4.8ab (383 mg, 88%) as a colorless oil. 
Data for 4.8ab: 
 bp: 209 °C (ABT, 0.5 mmHg) 
 1
H NMR: (500 MHz, CDCl3) 
δ 7.24 – 7.16 (m, 4H, C(ar)H), 4.31 – 4.22 (m, 2H, C(4)H2), 3.67 (dd, J = 9.4, 6.0 
Hz, 1H, C(2)H), 3.34 (dd, J = 14.1, 6.0 Hz, 1H, C(6)H), 3.19 (dd, J = 14.1, 9.4 
Hz, 1H, C(6)H’), 2.37 (s, 3H, C(13)H3), 1.29 (t, J = 7.2 Hz, 3H, C(5)H3) 
 
13
C NMR: (126 MHz, CDCl3) 
δ 165.7 C(3), 136.2 C(7), 133.6 C(8), 130.8, 129.6, 127.8, 126.4, 116.2 C(1), 
62.9 C(4), 38.4 C(2), 33.1 C(6), 19.2 C(13), 13.9 C(5) 
 IR: (neat) 
2983 (w), 2250 (w), 1741 (s), 1455 (w), 1370 (w), 1259 (m), 1200 (m), 1160 
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(m), 1027 (m), 860 (w), 753 (s) 
 HRMS: (EI)  
  m/z: [M]
+
 Calcd for C13H15NO2: 217.1103; Found: 217.1103 
 TLC: Rf 0.30 (pentane/Et2O 8:2) [silica gel, UV, iodine] 
 Analysis: C13H15NO2 
  Calcd: C, 71.87; H, 6.96; N, 6.45 
  Found: C, 71.95; H, 6.95; N, 6.57 
 
Ethyl 2-cyano-3-(2-fluorophenyl)propanoate (4.8ac) [AA-16-EW3728] 
 
Following General Procedure VI, RhCl3·3H2O (10.5 mg, 0.04 mmol, 2 mol%), CH3CN (4.0 
mL), ethyl cyanoacetate (0.213 mL, 2.0 mmol), 2-fluorobenzaldehyde (0.221 mL, 2.1 mmol, 
1.05 equiv), H2O (0.108 mL, 6.0 mmol, 3.0 equiv), and Et3N (0.70 mL, 5.0 mmol, 2.5 equiv) 
were sequentially added to a 40-mL vial. The reaction was stirred at room temperature for 24 h. 
Purification by silica gel column chromatography (pentane/Et2O 85:15), followed by Kugelrohr 
distillation, afforded 4.8ac (407 mg, 92%) as a colorless oil. The spectral data matched those 
previously reported in the literature.
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Data for 4.8ac: 
 bp: 188 °C (ABT, 0.5 mmHg) 
 1
H NMR: (500 MHz, CDCl3) 
δ 7.34 – 7.27 (m, 2H, C(10)H, C(12)H), 7.13 (td, J = 7.5, 1.1 Hz, 1H, C(11)H), 
7.10 – 7.04 (m, 1H, C(9)H), 4.28 – 4.21 (m, 2H, C(4)H2), 3.81 (dd, J = 8.8, 6.4 
Hz, 1H, C(2)H), 3.38 (dd, J = 14.0, 6.4 Hz, 1H, C(6)H), 3.19 (dd, J = 13.9, 8.8 
Hz, 1H, C(6)H’), 1.28 (t, J = 7.2 Hz, 3H, C(5)H3) 
 
13
C NMR: (126 MHz, CDCl3) 
δ 165.2 C(3), 161.0 (d, J = 246.4 Hz, C(8)), 131.4 (d, J = 3.9 Hz, C(12)), 129.7 
(d, J = 8.2 Hz, C(10)), 124.4 (d, J = 3.6 Hz, C(11)), 122.3 (d, J = 15.2 Hz, C(7)), 
115.8 C(1), 115.5 (d, J = 21.6 Hz, C(9)), 62.9 C(4), 37.9 (d, J = 1.6 Hz, C(2)), 
302 
 
29.5 (d, J = 2.4 Hz, C(6)), 13.81 C(5) 
 19
F NMR: (470 MHz, CDCl3) 
  δ ‒118.2 
 HRMS: (EI)  
  m/z: [M]
+
 Calcd for C12H12FNO2: 221.0852; Found: 221.0851 
 TLC: Rf 0.29 (pentane/Et2O 8:2) [silica gel, UV, iodine] 
  
Ethyl 2-cyano-3-(3-vinylphenyl)propanoate (4.8ad) [AA-16-EW3724] 
 
Following General Procedure VI, RhCl3·3H2O (10.5 mg, 0.04 mmol, 2 mol%), CH3CN (4.0 
mL), ethyl cyanoacetate (0.213 mL, 2.0 mmol), 3-vinylbenzaldehyde (0.267 mL, 2.1 mmol, 1.05 
equiv), H2O (0.108 mL, 6.0 mmol, 3.0 equiv), and Et3N (0.70 mL, 5.0 mmol, 2.5 equiv) were 
sequentially added to a 40-mL vial. The reaction was stirred at room temperature for 24 h. 
Purification by silica gel column chromatography (pentane/Et2O 8:2) afforded 4.8ad (423 mg, 
92%) as a pale yellow oil. 4.8ad underwent polymerization over the course of a few hours at 
room temperature. 
Data for 4.8ad: 
 1
H NMR: (500 MHz, CDCl3) 
δ 7.38 – 7.28 (m, 3H, C(8)H, C(10)H, C(11)H), 7.17 (d, J = 7.3 Hz, 1H, 
C(12)H), 6.70 (dd, J = 17.6, 10.9 Hz, 1H, C(13)H), 5.76 (d, J = 17.6 Hz, 1H, 
C(14)Htrans), 5.27 (d, J = 10.9 Hz, 1H, C(14)Hcis), 4.24 (q, J = 7.1 Hz, 2H, 
C(4)H2), 3.73 (dd, J = 8.4, 5.9 Hz, 1H, C(2)H), 3.27 (dd, J = 13.8, 5.8 Hz, 1H, 
C(6)H), 3.19 (dd, J = 13.8, 8.4 Hz, 1H, C(6)H’), 1.26 (t, J = 7.1 Hz, 3H, C(5)H3) 
 
13
C NMR: (126 MHz, CDCl3) 
δ 165.5 C(3), 138.1 C(9), 136.3 C(13), 135.5 C(7), 129.0C(11), 128.4 C(12), 
126.8 C(8), 125.6 C(10), 116.1 C(1), 114.5 C(14), 62.9 C(4), 39.6 C(2), 35.6 
C(6), 13.9 C(5) 
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 HRMS: (EI)  
  m/z: [M]
+
 Calcd for C14H15NO2: 229.1103; Found: 229.1113 
 TLC: Rf 0.31 (pentane/Et2O 8:2) [silica gel, UV, iodine] 
 
Ethyl 2-cyano-3-(4-(methylthio)phenyl)propanoate (4.8ae) [AA-16-EW3727]  
 
Following General Procedure VI, RhCl3·3H2O (10.5 mg, 0.04 mmol, 2 mol%), CH3CN (4.0 
mL), ethyl cyanoacetate (0.213 mL, 2.0 mmol), 4-(methylthio)benzaldehyde (0.279 mL, 2.1 
mmol, 1.05 equiv), H2O (0.108 mL, 6.0 mmol, 3.0 equiv), and Et3N (0.70 mL, 5.0 mmol, 2.5 
equiv) were sequentially added to a 40-mL vial. The reaction was stirred at room temperature for 
24 h. Purification by silica gel column chromatography (pentane/Et2O 8:2), followed by 
Kugelrohr distillation, afforded 4.8ae (365 mg, 73%) as a yellow oil. 
Data for 4.8ae: 
 bp: 244 °C (ABT, 0.5 mmHg) 
 1
H NMR: (500 MHz, CDCl3) 
δ 7.22 (d, J = 8.6 Hz, 2H, C(9)H), 7.19 (d, J = 8.5 Hz, 2H, C(8)H), 4.24 (q, J = 
7.1 Hz, 2H, C(4)H2), 3.69 (dd, J = 8.3, 5.8 Hz, 1H, C(2)H), 3.23 (dd, J = 13.9, 
5.8 Hz, 1H, C(6)H), 3.15 (dd, J = 13.9, 8.3 Hz, 1H, C(6)H’), 2.47 (s, 3H, 
C(11)H3), 1.28 (t, J = 7.1 Hz, 3H, C(5)H3) 
 
13
C NMR: (126 MHz, CDCl3) 
δ 165.4 C(3), 138.1 C(10), 131.9 C(7), 129.4 C(8), 126.8 C(9), 116.0 C(1), 62.9 
C(4), 39.6 C(2), 35.1 C(6), 15.6 C(11), 13.9 C(5) 
 IR: (neat) 
2983 (w), 2923 (w), 2250 (w), 1739 (s), 1601 (w), 1495 (m), 1441 (w), 1369 (w), 
1257 (m), 1193 (m), 1094 (m), 1025 (m), 856 (w), 830 (w), 804 (m) 
 HRMS: (EI)  
  m/z: [M]
+
 Calcd for C13H15NO2S: 249.0823; Found: 249.0826 
 TLC: Rf 0.16 (pentane/Et2O 8:2) [silica gel, UV, iodine] 
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 Analysis: C13H15NO2S 
  Calcd: C, 62.63; H, 6.06; N, 5.62 
  Found: C, 62.53; H, 5.99; N, 5.58 
 
Ethyl 2-cyano-3-(4-methoxyphenyl)propanoate (4.8af) [AA-16-EW3709] 
 
Following General Procedure VI, RhCl3·3H2O (10.5 mg, 0.04 mmol, 2 mol%), CH3CN (4.0 
mL), ethyl cyanoacetate (0.213 mL, 2.0 mmol), p-anisaldehyde (0.256 mL, 2.1 mmol, 1.05 
equiv), H2O (0.072 mL, 4.0 mmol, 2.0 equiv), and Et3N (0.70 mL, 5.0 mmol, 2.5 equiv) were 
sequentially added to a 40-mL vial. The reaction was stirred at room temperature for 18 h. 
Purification by silica gel column chromatography (pentane/Et2O 7:3), followed by Kugelrohr 
distillation, afforded 4.8af (433 mg, 93%) as a colorless oil. The spectral data matched those 
previously reported in the literature.
34 
Data for 4.8af: 
 bp: 210 °C (ABT, 0.5 mmHg) 
 1
H NMR: (500 MHz, CDCl3) 
δ 7.19 (d, J = 8.6 Hz, 2H, C(8)H), 6.87 (d, J = 8.6 Hz, 2H, C(9)H), 4.24 (q, J = 
7.1 Hz, 2H, C(4)H2), 3.80 (s, 3H, C(11)H3), 3.68 (dd, J = 8.3, 5.8 Hz, 1H, 
C(2)H), 3.22 (dd, J = 13.9, 5.8 Hz, 1H, C(6)H), 3.15 (dd, J = 13.9, 8.3 Hz, 1H, 
C(6)H’), 1.28 (t, J = 7.1 Hz, 3H, C(5)H3) 
 
13
C NMR: (126 MHz, CDCl3) 
δ 165.5 C(3), 159.1 C(10), 130.1 C(8), 127.2 C(7), 116.2 C(1), 114.2 C(9), 62.8 
C(4), 55.2 C(11), 39.9 C(2), 35.0 C(6), 13.9 C(5) 
 HRMS: (EI)  
  m/z: [M]
+
 Calcd for C13H15NO3: 233.1052; Found: 233.1056 
 TLC: Rf 0.15 (pentane/Et2O 8:2) [silica gel, UV, iodine] 
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Ethyl 2-cyano-3-(2,4,6-trimethoxyphenyl)propanoate (4.8ag) [AA-16-EW3718] 
 
Following General Procedure VI, RhCl3·3H2O (10.5 mg, 0.04 mmol, 2 mol%), CH3CN (4.0 
mL), ethyl cyanoacetate (0.213 mL, 2.0 mmol), 2,4,6-trimethoxybenzaldehyde (412 mg, 2.1 
mmol, 1.05 equiv), H2O (0.072 mL, 4.0 mmol, 2.0 equiv), and Et3N (0.70 mL, 5.0 mmol, 2.5 
equiv) were sequentially added to a 40-mL vial. The reaction was stirred at room temperature for 
18 h. Purification by silica gel column chromatography (pentane/Et2O 1:1), followed by 
recrystallization (hexane/acetone 9:1), afforded 4.8ag (535 mg, 91%) as a white, crystalline 
solid. 
Data for 4.8ag: 
 mp: 81-82 °C (hexane/acetone 9:1) 
 1
H NMR: (500 MHz, CDCl3) 
δ 6.12 (s, 2H, C(9)H), 4.23 (q, J = 7.1 Hz, 2H, C(4)H2), 3.89 – 3.75 (m, 10H, 
C(2)H, C(11)H3, C(12)H3), 3.29 (dd, J = 13.3, 9.2 Hz, 1H, C(6)H), 3.19 (dd, J = 
13.4, 6.8 Hz, 1H, C(6)H’), 1.30 (t, J = 7.1 Hz, 3H, C(5)H3) 
 
13
C NMR: (126 MHz, CDCl3) 
δ 166.4 C(3), 160.7 C(10), 159.1 C(8), 116.8 C(1), 104.2 C(7), 90.4 C(9), 62.4 
C(4), 55.6 C(11), 55.3 C(12), 37.1 C(2), 23.6 C(6), 13.9 C(5) 
 IR: (neat) 
3004 (w), 2948 (w), 2836 (w), 2252 (w), 1732 (s), 1597 (s), 1501 (m), 1469 (m), 
1459 (m), 1420 (m), 1370 (w), 1343 (w), 1272 (m), 1194 (s), 1147 (s), 1120 (s), 
1056 (m), 1038 (m), 995 (w), 946 (m), 820 (s), 809 (s)  
 HRMS: (EI)  
  m/z: [M]
+
 Calcd for C15H19NO5: 293.1263; Found: 293.1269 
 TLC: Rf 0.08 (pentane/Et2O 8:2) [silica gel, UV, iodine] 
 Analysis: C15H19NO5 
  Calcd: C, 61.42; H, 6.53; N, 4.78 
  Found: C, 61.30; H, 6.58; N, 4.79 
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Ethyl 3-(4-(allyloxy)phenyl)-2-cyanopropanoate (4.8ah) [AA-16-EW3730] 
 
Following General Procedure VI, RhCl3·3H2O (10.5 mg, 0.04 mmol, 2 mol%), CH3CN (4.0 
mL), ethyl cyanoacetate (0.213 mL, 2.0 mmol), 4-allyloxybenzaldehyde (0.322 mL, 2.1 mmol, 
1.05 equiv), H2O (0.072 mL, 4.0 mmol, 2.0 equiv), and Et3N (0.70 mL, 5.0 mmol, 2.5 equiv) 
were sequentially added to a 40-mL vial. The reaction was stirred at room temperature for 18 h. 
Purification by silica gel column chromatography (pentane/Et2O 8:2) afforded 4.8ah (450 mg, 
87%) as a colorless oil. 
Data for 4.8ah: 
 1
H NMR: (500 MHz, CDCl3) 
δ 7.18 (d, J = 8.5 Hz, 2H, C(8)H), 6.88 (d, J = 8.6 Hz, 2H, C(9)H), 6.05 (ddt, J = 
16.9, 10.3, 5.2 Hz, 1H, C(12)H), 5.41 (ddd, J = 17.3, 2.9, 1.4 Hz, 1H, 
C(13)Htrans), 5.29 (ddd, J = 10.5, 2.3, 1.2 Hz, 1H, C(13)Hcis), 4.52 (dt, J = 5.3, 
1.3 Hz, 2H, C(11)H2), 4.23 (q, J = 7.1 Hz, 2H, C(4)H2), 3.67 (dd, J = 8.2, 5.8 Hz, 
1H, C(2)H), 3.21 (dd, J = 13.9, 5.8 Hz, 1H, C(6)H), 3.14 (dd, J = 13.9, 8.3 Hz, 
1H, C(6)H’), 1.27 (t, J = 7.2 Hz, 3H, C(5)H3) 
 
13
C NMR: (126 MHz, CDCl3) 
δ 165.5 C(3), 158.1 C(10), 133.1 C(12), 130.1 C(8), 127.4 C(7), 117.6 C(13), 
116.2 C(1), 114.9 C(9), 68.7 C(11), 62.8 C(4), 39.9 C(2), 34.9 C(6), 13.9 C(5) 
 IR: (neat) 
2984 (w), 2924 (w), 2868 (w), 2254 (w), 1888 (w), 1725 (s), 1612 (w), 1511 (s), 
1443 (w), 1430 (w), 1371 (m), 1345 (w), 1298 (m), 1247 (s), 1216 (s), 1180 (s), 
1111 (m), 1022 (s), 997 (m), 943 (s), 744 (m), 646 (m)    
 HRMS: (EI)  
  m/z: [M]
+
 Calcd for C15H17NO3: 259.1208; Found: 259.1197 
 TLC: Rf 0.19 (pentane/Et2O 8:2) [silica gel, UV, iodine] 
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 Analysis: C15H17NO3 
  Calcd: C, 69.48; H, 6.61; N, 5.40 
  Found: C, 69.36; H, 6.49; N, 5.55 
 
Ethyl 2-cyano-3-(4-(dimethylamino)phenyl)propanoate (4.8ai) [AA-16-EW3722] 
 
Following General Procedure VI, RhCl3·3H2O (10.5 mg, 0.04 mmol, 2 mol%), CH3CN (4.0 
mL), ethyl cyanoacetate (0.213 mL, 2.0 mmol), 4-dimethylaminobenzaldehyde (313 mg, 2.1 
mmol, 1.05 equiv), H2O (0.072 mL, 4.0 mmol, 2.0 equiv), and Et3N (0.70 mL, 5.0 mmol, 2.5 
equiv) were sequentially added to a 40-mL vial. The reaction was stirred at room temperature for 
18 h. Purification by silica gel column chromatography (pentane/Et2O 7:3), followed by 
Kugelrohr distillation, afforded 4.8ai (445 mg, 90%) as a yellow oil. 
Data for 4.8ai: 
 bp: 220 °C (ABT, 0.5 mmHg) 
 1
H NMR: (500 MHz, CDCl3) 
δ 7.13 (d, J = 8.7 Hz, 2H, C(8)H), 6.69 (d, J = 8.7 Hz, 2H, C(9)H), 4.23 (q, J = 
7.1 Hz, 2H, C(4)H2), 3.65 (dd, J = 8.3, 5.8 Hz, 1H, C(2)H), 3.18 (dd, J = 13.9, 
5.8 Hz, 1H, C(6)H), 3.11 (dd, J = 13.9, 8.3 Hz, 1H, C(6)H’), 2.94 (s, 6H, 
C(11)H3), 1.28 (t, J = 7.1 Hz, 3H, C(5)H3) 
 
13
C NMR: (126 MHz, CDCl3) 
δ 165.7 C(3), 150.0 C(10), 129.7 C(8), 122.7 C(7), 116.4 C(1), 112.6 C(9), 62.7 
C(4), 40.5 C(11), 40.1 C(2), 35.1 C(6), 13.9 C(5) 
 IR: (neat) 
2983 (w), 2936 (w), 2804 (w), 2249 (w), 1739 (s), 1614 (s), 1522 (s), 1477 (w), 
1444 (m), 1342 (m), 1257 (m), 1193 (s), 1162 (s), 1026 (m), 946 (m), 856 (w), 
804 (m) 
 HRMS: (EI)  
  m/z: [M]
+
 Calcd for C14H18N2O2: 246.1368; Found: 246.1365 
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 TLC: Rf 0.13 (pentane/Et2O 8:2) [silica gel, UV, iodine] 
 Analysis: C14H18N2O2 
  Calcd: C, 68.27; H, 7.37; N, 11.37 
  Found: C, 68.11; H, 7.07; N, 11.47 
 
Ethyl 2-cyano-3-(furan-2-yl)propanoate (4.8aj) [AA-16-EW3719] 
 
Following General Procedure VI, RhCl3·3H2O (10.5 mg, 0.04 mmol, 2 mol%), CH3CN (4.0 
mL), ethyl cyanoacetate (0.213 mL, 2.0 mmol), furfural (0.174 mL, 2.1 mmol, 1.05 equiv), H2O 
(0.072 mL, 4.0 mmol, 2.0 equiv), and Et3N (0.70 mL, 5.0 mmol, 2.5 equiv) were sequentially 
added to a 40-mL vial. The reaction was stirred at room temperature for 18 h. Purification by 
silica gel column chromatography (pentane/Et2O 8:2), followed by Kugelrohr distillation, 
afforded 4.8aj (313 mg, 81%) as a pale yellow oil. The spectral data matched those previously 
reported in the literature.
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Data for 4.8aj: 
 bp: 188 °C (ABT, 0.5 mmHg) 
 1
H NMR: (500 MHz, CDCl3) 
δ 7.37 – 7.35 (m, 1H, C(10)H), 6.33 (dd, J = 3.0, 2.0 Hz, 1H, C(9)H), 6.25 (d, J 
= 3.2 Hz, 1H, C(8)H), 4.27 (q, J = 7.1 Hz, 2H, C(4)H2), 3.82 (dd, J = 7.9, 6.1 Hz, 
1H, C(2)H), 3.33 (dd, J = 15.1, 6.1 Hz, 1H, C(6)H), 3.27 (dd, J = 15.1, 8.0 Hz, 
1H, C(6)H’), 1.31 (t, J = 7.1 Hz, 3H, C(5)H3) 
 
13
C NMR: (126 MHz, CDCl3) 
δ 165.1 C(3), 148.8 C(7), 142.5 C(10), 115.8 C(1), 110.5 C(9), 108.3 C(8), 63.0 
C(4), 37.0 C(2), 28.5 C(6), 13.9 C(5) 
 HRMS: (EI)  
  m/z: [M]
+
 Calcd for C10H11NO3:193.0739; Found: 193.0731 
 TLC: Rf 0.28 (pentane/Et2O 8:2) [silica gel, UV, iodine] 
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Ethyl 2-cyano-3-(thiophen-2-yl)propanoate (4.8ak) [AA-16-EW3711] 
 
Following General Procedure VI, RhCl3·3H2O (10.5 mg, 0.04 mmol, 2 mol%), CH3CN (4.0 
mL), ethyl cyanoacetate (0.213 mL, 2.0 mmol), 2-thiophenecarboxaldehyde (0.196 mL, 2.1 
mmol, 1.05 equiv), H2O (0.072 mL, 4.0 mmol, 2.0 equiv), and Et3N (0.70 mL, 5.0 mmol, 2.5 
equiv) were sequentially added to a 40-mL vial. The reaction was stirred at room temperature for 
18 h. Purification by silica gel column chromatography (pentane/Et2O 8:2), followed by 
Kugelrohr distillation, afforded 4.8ak (397 mg, 95%) as a pale yellow oil. The spectral data 
matched those previously reported in the literature.
34 
Data for 4.8ak: 
 bp: 185 °C (ABT, 0.5 mmHg) 
 1
H NMR: (500 MHz, CDCl3) 
δ 7.23 (dd, J = 5.1, 1.1 Hz, 1H, C(10)H), 7.01 (d, J = 2.8 Hz, 1H, C(8)H), 6.97 
(dd, J = 5.0, 3.5 Hz, 1H, C(9)H), 4.27 (q, J = 7.2 Hz, 2H, C(4)H2), 3.76 (dd, J = 
7.5, 6.0 Hz, 1H, C(2)H), 3.54 – 3.42 (m, 2H, C(6)H2), 1.30 (t, J = 7.1 Hz, 3H, 
C(5)H3) 
 
13
C NMR: (126 MHz, CDCl3) 
δ 165.0 C(3), 136.6 C(7), 127.3 C(8), 127.2 C(9), 125.3 C(10), 115.9 C(1), 63.1 
C(4), 39.9 C(2), 29.9 C(6), 13.9 C(5) 
 HRMS: (EI)  
  m/z: [M]
+
 Calcd for C10H11NO2S: 209.0511; Found: 209.0512 
 TLC: Rf 0.23 (pentane/Et2O 8:2) [silica gel, UV, iodine] 
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Ethyl 2-cyano-3-(pyridin-3-yl)propanoate (4.8al) [AA-16-EW3720] 
 
Following General Procedure VI, RhCl3·3H2O (10.5 mg, 0.04 mmol, 2 mol%), CH3CN (4.0 
mL), ethyl cyanoacetate (0.213 mL, 2.0 mmol), 3-pyridinecarboxaldehyde (0.197 mL, 2.1 mmol, 
1.05 equiv), H2O (0.072 mL, 4.0 mmol, 2.0 equiv), and Et3N (0.70 mL, 5.0 mmol, 2.5 equiv) 
were sequentially added to a 40-mL vial. The reaction was stirred at room temperature for 18 h. 
Purification by silica gel column chromatography (CH2Cl2/Et2O 8:2), followed by Kugelrohr 
distillation, afforded 4.8al (356 mg, 87%) as a pale yellow oil. 
Data for 4.8al: 
 bp: 205 °C (ABT, 0.5 mmHg) 
 1
H NMR: (500 MHz, CDCl3) 
δ 8.55 (dd, J = 4.8, 1.6 Hz, 1H, C(9)H), 8.52 (d, J = 2.1 Hz, 1H, C(8)H), 7.65 (dt, 
J = 7.9, 1.9 Hz, 1H, C(11)H), 7.28 (dd, J = 7.8, 4.8 Hz, 1H, C(10)H), 4.24 (q, J = 
7.1 Hz, 2H, C(4)H2), 3.75 (dd, J = 8.0, 5.9 Hz, 1H, C(2)H), 3.27 (dd, J = 14.1, 
5.9 Hz, 1H, C(6)H), 3.21 (dd, J = 14.1, 8.0 Hz, 1H, C(6)H’), 1.26 (t, J = 7.2 Hz, 
3H, C(5)H3) 
 
13
C NMR: (126 MHz, CDCl3) 
δ 164.9 C(3), 150.2 C(8), 149.2 C(9), 136.6 C(11), 130.8 C(7), 123.5 C(10), 
115.6 C(1), 63.1 C(4), 39.0 C(2), 32.6 C(6), 13.8 C(5) 
 IR: (neat) 
2985 (w), 2940 (w), 2251 (w), 1738 (s), 1576 (w), 1480 (w), 1426 (m), 1370 (w), 
1252 (m), 1205 (m), 1106 (w), 1028 (s), 857 (w), 796 (w), 713 (s)    
 HRMS: (EI)  
  m/z: [M]
+
 Calcd for C11H12N2O2: 204.0899; Found: 204.0907 
 TLC: Rf 0.19 (CH2Cl2/Et2O 8:2) [silica gel, UV, iodine] 
 Analysis: C11H12N2O2 
  Calcd: C, 64.69; H, 5.92; N, 13.72 
  Found: C, 64.96; H, 6.13; N, 13.49 
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Ethyl 3-(4-bromophenyl)-2-cyanopropanoate (4.8am) [AA-16-EW3710] 
 
Following General Procedure VI, RhCl3·3H2O (15.8 mg, 0.06 mmol, 3 mol%), CH3CN (4.0 
mL), ethyl cyanoacetate (0.213 mL, 2.0 mmol), 4-bromobenzaldehyde (389 mg, 2.1 mmol, 1.05 
equiv), H2O (0.180 mL, 10.0 mmol, 5.0 equiv), and Et3N (0.70 mL, 5.0 mmol, 2.5 equiv) were 
sequentially added to a 40-mL vial. The reaction was stirred at room temperature for 36 h. 
Purification by silica gel column chromatography (pentane/Et2O 75:25), followed by Kugelrohr 
distillation, afforded 4.8am (461 mg, 82%) as a white solid. The spectral data matched those 
previously reported in the literature.
34 
Data for 4.8am: 
 bp: 234 °C (ABT, 0.5 mmHg) 
 mp: 39-40 °C 
 1
H NMR: (500 MHz, CDCl3) 
δ 7.47 (d, J = 8.4 Hz, 2H, C(9)H), 7.16 (d, J = 8.4 Hz, 2H, C(8)H), 4.24 (q, J = 
7.1 Hz, 2H, C(4)H2), 3.70 (dd, J = 8.2, 5.8 Hz, 1H, C(2)H), 3.23 (dd, J = 13.9, 
5.8 Hz, 1H, C(6)H), 3.16 (dd, J = 13.9, 8.2 Hz, 1H, C(6)H’), 1.28 (t, J = 7.1 Hz, 
3H, C(5)H3) 
 
13
C NMR: (126 MHz, CDCl3) 
δ 165.2 C(3), 134.2 C(7), 132.0 C(9), 130.8 C(8), 121.9 C(10), 115.8 C(1), 63.1 
C(4), 39.3 C(2), 35.0 C(6), 13.9 C(5) 
 HRMS: (EI)  
  m/z: [M]
+
 Calcd for C12H12BrNO2: 281.0051; Found: 281.0050 
 TLC: Rf 0.20 (pentane/Et2O 8:2) [silica gel, UV, iodine] 
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Ethyl 2-cyano-3-(4-(trifluoromethyl)phenyl)propanoate (4.8an) [AA-16-EW3713] 
 
Following General Procedure VI, RhCl3·3H2O (15.8 mg, 0.06 mmol, 3 mol%), CH3CN (4.0 
mL), ethyl cyanoacetate (0.213 mL, 2.0 mmol), 4-(trifluoromethyl)benzaldehyde (0.287 mL, 2.1 
mmol, 1.05 equiv), H2O (0.180 mL, 10.0 mmol, 5.0 equiv), and Et3N (0.70 mL, 5.0 mmol, 2.5 
equiv) were sequentially added to a 40-mL vial. The reaction was stirred at room temperature for 
36 h. Purification by silica gel column chromatography (pentane/Et2O 7:3), followed by 
Kugelrohr distillation and recrystallization (pentane), afforded 4.8an (294 mg, 54%) as a white, 
crystalline solid. 
Data for 4.8an: 
 bp: 203 °C (ABT, 0.5 mmHg) 
 mp: 33-34 °C (pentane) 
 1
H NMR: (500 MHz, CDCl3) 
δ 7.61 (d, J = 8.1 Hz, 2H, C(9)H), 7.41 (d, J = 8.1 Hz, 2H, C(8)H), 4.25 (q, J = 
7.1 Hz, 2H, C(4)H2), 3.75 (dd, J = 8.3, 5.8 Hz, 1H, C(2)H), 3.33 (dd, J = 13.9, 
5.8 Hz, 1H, C(6)H), 3.26 (dd, J = 13.9, 8.3 Hz, 1H, C(6)H’), 1.28 (t, J = 7.2 Hz, 
3H, C(5)H3) 
 
13
C NMR: (126 MHz, CDCl3) 
δ 165.1 C(3), 139.3 C(7), 130.2 (q, J = 32.6 Hz, C(10)), 129.5 C(8), 125.8 (q, J = 
3.7 Hz, C(9)), 123.9 (q, J = 272.0 Hz, C(11)), 115.7 C(1), 63.2 C(4), 39.1 C(2), 
35.2 C(6), 13.9 C(5) 
 19
F NMR: (470 MHz, CDCl3) 
  δ -63.07  
 IR: (neat) 
2988 (w), 2251 (w), 1742 (m), 1619 (w), 1447 (w), 1421 (w), 1322 (s) 1263 (m), 
1161 (m), 1109 (s), 1066 (s), 1019 (m), 855 (w), 819 (w) 734 (w) 
 HRMS: (EI)  
  m/z: [M]
+
 Calcd for C13H12F3NO2: 271.0820; Found: 271.0821 
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 TLC: Rf 0.17 (pentane/Et2O 8:2) [silica gel, UV, iodine] 
 Analysis: C13H12F3NO2 
  Calcd: C, 57.57; H, 4.46; N, 5.16 
  Found: C, 57.70; H, 4.44; N, 5.40 
 
Ethyl 2-cyano-3-(naphthalen-2-yl)propanoate (4.8ao) [AA-16-EW3725] 
 
Following General Procedure VI, RhCl3·3H2O (15.8 mg, 0.06 mmol, 3 mol%), CH3CN (2.0 
mL), ethyl cyanoacetate (0.213 mL, 2.0 mmol), 2-naphthaldehyde (328 mg, 2.1 mmol, 1.05 
equiv), H2O (0.180 mL, 10.0 mmol, 5.0 equiv), and Et3N (0.70 mL, 5.0 mmol, 2.5 equiv) were 
sequentially added to a 40-mL vial. The reaction was stirred at room temperature for 36 h. 
Purification by silica gel column chromatography (pentane/Et2O 7:3), followed by Kugelrohr 
distillation, afforded 4.8ao (349 mg, 69%) as a white solid. 
Data for 4.8ao: 
 bp: 251 °C (ABT, 0.5 mmHg) 
 mp: 42-43 °C 
 1
H NMR: (500 MHz, CDCl3) 
δ 7.86 – 7.79 (m, 3H, C(9)H, C(11)H, C(14)H), 7.75 (s, 1H, C(16)H), 7.53 – 
7.46 (m, 2H, C(12), C(13)), 7.39 (dd, J = 8.4, 1.8 Hz, 1H, C(8)), 4.24 (qd, J = 
7.1, 0.5 Hz, 2H, C(4)H2), 3.82 (dd, J = 8.4, 5.9 Hz, 1H, C(2)H), 3.45 (dd, J = 
13.9, 5.8 Hz, 1H, C(6)H), 3.37 (dd, J = 13.9, 8.4 Hz, 1H, C(6)H’), 1.25 (t, J = 7.2 
Hz, 3H, C(5)H3) 
 
13
C NMR: (126 MHz, CDCl3) 
δ 165.4 C(3), 133.3 C(7), 132.7, 132.6, 128.6 C(9), 128.0 C(16), 127.7, 127.6, 
126.6 C(8), 126.3, 126.1, 116.1 C(1), 62.9 C(4), 39.5 C(2), 35.8 C(6), 13.8 C(5) 
 IR: (neat) 
3051 (w), 2984 (w), 2938 (w), 2906 (w), 2250 (w), 1731 (s), 1600 (w), 1507 (w), 
1463 (w), 1368 (w), 1245 (s), 1095 (w), 1028 (m), 903 (m), 852 (m), 821 (m), 
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803 (m), 749 (s) 
 HRMS: (EI)  
  m/z: [M]
+
 Calcd for C16H15NO2: 253.1103; Found: 253.1096 
 TLC: Rf 0.17 (pentane/Et2O 8:2) [silica gel, UV, iodine] 
 Analysis: C16H15NO2 
  Calcd: C, 75.87; H, 5.97; N, 5.53 
  Found: C, 75.86; H, 5.91; N, 5.54 
 
Ethyl 2-cyano-4,4-dimethylpentanoate (4.8aq) [AA-16-EW3712] 
 
Following General Procedure VI, RhCl3·3H2O (10.5 mg, 0.04 mmol, 2 mol%), CH3CN (4.0 
mL), ethyl cyanoacetate (0.213 mL, 2.0 mmol), pivaldehyde (0.228 mL, 2.1 mmol, 1.05 equiv), 
H2O (0.072 mL, 4.0 mmol, 2.0 equiv), and Et3N (0.70 mL, 5.0 mmol, 2.5 equiv) were 
sequentially added to a 40-mL vial. The reaction was stirred at room temperature for 18 h. 
Purification by silica gel column chromatography (pentane/Et2O 9:1), followed by Kugelrohr 
distillation, afforded 4.8aq (329 mg, 90%) as a colorless oil. 
Data for 4.8aq: 
 bp: 130 °C (ABT, 0.5 mmHg) 
 1
H NMR: (500 MHz, CDCl3) 
δ 4.26 (q, J = 7.2 Hz, 2H, C(4)H2), 3.42 (dd, J = 8.6, 4.6 Hz, 1H, C(2)H), 1.95 
(dd, J = 14.2, 4.6 Hz, 1H, C(6)H), 1.89 (dd, J = 14.2, 8.6 Hz, 1H, C(6)H’), 1.32 
(t, J = 7.2 Hz, 3H, C(5)H3), 1.00 (s, 9H, C(8)H3) 
 
13
C NMR: (126 MHz, CDCl3) 
δ 166.8 C(3), 117.7 C(1), 62.8 C(4), 43.2 C(6), 33.6 C(2), 30.7 C(7), 28.9 C(8), 
13.9 C(5) 
 IR: (neat) 
2960 (w), 2249 (w), 1743 (s), 1477 (w), 1399 (w), 1369 (m), 1244 (m), 1195 
(m), 1028 (m), 916 (w), 856 (w) 
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 HRMS: (EI)  
  m/z: [MH]
+
 Calcd for C10H18NO2: 184.1338; Found: 184.1338 
 TLC: Rf 0.48 (pentane/Et2O 8:2) [silica gel, iodine] 
 Analysis: C10H17NO2 
  Calcd: C, 65.54; H, 9.35; N, 7.64 
  Found: C, 65.75; H, 9.33; N, 7.79 
 
Ethyl 2-cyano-3-cyclohexylpropanoate (4.8ar) [AA-16-EW3721] 
 
Following General Procedure VI, RhCl3·3H2O (10.5 mg, 0.04 mmol, 2 mol%), CH3CN (4.0 
mL), ethyl cyanoacetate (0.213 mL, 2.0 mmol), cyclohexanecarboxaldehyde (0.254 mL, 2.1 
mmol, 1.05 equiv), H2O (0.072 mL, 4.0 mmol, 2.0 equiv), and Et3N (0.70 mL, 5.0 mmol, 2.5 
equiv) were sequentially added to a 40-mL vial. The reaction was stirred at room temperature for 
18 h. Purification by silica gel column chromatography (pentane/Et2O 9:1), followed by 
Kugelrohr distillation, afforded 4.8ar (404 mg, 97%) as a colorless oil. 
Data for 4.8ar: 
 bp: 158 °C (ABT, 0.5 mmHg) 
 1
H NMR: (500 MHz, CDCl3) 
δ 4.25 (q, J = 7.1 Hz, 2H, C(4)H2), 3.54 (dd, J = 9.4, 6.2 Hz, 1H, C(2)H), 1.89 – 
1.77 (m, 2H, C(6)H2), 1.77 – 1.63 (m, 5H, C(8-12)Heq), 1.57 – 1.47 (m, 1H, 
C(7)H), 1.31 (t, J = 7.1 Hz, 3H, C(5)H3), 1.29 – 1.20 (m, 2H, C(9)Hax, 
C(11)Hax), 1.19 – 1.09 (m, 1H, C(10)Hax), 1.02 – 0.84 (m, 2H, C(8)Hax, 
C(12)Hax) 
 
13
C NMR: (126 MHz, CDCl3) 
δ 166.5 C(3), 116.7 C(1), 62.7 C(4), 37.0 C(6), 35.3 C(2), 35.2 C(7), 33.0 C(12), 
31.9 C(8), 26.1 C(10), 25.8 C(9), 25.7 C(11), 13.9 C(5) 
 IR: (neat) 
2984 (w), 2924 (m), 2852 (w), 2249 (w), 1742 (s), 1449 (m), 1321 (w), 1247 
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(m), 1188 (m), 1096 (w), 1023 (m), 855 (w) 
 HRMS: (EI)  
  m/z: [M-H]
+
 Calcd for C12H18NO2: 208.1338; Found: 208.1340 
 TLC: Rf 0.52 (pentane/Et2O 8:2) [silica gel, iodine] 
 Analysis: C12H19NO2 
  Calcd: C, 68.87; H, 9.15; N, 6.69 
  Found: C, 69.15; H, 9.00; N, 6.88 
 
Ethyl 2-cyano-4-methylpentanoate (4.8as) [AA-16-EW3715] 
 
Following General Procedure VI, RhCl3·3H2O (10.5 mg, 0.04 mmol, 2 mol%), CH3CN (4.0 
mL), ethyl cyanoacetate (0.213 mL, 2.0 mmol), isobutyraldehyde (0.192 mL, 2.1 mmol, 1.05 
equiv), H2O (0.072 mL, 4.0 mmol, 2.0 equiv), and Et3N (0.70 mL, 5.0 mmol, 2.5 equiv) were 
sequentially added to a 40-mL vial. The reaction was stirred at room temperature for 18 h. 
Purification by silica gel column chromatography (pentane/Et2O 9:1), followed by Kugelrohr 
distillation, afforded 4.8as (307 mg, 91%) as a colorless oil. 
Data for 4.8as: 
 bp: 121 °C (ABT, 0.5 mmHg) 
 1
H NMR: (500 MHz, CDCl3) 
δ 4.26 (q, J = 7.1 Hz, 2H, C(4)H2), 3.51 (dd, J = 9.3, 5.9 Hz, 1H, C(2)H), 1.91 – 
1.81 (m, 2H, C(6)H, C(7)H), 1.81 – 1.74 (m, 1H, C(6)H’), 1.32 (t, J = 7.1 Hz, 
3H, C(5)H3), 0.99 (d, J = 6.3 Hz, 3H, C(8)H3), 0.96 (d, J = 6.4 Hz, 3H, C(9)H3) 
 
13
C NMR: (126 MHz, CDCl3) 
δ 166.4 C(3), 116.6 C(1), 62.7 C(4), 38.3 C(6), 35.9 C(2), 26.0 C(7), 22.4 C(8), 
21.2 C(9), 13.9 C(5) 
 IR: (neat) 
2962 (w), 2875 (w), 2249 (w), 1742 (s), 1470 (w), 1390 (w), 1370 (w), 1265 (m), 
1244 (m), 1185 (m), 1113 (w), 1023 (m), 927 (w), 857 (w) 
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 HRMS: (EI)  
  m/z: [M]
+
 Calcd for C9H15NO2: 169.1103; Found: 169.1106 
 TLC: Rf 0.36 (pentane/Et2O 8:2) [silica gel, iodine] 
 Analysis: C9H15NO2 
  Calcd: C, 63.88; H, 8.93; N, 8.28 
  Found: C, 63.89; H, 9.17; N, 8.39 
 
Ethyl 2-cyano-5-methylhexanoate (4.8at) [AA-16-EW3716] 
 
Following General Procedure VI, RhCl3·3H2O (10.5 mg, 0.04 mmol, 2 mol%), CH3CN (4.0 
mL), ethyl cyanoacetate (0.213 mL, 2.0 mmol), isovaleraldehyde (0.230 mL, 2.1 mmol, 1.05 
equiv), H2O (0.072 mL, 4.0 mmol, 2.0 equiv), and Et3N (0.70 mL, 5.0 mmol, 2.5 equiv) were 
sequentially added to a 40-mL vial. The reaction was stirred at room temperature for 18 h. 
Purification by silica gel column chromatography (pentane/Et2O 9:1), followed by Kugelrohr 
distillation, afforded 4.8at (347 mg, 95%) as a colorless oil. The spectral data matched those 
previously reported in the literature.
34 
Data for 4.8at: 
 bp: 138 °C (ABT, 0.5 mmHg) 
 1
H NMR: (500 MHz, CDCl3) 
δ 4.26 (q, J = 7.1 Hz, 2H, C(4)H2), 3.46 (dd, J = 7.6, 6.4 Hz, 1H, C(2)H), 2.03 – 
1.86 (m, 2H, C(6)H2), 1.66 – 1.55 (m, 1H, C(8)H), 1.42 – 1.35 (m, 2H, C(7)H2), 
1.32 (t, J = 7.1 Hz, 3H, C(5)H3), 0.92 (d, J = 6.6 Hz, 3H, C(9)H3), 0.91 (d, J = 
6.6 Hz, 3H, C(10)H3) 
 
13
C NMR: (126 MHz, CDCl3) 
δ 166.2 C(3), 116.6 C(1), 62.7 C(4), 37.7 C(2), 35.6 C(7), 27.8 C(6), 27.5 C(8), 
22.3 C(9), 22.1 C(10), 14.0 C(5) 
 HRMS: (ESI)  
  m/z: [MH]
+
 Calcd for C10H18NO2: 184.1338; Found: 184.1339 
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 TLC: Rf 0.37 (pentane/Et2O 8:2) [silica gel, iodine] 
 
Ethyl 2-cyano-5-phenylpentanoate (4.8au) [AA-16-EW3717] 
 
Following General Procedure VI, RhCl3·3H2O (10.5 mg, 0.04 mmol, 2 mol%), CH3CN (4.0 
mL), ethyl cyanoacetate (0.213 mL, 2.0 mmol), hydrocinnamaldehyde (0.277 mL, 2.1 mmol, 
1.05 equiv), H2O (0.108 mL, 6.0 mmol, 3.0 equiv), and Et3N (0.70 mL, 5.0 mmol, 2.5 equiv) 
were sequentially added to a 40-mL vial. The reaction was stirred at room temperature for 24 h. 
Purification by silica gel column chromatography (pentane/Et2O 8:2), followed by Kugelrohr 
distillation, afforded 4.8au (329 mg, 71%) as a colorless oil. The spectral data matched those 
previously reported in the literature.
34 
Data for 4.8au: 
 bp: 211 °C (ABT, 0.5 mmHg) 
 1
H NMR: (500 MHz, CDCl3) 
δ 7.30 (t, J = 7.5 Hz, 2H, C(11)H), 7.21 (t, J = 7.4 Hz, 1H, C(12)H), 7.18 (d, J = 
7.4 Hz, 2H, C(10)H), 4.25 (q, J = 7.1 Hz, 2H, C(4)H2), 3.48 (t, J = 6.8 Hz, 1H, 
C(2)H), 2.69 (t, J = 7.5 Hz, 2H, C(8)H2), 2.01 – 1.94 (m, 2H, C(6)H2), 1.90 – 
1.79 (m, 2H, C(7)H2), 1.31 (t, J = 7.1 Hz, 3H, C(5)H3) 
 
13
C NMR: (126 MHz, CDCl3) 
δ 166.0 C(3), 140.8 C(9), 128.5 C(11), 128.3 C(10), 126.2 C(12), 116.4 C(1), 
62.8 C(4), 37.4 C(2), 34.9 C(8), 29.2 C(6), 28.3 C(7), 14.0 C(5) 
 HRMS: (EI)  
  m/z: [M]
+
 Calcd for C14H17NO2: 231.1259; Found: 231.1267 
 TLC: Rf 0.28 (pentane/Et2O 8:2) [silica gel, UV, iodine] 
 
 
 
319 
 
Table 4.1, entry 16 [AA-16-EW3714] 
Following General Procedure VI, RhCl3·3H2O (15.8 mg, 0.06 mmol, 3 mol%), CH3CN (4.0 
mL), ethyl cyanoacetate (0.213 mL, 2.0 mmol), 4-nitrobenzaldehyde (317 mg, 2.1 mmol, 1.05 
equiv), H2O (0.180 mL, 10.0 mmol, 5.0 equiv), and Et3N (0.70 mL, 5.0 mmol, 2.5 equiv) were 
sequentially added to a 40-mL vial. The reaction was stirred at room temperature for 36 h. 
Analysis of the reaction mixture by GC-MS showed only trace amounts of 4.8ap, and 4.9ap’ as 
the major product. 
 
Table 4.1, entry 22 [AA-16-EW3732] 
Following General Procedure VI, RhCl3·3H2O (10.5 mg, 0.04 mmol, 2 mol%), CH3CN (4.0 
mL), ethyl cyanoacetate (0.213 mL, 2.0 mmol), 4-(2-trimethylsilylethynyl)benzaldehyde (425 
mg, 2.1 mmol, 1.05 equiv), H2O (0.108 mL, 6.0 mmol, 3.0 equiv), and Et3N (0.70 mL, 5.0 mmol, 
2.5 equiv) were sequentially added to a 40-mL vial. The reaction was stirred at room temperature 
for 24 h. The conversion to 4.8av was determined to be 19% by analysis of the crude reaction 
mixture by 
1
H NMR (based on 1,1,2,2-tetrachloroethane as the standard), with 4.9av being the 
major component of the mixture. 
 
Table 4.1, entry 23 [AA-16-EW3741] 
Following General Procedure VI, RhCl3·3H2O (10.5 mg, 0.04 mmol, 2 mol%), CH3CN (4.0 
mL), ethyl cyanoacetate (0.213 mL, 2.0 mmol), 4-prop-2-ynoxybenzaldehyde (336 mg, 2.1 
mmol, 1.05 equiv), H2O (0.072 mL, 4.0 mmol, 2.0 equiv), and Et3N (0.70 mL, 5.0 mmol, 2.5 
equiv) were sequentially added to a 40-mL vial. The reaction was stirred at room temperature for 
18 h. Analysis of the reaction mixture by GC-MS showed no 4.8aw, and 4.9aw as the major 
product. 
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General Procedure VII: Reaction of ethyl cyanoacetate with ketones (Table 4.2) 
 
RhCl3·3H2O was added to a 40-mL glass vial, followed by acetonitrile, ethyl cyanoacetate 
4.6a, the ketone 4.7, deionized water, and triethylamine. A stir bar was added, and the vial was 
placed in an autoclave. The autoclave was pressurized with CO and vented three times, and then 
pressurized to 10 bar. The reaction was stirred at room temperature for the indicated time. After 
venting and purging the autoclave with nitrogen, the vial was removed. The volatiles were 
removed under reduced pressure, the residue was dissolved in CH2Cl2, and loaded on silica gel 
(1 g). The crude mixture was purified by silica gel column chromatography (2.5 x 20-25 cm), 
followed by distillation. 
 
Ethyl 2-cyano-2-cyclohexylacetate (4.8ax) [AA-16-EW3738] 
 
Following General Procedure VII, RhCl3·3H2O (10.5 mg, 0.04 mmol, 2 mol%), CH3CN (1.0 
mL), ethyl cyanoacetate (0.213 mL, 2.0 mmol), cyclohexanone (0.217 mL, 2.1 mmol, 1.05 
equiv), H2O (0.180 mL, 10.0 mmol, 5.0 equiv), and Et3N (1.95 mL, 14.0 mmol, 7.0 equiv) were 
sequentially added to a 40-mL vial. The reaction was stirred at room temperature for 30 h. 
Purification by silica gel column chromatography (pentane/Et2O 95:5), followed by Kugelrohr 
distillation, afforded 4.8ax (364 mg, 93%) as a colorless oil. The spectral data matched those 
previously reported in the literature.
35
 
Data for 4.8ax: 
 bp: 178 °C (ABT, 0.5 mmHg) 
 1
H NMR: (500 MHz, CDCl3) 
δ 4.28 – 4.23 (m, 2H, C(4)H2), 3.36 (d, J = 5.7 Hz, 1H, C(2)H), 2.10 – 1.96 (m, 
1H, C(6)H), 1.86 – 1.64 (m, 5H, C(7-11)Heq), 1.31 (t, J = 7.1 Hz, 3H, C(5)H3), 
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1.29 – 1.10 (m, 5H, C(7-11)Hax) 
 
13
C NMR: (126 MHz, CDCl3) 
δ 165.8 C(3), 115.7 C(1), 62.5 C(4), 44.5 C(2), 38.8 C(6), 31.0, 29.3, 25.7, 25.5, 
25.4, 14.0 C(5) 
 HRMS: (ESI)  
  m/z: [MH]
+
 Calcd for C11H18NO2: 196.1338; Found: 196.1332 
 TLC: Rf 0.48 (pentane/Et2O 8:2) [silica gel, iodine] 
 
Ethyl 2-cyano-2-cyclopentylacetate (4.8ay) [AA-16-EW3739] 
 
Following General Procedure VII, RhCl3·3H2O (10.5 mg, 0.04 mmol, 2 mol%), CH3CN (1.0 
mL), ethyl cyanoacetate (0.213 mL, 2.0 mmol), cyclopentanone (0.186 mL, 2.1 mmol, 1.05 
equiv), H2O (0.180 mL, 10.0 mmol, 5.0 equiv), and Et3N (1.95 mL, 14.0 mmol, 7.0 equiv) were 
sequentially added to a 40-mL vial. The reaction was stirred at room temperature for 30 h. 
Purification by silica gel column chromatography (pentane/Et2O 85:15), followed by Kugelrohr 
distillation, afforded 4.8ay (285 mg, 79%) as a colorless oil. 
Data for 4.8ay: 
 bp: 147 °C (ABT, 0.5 mmHg) 
 1
H NMR: (500 MHz, CDCl3) 
δ 4.29 – 4.22 (m, 2H, C(4)H2), 3.49 (d, J = 6.7 Hz, 1H, C(2)H), 2.48 (h, J = 7.0 
Hz, 1H, C(6)H), 1.95 – 1.81 (m, 2H, C(7)H, C(10)H), 1.79 – 1.68 (m, 2H, 
C(8)H, C(9)H), 1.66 – 1.55 (m, 2H, C(8)H’, C(9)H’), 1.53 – 1.36 (m, 2H, 
C(7)H’, C(10)H’), 1.31 (t, J = 7.1 Hz, 3H, C(5)H3) 
 
13
C NMR: (126 MHz, CDCl3) 
δ 166.1 C(3), 116.0 C(1), 62.5 C(4), 42.5 C(2), 40.1 C(6), 30.7 C(7), 29.7 C(10), 
25.0 C(8), 24.9 C(9), 14.0 C(5) 
 IR: (neat) 
3395 (w), 3209 (w), 2958 (w), 2872 (w), 2252 (w), 1740 (s) 1668 (w), 1614 (w), 
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1514 (w), 1392 (w), 1369 (w), 1246 (s), 1186 (s), 1028 (s), 854 (w), 814 (w) 
 HRMS: (ESI)  
  m/z: [MH]
+
 Calcd for C10H16NO2: 182.1181; Found: 182.1177 
 TLC: Rf 0.44 (pentane/Et2O 8:2) [silica gel, iodine] 
 Analysis: C10H15NO2 
  Calcd: C, 66.27; H, 8.34; N, 7.73 
  Found: C, 65.94; H, 8.25; N, 7.60 
 
Ethyl 2-cyano-2-cyclobutylacetate (4.8az) [AA-16-EW3740] 
 
Following General Procedure VII, RhCl3·3H2O (10.5 mg, 0.04 mmol, 2 mol%), CH3CN (1.0 
mL), ethyl cyanoacetate (0.213 mL, 2.0 mmol), cyclobutanone (0.149 mL, 2.1 mmol, 1.05 
equiv), H2O (0.180 mL, 10.0 mmol, 5.0 equiv), and Et3N (1.95 mL, 14.0 mmol, 7.0 equiv) were 
sequentially added to a 40-mL vial. The reaction was stirred at room temperature for 30 h. 
Purification by silica gel column chromatography (pentane/Et2O 9:1), followed by Kugelrohr 
distillation, afforded 4.8az (157 mg, 47%) as a colorless oil. The spectral data matched those 
previously reported in the literature.
36
 
Data for 4.8az: 
 bp: 95 °C (ABT, 0.5 mmHg) 
 1
H NMR: (500 MHz, CDCl3) 
δ 4.22 (q, J = 7.1 Hz, 2H, C(4)H2), 3.49 (d, J = 7.3 Hz, 1H, C(2)H), 2.91 (h, J = 
8.1 Hz, 1H, C(6)H), 2.20 – 2.10 (m, 2H, C(7)H, C(9)H), 2.08 – 1.82 (m, 4H, 
C(7)H’, C(8)H2, C(9)H’), 1.29 (t, J = 7.1 Hz, 3H, C(5)H3) 
 
13
C NMR: (126 MHz, CDCl3) 
δ 165.4 C(3), 115.6 C(1), 62.5 C(4), 43.1 C(2), 35.1 C(6), 26.5 C(7), 25.8 C(9), 
17.7 C(8), 14.0 C(5) 
 HRMS: (ESI)  
  m/z: [MH]
+
 Calcd for C9H14NO2: 168.1025; Found: 168.1019 
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 TLC: Rf 0.42 (pentane/Et2O 8:2) [silica gel, iodine] 
 
General Procedure VIII: Reaction of other active methylene compounds with aldehydes 
(Table 4.3) 
 
RhCl3·3H2O was added to a 40-mL glass vial, followed by acetonitrile, the active methylene 
compound 4.6, the aldehyde 4.7, deionized water, and triethylamine. A stir bar was added, and 
the vial was placed in an autoclave. The autoclave was pressurized with CO and vented three 
times, and then pressurized to 10 bar. The reaction was stirred at room temperature for the 
indicated time. After venting and purging the autoclave with nitrogen, the vial was removed. The 
volatiles were removed under reduced pressure, the residue was dissolved in CH2Cl2, and loaded 
on silica gel (1 g). The crude mixture was purified by silica gel column chromatography (2.5 x 
20-25 cm), followed by distillation or recrystallization. 
 
2-(4-Methoxybenzyl)-3-oxo-3-phenylpropanenitrile (4.8df) [AA-16-EW3734] 
 
Following General Procedure VIII, RhCl3·3H2O (15.8 mg, 0.06 mmol, 3 mol%), CH3CN (3.0 
mL), benzoylacetonitrile (290 mg, 2.0 mmol), p-anisaldehyde (0.256 mL, 2.1 mmol, 1.05 equiv), 
H2O (0.180 mL, 10.0 mmol, 5.0 equiv), and Et3N (1.12 mL, 8.0 mmol, 4.0 equiv) were 
sequentially added to a 40-mL vial. The reaction was stirred at room temperature for 24 h. 
Purification by silica gel column chromatography (pentane/Et2O 75:25 to 1:1), followed by 
Kugelrohr distillation, afforded 4.8df (463 mg, 87%) as a yellow oil.  
Data for 4.8df: 
 bp: 256 °C (ABT, 0.5 mmHg)
 
 
 1
H NMR: (500 MHz, CDCl3) 
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δ 7.95 (dd, J = 8.4, 1.2 Hz, 2H, C(5)H), 7.65 (t, J = 7.4 Hz, 1H, C(7)H), 7.51 (t, J 
= 7.8 Hz, 2H, C(6)H), 7.20 (d, J = 8.7 Hz, 2H, C(10)H), 6.86 (d, J = 8.7 Hz, 2H, 
C(11)H), 4.51 (dd, J = 8.8, 5.8 Hz, 1H, C(2)H), 3.78 (s, 3H, C(13)H3), 3.30 (dd, 
J = 14.1, 5.8 Hz, 1H, C(8)H), 3.19 (dd, J = 14.1, 8.8 Hz, 1H, C(8)H’) 
 
13
C NMR: (126 MHz, CDCl3) 
δ 190.2 C(3), 159.0 C(12), 134.5 C(7), 134.0 C(4), 130.1 C(10), 129.1 C(6), 
128.7 C(5), 127.8 C(9), 117.0 C(1), 114.2 C(11), 55.2 C(13), 42.1 C(2), 34.8 
C(8) 
 IR: (neat) 
3003 (w), 2935 (w), 2836 (w), 2249 (w), 1688 (m), 1611 (m), 1596 (m), 1582 
(m), 1512 (s), 1448 (m), 1301 (m), 1246 (s), 1178 (s), 1110 (w), 1030 (m), 949 
(w),, 874 (w), 810 (m), 744 (m), 690 (s)   
 HRMS: (EI)  
  m/z: [M]
+
 Calcd for C17H15NO2: 265.1103; Found: 265.1111 
 TLC: Rf 0.16 (pentane/Et2O 7:3) [silica gel, UV, iodine] 
 Analysis: C17H15NO2 
  Calcd: C, 76.96; H, 5.70; N, 5.28 
  Found: C, 76.63; H, 5.61; N, 5.23 
 
2-Cyano-3-(4-methoxyphenyl)propanamide (4.8ef) [AA-16-EW3735] 
 
Following General Procedure VI, RhCl3·3H2O (10.5 mg, 0.04 mmol, 2 mol%), CH3CN (4.0 
mL), 2-cyanoacetamide (168, 2.0 mmol), p-anisaldehyde (0.256 mL, 2.1 mmol, 1.05 equiv), H2O 
(0.180 mL, 10.0 mmol, 5.0 equiv), and Et3N (1.12 mL, 8.0 mmol, 4.0 equiv) were sequentially 
added to a 40-mL vial. The reaction was stirred at room temperature for 24 h. After evaporation 
of the volatiles, the residue was suspended in Et2O and filtered. The solid residue was 
redissolved in acetone and filtered through a silica plug eluting with acetone. The filtrate was 
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concentrated to provide an off-white solid. Recrystallization (EtOH, abs.) afforded 4.8ef (344 
mg, 84%) as a white, crystalline solid. 
Data for 4.8ef: 
 mp: 170-171 °C (EtOH, abs.) 
 1
H NMR: (500 MHz, d6-acetone) 
δ 7.26 (d, J = 8.6 Hz, 2H, C(6)H), 7.20 (br s, 1H, NH), 6.88 (d, J = 8.7 Hz, 2H, 
C(7)H), 6.78 (br s, 1H, NH), 3.86 (dd, J = 8.5, 6.6 Hz, 1H, C(2)H), 3.78 (s, 3H, 
C(9)H3), 3.20 (dd, J = 13.8, 6.6 Hz, 1H, C(4)H), 3.08 (dd, J = 13.8, 8.5 Hz, 1H, 
C(4)H’) 
 
13
C NMR: (126 MHz, d6-acetone) 
δ 167.2 C(3), 159.9 C(8), 131.1 C(6), 129.7 C(5), 118.8,C(1) 114.7 C(7), 55.5 
C(9), 41.0 C(2), 35.9 C(4) 
 IR: (neat) 
3397 (m), 3321 (w), 3274 (w), 3210 (w), 3042 (w), 2942 (w), 2843 (w), 2252 
(w), 1669 (s), 1611 (m), 1584 (w), 1514 (s), 1455 (w), 1406 (m), 1325 (w), 1304 
(m), 1240 (s), 1173 (m), 1119 (w), 1027 (s), 895 (w), 825 (s), 815 (m), 736 (w) 
 HRMS: (EI)  
  m/z: [M]
+
 Calcd for C11H12N2O2: 204.0899; Found: 204.0899 
 Analysis: C11H12N2O2 
  Calcd: C, 64.69; H, 5.92; N, 13.72 
  Found: C, 64.39; H, 5.93; N, 13.61 
 
3-Phenyl-2-(pyridin-2-yl)propanenitrile (4.8fa) [MYI] 
 
Following General Procedure VIII, RhCl3·3H2O (15.8 mg, 0.06 mmol, 3 mol%), CH3CN (1.0 
mL), 2-pyridylacetonitrile (0.223 mL, 2.0 mmol), benzaldehyde (0.214 mL, 2.1 mmol, 1.05 
equiv), H2O (1.80 mL, 100.0 mmol, 50.0 equiv), and Et3N (0.70 mL, 5.0 mmol, 2.5 equiv) were 
sequentially added to a 40-mL vial. The reaction was stirred at room temperature for 72 h. 
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Purification by silica gel column chromatography (CH2Cl2/Et2O 9:1), followed by 
recrystallization (hexane/Et2O 9:1), afforded 4.8fa (283 mg, 68%) as a white, crystalline solid. 
The spectral data matched those previously reported in the literature.
37
  
Data for 4.8fa: 
 mp: 62-64 °C (hexane/Et2O 9:1) 
 1
H NMR: (500 MHz, CDCl3) 
δ 8.64 (d, J = 4.6 Hz, 1H, C(7)H), 7.67 (td, J = 7.7, 1.5 Hz, 1H, C(5)H), 7.32 – 
7.26 (m, 5H, C(4)H, C(6)H, C(11)H, C(12)H), 7.17 (d, J = 6.7 Hz, 2H, C(10)H), 
4.21 (dd, J = 8.6, 5.9 Hz, 1H, C(2)H), 3.37 (dd, J = 13.6, 5.8 Hz, 1H, C(8)H), 
3.26 (dd, J = 13.6, 8.7 Hz, 1H, C(8)H’) 
 
13
C NMR: (126 MHz, CDCl3) 
δ 154.5 C(3), 150.0 C(7), 137.2 C(5), 136.2 C(9), 129.2 C(10), 128.6 C(11), 
127.4, 123.1, 122.2, 119.6 C(1), 42.0 C(2), 40.0 C(8) 
 HRMS: (ESI)  
  m/z: [MH]
+
 Calcd for C14H13N2: 209.1079; Found: 209.1086 
 TLC: Rf 0.5 (CH2Cl2/Et2O 8:2) [silica gel, UV, iodine] 
 
Deuterium incorporation experiment (Scheme 4.7) [AA-16-EW3742] 
In the glove box, Rh4(CO)12 (3.7 mg, 0.005 mmol, 1.25 mol%) was added to a 10-mL glass 
vial. The vial was sealed and removed from the glove box. Acetonitrile (0.8 mL), the pre-formed 
Knoevenagel condensation adduct 4.9af (93 mg, 0.4 mmol), D2O (0.108 mL, 6.0 mmol, 15.0 
equiv), and triethylamine (0.139 mL, 1.0 mmol, 2.5 equiv) were sequentially added to the vial. A 
stir bar was added, and the vial was placed in an autoclave. The autoclave was pressurized with 
CO and vented three times, and then pressurized to 10 bar. The reaction was stirred at room 
temperature for 24 h. After venting and purging the autoclave with nitrogen, the vial was 
removed. The volatiles were removed under reduced pressure, the residue was dissolved in 
CH2Cl2, and filtered through a silica plug (eluting with CH2Cl2). Deuterium incorporation at C(3) 
was determined to be 92% by mass spectrometry analysis (ESI) of the filtrate.
38,39
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Appendix A:  
Transmetalation from silicon to chromium, zinc, and copper 
 
A.1. INTRODUCTION 
The transmetalation from silicon to palladium has been extensively studied,
1
 but the use of 
other transition metals is underdeveloped. Among the transition elements, the possibility of 
accessing organochromium(III) and organocopper(I) species by direct transmetalation from 
silicon is of great synthetic utility, as it combines the advantages of silanol mediation with the 
unique features of organochromium and -copper reactivity. Organochromium(III) species, 
normally accessed from halides and the air-sensitive CrCl2 in the Nozaki-Hiyama-Kishi 
protocol,
2
 display high chemoselectivity toward the addition to aldehydes (amenable to 
enantioselective variants),
3
 as well as good functional group compatibility. Organocopper(I) 
reagents are among the most heavily used organometallic reagents in organic synthesis due to 
their distinctive reactivity patterns and are usually obtained by transmetalation from Grignard or 
organolithium reagents. 
A.2. TRANSMETALATION FROM SILICON TO CHROMIUM AND ZINC 
The possibility of accessing organochromium(III) reagents by transmetalation from silicon 
was explored using an organosilanolate in combination with different chromium(III) sources. 
Preliminary studies in our group had shown that sodium allylsilanolate Na
+
(A.1)
−
 adds to 
benzaldehyde in the presence of 0.5 equivalents of Cr(OAc)3∙H2O in 49% yield (Scheme A.1).
4
 
However, this process is complicated by the existence of a background addition reaction of 
allylsilanolate to the aldehyde without Cr(III) intermediacy. In addition, these reaction conditions 
also afforded benzyl alcohol (14%), likely via a Cannizzaro-type process.  
 
Scheme A.1. Initial studies with allylsilanolate Na
+
(A.1)
−
. 
330 
 
In view of these results, experiments were conducted with an aliphatic aldehyde (less prone 
to undergo the Cannizzaro reaction) and with an alkynyl silanolate (A.3)
−
, whereby the increased 
strength of the alkynyl carbon-metal bond would serve to lower the barrier for the 
transmetalation step. The preparation of decynylsilanol A.3 was carried out in two simple steps 
(Scheme A.2). Lithiation of 1-decyne and subsequent capture with Me2SiClH afforded 
hydrosilane A.2 (98%), which was oxidatively hydrolyzed with [RuCl2(p-cymene)]2 to provide 
A.3 (88%). The deprotonation of A.3 was carried out with BuLi or Et2Zn and the resulting 
silanolates (A.3)
−
 could be stored for several weeks as solutions in benzene at ‒27 °C. Previous 
attempts to generate sodium and potassium alkynylsilanolates had failed, leading to complete 
dimerization of the substrate to disiloxane. 
 
Scheme A.2. Preparation of silanolates (A.3)
−
. 
The screening of chromium sources was preceded by a series of control experiment aimed at 
assessing the compatibility between the metal silanolate and hydrocinnamaldehyde in different 
solvents (Table A.1). Unfortunately, it was found that Li
+
(A.3)
−
 was not a suitable substrate as it 
readily desilylated to 1-decyne at room temperature, gave significant amounts of addition 
product A.4  even in the absence of a chromium source, and led to substantial consumption of 
the aldehyde (entries 1-7). On the other hand, the zinc silanolate Zn
+
(A.3)
−
 displayed a much 
more encouraging reactivity profile when DME and toluene were used as the solvents (entries 
12-15), and therefore it was chosen for further optimization. 
 
 
 
 
 
 
331 
 
Table A.1. Control experiments. 
 
Entry Silanolate Solvent T 
A.4  
(%)
a
 
1-decyne 
(%)
a
 
A.3  
(%)
a
 
Aldehyde 
(%)
a
 
1 Li
+
(A.3)
−
 THF rt 10.2 39.4 74.6 28.6 
2 Li
+
(A.3)
−
 DMF rt 8.1 79.7 0.0 7.2 
3 Li
+
(A.3)
−
 DMSO rt 28.0 (100)
b
 0.0 44.7 
4 Li
+
(A.3)
−
 NMP rt 4.0 (100)
b
 0.0 14.3 
5 Li
+
(A.3)
−
 toluene rt 9.0 70.9 17.3 27.3 
6 Li
+
(A.3)
−
 DME rt 9.0 70.1 12.0 20.1 
7 Li
+
(A.3)
−
 dioxane rt 9.4 63.6 35.2 16.5 
8 Zn
+
(A.3)
−
 THF rt 26.9 36.6 15.3 75.0 
9 Zn
+
(A.3)
−
 DMF rt 4.6 90.6 5.4 93.2 
10 Zn
+
(A.3)
−
 DMSO rt traces (100)
b
 3.1 98.8 
11 Zn
+
(A.3)
−
 NMP rt traces (100)
b
 0.0 97.1 
12 Zn
+
(A.3)
−
 toluene rt 0.0 14.8 95.3 98.9 
13 Zn
+
(A.3)
−
 toluene 4 °C 0.0 27.6 55.8 96.9 
14 Zn
+
(A.3)
−
 DME rt 3.6 12.7 65.5 97.6 
15 Zn
+
(A.3)
−
 DME 4 °C 0.0 30.8 55.3 89.7 
16 Zn
+
(A.3)
−
 dioxane rt 21.4 59.8 40.2 77.1 
a. Conversion based on GC analysis relative to an internal standard; b. The solvent peak coelutes. 
A screening of readily available Cr(III) sources was carried out in DME and toluene at room 
temperature and 4 °C (Table A.2). Whereas the majority of the Cr sources were unsuccessful in 
delivering the addition product, significant amounts of A.4 were observed with anhydrous CrCl3 
in DME (entries 9 and 12). However, considering the low solubility of CrCl3 in DME, these 
results can be interpreted in terms of enhancement of background reactivity due to the Lewis-
acidic properties of CrCl3 rather than a transmetalation process. In an attempt to facilitate the 
formation of the Si-O-Cr linkage, the organic-soluble CrCl3·3THF,
5
 Cp2CrI
6
 and CpCrCl2·THF
7
 
complexes were synthesized according to literature procedures. Treatment of Zn
+
(A.3)
−
 with 
these Cr(III) sources, however, did not lead to any substantial improvement (entries 13-18). 
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Table A.2. Studies of transmetalation from silicon to chromium. 
 
Entry Cr(III) source Solvent T Time 
A.4  
(%)
a
 
1-decyne 
(%)
a
 
A.3  
(%)
a
 
Aldehyde 
(%)
a
 
1 CrCl3 toluene rt 6 h 0.0 16.7 55.3 87.1 
2 CrI3 toluene rt 6 h 7.7 47.0 8.9 73.8 
3 Cr(OAc)3, basic toluene rt 6 h 0.0 63.4 9.1 28.6 
4 CrCl3·6H2O toluene rt 18 h 0.0 84.0 10.8 traces 
5 CrK(SO4)2·12H2O toluene rt 18 h 0.0 94.9 0.0 74.3 
6 Cr2(SO4)3·xH2O toluene rt 18 h 0.0 87.9 10.5 traces 
7 Cr(acac)3 toluene rt 18 h 0.0 26.0 66.5 35.7 
8 CrBr3 toluene rt 18 h 0.0 47.1 24.2 15.8 
9 CrCl3 DME rt 18 h 54.8 21.6 0.0 8.8 
10 CrI3 DME rt 6 h 0.0 37.0 26.4 94.0 
11 Cr(OAc)3, basic DME rt 6 h 0.0 78.9 0.0 33.4 
12 CrCl3 DME 4 °C 18 h 27.2 28.0 41.7 58.5 
13 CrCl3·3THF toluene rt 3 h 13.4 33.5 10.3 traces 
14 CrCl3·3THF DME 4 °C 3 h 8.1 22.2 traces traces 
15 Cp2CrI toluene rt 3 h 0.0 18.6 73.9 traces 
16 Cp2CrI DME 4 °C 3 h 0.0 23.1 39.4 traces 
17 CpCrCl2·THF toluene rt 18 h 27.0 14.7 0.0 traces 
18 CpCrCl2·THF DME 4 °C 18 h 5.5 20.9 7.5 13.7 
 a. Conversion based on GC analysis relative to an internal standard. 
Overall, these results suggest that the silicon-to-chromium transmetalation via a Si-O-Cr 
linkage is an unfavorable process, which is unsurprising if one considers the bond dissociation 
energies (BDE) of the species involved. Whereas chromium forms a very strong bond with 
oxygen (103 kcal/mol), the BDE of the Cr‒C bond which would result after transmetalation is 
only 33 kcal/mol (Scheme A.3a).
8
  
 
Scheme A.3. Thermodynamic barrier to transmetalation. 
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The process that we envisioned is therefore made extremely unfavorable by its intrinsic 
thermodynamics. However, it is not illogical to assume that a similar transmetalation process 
could take place directly from a zinc silanolate (Scheme A.3b). Indeed, the carbophilicity of zinc 
equals its oxophilicity (Zn‒O BDE = 65 kcal/mol, Zn‒C BDE = 64 kcal/mol), thus removing the 
thermodynamic barrier to transmetalation.  
The ease of silicon-to-zinc transmetalation was anticipated by the high amounts of 1-decyne 
obtained in control reactions with Lewis-basic solvents (Table A.1), and was demonstrated in a 
series of independent experiments (Table A.3). Simply stirring the Zn-silanolate Zn
+
(A.3)
−
 in 
Lewis-basic solvents at room temperature for one hour, followed by aqueous quench, led, in 
most cases, to complete conversion of the silanolate to 1-decyne via a putative organozinc 
intermediate.  
Table A.3. Studies of transmetalation from silicon to zinc. 
 
Entry Solvent Time 
1-decyne 
(%)
a
 
A.3  
(%)
a
 
1 THF 1 h 82.9 10.4 
2 DMF 1 h 93.3 2.2 
3 DMSO 1 h (100)
b
 5.0 
4 NMP 1 h (100)
b
 2.0 
5 dioxane 18 h 95.7 1.7 
a. Conversion based on GC analysis relative to an internal 
standard; b. The solvent peak coelutes. 
A.3. TRANSMETALATION FROM SILICON TO COPPER 
Unlike chromium, the transmetalation from silicon to copper has a low thermodynamic 
barrier (Cu‒O BDE = 65 kcal/mol; Cu‒C BDE = 53 kcal/mol) and is precedented. Our group 
demonstrated the transmetalation from alkynylsilanol A.5 to the stable Cu(I) acetylide A.6,
9
 and 
the beneficial use of CuI to facilitate the cross-coupling between A.5 and 4-iodoanisole (Scheme 
A.4).
10
 Other reports detail the transmetalation from silicon to copper in the presence of polar 
solvents at high temperatures,
 11,12
  with activated substrates,
13
 or under fluoride activation.
14,15
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Scheme A.4. Known examples of transmetalation from silicon to copper. 
In the present study, the transmetalation from silicon to copper was explored using lithium 1-
decenylsilanolate (Li
+
(A.8)
−
, Scheme A.5) rather than an alkynylsilanolate as the substrate. 
Although A.5 had been shown to undergo smooth transmetalation to copper, that might have 
resulted from π-complexation of Cu rather than formation of the Si-O-Cu linkage.11 Moreover, 
alkynyl groups are known to be non-transferable (“dummy”) ligands.16 Li+(A.8)− was prepared 
from 1-decyne by treatment with DIBAL and I2 (A.7, 73%), and the Li-silanolate was directly 
accessed by lithium/halogen exchange followed by capture with hexamethylcyclotrisiloxane 
(91%). 
 
Scheme A.5. Preparation of silanolate Li
+
(A.8)
−
. 
A survey of conditions was performed by combining Li
+
(A.8)
−
 with several readily available 
Cu(I) sources (Table A.4). The generation of an organocopper(I) intermediate was assessed by 
quenching the reaction with water and determining the yield of 1-decene. Only CuBr·Me2S, 
CuI·Me2S, CuSCN and CuCl in DMF at 60 °C afforded some amounts of 1-decene (entries 8, 9, 
12 and 13); the silanol A.8 was recovered unreacted in most other cases. 
Having assessed the poor reactivity of the alkenylsilanolate Li
+
(A.8)
−
 toward transmetalation 
to copper, we explored the possibility of fluoride activation. Although the addition of LiF and 
CsF was ineffective, a report from Shibasaki et al. indicated that the complex CuF·3PPh3·2EtOH 
mediates the addition of vinyltrimethoxysilane to benzaldehyde in the presence of diphosphine 
ligands.
15
 On the basis of this report, and foreseeing the incompatibility of an organocopper 
intermediate with a protic ligand, we synthesized the complex CuF·3PPh3 and combined it with 
Li
+
(A.8)
−
 in DMF and THF (Table A.5). Upon mixing the reactants, a bright yellow color was 
observed; GC analysis (after H2O quenching) showed complete conversion of Li
+
(A.8)
−
 to 1-
decene in as little as 30 min at 60 °C (entries 3 and 6). 
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Table A.4. Studies of transmetalation from silicon to copper. 
 
Entry Cu(I) source Solvent T 
1-decene  
(%)
a
 
A.8  
(%)
a
 
1 CuBr·Me2S THF rt traces 73.3 
2 CuI·Me2S THF rt traces 88.1 
3 CuSPh THF rt 0.0 85.9 
4 CuBr·3PPh3 THF rt 0.0 91.3 
5 CuSCN THF rt traces 84.5 
6 CuCl DME rt traces 92.8 
7 CuCN NMP rt 0.0 99.1 
8 CuBr·Me2S DMF 60 °C 16.9 48.8 
9 CuI·Me2S DMF 60 °C 24.8 40.9 
10 CuSPh DMF 60 °C traces 86.3 
11 CuBr·3PPh3 DMF 60 °C traces 94.6 
12 CuSCN DMF 60 °C 13.7 56.1 
13 CuCl DMF 60 °C 15.4 57.0 
14 CuCN DMF 60 °C traces 90.8 
a. Conversion based on GC analysis relative to an internal standard. 
Table A.5. Studies of transmetalation from silicon to copper using CuF·3PPh3. 
 
Entry Solvent T Time 
1-decene 
(%)
a
 
A.8  
(%)
a
 
1 THF rt 30 min 75.6 8.8 
2 THF rt 2 h 95.4 0.0 
3 THF 60 °C 30 min 99.2 0.0 
4 DMF rt 30 min 75.6 5.2 
5 DMF rt 2 h 92.7 0.0 
6 DMF 60 °C 30 min 97.4 1.0 
a. Conversion based on GC analysis relative to an internal standard. 
Confident of having generated an alkenylcopper(I) intermediate via transmetalation, we 
explored its capacity to perform copper-like reactivity. In a series of experiments,  Li
+
(A.8)
−
 was 
combined with CuF·3PPh3 in the presence of an external ligand (dppm, dppe, dppp, dppb, dppbz, 
dppf, or TMEDA). The mixtures were then treated with 2-cyclopentenone and a Lewis acid 
(BF3·Et2O or TMSCl). Unfortunately, the expected conjugate addition was never observed. 
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Moreover, attempts to capture the alkenylcopper intermediate with other electrophiles (iodine, 
acetyl chloride, benzaldehyde) also failed.  
Puzzled by these observations, we performed a transmetalation experiment in d8-THF and 
monitored the reaction by 
1
H NMR. Surprisingly, in the absence of an added proton source, ca. 
10% of 1-decene was observed after 30 min. In addition, quenching a transmetalation reaction 
with D2O only gave 25% of [1-D]-1-decene (GC-MS), the remaining 75% being [1-H]-1-decene. 
In the impossibility to determine the nature of such unwanted proton source, which hampers the 
development of methods based on the Si-to-Cu transmetalation, this line of research was 
abandoned. 
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Appendix B:  
Cyclobutanones in the synthesis of quaternary stereocenters via C-C 
bond activation 
 
B.1. INTRODUCTION 
Despite recent advances, the synthesis of quaternary stereocenters is still considered a 
challenging endeavor.
1
 Particularly difficult is the synthesis of quaternary stereocenters in 
acyclic substrates, especially when those stereocenters are isolated from functional groups that 
could serve as synthetic handles (see Section 2.2.2).
2
  
A novel approach, involving C-C bond activation, has been investigated with the goal of 
providing a new, generally applicable tool for asymmetric synthesis (Scheme B.1). The proposed 
approach entails the development of a suitable metal/chiral ligand catalytic system capable of 
converting a 3,3-disubstituted cyclobutanone i into a diastereomerically enriched 
metallacyclopentanone ii via asymmetric carbon-carbon bond cleavage. In combination with a 
X-Y reagent, this process will lead to the ring-opening of ii (through oxidative addition or 
transmetalation) to form acyclic products iii/iv containing a quaternary stereocenter. Suitable 
processes include hydrogenation, Heck- and Suzuki-type couplings, hydroboration, and 
hydroacylation reactions. 
The anticipated versatility of metallacyclobutanone ii should allow for the formation of a 
variety of acyclic building blocks which, owing to their different functionalization, may be 
incorporated into various synthetic plans. Thus, several classes of compounds containing 
quaternary stereocenters, currently difficult to synthesize with the existing methods, may become 
available in a few, simple steps. 
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Scheme B.1. Proposed desymmetrization approach via C-C bond activation. 
B.2. C-C BOND ACTIVATION 
The core of the proposed desymmetrization approach lies in a carbon-carbon bond activation 
process. C-C Bond activation with the aid of transition metals represents an emerging topic of 
research and has provided the organic chemist with new tools, even in the field of asymmetric 
synthesis.
3
 Carbon-carbon bonds are generally considered unreactive toward metal insertion, 
because they are: (1) strong; (2) inaccessible (blocked by C-H bonds); (3) statistically less 
abundant than C-H bonds; (4) less favorably oriented than C-H bonds; and (5) prone to reductive 
elimination after insertion of the metal. Because of these challenges, C-H activation has 
traditionally outcompeted C-C activation. Nevertheless, several successful approaches for C-C 
activation have been developed which rely upon a thermodynamic driving force to facilitate the 
cleavage of C-C bonds. Among these strategies, relief of ring-strain in cyclopropanes and 
cyclobutanes is one of the more commonly utilized.  
Cyclobutanes represent suitable substrates for C-C activation because the ring-opening 
provides a thermodynamic driving force of 26.5 kcal/mol.
4
 Two modes of C-C activation of 
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cyclobutanes have been described: direct oxidative addition and β-carbon elimination (Scheme 
B.2). Naturally, an issue of selectivity arises as to which C-C bond undergoes cleavage. 
 
Scheme B.2. Modes of C-C activation of cyclobutanes. 
The use of cyclobutanones addresses the issue of site-selectivity because the carbonyl serves 
as a directing group. Indeed, cyclobutanones are known to undergo oxidative addition of late, 
low-valent transition metals at the C-C bond adjacent to the carbonyl.
5
 This preference is 
confirmed by the numerous reports of crystal structures detailing oxidative addition to such 
bonds.
6
 Consequently, cyclobutanones have become a preferential platform for C-C activation. 
Several methods have been described, including stereoselective ones (Scheme B.3). Murakami 
and coworkers reported the C-C activation of cyclobutanone B.1 with a Rh(I) catalyst.
7
 Rh(I) 
inserts into the less congested acyl-carbon bond. Under a hydrogen atmosphere, the reductive 
ring cleavage product B.2 is obtained. In an alternative pathway, cyclobutanone B.3 undergoes 
oxidative addition, carborhodation of the tethered olefin, and reductive elimination to provide 
ketone B.4.
8
 A similar process was illustrated by Dong et al. for the enantioselective synthesis of 
B.6 in the presence of (R)-DTBM-SEGPHOS.
9
 Cyclobutanones are also capable of accessing the 
β-carbon elimination manifold following a 1,2-addition to the carbonyl. This approach was used 
by Murakami et al. in the enantioselective synthesis of B.9, which proceeds through the Rh-
alkoxide B.8.
10
 Metal-alkoxides can also be accessed from cyclobutanols, as shown by Uemura 
et al. and Cramer et al. in the desymmetrization of B.10
11
 and B.12.
12
 
The transformations shown in Scheme B.3, although limited to very specialized substrates, 
set the foundations for the development of the present synthetic method. Specifically, they lend 
support to the feasibility of the oxidative addition to i in a stereocontrolled fashion. It should also 
be noted that the high temperatures required for C-C cleavage still allow for high 
enantioselectivity. 
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Scheme B.3. Selected examples of C-C activation of cyclobutanones and cyclobutanols. 
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B.3. METHOD DEVELOPMENT 
The successful desymmetrization of 3,3-disubstituted cyclobutanones requires a metal/ligand 
catalytic system that addresses the following challenges: (1) clean insertion into the C-CO bond 
with minimal side reactivity; (2) good enantioselectivity; (3) capacity of supporting the 
subsequent transformations of metallacyclopentanone ii; (4) good product-selectivity toward one 
of the possible products iii and iv. Although product-selectivity in C-C cleavage processes is 
mainly substrate-controlled,
13
 it is clear that these requirements add several layers of complexity 
to the method under development. Therefore, it appears that suitable reaction conditions were not 
likely to be identified by a mere screening of a small set of variables based upon literature 
precedents. Rather, a randomization of conditions guided by a Design of Experiment (DoE) 
protocol was undertaken. This statistical approach has been shown to lead to a rapid optimization 
of reaction conditions in cases where multiple variables had to be tested.
14
 
The choice of experimental variables took into account the following considerations: 
1. Metal. The ability to back-donate electron density into C-C antibonding orbitals and to 
change oxidation state by +2 are necessary requirements for the C-C cleavage step. 
Moreover, for a second oxidative addition to occur (Scheme B.1), a further +2 change in 
oxidation state must be supported by the metal. Therefore, late, low-valent transition metals 
(such as Ni, Pd, Pt, Co, Rh, and Ir, in low oxidation state) are suitable choices. 
2. Ligand. Axially chiral phosphines and chiral dienes are classes of privileged ligands for 
enantioselective C-C activation processes. Additionally, phosphoramidites, various P,N-
ligands, and chiral phosphines have also been employed. Recently, Murakami has reported a 
Rh complex bearing a pincer PBP ligand (B.14, Figure B.1) capable of undergoing oxidative 
addition to cyclobutanones at room temperature.
6c,15
 Unfortunately, chiral PBP ligands are 
unknown. 
 
Figure B.1. Rh-PBP pincer complex. 
B.3.1. Hydrogenation 
The simplest manipulation of metallacyclopentanones is represented by the addition of 
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dihydrogen (Scheme B.4). This process yields a unique product B.16. Based on Murakami’s 
investigation of the hydrogenative ring-opening of cyclobutanones,
7,16
 a thorough screening of 
reaction conditions was carried out starting from cyclobutanone B.15 as a model substrate.  
More than 300 permutations of the metal source/ligand/solvent/temperature were tested. 
Product B.16 was obtained in 20% yield and 67:33 er at best (using [Rh(cod)Cl]2/Segphos in 
dioxane at 100 °C), thus demonstrating the viability of this transformation. However, further 
optimization failed to identify conditions to maximize yield and enantioenrichment, and to 
minimize the formation of the undesired reduction product B.17 (always obtained as the major 
product of the reaction). 
 
Scheme B.4. DoE approach for the C-C cleavage/hydrogenation reaction. 
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B.3.2. Boronic acid coupling 
A similar DoE approach was employed for the investigation of the C-C bond 
cleavage/boronic acid coupling reaction, in which a boronic acid engages in transmetalation after 
insertion of the metal into the C-C bond (Scheme B.5).
17
 This process results in the formation of 
two possible constitutionally isomeric products B.18 and B.19, however without the 
complication of ketone reduction.  
The combination of B.15 with phenylboronic acid was chosen as the test reaction for 
optimization. A survey of reaction conditions showed that the product B.18 could be obtained in 
small amounts (15%) exclusively in the presence of Rh(acac)(ethylene)2 and BI-DIME, but with 
no enantioenrichment (er = 52:48). The yield could not be increased even using the pre-formed, 
electron-rich rhodium complexes B.14 and B.20. 
 
Scheme B.5. DoE approach for the C-C cleavage/boronic acid coupling reaction. 
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Further optimization was later carried out in collaboration with Boehringer-Ingelheim. A 
number of BI-type ligands were tested in an attempt to maximize yield and enantioselectivity 
(Figure B.2), but no improvement was observed relative to the parent ligand BI-DIME.  
 
Figure B.2. Other BI-type ligands. 
The poor reactivity profile was addressed by employing boronic acid equivalents (Bpin, 
MIDA), borate salts, and stannanes. Marginal improvement of the conversion could be obtained 
by combining the soluble ammonium borate salt B.21 with a Lewis acid (Zn(OTf)2) (Scheme 
B.6). Under these modified conditions, the yield could be increased to 35%, along with 
formation of cyclopropane B.22 and cyclobutene B.23 as the byproducts. As already noted 
before, the product was racemic. 
 
Scheme B.6. Combination of a borate salt and a Lewis acid. 
Overall, the envisioned C-C cleavage/boronic acid coupling process was complicated by 
several factors. First, oxidative addition of the metal into the C-C bond is an unfavorable process 
and requires high temperatures. The oxidative addition could be facilitated by the addition of a 
Lewis acid (which, by coordinating to the carbonyl, lowers the LUMO of the C-C bond). 
However, a more facile oxidative addition also results in the formation of B.22 by extrusion of 
CO from the intermediate metallacyclopentanone. Second, given the exclusive formation of 
product B.18 and no observable B19, it is not unreasonable to assume that the reaction may 
proceed via addition of an arylrhodium intermediate to the carbonyl/β-alkyl elimination, rather 
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than direct C-C insertion.
18
 This competitive reaction pathway accounts for the formation of 
byproduct B.23 (by arylrhodium addition/dehydration), which is prevalent when transmetalation 
from boron to rhodium is facilitated (as in the case of soluble borate salts). Third, the asymmetric 
environment provided by BI-DIME and congener ligands does not induce a sufficient bias for 
desymmetrization. Therefore, the product was always obtained in racemic form. 
B.4. EXPERIMENTAL SECTION 
2,2-dichloro-3-phenyl-3-propylcyclobutan-1-one [AA-15-DJ5183] 
 
Freshly prepared zinc-copper couple (6.54 g, 100.0 mmol Zn, 2.5 equiv), Et2O (80 mL), and 
α-propylstyrene (6.47 mL, 40.0 mmol) were added to a flame-dried, three-neck, 500-mL round-
bottom flask equipped with an argon inlet, an addition funnel, a septum, and a stir bar. A solution 
of trichloroacetyl chloride (9.0 mL, 80.0 mmol, 2.0 equiv) and P(O)Cl3 (7.5 mL, 80.0 mmol, 2.0 
equiv) in Et2O (80 mL) was added dropwise via addition funnel at room temperature over 1 h. 
The reaction mixture was stirred for 20 h. The mixture was then filtered over celite and washed 
repeatedly with Et2O (200 mL). The filtrate was stirred with saturated NaHCO3 (300 mL) until 
bubbling subsided. 2 M KOH (20 mL) was added to neutrality. The layer were separated and the 
organic layer was washed with brine (200 mL), dried over MgSO4, filtered and concentrated. 
Purification by silica gel column chromatography (pentane/Et2O 98:2), followed by 
recrystallization (pentane), afforded 2,2-dichloro-3-phenyl-3-propylcyclobutan-1-one (4.86 g, 
47%) as a white, crystalline solid.  
Data: 
 mp: 81-82 °C (pentane) 
 1
H NMR: (500 MHz, CDCl3) 
 δ 7.41 (t, J = 7.5 Hz, 2H, C(10)H), 7.34 (t, J = 7.4 Hz, 1H, C(11)H), 7.21 (d, J = 
7.5 Hz, 2H, C(9)H), 3.86 (dd, J = 16.5, 2.5 Hz, 1H, C(4)H), 3.12 (d, J = 16.5 Hz, 
1H, C(4)H’), 2.14 – 2.04 (m, 1H, C(5)H), 1.64 – 1.52 (m, 1H, C(5)H’), 1.26 – 
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1.11 (m, 1H, C(6)H), 0.94 – 0.86 (m, 1H, C(6)H’), 0.84 (t, J = 6.4 Hz, 3H, 
C(7)H3) 
 
13
C NMR: (126 MHz, CDCl3) 
δ 191.9 C(1), 139.5 C(8), 128.4 C(10), 127.5 C(11), 126.9 C(9), 92.6 C(2), 54.0 
C(3), 49.7 C(4), 42.2 C(5), 18.8 C(6), 14.07 C(7) 
 IR: (neat) 
2957 (w), 2872 (w), 1800 (s), 1459 (w), 1399 (w), 1326 (w), 1281 (w), 1114 (w), 
1076 (w), 1004 (m), 924 (m), 809 (m), 760 (s), 702 (s), 570 (s) 
 HRMS: (EI)  
  m/z: [M]
+
 Calcd for C13H14Cl2O: 256.0422; Found: 256.0423 
 TLC: Rf 0.66 (pentane/Et2O 9:1) [silica gel, UV, anisaldehyde] 
 Analysis: C13H14Cl2O 
  Calcd: C, 60.72; H, 5.49  
  Found: C, 60.65; H, 5.48  
 
3-Phenyl-3-propylcyclobutan-1-one (B.15) [AA-15-DJ5178] 
 
In a 50-mL Schlenk flask, HCl-washed Zn powder (3.92 g, 60.0 mmol, 10.0 equiv) was 
added to a suspension of 2,2-dichloro-3-phenyl-3-propylcyclobutan-1-one (1.54 g, 6.0 mmol) in 
glacial acetic acid (12 mL). The reaction  mixture was stirred at room temperature for 12 h. The 
mixture was then filtered over celite and washed repeatedly with Et2O (100 mL). The filtrate was 
stirred with saturated NaHCO3 (300 mL) until bubbling subsided. The layer were separated and 
the organic layer was washed with saturated NaHCO3 (2 x 100 mL), brine (100 mL), dried over 
MgSO4, filtered and concentrated. Purification by silica gel column chromatography 
(pentane/Et2O 9:1), followed by recrystallization (pentane), afforded B.15 (1.10 g, 97%) as a 
white, crystalline solid.  
Data for B.15: 
 mp: 54-55 °C (pentane) 
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 1
H NMR: (500 MHz, CDCl3) 
δ 7.38 (t, J = 7.6 Hz, 2H, C(9)H), 7.30 – 7.23 (m, 3H, C(8)H, C(10)H), 3.47 – 
3.38 (m, 2H. C(2)H), 3.20 – 3.12 (m, 2H, C(2)H’), 1.88 – 1.76 (m, 2H, C(4)H2), 
1.21 – 1.09 (m, 2H, C(5)H2), 0.86 (t, J = 7.3 Hz, 3H, C(6)H3) 
 
13
C NMR: (126 MHz, CDCl3) 
δ 206.5 C(1), 146.2 C(7), 128.2 C(9), 126.6 C(8), 126.1 C(10), 57.5 C(2), 45.5 
C(4), 37.8 C(3), 18.8 C(5), 14.1 C(6) 
 IR: (neat) 
3029 (w), 2952 (w), 2869 (w), 1768 (s), 1499 (w), 1449 (w), 1381 (m), 1180 (w), 
1138 (m), 1105 (m), 914 (w), 771 (s), 706 (s) 
 HRMS: (ESI)  
  m/z: [MH]
+
 Calcd for C13H17O: 189.1279; Found: 189.1281 
 TLC: Rf 0.66 (pentane/Et2O 9:1) [silica gel, UV, anisaldehyde] 
 Analysis: C13H16O 
  Calcd: C, 82.94; H, 8.57 
  Found: C, 82.62; H, 8.58  
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Appendix C:  
Atroposelective cross-coupling of arylsilanolates using BI ligands 
 
C.1. INTRODUCTION 
The atroposelective synthesis of biaryls is an important goal in organic synthesis owing to the 
profound impact of biaryls as tools in asymmetric synthesis
1
 and the fact that hundreds of natural 
products possess biaryl atropisomeric motifs embedded in their structures.
2
 Numerous, creative 
strategies have been developed for the stereoselective synthesis of biaryls, and the topic is an 
active field of research.
3
 
Among the strategies devised for the synthesis of biaryls, the formation of an aryl-aryl C-C 
bond in an enantioselective fashion by palladium-catalyzed cross-coupling represents an 
attractive technique, due to its catalytic nature.
4
 However, one of the major limitations is the 
need for a polar directing group in one of the cross-coupling partners to achieve high yield and 
selectivity. In this context, Buchwald and coworkers have described the atroposelective Suzuki 
coupling using KenPhos as the chiral ligand (Scheme C.1). For this process to be stereoselective, 
the use of polar directing groups (amides, esters, phosphonates, phosphine oxides, nitro) is 
necessary, as such groups are expected to play a significant role in the selectivity-determining 
step.
5
 
 
Scheme C.1. Enantioselective Suzuki cross-coupling in the presence of polar directing groups. 
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On the other hand, atroposelective cross-coupling reactions without directing groups are rare, 
and usually display low to moderate stereoselectivity.
4
 In our laboratories, we have recently 
investigated the of use of naphthylsilanolates in atroposelective cross-coupling reactions without 
the aid of polar groups.
6
 The reaction of silanolate K
+
(C.1)
−
 with 1-bromonaphthalene proceeded 
with high selectivity in the presence of the chiral bis-hydrazone ligand C.2 (Scheme C.2). 
However, the same reaction conditions did not allow for a highly stereoselective coupling of 
other substrates, thus limiting the generality of this method. 
 
Scheme C.2. Enantioselective cross coupling of silanolate K
+
(C.1)
−
 without a polar directing group. 
In an attempt to overcome this issue, our group has initiated a collaboration with Boehringer-
Ingelheim for the development of the atroposelective cross-coupling of arylsilanolates utilizing 
oxaphosphole ligands such as BI-DIME (Figure C.1).  
 
Figure C.1. The oxaphosphole ligand BI-DIME. 
The BI-DIME ligand scaffold, developed at Boehringer-Ingelheim to enable the cross-
coupling between hindered substrates, is stereogenic at phosphorus and therefore represents a 
suitable candidate for the intended stereoselective process.
7
 Indeed, derivatives of BI-DIME have 
been used in highly stereoselective Suzuki reactions (Scheme C.3).
8
 However, as noted above, 
the attainment of stereoselectivity was contingent upon the use of polar directing groups such as 
diethyl phosphonates, benzoxazolidinones, or oxazolidinylphosphinates. 
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Scheme C.3. Enantioselective Suzuki cross-coupling reactions with BI ligands. 
 C.2. OPTIMIZATION OF CROSS-COUPLING CONDITIONS 
Cross-coupling conditions were surveyed using the combination of silanolate K
+
(C.1)
−
 with 
1-bromo-2-methoxynaphthalene (C.5) at 90 °C as the benchmark reaction. Initially, a screening 
of BI-type ligands was performed (Scheme C.4). Previous studies on the stereoselective Suzuki 
reaction had shown that BI-DIME ligands bearing substituents at C(2) were highly 
stereoselective.
8
 Therefore, this class of BI ligands was investigated thoroughly, encompassing 
sterically- and electronically-diverse alkyl and aryl substituents. 
As expected, unsubstituted BI-DIME provided the binaphthalene product C.6 in low er 
(57:43). However, use of 2-substituted BI ligands increased the er to a significant extent (up to 
79:21). Unfortunately, the conversion was always low, as the cross-coupling reaction primarily 
yielded product C.7 (arising from transfer of a methyl group from silicon).  
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Scheme C.4. Survey of ligands. Conversions were obtained by GC analysis relative to biphenyl as the 
internal standard; enantiomeric ratios were measured by HPLC (column: ChiralPak AD-3) or SFC 
(column: ChiralPak OJ). 
From these results, the following observations were made: (1) 2-substituted BI ligands 
enhance the stereoselectivity of the cross-coupling reaction, but steric and electronic variations 
on the substituent at C(2) have a minimal impact; (2) the transmetalation and reductive 
elimination steps leading to the hindered, tetra-ortho-substituted cross-coupling product C.6 are 
challenging; therefore, a lower energy reaction pathway is found in the transfer of methyl (rather 
than aryl) from Si to Pd, leading to byproduct C.7; (3) the results appeared irreproducible across 
multiple runs, likely due to the inefficient reduction of the palladium(II) precursor to Pd(0) by 
the phosphine, and the formation of heterogeneous palladium species. 
The issue of reproducibility was addressed by resorting to Pd(II) pre-catalysts. Pre-catalysts 
are pre-formed palladium(II) complexes that generate the catalytically active, ligated Pd(0) 
species in situ, ensuring a 1:1 ligand to Pd ratio.
9
 Thus, the use of pre-catalysts circumvents the 
need for added phosphine to carry out the reduction of Pd(II) to Pd(0) (which may be inefficient, 
and generates non-innocent phosphine oxide).
10
 Thanks to the extensive development by 
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Buchwald and coworkers, Pd(II) pre-catalysts have found multiple applications in cross-coupling 
reactions, especially in those cases where traditional methods fail.
11
 
For the purposes of this project, we chose to employ the latest pre-catalyst technology, 
namely Buchwald 4
th
-generation (i)
12
 and Johnson-Matthey-type (ii)
13
 pre-catalysts (Scheme 
C.5). We envisioned that the formation of ligated Pd(0) from i and ii would be possible simply 
with a sacrificial amount of silanolate. For the Buchwald 4
th
-generation pre-catalyst i, the 
silanolate may act as a base to deprotonate the nitrogen atom in the palladacyle, thus triggering 
reductive elimination to form N-methylcarbazole and the catalytically active species L-Pd(0) 
(Scheme C.5a). For the Johnson-Matthey pre-catalyst ii, the silanolate would first bind to the 
cationic Pd center. Transmetalation from Si to Pd and reductive elimination would form Pd(0) 
and hydrocarbon iii (Scheme C.5b). 
 
Scheme C.5. Pd(II) pre-catalysts and proposed reduction pathways by silanolate. 
The synthesis of the Buchwald 4
th
-generation pre-catalysts containing 2-methyl-BI-DIME 
(C.8) was accomplished starting from commercially-available dimeric palladacycle C.9 (Scheme 
C.6). The desired pre-catalyst C.10 was obtained in 68% yield by treating C.9 with two 
equivalents of C.8. For the Johnson Matthey scaffold, we chose to employ the variants 
containing a crotyl and a cynnamyl group. The use of the hexafluoroantimonate counterion 
(instead of triflate) enabled the synthesis and isolation of the desired pre-catalysts C.11 and C.12 
in high yield from commercially-available [(crotyl)PdCl]2 and [(cinnamyl)PdCl]2. 
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Scheme C.6. Synthesis of Pd(II) pre-catalysts containing BI ligand C.8. 
The employment of pre-catalysts C.10, C.11 and C.12 in the catalytic cross-coupling 
reaction did not reveal any substantial improvement relative to the use of the free ligand C.8 in 
combination with palladium acetate (Table C.1). Specifically, Johnson-Matthey pre-catalysts 
C.11 and C.12 maintained the same levels of conversion and stereoselectivity as C.8/Pd(OAc)2, 
whereas with C.10 the conversion dropped. N-methylcarbazole (from C.10), hydrocarbons C.13 
(from C.11) and C.14 (from C.12) were detected in the reaction mixtures, thus confirming the 
envisioned silanolate-mediated reduction pathways (Scheme C.5). 
Table C.1. Use of pre-catalysts in the cross-coupling reaction. 
 
Entry Catalyst C.6 (%) er 
1 C.10 10 78:22 
2 C.11 28 78:22 
3 C.12 35 77:23 
4 C.8/Pd(OAc)2 37 77:23 
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Further optimization was attempted by varying other reaction parameters: 
1. Temperature. Performing the reaction at higher temperature (110 °C) increased the 
conversion to the product (up to 58%)  and limited the extent of methyl transfer (Table C.2). 
However, across the range of temperatures under examination (70-110 °C), the enantiomeric 
composition did not drastically change. This indicates that, even at high temperature, the 
ligand C.8 is tightly coordinated to palladium, and the low er is due to the poor 
stereochemical bias induced by the ligand itself. 
Table C.2. Effect of the temperature. 
 
Entry T (°C) C.6 (%) er 
1 70 6 82:18 
2 90 35 77:23 
3 110 58 74:26 
 
2. Solvent. The outcome of the cross-coupling reaction appeared to be unaffected by the 
solvent. When the reactions were performed in benzotrifluoride or cyclopentyl methyl ether 
(CPME), the results were similar to those previously obtained in toluene (Table C.3). 
Table C.3. Effect of the solvent. 
 
Entry Solvent T (°C) C.6 (%) er 
1 Benzotrifluoride 70 10 82:18 
2 Benzotrifluoride 90 34 76:24 
3 CPME 70 14 82:18 
4 CPME 90 39 78:22 
5 Toluene 90 37 77:23 
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3. Metal cation. Although cesium arylsilanolates are known to undergo transmetalation at a 
much faster rate than the potassium salts,
14
 Cs
+
(C.1)
−
 completely suppressed the cross-
coupling reaction because of its insolubility in the reaction solvents (benzotrifluoride or 
CPME). 
4. Halide. The use of 1-iodo-2-methoxynaphthalene gave comparable results to C.5. 
C.3. USE OF OTHER CROSS-COUPLING PARTNERS 
The failure to improve yield and enantiomeric composition in the formation of C.6 made us 
consider other pairwise combinations of cross-coupling partners. Initially, we examined the 
reversal of the role of electrophile and nucleophile in the formation of C.6 (Scheme C.7). When 
bromide C.15 was combined with silanolate K
+
(C.16)
−
 (in the presence of pre-catalyst C.12), the 
same cross-coupling product C.6 was accessed. Although the yield was lower (26%), the 
enantiomeric composition remained the same as previously observed. These data are consistent 
with a selectivity-determining reductive elimination step from a common intermediate iv, 
accessed independently from both pathways.
6
 The presence of a substituent at C(2) on the ligand 
seems to be necessary to force the two naphthyl moieties to adopt the arrangement shown, 
leading to the stereoselective formation of C.6 upon reductive elimination.
8a
 
 
Scheme C.7. Alternative routes for the formation of cross-coupling product C.6. 
The synthesis of other tetra-ortho-substituted biaryls (2,2′-dimethyl-1,1′-binaphthalene, 2,2′-
dimethoxy-1,1′-binaphthalene) was attempted next. However, yields and enantiomeric ratios 
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remained low. Thus, we focused our attention on less challenging tri-ortho-substituted systems, 
reasoning that a decreased steric hindrance may facilitate the transmetalation and reductive 
elimination steps, and allow for the reaction to take place at lower temperature. 
As was previously done for C.6, the cross-coupling product C.17 was accessed from both 
possible combinations of electrophiles and nucleophiles (Scheme C.8). The cross-coupling 
reactions were carried out with pre-catalyst C.12 at 70 °C. As expected, the use of silanolate 
K
+
(C.1)
− 
with bromide C.19 resulted in moderately high conversion to C.17 (66%), confirming 
that a lower kinetic barrier exists for the formation of a less hindered, tri-ortho-substituted 
product. However, the alternative combination of reagents (K
+
(C.18)
−
 with C.15) resulted in 
much lower yield (19%). Moreover, the products formed from the two pathways displayed 
significantly different (and low) enantiomeric composition. Similar observations were made for 
the cross-coupling reactions leading to the trisubstituted product C.20. 
 
Scheme C.8. Cross-coupling of tri-ortho-substituted systems. 
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These results indicate that different mechanistic considerations apply, depending on the steric 
hindrance of the cross-coupling product (tri- vs. tetra-ortho-substituted). For the tetrasubstituted 
systems, the cross-coupling reaction is slower but more selective. The reductive elimination step 
is selectivity-determining, and the substituent at C(2) of the ligand is required for achieving 
enantioenrichment (Scheme C.7). On the contrary, the pre-reductive elimination intermediate is 
short-lived in the case of trisubstituted systems, owing to the reduced steric barrier to reductive 
elimination. Therefore, the transmetalation step may become selectivity-determining. The lower 
enantioenrichment observed for C.17 and C.20 could be the result of a lower capacity of the 
ligand to enforce steric bias in the pre-transmetalation intermediate. The lower cross-coupling 
rates observed when starting from the sterically hindered, electron-rich bromides C.5 and C.15 
(Scheme C.8) might arise from a slower oxidative addition step. 
C.4. EXPERIMENTAL SECTION 
Preparation of pre-catalyst C.10
15
 [AA-16-EO7703] 
 
In a glove box, an oven-dried, 10-mL Schlenk flask was charged with the Pd-mesylate dimer 
C.9 (104 mg, 0.136 mmol, 1.0 equiv). A solution of C.8 (94 mg, 0.273 mmol, 2.0 equiv) in 
DCM (2 mL) was added and the reaction mixture was stirred at room temperature for 1 h. The 
flask was sealed, removed from the glove box, and the solvent was evaporated under high 
vacuum. In the glove box, pentane (5 mL) was added to the residue to precipitate the product, 
which was then isolated via vacuum filtration and dried under vacuum overnight to provide C.10 
(135 mg, 68%) as a tan solid.  
Data for C.10: 
 1
H NMR: (500 MHz, CD2Cl2) 
δ 7.76 (s, 1H), 7.59 (d, J = 6.4 Hz, 1H), 7.45 – 7.37 (m, 2H), 7.36 – 7.28 (m, 
3H), 7.23 (d, J = 7.8 Hz, 1H), 7.02 (dd, J = 9.5, 6.2 Hz, 1H), 6.95 (dd, J = 7.4, 
3.2 Hz, 1H), 6.86 (d, J = 8.4 Hz, 1H), 6.71 (d, J = 8.4 Hz, 1H), 6.56 – 6.48 (m, 
3H), 4.78 – 4.64 (m, 1H), 4.25 (s, 3H), 3.74 (s, 3H), 2.71 (s, 3H), 2.42 (dd, J = 
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5.7, 2.9 Hz, 3H), 1.26 (dd, J = 16.1, 6.7 Hz, 3H), 0.82 (d, J = 15.2 Hz, 9H) 
 
31
P NMR: (202 MHz, CD2Cl2) 
  δ 63.7 
 
Preparation of pre-catalyst C.11
16
 [AA-16-EO7708] 
 
In a glove box, an oven-dried, 25-mL round-bottom flask was charged with [(crotyl)PdCl]2 
(62 mg, 0.157 mmol, 1.0 equiv) followed by AgSbF6 (108 mg, 0.314 mmol, 2.0 equiv) and THF 
(6 mL). The reaction mixture was stirred at room temperature for 30 min while protected from 
light. The resulting mixture containing precipitated AgCl was filtered via syringe filter and the 
filtrate was transferred into an oven-dried, 25 mL Schlenk flask containing C.8 (108 mg, 0.314 
mmol, 2.0 equiv). The residual solid in the first flask was rinsed with additional THF (3 mL), 
and again filtered. The mixture was stirred at room temperature for 2 h. The flask was sealed, 
removed from the glove box, and THF was evaporated under high vacuum. The resulting 
semisolid was triturated with pentane (2 x 5 mL). In the glove box, the yellow solid was 
collected and dried under vacuum. The product C.11 (152 mg, 65%)  was obtained as a 3:2 
mixture of isomers (as judged by 
1
H and 
31
P NMR) and contains (ligated?) THF. 
Data for C.11: 
 1
H NMR: (500 MHz, CDCl3) 
δ 7.56 – 7.49 (m), 7.42 (t, J = 8.2 Hz), 7.12 – 6.97 (m), 6.94 (d, J = 8.4 Hz), 6.84 
(d, J = 7.9 Hz), 5.75 (td, J = 12.4, 7.4 Hz), 5.70 – 5.59 (m, 1H), 5.44 – 5.31 (m, 
1H), 5.32 – 5.21 (m, 1H), 5.22 – 5.10 (m, 1H), 3.88 – 3.85 (m), 3.83 (s), 3.81 (s), 
3.71 (s), 2.92 (d, J = 10.2 Hz, 1H, minor isomer), 2.83 (d, J = 11.4 Hz, 1H, major 
isomer), 2.03 – 1.96 (m), 1.96 – 1.90 (m), 1.75 (dd, J = 18.5, 7.1 Hz, 3H, minor 
isomer), 1.60 (dd, J = 18.3, 7.1 Hz, 3H, major isomer), 0.86 (d, J = 16.3 Hz, 9H, 
major isomer), 0.80 (d, J = 16.2 Hz, 9H, minor isomer) 
 
31
P NMR: (202 MHz, CDCl3) 
  δ 61.7, 60.4 
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Preparation of pre-catalyst C.12
16 
[AA-16-EO7766] 
 
In a glove box, an oven-dried, 25-mL round-bottom flask was charged with 
[(cinnamyl)PdCl]2 (158 mg, 0.305 mmol, 1.0 equiv) followed by AgSbF6 (210 mg, 0.610 mmol, 
2.0 equiv) and THF (12 mL). The reaction mixture was stirred at room temperature for 30 min 
while protected from light. The resulting mixture containing precipitated AgCl was filtered via 
syringe filter and the filtrate was transferred into an oven-dried, 50 mL Schlenk flask containing 
C.8 (210 mg, 0.610 mmol, 2.0 equiv). The residual solid in the first flask was rinsed with 
additional THF (5 mL), and again filtered. The mixture was stirred at room temperature for 2 h. 
The flask was sealed, removed from the glove box, and THF was evaporated under high vacuum. 
DCM (3 mL) was added to the resulting semisolid and pentane (10 mL) was added while stirring 
to fully precipitate the product. The yellow solid was collected by filtration in the glove box and 
dried under vacuum. The product C.12 (451 mg, 92%)  was obtained as a ca. 1:1 mixture of 
isomers (as judged by 
1
H and 
31
P NMR) and contains (ligated?) THF. 
Data for C.12: 
 1
H NMR: (500 MHz, CDCl3) 
δ 7.82 (d, J = 7.8 Hz, 2H), 7.80 (d, J = 7.3 Hz, 2H), 7.61 – 7.40 (m, 10H), 7.12 
(t, J = 8.4 Hz, 1H), 7.01 – 6.89 (m, 5H), 6.84 (d, J = 8.2 Hz, 1H), 6.78 (d, J = 
8.4 Hz, 1H), 6.25 (dtd, J = 19.4, 12.6, 6.8 Hz, 2H), 6.06 (dd, J = 12.9, 9.2 Hz, 
1H), 5.98 (dd, J = 13.2, 8.6 Hz, 1H), 5.63 (d, J = 8.0 Hz, 1H), 5.19 – 5.10 (m, 
2H), 4.18 (d, J = 5.5 Hz, 1H), 4.08 (d, J = 5.5 Hz, 1H), 3.83 – 3.68 (m), 3.46 (s, 
3H), 3.41 (m), 3.27 (d, J = 11.8 Hz, 1H), 3.22 (d, J = 11.4 Hz, 1H), 2.83 (s, 3H), 
1.88 – 1.82 (m), 1.79 (dd, J = 18.5, 7.2 Hz, 3H), 1.65 – 1.57 (m), 0.85 (d, J = 
16.4 Hz, 9H), 0.77 (d, J = 16.2 Hz, 9H) 
 
31
P NMR: (202 MHz, CDCl3) 
  δ 63.6, 62.5  
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